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Abstract 
Tuberculosis (TB) is an infectious disease that damages lungs and other 
parts of the human body, causing serious illness and death. Timor-Leste has 
one of the highest rates of TB in Southeast Asia. The estimated prevalence 
of TB was 758 per 100,000 population, and more than 800 people died as a 
result of TB in Timor-Leste in 2012. The country has undergone major 
conflicts as a result of colonial influences, most notably the conflict in 1999, 
which resulted in the loss of many lives, major damage to health 
infrastructure, and a shortage of public utilities. The most recent civil unrest in 
2006 also resulted in major displacement of the locals, forcing a large 
number of people into poorly set-up, temporary camps where they 
experienced overcrowding. According to the United Nations’ Human 
Development Index, 2014, Timor-Leste continues to be one of the poorest 
nations in the world. Due to the impoverished living conditions, including poor 
housing, high levels of malnutrition, low individual earnings and unstable 
employment, it is difficult for the country to fight against TB. Despite these 
challenges, the local government continues to work collaboratively with 
international and local non-government agencies, and private and church-
based clinics in the expansion of the Directly Observed Treatment Short-
course (DOTS), the World Health Organization’s (WHO) internationally 
recognized strategy to fight against TB. However, to date, the effectiveness 
of the program is yet to be determined and health professionals have little 
reliable data on the levels of treatment adherence and the barriers to or 
enabling factors for adherence. One study has qualitatively determined 
factors affecting implementation of the DOTS strategy, while another RCT 
study has investigated nutrition as a factor in promoting adherence in Timor 
Leste. Yet, no study has quantitatively assessed TB treatment adherence. In 
order to fill this gap, this study used a mixed-methods approach to determine 
levels of TB treatment non-adherence and their relationships to various 
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factors, including but not limited to service delivery, social & demographic 
and individual and disease related factors.  
 
The study involved two main parts and the first part involved qualitative, 
semi-structured, face-to-face interviews of ten health professionals and ten 
TB patients from the private and public sectors. The health professionals 
interviewed included a national TB program manager, a clinic doctor, a TB 
program adviser, district TB coordinators, TB program assistants and 
international and local non-government TB program implementers. The 
patients were conveniently selected from a private clinic and a public health 
centre through the TB registers as they came to visit their respective health 
service for consultations and medication refills. The selection was based on 
the subjective assessment of non-adherence of individual patients (i.e. 
missed appointment), as observed by the clinic staff throughout the treatment 
period. The second part of the study involved a cross-sectional survey of 347 
TB patients in six community health centres and three specialist clinics with a 
response rate of 97% (n = 347/359). 
 
The cultural appropriateness of the qualitative and quantitative instruments 
was carefully considered in the design and implementation process. The 
survey instrument was developed through the use of a systematic procedure 
and the repetitive test of the tool was conducted to ensure its suitability. 
Furthermore, to improve the validity and reliability, the tools were reviewed by 
experts with national and international disciplinary background and 
experiences.  
 
The qualitative study revealed themes that were common to health 
professionals and patients in relation to treatment adherence. Health 
professionals cited many factors associated with medication non-adherence, 
including lack of access, distance between patients’ residences and health 
services, poor nutritional status, and lack of treatment knowledge. Patients 
reported that a lack of financial support, limited access to transport, aging, 
and low energy levels affected treatment adherence. Health professionals 
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and patients suggested that non-adherence to TB treatment was relatively 
common among people with TB in Timor-Leste. 
 
The quantitative survey used two measures of non-adherence, with a cut-off 
of <80% regimen intake classified as suboptimal adherence and ≥80% as 
optimal adherence. A Visual Analogue Scale (VAS) estimated the prevalence 
of the past month of non-adherence to be 39.6% and the Medication 
Adherence Rating Scale (MARS), which measures patients’ adherence 
behaviours in the past month, found non-adherence rates as low as 25.3%. 
The observed agreement between the two measures was 69.4% with a 
kappa coefficient of 0.323 (SE = 0.052, p < 0.0001).  
 
Analysis of the interviews and administered surveys with the 347 patients 
found that medication non-adherence was significantly associated with low 
wages or lack of family financial support, alcohol use, untreated depression, 
stigma, use of traditional healers for health care, lack of TB knowledge, lack 
of caregivers’ support in taking medication, and chance health locus of 
control. No association was observed between TB medication adherence and 
gender, age, education and marital status, disclosure of treatment status, 
distance between clinic and patients’ residences, cigarette smoking, patient-
health professional communication and social connectedness with family, 
friends, neighbours and health volunteers.  
 
To date, this is one of the largest studies in Southeast Asia to examine TB 
medication non-adherence and its associated factors. The evidence 
suggested practical measures that program planners and service providers 
can implement to improve the outcome of TB treatment. The results 
suggested that clinics and outreach services should integrate professional 
counselling for patients with depressive symptoms and heavy alcohol use. 
Health education should target common but potentially harmful beliefs that 
chance or luck determines health outcomes.   
 
Further, the results also showed that there is a strong need to collaborate 
with traditional healers to work cooperatively in assisting patients with TB 
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treatment. In addition, incentives should be provided to those who struggle 
financially. Despite the lack of significant correlations between social 
supports and adherence in the findings, the data showed that patients who 
received sufficient supports were more likely to have better mental health and 
this may lead to better treatment adherence than those who received no 
support.  Adherence may be maximised by improving patients’ psychological 
well-being. Patients’ mental health and overall medication adherence may be 
improved by assisting patients to maintain social connectedness with friends, 
family, health professionals and people in the community. The findings of this 
study also highlighted the benefits of using a mixed-method approach in 
examining complex barriers and facilitating factors for medication adherence.  
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Chapter 1:  Introduction 
1.1 Background 
Tuberculosis (TB) is an infectious disease that leads to death, morbidity and 
disability. It is ranked the second most fatal communicable disease 
worldwide after HIV/AIDS (Armijos, Weigel, Qincha, & Ulloa, 2008; Ayisi et 
al., 2011; Clark, Karagoz, Apikoglu-Rabus, & Izzettin, 2007; Naidoo & 
Mwaba, 2010). There are approximately 9 million new cases of TB per year 
(Stop TB Partnership, 2015), and TB itself contributes to 2.8% of the global 
disability burden (Armijos et al., 2008). Over 95% of TB deaths occur in low 
and middle-income countries and approximately 10 million children 
worldwide have been orphaned due to death of a parent from TB (Stop TB 
Partnership, 2015; WHO, 2014). In 2013 alone, 1.5 million people died from 
the disease, and an estimated 550,000 children became ill, and of these, 
80,000 HIV-negative children died of TB (WHO, 2014b). Southeast Asia and 
the Western Pacific Regions collectively accounted for 56% of the cases in 
2013 (WHO, 2014b). 
 
In an effort to eliminate the TB disease worldwide, many multilateral 
agencies provide much-needed funding every year. However, it is estimated 
that there is a funding gap of $1.6 billion per year from the Global Fund of 
the $4.8 billion total resources needed each year from 2014-2016. This 
funding is needed to combat TB in 118 countries eligible for financial support 
from the Global Fund (WHO, 2013b).  
 
Historically, TB had been known as a prime example of a “social disease”, 
the control of which requires social, economic and environmental 
interventions (Lönnroth, Jaramillo, Williams, Dye, & Raviglione, 2009). After 
World War II, a medically oriented TB control model emerged (Berridge, 
2005), and much hope was placed on mass vaccination with Bacille 
Calmette–Guιrin BCG (Brimnes, 2007). Effective chemotherapy became 
available for TB treatment at the end of 1940s. Availability of the 
2 Chapter 1: Introduction 
chemotherapy resulted in switching the TB control model to a mostly 
curative focus. It was predicted that effective TB treatment would result in 
the rapid decline of TB incidence (Hinman, Judd, Kolnik, & Daitch, 1976). 
Yet, recent observations have indicated that the effectiveness of the current 
TB control strategy has been lower than expected (Behera, 2008; Lienhardt 
et al., 2012; WHO, 2010). The ongoing quest for a better TB vaccine and 
enhanced chemotherapy for preventive treatment should improve TB 
prevention (Lönnroth et al., 2009). Furthermore, actions to address the 
social determinants of TB as well as behavioral and psychological risk 
factors associated the disease are required. Many factors directly and 
indirectly influence the risk of exposure to TB, the risk of acquiring TB 
infection and the likelihood of progression to active TB (Lönnroth et al., 
2009). Effective control programs require high levels of adherence to TB 
medication, yet this goal is difficult to achieve.  
 
Researchers have identified numerous factors associated with medication 
non-adherence, including the psychological challenges faced as a 
consequence of having TB (Ailinger, Martyn, Lasus, & Lima Garcia, 2010; 
Armijos et al., 2008; Ayisi et al., 2011; Naidoo & Mwaba, 2010), the quality 
of health care received, and the use of traditional healing systems, such as 
herbal or animal derivatives (Naidoo & Mwaba, 2010). Psychosocial factors, 
including feelings of helplessness, depression, and a lack of appropriate 
social support were found to act as barriers to adherence to the Directly 
Observed Treatment Short-course (DOTS) program (Naidoo & Mwaba, 
2010).  
 
Factors associated with TB medication adherence can be grouped in in 
three ways. First, the health service-related factors which includes the 
quality and availability of services, complexity of regimens and management 
of medication side-effects, and patient-provider relationships. Second, social 
connectedness (trust, confidentiality, disclosure, type and source of support 
and relationships). Third, socio-demographic characteristics, personal 
beliefs, mental health, and risk behaviours such as drinking alcohol and 
tobacco smoking (Peltzer, 2014). These factors can directly or indirectly 
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influence treatment adherence. Therefore, understanding the characteristics 
of each factor is necessary for the design of effective strategies that can 
optimize adherence.  
 
Most studies on TB medication adherence have been conducted in the 
United States, Africa and Asian countries, and there is considerable 
variation in the estimates of adherence found among these studies (Ailinger, 
Black, Nguyen, & Lasus, 2007; Eticha & EKassa, 2014; Kaona, Tuba, 
Siziya, & Sikaona, 2004; Nackers et al., 2012; Weiguo et al., 2009). The 
most common approach used by these studies to gather information was 
self-reported questionnaire in which participants described their adherence 
over a specified time interval (Ahmad, Mahendradhata, Utarini, & de Vlas, 
2011; Ailinger et al., 2007; Eticha & EKassa, 2014; Kaona et al., 2004; Kipp 
et al., 2011a; O'Donnell, Wolf, Werner, Horsburgh, & Padayatchi, 2014; 
Weiguo et al., 2009). Although, the recommended threshold for TB 
adherence has been determined, those literature reviews identified (see 
Table 4) had used a cut-off point that varies. However, the use of different 
thresholds has led to potential under- or over-estimation of the actual 
adherence.  
 
The current study was conducted in Timor Leste, a small nation located in 
Southeast Asia, with an estimated total population of 1.28 million in January, 
2015 and a population density of 86.3 per square kilometer as of April, 
2015. According to World Bank data, in 2015 almost 53% of people lived on 
less than US$1.25 per day. In developing nations such as Timor-Leste 
where poverty is widespread, people are facing high incidences of infectious 
diseases, such as TB, malaria, measles, and many others. The country has 
high rates of illiteracy, low health literacy and low community TB awareness, 
and relatively poor use of health facilities. It also has mountainous terrain, 
long distances between residences and health centres, poor road conditions 
and undeveloped health systems, especially in rural areas (Ministry of 
Health Timor Leste, 2010). 
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Timor-Leste remains one of the least developed nations in Asia, ranking 128 
out of 179 countries on the Human Development Index (HDI) in 2014 
(United Nation Development Programme, 2014). In 2005, the government 
established the National TB Program (NTP), which is now implementing 
grants from the Global Fund, to strengthen government TB services, 
including national-level institutions, six referral hospitals, and sub-district 
community health centres (CHCs), of which there are 65 across the country, 
183 health posts and 162 mobile clinics. The CHCs, health posts and mobile 
clinics provide primary care while the referral hospitals provide mainly 
secondary and tertiary care. The total health expenditure was US$96 per 
capita (WHO, 2013a). In addition, the MoH in Timor-Leste is supported by 
bilateral aid, multilateral agencies, such as the United Nations and the 
Global Fund through financial, and technical assistance for various health 
priority programs. The WHO's DOTS approach is the cornerstone of the 
NTP strategy and is theoretically available at all CHCs. However, adherence 
to the DOTS strategy in practice is variable across health services in the 
country. 
 
Despite the growing evidence on TB treatment in resource-rich and 
resource-poor settings, information about adherence to TB treatment in 
Timor-Leste is lacking. Through funding support from many different 
international donors, Timor-Leste has expanded its TB program across 
health services in an attempt to improve treatment services. However, 
despite this expansion, program staff still have inadequate data on the 
levels of TB adherence and its associated factors to help them optimise 
treatment efficiencies. Thus far, in Timor Leste, there has been only one 
randomised control trial (RCT) that investigated the impact of nutritional 
support on the overall outcome of TB treatment (Martins, Morris, & Kelly, 
2009), one qualitative study on factors associated with successful 
implementation of DOTS in Timor-Leste (Martins, Grace, & Kelly, 2008) and 
a knowledge, attitude and practice survey of households with TB patients 
(Ministry of Health Timor Leste, 2011). To date, no study has quantitatively 
investigated factors associated with TB treatment. Hence, the current study 
will use a mixed-methods approach to investigate barriers and enabling 
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factors, involving health service delivery factors, education, financial, 
personal, social, psychological, and disease related-factors associated with 
medication adherence among TB patients in Timor Leste. 
1.2 Aim and Research Questions  
  Aim  
The overall aim of this study was to identify factors affecting medication adherence 
among TB patients in Timor-Leste, including health service delivery, education, 
financial, personal, social, psychological, and disease-related factors.  
Research Questions 
1. To what extent do tuberculosis patients in Timor-Leste adhere to their 
treatment regimen? 
2. Which factors in service delivery, social and financial and/or individual 
disease-related aspects influence TB medication adherence in Timor 
Leste? 
3. What are the practical implications for future program interventions to 
improve tuberculosis medication adherence? 
1.3 Significance of the Study  
To date, health professionals and TB program staff in Timor-Leste have limited 
evidence on TB treatment adherence and barriers or enabling factors to 
treatment optimization. The current study contributes to the field of TB care 
and treatment in Timor-Leste in a number of ways. First, the results of the 
study are likely to inform the design of a comprehensive approach to effective 
interventions, which is necessary to practically measure a level of medication 
adherence and explore barriers and enabling factors associated with treatment 
adherence (WHO, 2008a).  
 
This study combines qualitative exploratory methods and a quantitative survey 
to learn medication adherence practices from TB patients and health 
professionals from public and private sectors. The study aims to provide in-
depth evidence on the cultural, contextual and structural constraints and 
enabling factors on TB care programs. As Timor-Leste is striving towards the 
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elimination of TB, the study is likely to provide a comprehensive guide to policy 
makers and key stakeholders to develop appropriate and effective 
interventions, in which adherence to treatment regimens can be improved.  
 
1.4 Structure of the Thesis 
Chapter 2 reviews the international literature related to TB medication 
adherence. It begins with an overview of the TB program and health system in 
Timor-Leste and reviews the guidelines for TB treatment, treatment 
classification, definition of treatment completion, and management of 
treatment interruptions. This is followed by a review of the determinants of 
adherence, including aspects of health services, socio-economic and 
demographic factors and individual disease-related factors. The next section 
provides a summary of quantitative studies on adherence. Chapter 2 
concludes with an introduction to the main research aims and conceptual 
framework of the study.  
 
Chapter 3 describes the design, methods and measurement instruments 
employed in this study. It begins by describing the study design, the research 
process, study sites and population, sample size and data collection methods. 
This is followed by a description of the survey instrument development and 
testing, data analysis management, and ethical considerations.  
 
Chapter 4 describes the results from the qualitative study. The chapter starts by 
describing the treatment adherence of TB patients and factors influencing their 
adherent behaviours. The main purpose of conducting the qualitative study is to 
gain a better understanding of TB treatment from patients and health 
professionals’ points of view. At the same time, the qualitative study also 
enabled the researcher to identify potential factors that may not have been 
foreseen in the literature to be included in the final instrument. Finally, Chapter 
4 provides the insights of health professionals and patients on treatment 
adherence, barriers and enabling factors on TB treatment.  
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Chapter 5 reports the results from the quantitative survey of 347 TB patients. 
The chapter begins by describing the characteristics of the study sample. This 
is followed by the estimates of non-adherence levels for TB treatment among 
the sample, as measured by the Visual Analogue Scale (VAS) and Medication 
Adherence Rating Scale (MARS). Finally, the chapter presents the results of the 
univariate and multivariate statistical analyses of various factors associated with 
the VAS adherence. 
 
Chapter 6 triangulates findings from the cross-sectional survey, and considers 
these findings in relation to previous research. The chapter then discusses the 
strengths and limitations of this study. Finally, the chapter includes discussion of 
the future research implication and recommendations for public health practice.  
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Chapter 2:  Literature Review 
INTRODUCTION 
 
To undertake a literature review of studies of TB medication adherence, online 
search engines and electronic databases such as EBSCOhost, ProQuest, 
Science Direct, Web of Science, informit and Google Scholar and publications 
by both government and non-government organizations were utilized. Keywords 
included ‘tuberculosis AND medication adherence’, ‘tuberculosis AND patient 
compliance’, ‘tuberculosis AND social/economic factors’ and ‘tuberculosis AND 
treatment AND adherence OR compliance’. 
 
As defined by many authors and international organizations, the term 
adherence (also compliance or concordance) describes the degree to which 
patients take medications correctly as prescribed by their health care providers 
(Bell, Airaksinen, Lyles, Chen, & Aslani, 2007; Dick, Jaramillo, Maher, & 
Volmink, 2003; Elliott RA, 2009; Haynes, 1979; National Institute for Health and 
Clinical Excellence, 2008; Osterberg & Blaschke, 2005; Tilson, 2004). 
 
The word, “adherence”, is preferred by many health care providers, as 
“compliance” suggests that patients passively follow doctors’ orders rather than 
the treatment plan being based on a therapeutic alliance established between 
the patient and the physician. The term, “concordance”, is not synonymous with 
either “compliance” or “adherence” (Bell et al., 2007). Concordance does not 
refer to the patient’s behaviour of taking medications, but the nature of patient-
health care provider’s interaction. The word, "compliance", is based on the 
notion that the consultations between the prescriber and the patient are equally 
negotiated, and they both agree on the regimen that the patient will take 
(Aronson, 2007). Major barriers to treatment adherence have been identified by 
researchers as health system-related, contextual and patient-related factors 
(Ailinger et al., 2010; Armijos et al., 2008; Ayisi et al., 2011; Clark et al., 2007; 
Gough & Kaufman, 2011; Naidoo & Mwaba, 2010; Qian, Smith, Tuohong, 
10 Chapter 2: Literature Review 
Shenglan, & Garner, 2011). Worldwide qualitative studies on these sub-themes 
are summarised in Appendix A. 
 
It is strongly recommended that patient-centred care be the initial management 
strategy. This strategy should include an adherence plan that emphasizes 
DOTS, in which patients are under direct observation during the ingestion of 
anti-tuberculosis medication. Programs utilizing DOTS as a central element in a 
comprehensive, patient-centred approach maximize the likelihood of treatment 
completion (Bock et al., 2002; Horsburgh, Feldman, & Ridzon, 2000; Peloquin, 
2003; Zierski, 1976).  
 
In order to make informed treatment decisions, an evidence-based rating 
system was developed by McGowan, Chesney, Crossley, and LaForce (1992). 
The rating recommendation assigns letters indicating the strength of the 
recommendations, and a Roman numerals indicating the quality of the evidence 
(see Table 1) (Ma, Lienhardt, McIlleron, Nunn, & Wang; McGowan et al., 1992). 
Health care professionals can differentiate the recommendations based on the 
results of clinical trials and those clinical practices and scientific rationales when 
clinical data is not available (Horsburgh et al., 2000; Peloquin, 2003).  
 
Table 1 Evidence-Based Rating System 
Infectious Diseases Society of America/United States Public Health Service 
rating system for the strength of treatment recommendations based on quality 
evidence. 
 Strength of the recommendation 
A Preferred, should generally be offered 
B Alternative; acceptable to offer 
C Offer when preferred or alternative regimens cannot be given 
D Should generally not be offered 
E Should never be offered 
  
 Quality of evidence supporting the recommendation 
I. At least one properly randomized trial with clinical end point  
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II. Clinical trials that either are not randomized or were conducted in 
other populations 
III Expert Opinion  
Note. Adapted from (McGowan et al., 1992). Guidelines for the use of 
systemic glucocorticosteroids in the management of selected infections. Working 
Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of 
America 
 
2.1 Tuberculosis Treatment Adherence 
The overall goal for TB treatments is to cure the individual patient and to 
minimize the transmission of Mycobacterium tuberculosis to other persons. 
Hence, successful treatment of TB has benefits both for the individual patent 
and the community in which the patient resides (Dick et al., 2003; Peloquin, 
2003; WHO, 2008b). 
 
Adherence to TB treatment is similar to other forms of infectious and chronic 
diseases. Adherence appears to be better during the initial, acute phase of the 
illness when patients are more symptomatic. Those patients who continue to 
adhere to the TB treatment program are hopeful that they will recover fully 
because they can see the effectiveness of the drugs. The history of treatment 
success of family members who have been affected by TB also motivates 
patients to comply with their treatments. Naidoo, Dick, and Cooper (2009) found 
that many patients report that TB medication had cured members of their family 
and friends who were infected with the disease.  
 
Complexity of the treatment and occurrence of side-effects are reported to be 
associated with patients stopping or interrupting their treatments (Hand & 
Bradley, 1996; Haynes, 1979; Liam, Lim, Wong, & Tang, 1999; Sockrider & 
Wolle, 1996). Moreover, patients who experience medication side effects and 
notice no improvement in their health are more likely to choose other treatment 
options, such as the traditional healer. This is worse in cases where there is no 
health service available in their communities, and the traditional healer is more 
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accessible to them (Armijos et al., 2008; Coreil, Lazardo, & Heurtelou, 2004; 
Jaramillo, 1998; Liefooghe, Baliddawa, Kipruto, Vermeire, & De Munynck, 
1997). 
 
A literature review on adherence to TB care in a Canadian Aboriginal population 
found that poor adherence to TB treatment was the most common cause of 
initial treatment failure and disease relapse (Orr, 2011). Consequently, such 
failure contributed to higher levels of transmission of the disease and higher 
chances of developing multi-drug resistance (Baylan, 2011; Qian et al., 2011; 
Tahir et al., 2006). TB adherence is a general concern worldwide (Orr, 2011). 
To better facilitate potential interventions, reduce barriers and improvement to 
adherence, further understanding is needed in the aspects of health service, 
personal and social determinants of adherence behaviour (Garner, Smith, 
Munro, & Volmink, 2007).  
 
Globally, 79% of people with TB do not have access to DOTS, the WHO’s 
internationally recognized approach to TB control (WHO, 2015a). It is estimated 
that up to 50 million people may be infected with drug-resistant TB. Thus far, 
there are no affordable cures for developing and under-developed nations 
(WHO, 2015a). A new analysis focusing on the trend of multi-drug resistance 
TB (MDR-TB) from 2008-2013 found that, at the global level, the proportion of 
new cases for MDR-TB has remained unchanged, at around 3.5%. The 
seriousness of such epidemics in some countries jeopardises the progress 
against the disease (WHO, 2015b).  
 
In ensuring effective treatments, the DOTS is the most cost-effective strategy 
and is recommended globally (WHO, 2003b). The DOTS strategy requires 
every individual patient to be categorized according to their conditions and TB 
treatment history, so that appropriate drugs can be administered to individual 
patients at the time of diagnosis. Patients who have severe forms of 
tuberculosis are allocated into category one, and those who have interrupted 
treatments are allocated to a different category to those who are newly 
diagnosed (refer to Table 2 and  3 for descriptions and definitions of TB 
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treatment outcomes) (Ministry of Health Timor Leste, 2008; WHO, 2003b, 
2008a, 2008b).  
Table 2 WHO TB Treatment Category 
Category  Description  
I New cases of smear-positive tuberculosis and other newly diagnosed 
seriously ill patients with severe forms of tuberculosis i.e. disseminated 
tuberculosis, tuberculosis meningitis, tuberculosis spondyolitis with 
neurological complications, tuberculosis pericarditis, peritonitis, bilateral or 
extensive pleurisy, smear negative pulmonary tuberculosis with extensive 
parenchymal involvement, intestinal tuberculosis, genitor-urinary 
tuberculosis etc.  
II Relapse or failure patients, those who interrupted treatments or patients 
who previously treated for more than one month not under a DOTS 
treatment program 
III New cases of new-smear negative tuberculosis and extra-pulmonary 
tuberculosis.  
Note. Adapted from WHO. (2008a). Implementing the Stop TB Strategy: A handbook 
for national tuberculosis control programmes. Retrieved from 
http://whqlibdoc.who.int/publications/2008/9789241546676_eng.pdf 
 
If patients take medication regularly, the one-year cure rate can reach up to 
95% or higher (WHO, 2003b). As a part of the DOTS standardized strategy, 
WHO (2003b) recommended that  the case detection and treatment success 
rates are to be at least 70% of case detection of new smear positive and 85% of 
those detected cases expected to be successfully treated. Research has shown 
that 20-50% of TB patients do not complete their treatment successfully or 
interrupt the regimens by themselves (Hsieh et al., 2008).  
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Table 3 WHO TB treatment Outcome and Definition 
Outcome Description  
Cure Patients are considered as cured if the initial smear/culture was 
positive before the onset of treatment and had a negative sputum 
smear results, on at least two occasions, one of which was at the end 
of the treatment.  
Treatment 
completed 
Sputum smear-positive patient who has completed treatment with 
negative smears at the end of the intensive phase, but the smear was 
done at the end of treatment. Or a sputum smear-negative TB patient 
who has received a full course of treatment and has not become 
smear positive during or at the end of treatment. Or extra-pulmonary 
tuberculosis patient who has received a full course of anti-
tuberculosis chemotherapy but failed to have the required number of 
smear or/and cultures.  
Death Patients who died during treatment for TB, regardless of the cause of 
death. 
Treatment 
failure 
Patient who failed to achieve bacteriological conversion within 5 
months after the start of treatment or after previous conversion 
becomes sputum smear or culture positive again. Also patient who 
was initially smear negative before starting treatment and became 
smear positive after completing the initial treatment. 
Transfer out Patient who has been transferred before the completion of his/her 
treatment to another recording and reporting unit and for whom the 
treatment outcome was unknown.  
Note. Adapted from WHO. (2008a). Implementing the Stop TB Strategy: A handbook 
for national tuberculosis control programmes. Retrieved from 
http://whqlibdoc.who.int/publications/2008/9789241546676_eng.pdf 
 
If patients take medication regularly, the one-year cure rate can reach up to 
95% or higher (WHO, 2003b). As a part of the DOTS standardized strategy, 
WHO (2003b) recommended that  the case detection and treatment success 
rates are to be at least 70% of case detection of new smear positive and 85% of 
those detected cases expected to be successfully treated. Research has shown 
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that 20-50% of TB patients interrupt or do not complete treatment regimens by 
themselves (Hsieh et al., 2008).  
 
A qualitative study in South Africa by Naidoo and Mwaba (2010) examined the 
willingness of TB patients to adhere to treatment regimens found that many 
factors were associated with adherence and non-adherence to the DOTS 
strategy (Naidoo & Mwaba, 2010). Influencing social, economic and disease-
related factors such as poverty, having one or more co-morbid health 
conditions, alcohol consumption and tobacco smoking were significant 
predictors of treatment non-adherence (Naidoo et al., 2013) 
 
Major progress in global TB control followed the widespread implementation of 
the DOTS strategy in countries with a high burden of TB. Yet, global statistics 
have indicated that DOTS alone has not been sufficient to achieve TB control 
and elimination (Behera, 2009). To successfully implement the strategy of 
DOTS, it is vital to understand the components of the strategy and its 
implementation approaches (Ministry of Health Timor Leste, 2011). Hence, 
addressing the TB control problem requires sustained efforts and good 
resources, both human and physical infrastructures as well as strong 
commitments from every government, and this is clearly highlighted in the Stop 
TB strategy (WHO, 2006). Unfortunately, as a young nation, Timor-Leste faces 
multiple obstacles towards its development. There are priorities which need to 
be addressed by its leaders and TB program implementation may not be a 
sufficiently high priority. This is evident in the Timor-Leste Stop TB Strategy 
Plan that the allocation and utilization of domestic resources at district levels for 
TB control specifically, is low (Ministry of Health Timor Leste, 2010). 
Furthermore, data showed that almost 80% of financing for TB control in 2014 
was funded by the Global Fund (WHO, 2015c).  
 
The WHO (2003b) suggested that a successful DOTS program would depend 
on political commitment with increased and sustained financing, case detection 
through quality-assured bacteriology, standardized treatment with supervision 
and patient support, and an effective drug supply and management system. To 
ensure maximum results, a monitoring and evaluation system must be in place 
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for impact measurement (Ministry of Health Timor Leste, 2008; WHO, 2003b, 
2011). Realistic achievement of these recommendations will reflect the good 
performance of a system. Consequently, it enhances effectiveness of DOTS 
and ultimately, it will contribute towards the progress of eliminating TB globally.  
 
2.1.1 Drug Side-Effects and Multi-Drug Resistant Tuberculosis 
Research indicates that side-effects of TB drugs are responsible for the 
termination of therapy in up to 23% of cases during the intensive phase 
(Schaberg, Rebhan, & Lode, 1996). Furthermore, defaulting is found to be 
significantly associated with medication side-effects (Awofeso, 2008). The likely 
chance of encountering side-effects is higher for patients being treated with 
second-line drugs for multi-drug resistance TB (MDR-TB), during which as 
many as 86% of patients may develop drug side-effects (Anderson et al., 2013; 
Leimane et al., 2005; Torun et al., 2005). In Jiangsu Province, China, Weiguo et 
al. (2009) found that 37.8% of patients listed the main reasons for being non-
adherent to treatment were drug side-effects. To reduce the adverse effects of 
medication adherence in TB treatment, it is crucial that health staff are 
adequately trained for the management and recognition of side-effects.  
 
Anti-tuberculosis (TB) drug resistance is currently considered a major public 
health issue worldwide, which threatens the progress made in TB care (WHO, 
2012c). MDR-TB is defined as tuberculosis that is resistant to the two most 
powerful first-line anti-TB drugs, named isoniazid (INH) & rifampicin (RMP). 
MDR-TB develops during the treatment of fully sensitive TB when the course of 
antibiotics is interrupted and there is a lack of drugs in the body to fully kill 100% 
of bacteria (WHO, 2008a, 2009). The strongest concern in relation to MDR-TB 
is that the complete treatment will take as long as 24 months (6 months of the 
intensive phase and 18 months of the continuation phase). Patients are likely to 
develop MDR-TB when they inconsistently adhere to anti-TB prescribed drugs, 
making it much harder to achieve a higher cure rate (Naidoo et al., 2009). In 
addition to the length of treatment, the cost of treatment is 100 times higher 
compared to the cost of curing a TB patient infected with drug-sensitive TB 
(Fourie, 2001; Naidoo et al., 2009). MDR-TB is fatal, as it spreads from person 
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to person as readily as drug-sensitive TB and in the same manner. In other 
words, whoever develops the active disease with a drug-resistant TB strain can 
transmit this form of TB to other individuals (WHO, 2008a, 2009). Given the 
severe impact of drug resistance in TB program interventions, prevention and 
control should be emphasized through TB program case detection, quality 
assurance and systematic treatment observation, especially with patients who 
are at high risk (Shao et al., 2011). 
 
2.1.2 Recommended TB treatment regimens 
There are five basic regimens recommended for adults who have been 
diagnosed with or presumed to be susceptible to TB. These regimens include 
isoniazid (INH), rifampin (RIF), ethambutol (EMB), pyrazinamide (PZA) and 
streptomycin (SM).The recommendation that a 4-drug regimen be used initially 
for all patients is based on the current proportion of new TB cases caused by 
organisms that are resistant to INH (2008). In the presence of INH resistance 
there were fewer treatment failures and relapses if a regimen contained the four 
drugs that were used in the initial phase (Peloquin, 2003). Each regimen has an 
initial phase of 2 months followed by a continuation phase of 6 months 
(Peloquin, 2003). The initial phase, it is indicated by a respective number (1, 2, 
3 or 4) and a continuation phase is denoted by the respective number and a 
letter (a, b or c) (Peloquin, 2003). 
 
2.1.3 Definition of TB treatment completion  
TB treatment completion is defined by the number of doses taken by a patient 
regardless of treatment duration. Thus, the determination of treatment 
completion is based on the total doses taken, not the duration of therapy 
(Peloquin, 2003). For instance, the 6-month daily regimen of 7 days a week 
treatment should consist of at least 182 doses of INH and RIF, and 56 doses of 
PZA (Bumburidi et al., 2006; Peloquin, 2003; Zierski, 1976). In some cases, due 
to toxicity or non-adherence to the treatment regimen, specified doses cannot 
be administered within the target period. Consequently, the remaining doses 
need to be administered within a recommended maximum time of 9 months. If 
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treatment is not completed within the maximum period given, the patient should 
be assessed to determine the appropriate treatment regimen. This will either be 
that the patient continues treatment for a longer duration or restarts treatment 
from the beginning with more restrictive measures (Bumburidi et al., 2006; 
Gross et al., 1994; Horsburgh et al., 2000; Peloquin, 2003). 
 
2.1.4 Treatment Interruptions  
Numerous reasons for the interruption of medication adherence in TB 
treatments have been revealed in research, including patients' lack of 
knowledge and poor understanding of the treatment. Some patients may halt 
their antibiotics when feeling better after a few months. Patients may also forget 
or skip medication from time to time (Armijos et al., 2008; Ayisi et al., 2011; 
Corless et al., 2009; Craig et al., 2007; Mulenga et al., 2010; Naidoo et al., 
2009; Qian et al., 2011). 
 
Interruption of TB treatment is common and healthcare professionals 
responsible for supervision must decide upon the available treatment option 
(Connolly, Davies, & Wilkinson, 1999; Peloquin, 2003). If such a case is 
encountered, the patient would either continue the regimen as originally 
intended or restart a complete course of treatment. It is critical that the 
treatment option chosen is based on the duration of the interruption and the 
bacteriological status of the patient before and after the interruption (Peloquin, 
2003).  
 
An approach modified from the New York City Bureau of Tuberculosis Control 
Clinical Policies and Protocols presented an example of management treatment 
interruption (refer to Appendix J) (Gross et al., 1994). If the treatment 
interruption occurs in the intensive phase and the lapse is 14 days or more, it is 
recommended that the treatment be restarted from the beginning. Additionally, 
during the continuation phase, if the patient has received less than 80% of the 
total doses and the lapse is 3 months or more in duration, treatment should be 
restarted (Gross et al., 1994; Peloquin, 2003; Zierski, 1976).  
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There are numerous relevant factors that can be taken into consideration when 
defining treatment interruptions, and these factors include the health service 
delivery system, and socio-cultural, economic and individual-related factors. In a 
circumstance where the patient’s prescribed regimen is interrupted, a decision 
by the responsible health professional, based on his or her knowledge, would 
shape the outcome of an individual patient’s treatment. The overall aim of this 
research study is to measure non-adherence of a patient with a TB prescribed 
regimen. By using the VAS and a number of non-compliant questions, the level 
of non-adherence can be measured.  
 
2.2 Determinants on Sub-optimal Adherence  
Numerous factors that influence adherence to TB treatment have been 
identified. These have been grouped in various ways, such as an ecological 
framework that involved individuals, through to organization levels or other 
frameworks that include more detailed categories. The WHO has grouped these 
categories as structural and economic factors, patient-related factors, regimen 
complexity, supportive relationships between the health providers and patients, 
and the patterns of health care delivery (Dick et al., 2003). The structure of 
categories involved in this study’s framework was drawn from the ecological 
framework and the WHO’s way of grouping. However, this thesis focuses on 
literature presented in appendices A & B, that specifically addresses factors 
associated with TB adherence that are divided into three categories 
(summarised in Figure 1). The first level involves factors related to the health 
service delivery, including accessibility and availability of services, delivery 
settings (i.e. availability of equipment and accessibility of health facilities), the 
patient-provider relationship and regimen complexity. The second level involves 
the social and economic factors, which include socio-demographic 
characteristics of individuals, such as gender, age, education, occupation, 
marital status and socio-economic status. The third category comprises the 
individual and disease-related factors, such as illness characteristics and 
severity, treatment duration (intensive and continuation phase), treatment 
progress over time, risk behaviours (tobacco smoking, illicit drug and alcohol 
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use), individual knowledge, beliefs and attitudes, and mental health problems. 
The demographic characteristics and individual disease-related factors directly 
affect the level of medication adherence, while service factors and social 
supports directly or indirectly influence patients’ adherence behaviours through 
individual-related factors. 
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Figure 1. Literature mapping of TB treatment adherence. 
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2.2.1 Health Service Delivery Factors   
There are a number of factors associated with health service delivery. This study aimed 
specifically at factors associated with service delivery such as cost associated with 
treatment, distance to and from an available service and patient-health professional 
relationship.  
 
Delivery Factors  
Structural factors in the health system affect adherence to TB treatments 
(Shargie & Lindtjørn, 2007). Structural factors identified as barriers, which have 
an impact on individual levels, include economic, social, policy, organizational 
and other environmental aspects (Sumartojo, 2000). Health systems that do not 
function in a manner designed to meet patients’ needs create a barrier to TB 
treatment adherence. A study in Zambia by Mulenga et al. (2010) found that 
healthcare access is correlated with treatment adherence. In North Africa, a 
case control study by Tachfouti, Slama, Berraho, and Nejjari (2012) showed 
that the distance to the nearest health services and the low quality of health 
professional and patient communication were associated with poor adherence 
(Tachfouti et al., 2012). Another study investigated the level of adherence and 
factors associated with the completion of TB treatment between an urban and a 
rural district in Timor Leste, where there was a different level of accessibility to 
health services. In-depth interviews were carried out with 28 TB patients and 
their nurses. Focus group discussions were carried out with patients, health 
workers and community members. The study found that non-adherence to TB 
treatment was due to local cultural beliefs, lack of access to services, and socio-
economic challenges experienced by individuals. These factors may cause 
have people to seek alternative treatments, such as traditional healers. Patients 
from rural districts provided additional reasons for defaulting, such as not being 
able to walk to the clinic, taking traditional medicine, and being busy with work 
(Martins et al., 2008).  
 
The following is a list of system barriers presented by a study on TB treatment 
adherence (Orr, 2011) 
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- Health workers or systems which fail to provide services according to the 
recommended guidelines or standards cannot expect adherent behaviors 
from their patients.  
- Long wait times for care would likely discourage patients to adhere to 
treatment.  
- Health care facilities or mechanisms which actively or passively promote 
feelings of physical insecurity or rejection.  
- Care that is apparently available, yet in reality not accessible due to an 
operational culture that does not serve patient needs, i.e. limited service 
availability and hours of operation, transportation barriers etc.  
- Lack of trust, respect and dignity in the relationship between patients and 
health workers.  
- Staff having a lack of knowledge and skills in the diagnosis and 
management of the side-effects. 
- Poor TB program management system resulting in drop-outs and losses 
from treatment and follow-up appointments 
- Care that focuses only on TB, yet fails to acknowledge and assist patients to 
overcome barriers, assist patients to counseling, concerns, homelessness, 
food, and other individual associated factors faced by TB patients. 
 
Patient- Care Provider Relationships 
Health care professionals play a vital role in TB treatment adherence. A lack of 
communication and support from health care workers discourages patients from 
adhering to treatment, while positive experiences and competent support 
creates meaningful connections and relationships with patients (Liam et al., 
1999; Martins et al., 2008; Munro, Lewin, Swart, & Volmink, 2007; Naidoo et al., 
2009). As a consequence, patients are likely to follow instructions and adhere to 
their treatment regimen. For example, in the study by Naidoo et al. (2009), 
patients were asked about their perception of the quality of the health care they 
received. Their responses clustered around one theme, namely, the attitude of 
the health care team at the clinic. Good communication between the health 
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practitioners and patients was one of the most powerful predictors of adherence 
(Naidoo et al., 2009). Ayisi et al. (2011) and his team conducted a qualitative 
study in three district hospitals in Kenya that provided basic curative and 
preventive services. The study demonstrated that the most common reason for 
defaulting on treatment was the lack of communication with providers and the 
lack of their involvement in the treatment process. Evidence from other settings 
also showed the importance of patient-health provider relationship, for instance, 
in China, research indicated that regular home visits by health workers 
appeared to reduce the risk of non-adherence (Weiguo et al., 2009). 
 
The relationship between the health care provider and the individual patient is 
indicative of a good therapeutic alliance, a process of collaboration between 
provider and patient, in which the practitioner effectively communicates with the 
patients about their problems and formulates a management plan that is 
conducive to patient compliance.  A therapeutic alliance is underpinned with 
values of empathy, trust and positive support. This is evident in a mental health 
systematic review, which found that the clinician-patient alliance and 
communication were associated with favourable outcomes of adherence 
(Thompson & McCabe, 2012). 
 
2.2.2 Socio-demographic & Economic Factors  
There are many socioeconomic factors that directly influence TB treatment 
adherence. According to the WHO evidence for action, factors, such as a lack 
of social support network, culture, beliefs and treatment, ethnicity, gender and 
age, and the high cost of transport directly or indirectly affect adherence (Dick et 
al., 2003). 
 
Research indicates that TB rates are often higher in urban areas compared to 
rural locations. One reasonable explanation is that TB transmission increases 
due to population density. Crowded living conditions and poor nutritional status 
increase the risk of infection, especially in urban areas (Aparicio, Capurro, & 
Castillo-Chavez, 2002; Holtgrave & Crosby, 2004; Lienhardt et al., 2012; 
Rieder, 1999; Shimao, 2005). Other social factors, such as living alone while 
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struggling to cover health insurance also pose major constraints to treatment 
adherence. This is supported by the findings in a survey conducted in Jiangsu 
Province, China that found that those who were divorced or widowed and 
patients who lacked health insurance were more likely to be non-adherent 
(Weiguo et al., 2009). 
 
One other factor that direct or indreclty influences treatment adherence is 
patients’ living conditions. Those who live in remote areas with poor conditions 
and lack of access to services are more likely to be non-adherent to treatment. 
This is evident in research which found poor resource settings pose barriers to 
TB treatment adherence (Munro, Lewin, Swart, et al., 2007; Munro, Lewin, 
Smith, et al., 2007). The challenges faced by TB patients undergoing treatment 
are beyond their control when they are associated with poverty and inadequate 
health services. It is well established that poor living conditions contribute to the 
spread of TB, often referred to as a disease of poverty, and it is certainly a 
barrier to treatment adherence (Naidoo et al., 2009). As a result of living in a 
poor resource setting, participants in the study by Naidoo (2009) found that the 
majority of participants had to endure the experience of being poor and living 
with the consequences of poverty, including crowded, dangerous living 
conditions, unemployment, limited formal education.  
 
A cross-sectional study conducted by Mulenga (2010) in Zambia indicated that 
seeking alternative treatment is common for those living in poor resource 
settings. As much as 64% of the sample responded that their way of coping with 
TB symptoms prior to visiting health care providers was self-treatment. In 
addition, the author emphasized that nearly all respondents (98%) presented at 
a health centre only when they felt really ill (Mulenga et al., 2010). Some 
patients were likely to seek alternative treatments depending on availability, 
affordability and accessibility of the various potential sources, such as 
traditional, spiritual and Western medicine. The uncertainty of treatment options 
and low availability of the sources of care can lead to considerable delays in 
treatment (Ayisi et al., 2011).  
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Many studies have estimated the burden of TB in specific, vulnerable population 
groups, for instance, prisoners and the homeless, and found that there is a 
strong association between social deprivation and TB risk (Bobrik, Danishevski, 
Eroshina, & McKee, 2005; Buskin, Gale, Weiss, & Nolan, 1994; Holtgrave & 
Crosby, 2004; Rieder, 1999).  Yet, the underlying pathways linking poverty and 
low socio-economic status to higher TB risk and low treatment adherence are 
not fully understood, suggesting that more research in diverse populations 
would be beneficial. 
 
The Impact of Financial Constraints in Resource Limited 
Settings  
Studies conducted in diverse global populations have demonstrated the 
importance of low household income as a major contributor to the diagnostic 
delay of tuberculosis, poor treatment adherence, and treatment failure (Armijos 
et al., 2008; Cambanis et al., 2005; Farmer, Robin, Ramilus, & Kim, 1991; 
Jackson, Sleigh, Wang, & Liu, 2006; Needham, Godfrey-Faussett, & Foster, 
1998). Many patients experience severe financial constraints to cover transport 
cost or purchasing of additional drugs, and the challenges often include 
competing financial demands that participants face (Naidoo et al., 2009). This 
finding is consistent with a study in Ecuador by Armijos (2008) that found that 
38.9% (7/18) of TB sufferers lacked enough money to buy medications. 
 
 Even when TB drugs are provided for free, costs still incur for sufferers and this 
evidence is shown in numerous studies across different settings. A qualitative 
descriptive study by Zvavamwe & Ehlers (2008) in the Omaheke, region of 
Namibia, Southern Africa, involved interviews with 40 community-based TB 
nurses. Although TB drugs were freely available to patients for treatment, the 
geographical inaccessibility of TB services, lack of transport and the time 
required to travel to a health service would cost much more than purchasing the 
drugs (Zvavamwe & Ehlers, 2008). 
 
 Another study emphasized the effect of the distance and cost of transport to 
treatment facilities on the overall treatment (Armijos et al., 2008), while a study 
Literature Review 27 
by Kebede et al. (2012) found that 23.7% of participants in the study missed 
doses due to a lack of money for transport. This finding is supported by a study 
in Myanmar that concluded that those who spent less amount of time to travel to 
and from the clinic were more likely to be adherent (Myo Su, Win Myint Oo, & 
Khay Mar, 2015 ). Evidence also suggests that many patients consider the cost 
of treatment and the implications for their employment, often choosing to remain 
at work rather than risk losing their jobs to undertake treatment (Munro, Lewin, 
Swart, et al., 2007).  
 
This complex interaction between the necessity of seeking care and balancing 
work commitments is also seen in other settings. For example, a qualitative 
study was conducted in Ho Chi Minh City, the largest city in Vietnam, with a 
population of approximately eight million (2014 estimate). The study used non-
probability sampling to identify 26 persons with diagnosed TB while under 
treatment. Some of the questions explored perceptions and experiences of the 
various health care providers’ competence, attitudes, perceptions and 
experiences of the quality of services, waiting times and costs. The results of 
the study indicated that associated treatment costs and the aspect of time 
became a major constraint for treatment completion. Almost all respondents 
reflected on the importance of avoiding time-consuming components of health 
care contacts, and thus avoiding loss of time from work (Lönnroth, Tran, 
Thuong, Quy, & Diwan, 2001). 
 
Balancing adherence to the medication regimen with other factors was also 
illustrated in a systematic review of research into medication and treatment 
adherence by Salla et al. (2007) that screened 7,814 papers by title, abstract 
and full texts derived from multiple international studies (from 1966 – 2005). Of 
these, 44 papers were included in the synthesis. These studies highlighted 
major themes covering structural factors, contextual and individual factors, such 
as the financial burden of treatment, knowledge, attitudes, beliefs, and 
community and household supports for adherence to treatment. The systematic 
review found that even when patients have the willingness to maintain 
adherence, contextual issues such as poverty may prevent them from doing so. 
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With the global pervasiveness of poverty, adherence to long-term therapy for 
chronic disease remains an issue worldwide.  
 
In resource-limited settings where income is generated solely based on daily 
effort, the demand affects patients to risk their chances to adhere to their 
treatment regimens. In a study in Zambia by Mulenga et al. (2010), participants 
were randomly selected by accessing registered smear-positive TB patients, 
new and retreatment cases across 26 treatment centers, from January, 2006 to 
July, 2007. The authors expected adherence to treatment of 50% ±10% with a 
non-response rate of 10%. The results showed that there was a high level of 
knowledge among participants. However, delays in seeking treatment and 
hoping that the symptoms would go away or believing it was not serious even 
when they suspected that they had TB, increased the severity of the disease. 
Only 17% of the participants were in formal employment and, for most 
respondents, income was dependent on their daily efforts. Therefore, they could 
not afford the time to seek and present themselves to an available health center 
for diagnosis (Mulenga et al., 2010). A study by Weiguo et al. (2009) was 
conducted in Jiangsu Province, China that showed the effect of financial burden 
on treatment adherence. The study found that those who experienced a heavy 
financial burden were less likely to complete treatment successfully, despite the 
Chinese government's policy of free TB service (Weiguo et al., 2009). In Kenya, 
a cross-sectional survey was conducted among new TB patients receiving 6 
months of standard TB treatment. Level of adherence was assessed with urine 
testing for isoniazid (INH), pill count, an interviewer-administered questionnaire 
and the VAS. The authors reported reasons for non-adherence such as running 
out of pills, were likely to be explained by missed clinical appointments or loss 
of pills, and being away from home, mostly due to economic activities (Nackers 
et al., 2012).  
 
Financial constraints were associated with patients in Timor-Leste was not 
necessarily about the cost of drugs. Generally, in Timor Leste, people 
understand that Government health services are free of charge. A survey 
conducted in 2011, investigated the ability of community members to pay to 
reach health facilities (Ministry of Health Timor Leste, 2011). The results 
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showed that the average cost for TB treatment was USD 80.55 ranging from 
USD 0 up to USD 3,300. The estimated cost varied as some patients may have 
used more than one health facility. Other costs associated with the treatment 
included diagnosis, additional drugs recommended by health professionals, and 
the cost of seeing traditional healers. Additional detail on the expenditure 
showed that the most expensive component was transportation (Ministry of 
Health Timor Leste, 2011). Also, the Timor-Leste National Stop TB Strategy 
Plan, 2011-2015, supports poor patients and those living in remote areas 
through compensation for indirect costs of TB treatment and food supplements 
where required (Ministry of Health Timor Leste, 2010). Yet, the effectiveness of 
such support in Timor-Leste is yet to be measured. The treatment process over 
6-8 months may require patients and/or family members to pay for 
transportation expenses, additional treatment recommended by health 
providers, self-remedies, and other associated costs (Martins et al., 2008; 
Ministry of Health Timor Leste, 2011). It is clear that treatment non-adherence 
in resource-limited settings is associated with a range of financial constraints, 
such as low household income, lack of transport, inaccessibility and poor quality 
of services, the cost of time and the risk of losing jobs. Each of these factors 
directly influences patients to be non-adherent to treatment (miss doses) 
because they miss appointments, away from home, and likely to seek 
alternative and easier treatment options, such as the traditional healer. 
Financial hardship also affects patients to delay treatment. It was evident that 
most often, patients delay seeking treatment by having self-treatment as they 
consider affordability cost associated with the treatment.  
 
Impact of nutrition on TB treatment  
Another important socio-economic factor that influences TB treatment 
adherence is nutrition. The first RCT study to assess the impact of food 
incentives on TB treatment in Timor-Leste was carried out in 2009 (Martins et 
al., 2009). The study employed newly diagnosed TB patients from three primary 
clinics in Dili, the capital city of Timor Leste. The majority of patients with TB 
were very poor and malnourished. The results showed that there was significant 
improvement in weight gain at the end of treatment. However, the study 
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concluded that food incentives had no significant benefit on the outcome of 
treatment adherence (Martins et al., 2009). One reason which was not 
highlighted in the study was that the participants had undertaken TB treatment 
in the capital city, where food is plentiful compared to the remote areas of the 
country. Participants’ feelings of impotence within the context of poor living 
conditions with limited access to nutritional support were evident by the fact that 
they had the information that anti-TB drug treatments were more effective if an 
individual is well-nourished, but they sometimes could not afford to buy basic 
food items, let alone the nourishing food recommended by the health care 
workers.An estimation of the cost associated with food incentives had been 
given and it was highlighted that the integration of food incentives on TB 
treatment programs can be very costly. However, studies have found the 
importance of nutritional intake by patients undertaking TB treatment (Baldwin 
et al., 2004; Gupta, Gupta, Atreja, Verma, & Vishvkarma, 2009; Ramakrishnan, 
Rajendran, Jacob, Fox, & Radhakrishna, 1961). A study conducted in India 
showed similar results, where the overall treatment response was similar in both 
groups. However, it was also noted that those receiving nutritional support 
tended to show more rapid clearance of bacteria and radiographic changes in 
addition to greater weight gain (Ramakrishnan et al., 1961). Nutritional 
supplementation may represent a novel approach for a fast recovery for TB 
patients in underdeveloped areas of the world and it may be an effective 
measure to control TB.Those studies have reported inconsistent findings; 
hence, further research to validate the influence of nutritional support and other 
barriers or enabling factors to TB treatment is encouraged. (Baldwin et al., 
2004; Gupta et al., 2009; Ramakrishnan et al., 1961).  
 
Family and Social Support 
One of the enabling factors to treatment adherence is family and social support. 
Family and social support have been found to affect adherence behaviours both 
directly (such as through positive encouragement and reinforcement) and 
indirectly (through stress relief, reduced anxiety and depression). Do (2011) 
investigated medication adherence among 615 people living with HIV (PLHIV) 
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across five clinics in Northern Vietnam using a multi-methods approach. 
Although medical regimens for care of people with HIV and TB are different, the 
influences of family and social support on individuals undergoing treatment may 
be similar. The study showed that the disclosure of information to others 
regarding treatment status was an important facilitator for medication 
adherence, while not being able to share treatment status was reported to be a 
major constraint. In Do’s (2011) study, a significant number of respondents 
believed that the sharing of information with relatives and friends had the 
potential to improve adherence. Conversely, some of the participants perceived 
that disclosure of information might cause risks, such as loss of business, loss 
of job, emotional injury and stigmatization from others. A qualitative study about 
the social impact of tuberculosis in Thailand similarly showed that social support 
aided patients in their adherence to treatment. However, stigma caused some 
patients with TB to conceal their status and prevented them from advocating for 
their healthcare. Similar findings regarding stigma and social support have also 
been documented from studies in other settings (Barnhoorn & Adriaanse, 1992; 
Eastwood & Hill, 2004; Jaramillo, 1998; Johansson, Long, Diwan, & Winkvist, 
2000; Johansson & Winkvist, 2002). 
 
Lack of social support is known to reduce individuals’ well-being and is 
positively associated with depression (Revenson & Schiaffino, 1990). It is also 
known to have adverse effects on an individual’s ability to cope with stressful 
events, such as suffering from an illness (DiMatteo & Martin, 2002). Balanova et 
al. (2006) found that there was relatively low default rates with the implantation 
of DOTS program in Russia, and this may be due to the extremely financed 
social support. Such success demonstrated that the sustainability of DOTS 
programs would depend on the integration of social support.  
 
TB control at both the national and international levels includes tools to identify 
patients with adverse social risk factors who might benefit from social support 
packages (Craig et al., 2007). A prospective cohort study by Craig et al. (2007) 
was conducted in London, employing a sample of 250 newly diagnosed 
tuberculosis patients between 2003 and 2005. The study aimed to examine the 
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impact of social factors on tuberculosis program management. The data was 
collected from medical records and risk assessment tools. Over a third of the 
patients faced difficulties adhering to medications and 30.3% had nobody to 
remind them about taking medications. A number of social risk factors were 
identified in the literature, including unstable housing, which were associated 
with poor adherence (Craig et al., 2007; Fourie, 2001). Lack of social support 
was also associated with extended periods of hospitalization (Craig et al., 
2007). A cluster RCT in Senegal, a resource-poor setting in African country, 
was carried out by Thiam (2007) between June, 2003 and January, 2005. The 
health centers were randomized for the intervention (n = 778) and control (n = 
744) groups (Thiam et al., 2007). The outcome of the RCT showed that 5.5% 
defaulted from the intervention group while 16.8% did so in the control group. 
This suggested that the risk of defaulting was significantly higher in the control 
group. Social and cultural influences beyond the patients’ control were found to 
have caused suboptimal adherence. Low socio-economic status was found to 
be related to poorer TB medication adherence, especially for those individuals 
who were chronically ill (Thiam et al., 2007) or who experienced a lack of family 
support (Awofeso, 2008; Mishra, Hansen, Sabroe, & Kafle, 2005). Limited or a 
narrowly defined social network, poor infrastructure, and general ill-health in 
their family and the community (Naidoo et al., 2009). 
 
Social Stigma 
Social stigma has been reported as an important factor that directly contributes 
to treatment non-adherence. Discrimination related to TB in most societies has 
been identified as one of the most important socio-cultural aspects that 
influences the illness experiences of those affected by the disease (Baral, Karki, 
& Newell, 2007; Brassard, Anderson, Menzies, Schwartzman, & Macdonald, 
2008; Dodor, Neal, & Kelly, 2008; Gibson, Cave, Doering, Ortiz, & Harms, 2005; 
Harper, 1987; Johansson, Long, Diwan, & Winkvist, 1999; Kipp et al., 2011a; 
Sengupta et al., 2006; Somma et al., 2008; Yang, Wonpat-Borja, Opler, & 
Corcoran, 2010). This is due to stigma being a socially constructed 
phenomenon that can shape the attitudes and behaviours of others towards 
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those affected by the disease (Harper, 1987; Karim, Chowdhury, Islam, & 
Weiss, 2007; Somma et al., 2008).  
 
A number of qualitative studies using focus group and face-to-face interviews 
have identified various factors associated with TB stigma, including 
socioeconomic status, level of education, gender and religion are significantly 
associated with TB stigma (Dodor & Kelly, 2010; Johansson et al., 2000; Kipp et 
al., 2011a; Rubel & Garro, 1992; Sengupta et al., 2006; Somma et al., 2008; 
Woith & Larson, 2008; Zhang, Liu, Bromley, & Tang, 2007). Several studies 
have found that incorrect knowledge of what causes TB, the mode of 
transmission and treatment also associated with levels of discrimination (Baral 
et al., 2007; Dodor & Kelly, 2010; Eastwood & Hill, 2004; Johansson et al., 
2000; Karim et al., 2007; Long, Johansson, Diwan, & Winkvist, 1999; Rubel & 
Garro, 1992; Sengupta et al., 2006; Somma et al., 2008). Evidence from 
numerous studies also shows that levels of contagiousness of TB transmission 
increases the likelihood of individual patients being stigmatized (Baral et al., 
2007; Dodor et al., 2008; Eastwood & Hill, 2004; Mavhu et al., 2010). TB stigma 
has also been found to be associated with marginalized groups, such as the 
poor, ethnic minorities, prisoners and those who have co-infections with 
HIV/AIDS (Baral et al., 2007; Dodor & Kelly, 2010; Eastwood & Hill, 2004; Karim 
et al., 2007; Long et al., 1999; Mavhu et al., 2010; Ngamvithayapong, Winkvist, 
& Diwan, 2000; Sengupta et al., 2006; Somma et al., 2008). 
 
A cross-sectional study was conducted in southern Thailand involving 480 
patients and 320 community members. (Kipp et al., 2011a). The study found 
that community members believed eating or drinking with a TB-infected person 
was a cause of TB, while patients believed working hard had caused TB. 
Stigma was found to be associated with low levels of education, which can lead 
to incorrect beliefs that TB increases the chance of getting HIV/AIDS (Kipp et 
al., 2011a). The study also found that stigma was higher among community 
members than patients.  
 
Patients perceived being stigmatized as the major challenge of being infected 
with TB. It was evident that many patients withdrew from the members of their 
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close social network because they felt embarrassed. It is also evident that there 
is an association of stigmatization with psychological stress through negative 
reactions of family and community members, as they feel ashamed and blamed 
for having TB (Armijos et al., 2008). The experience of facing prejudice, 
discrimination, and disadvantage is termed “enacted stigma” by Kelly et al. 
(1980), as cited  in Porter et al. (1999). Patients who have TB may believe that 
family members betray them because they feel ashamed of them for having TB. 
As a consequence, patients feel devalued in their family home (Naidoo et al., 
2009). The loss of control over their lives can lead patients to develop a sense 
of helplessness and other mental health problems, which are believed to be 
associated with poor treatment outcomes (Craig et al., 2007; Fourie, 2001; 
Naidoo & Mwaba, 2010).  
 
 A systematic literature review of TB stigma by Courthwright et al. (2010) found 
that the most common cause of TB stigma related to the risk of transmission of 
the disease by TB-infected individuals to susceptible members of the 
community. Furtermore, TB stigmatization is common due to its association with 
HIV, poverty and low social class (Courtwright & Turner, 2010). Knowing 
someone who has died of TB was also associated with higher community TB 
stigma compared with not knowing anyone with TB (Kipp et al., 2011a). Further 
results of the study showed that a low level of education, a belief that TB 
increases the chance of getting AIDS, and the stigma of AIDS were associated 
with higher TB stigma TB (Kipp et al., 2011a). To date, few quantitative studies 
on TB stigma and the potential factors associated with TB stigma have been 
published. These studies investigated education, beliefs, gender, family and 
social support from numerous cultures and drew similar conclusions regarding 
stigma towards TB patients. Generally, community or family members who are 
less educated with strong beliefs that TB is a disease of the poor or it is a sign 
of punishment for bad behaviours are more likely to discriminate patients with 
TB  (Baral et al., 2007; Brassard et al., 2008; Dodor et al., 2008; Eastwood & 
Hill, 2004; Harper, 1987; Johansson et al., 1999; Karim et al., 2007; Kipp et al., 
2011a; Long et al., 1999; Sengupta et al., 2006; Somma et al., 2008; Yang et 
al., 2010). 
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A knowledge, attitude and practice (KAP) survey in Timor-Leste  (Ministry of 
Health Timor Leste, 2011).found that, when participants were asked about their 
readiness to look after TB patients among their household members, 91% 
believed they were ready to look after. In relation to confidentiality, 18.6% of 
males, and 16.4% of females thought it was important that information on a 
household member suffering TB be kept secret. Although it appears that family 
and social supports are strong for most affected family members in this specific 
population, there were a significant number of people who said they were likely 
to refuse patients to live among them and were willing to isolate them. This may 
be due to those who have limited knowledge would not understand that once 
chronic patients undergo treatment and take regular medication for two weeks, 
they will no longer be contagious. Additionally, it was reported that lack of 
confidentiality increase levels of discrimination, especially if the information was 
shared with people who have limited knowledge (Ministry of Health Timor Leste, 
2011). 
 
2.2.3 Individual Factors Related to Adherence 
There are a number of factors involved in the individual disease-related factors, 
including level of education and patients’ knowledge about TB, health locus of 
control which; one’s belief that his or her health outcome is determined by 
chance or luck, risk behaviours such as alcohol consumption and/or cigarette 
smoking and mental health problems.  
 
Knowledge of tuberculosis patients 
Numerous studies have found that the higher the education level of an 
individual, the more successful treatment adherence seems to be (Armijos et 
al., 2008; Ayisi et al., 2011; Liam et al., 1999). A case control study conducted 
in Morocco, North Africa, employed 290 TB patients (85 defaulters and 205 
controls). A defaulter was defined as a TB patient who had interrupted 
treatment for 2 months or longer, while a non-defaulter was defined as a patient 
who followed the same treatment protocols and completed the whole treatment 
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regimen. The study found non-adherence was significantly associated with low 
education and poor treatment knowledge (Tachfouti et al., 2012). 
 
 One study in Ecuador involved a sample of 212 adults undergoing diagnostic 
TB testing. The results suggested that misconceptions or a lack of key 
knowledge could adversely affect early diagnosis, treatment, adherence to 
treatment and a further spread of the disease. It was also highlighted that 
education was the most important predictor of knowledge, beliefs, perception 
and attitudes (Armijos et al., 2008). The study by Liam et al. (1999) supported 
these finding, showing that TB patients with tertiary education had significantly 
higher knowledge scores compare to the rest of the participants with non-
tertiary education. Further, education level was an important determinant of the 
patients’ level of knowledge of tuberculosis (Liam et al., 1999) and treatment 
adherence (Kebede & Wabe, 2012). Patients with low education levels admitted 
that either they or their family members had stopped taking their TB medication 
for one or more weeks without their physician’s consent (Armijos et al., 2008), 
while 6 of 18 patients said they felt cured after a few months of treatment. 
 
 A survey in China concluded that illiterate patients were more likely to be non-
adherent (Weiguo et al., 2009). A study by Mulenga et al. (2010) also showed 
that 55% of participants stated that the most common reasons for stopping 
treatment were that they felt better and this was due to lack of knowledge about 
the treatment duration. Adhering to treatment was significantly associated with 
patients' knowledge. Periods of non-adherence to the TB treatment program 
were associated with participants stopping the treatment because they felt 
better (Naidoo et al., 2009). 
 
Similarly, a case control study of 384 TB patients conducted in Ndola, Zambia, 
found that 39.1% of females and 29.8% of males reported having stopped 
taking medication within the first two months of commencing treatment. Overall, 
29.8% of the sample had stopped taking TB drugs at some point during the 
treatment. The most common reason given for stopping treatment by adherent 
and non-adherent patients was feeling better (45.1% and 38.6% respectively). 
Additionally, adherent patients mentioned a lack of knowledge of the benefits of 
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completing treatment (25.7%), TB drugs being too strong (20.1%) and a lack of 
food at home (11. 4%). (Kaona et al., 2004) 
 
Another study was conducted in a rural South African community by Gonzalez-
Angulo et al. (2013). Fifty adult TB suspects were interviewed prior to diagnosis 
and 50 newly diagnosed TB patients were interviewed at pre- and post-
treatment. The results showed that almost 60% of the participants reported they 
knew of TB, while 25% responded correctly that TB was caused by a microbe. 
Other reported causes of TB included alcohol consumption (5%), poor personal 
hygiene (5%), tobacco smoking (12%), low ambient temperature (15%) and 
hereditary disease (6%) (Gonzalez-Angulo et al., 2013).  
 
Research shows that patients would decide to interrupt TB treatment if they had 
a lack of knowledge of the duration of the course and they were unsure about 
the importance of completing treatment (Ayisi et al., 2011; Khan, Walley, 
Newell, & Imdad, 2000; Sagbakken, Frich, & Bjune, 2008a). Non-adherence to 
treatment often due to a limited understanding and lack of treatment knowledge 
of the disease and its treatment process (Hand & Bradley, 1996; Haynes, 1979; 
Liam et al., 1999; Sockrider & Wolle, 1996). Availability of treatment options 
would enable choices for individual patients and the decisions made to be 
based on their level of knowledge about the disease (Harper, Ahmadu, Ogden, 
McAdam, & Lienhardt, 2003; Lienhardt et al., 2012; Munro, Lewin, Swart, et al., 
2007) 
  
A number of qualitative studies have observed care-seeking and attitudes 
towards treatment compliance (Arlt, Lindner, Rösler, & von Renteln-Kruse, 
2008; Ayisi et al., 2011; Blackwell, 1979; Liam et al., 1999; Mesfin, Newell, 
Walley, Gessessew, & Madeley, 2009; Needham, Bowman, Foster, & Godfrey-
Faussett, 2004; Zwi et al., 2009). These studies concluded that a lack of 
awareness of the duration of treatment and a lack of family support potentially 
contrubted to the reduction of adherence to treatment (Arlt et al., 2008; Ayisi et 
al., 2011, p. 9; Liam et al., 1999; Zwi et al., 2009).  
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Recently, a survey was conducted by the Ministry of Health Timor Leste (2011) 
to determine the knowledge attitudes and practices (KAP) regarding TB among 
communities in Timor Leste. Additionally, the survey explored the socio-
economic burden of TB on patients and their families in the community. The 
study covered five (40%) of the districts in Timor Leste, and was geographically 
representative. Multi-stage systematic random sampling was applied for the 
sample selection, and data were collected from patients and their household 
members. A number of variables, such as housing characteristics, access, 
distance and affordability of TB treatment, TB knowledge and health-seeking 
behaviour were included. For social and family support, participants were asked 
whether TB patients should be isolated to prevent the further spread of the 
disease, 48.6% (49% males & 48.2%) females) believed that TB patients should 
be isolated.The survey found that there was a low level of community 
awareness of TB and only 10% of the participants knew the mode of TB 
transmission. When assessing the participants’ knowledge of tuberculosis, such 
as mode of transmission, symptoms, diagnosis and treatment, the survey found 
that 65.3% reported to have only ever heard about TB. In comparing the 
knowledge of TB between rural and urban areas, the highest proportion of 
respondents who had heard about TB was 83.8% from urban areas. When the 
respondents were asked about the mode of tuberculosis transmission, only 
6.6% were correct, 71.5% answered incorrectly, and 21.9% did not know about 
tuberculosis transmission. (Ministry of Health Timor Leste, 2011).  
 
The finding of the Timor-Leste Ministry of Heath Survey is consistent with the 
ethnographic study by Martins et al. (2008) that concluded that participants with 
a low level of knowledge about TB and its treatment may cause them to seek 
alternative treatment such as traditional healers. Other barriers to treatment 
completion included the patients’ reasons for defaulting, such as feeling better, 
or no symptomatic improvement. Patients were willing to complete their 
treatment when they had strong knowledge about the treatment, a high 
willingness to be cured, or evidence of symptomatic improvement and 
satisfaction as a result of taking the drug. Furthermore, the study suggested that 
due to high illiteracy rates and low levels of knowledge about the disease, it was 
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a common belief that TB was a punishment for negative behaviour (Martins et 
al., 2008).  
 
Health Locus of Control 
‘Locus of control’ refers to the extent to which individuals believe they can 
control events affecting them, regardless of their actions being desirable or 
undesirable (Rotter, 1966). The causal attributions that individuals assign to their 
illness condition will affect their way of coping with it. If a treatment regimen 
recommended by a health practitioner is consistent with an individual’s 
understanding of what caused his or her illness, then the individual is more 
likely to adhere (Do, 2011). An individual who ascribes external factors that are 
out of his or her control as causing the illness is less likely to be self-motivated 
to improve his/her health status, as compared to an individual who believes they 
can control what happens to them (Do, 2011). Patients’ perceptions of the 
implication of tuberculosis symptoms, their beliefs and attitudes are potential 
determinants of compliance (Haynes, 1979). 
 
Risk Behaviour 
Risk behaviour behaviour in this study describes specific behaviours such as 
alcohol consumption, cigarette smoking and/or illicit drug use that direct or 
indirectly impact or causing significant harms to individuals’ health. Clinical 
experience suggests that drug use and alcohol problems are associated with 
treatment non-adherence and poor treatment outcomes (Craig et al., 2007; 
Fourie, 2001). A prospective cohort study in London by Craig (2007) with a 
sample of 202 participants suggested that drug and alcohol use were 
significantly associated with patients having difficulties taking their TB 
medication. Additionally, drug or alcohol use increased the duration of 
hospitalizations (Craig et al., 2007). Missed appointments were also associated 
with alcohol and drug use (Craig et al., 2007). Similarly, in Hong Kong, China, a 
study of TB defaulters found that tobacco smoking was one of the many factors 
that contributed towards treatment default, or poor adherence (Chang, Leung, & 
Tam, 2004). In Uganda a study found that alcohol consumption and tobacco 
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smoking was directly correlated with TB medication non-adherence (Amuha, 
Kutyabami, Kitutu, Odoi-Adome, & Kalyango, 2009). The findings from studies 
in various settings are also consistent with a cross-sectional survey in South 
Africa which found that high risk of alcohol mis-use and tobacco smoking are 
significant predictors of treatment non-adherence (Naidoo et al., 2013). 
 
Mental Health Problems 
Depression is another potentially significant impediment to effective treatment. 
Within the treatment context, negative thoughts, anxiety, hopelessness and 
depression are often associated with low adherence to health care instructions 
(Do, 2011). Feelings of helplessness and depression have been found to be 
significantly associated with an individuals’ ability to cope with stressful events, 
especially when suffering from an illness (DiMatteo & Martin, 2002). Naidoo and 
Mwaba (2010) considered mental health to be critically important for an 
individual infected with TB because individuals are likely to cease trying to 
achieve a positive outcome when they are unable to control events in their lives. 
 
The psychological wellbeing of an individual is important to the overall 
management of the disease (Peltzer et al., 2012). In his study, Seligman (1975) 
classified helplessness into three different categories, namely, motivational, 
when an individual stops trying to change an outcome, cognitive, when 
individuals have learnt no new responses that could help to prevent aversive 
outcomes in the future, and emotional, when a feeling of depression sets in 
(Seligman, 1975). 
 
Conversely, high self-efficacy has also been found to be associated with better 
disease management, such as adhering to prescribed medicines, managing 
stress, and following a recommended nutrition program (Dodge & Clark, 1999). 
One might also surmise that these individuals do not believe that adhering to 
the recommended treatment of the local health authorities will cure their illness 
condition and possibly view the treatment methods with scepticism and mistrust. 
Optimistic bias refers to “the belief that other people but not oneself will develop 
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a disease, have an accident, or experience other negative events” (Brannon & 
Feist, 2000, p. 106).  
 
Other social determinants associated with psychological stress include 
continued anxiety, low self-esteem, social isolation and control over one’s home 
and working life (Wilkinson & Marmot, 2003). A descriptive qualitative study by 
Armijos (2008) summarized feelings of isolation and loneliness 44%, and 
sadness 42%. Overall, 78% of the participants indicated that they had suffered 
significant psychological and emotional trauma after learning that they had to be 
tested for possible TB and had to receive treatment.  
 
Therefore, fighting to eliminate TB is not a simple task. It is an approach of all 
involved stakeholders, including international donors that provide sustainable 
funding, committed local government, the cooperation of health workers and 
communities, and the awareness of patients to undertake their treatment 
seriously. Failure in any of these areas is likely to affect the achievements of the 
program.  
 
2.3 Summary of Research into TB Medication Adherence  
The previous section discussed the findings from various studies on TB 
treatment and factors associated with TB sub-optimal adherence. From all the 
studies that have investigated factors associated with TB treatment, the majority 
are qualitative and have covered a whole range of contextual and individual 
factors associated with TB treatment (see Appendix A). 
 
 The present review identified a number of published articles on TB medication 
adherence studies using quantitative research methods. These studies were 
published from 2004 up to 2014, and most were conducted in regions of Africa 
(refer to Appendix B for a detailed summary of these quantitative studies). 
There are various measurement methods used to determine treatment 
adherence in these studies; structured questionnaires, pill counts, patients’ 
medical records and self-reported methods. However, levels of adherence to TB 
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treatment were most commonly assessed by asking patients about the number 
of doses missed over a specified recall period. 
 
A study conducted in Kenya used the VAS and other measures to determine 
adherence. The study found that VAS non-adherence was 7.5% with 92.5% of 
the participants reported to have taken 100% of their medications. Such high 
adherence rates may have been influenced by the method used, as self-
reported adherence measures are prone to social desirability bias, in which 
patients tend to provide answers that they believe would fit interviewer’s 
expectations, which is high adherence to treatment in this case (Nackers et al., 
2012). The majority of the studies had non-adherence rates between 20-30% 
(see Table 4). However, one of the studies conducted in Ethiopia on TB/HIV co-
infected patients used a 90% threshold and found that with recall periods of 3  
and 5 days, the levels of non-adherence were 53.3% and 55.8%, respectively 
(Eticha & EKassa, 2014). 
 
2.4 Tuberculosis Program and Research on Treatment in Timor-
Leste  
TB is recognised as one of the major public health problems in Timor-Leste 
(Ministry of Health Timor Leste, 2010), although large-scale research into TB 
prevalence and incidence is yet to be undertaken. It was estimated from smear 
positives data that the incidence rate of TB is between 115 and 175 new smear 
positive cases per 100,000 per year. As emphasized in the National TB 
Strategy Plan, 2010 and the Health Sector Strategy Plan, 2007, the high TB 
burden is linked to social and economic indicators in the country (Ministry of 
Health Timor Leste, 2007).  
 
Timor Leste’s National Stop TB Strategy Plan (2011-2015) aims to provide 
quality Community DOTS (C-DOTS) services through the CHCs. C-DOTS is a 
method used to strengthen DOTS by increasing case detection and improving 
patient outcomes within the community. It consists of training community 
members to support DOTS therapy in various ways, including, but not limited to, 
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identifying and referring suspect cases, assisting with collection of sputum 
samples, providing and observing the intake of daily drugs with patients in their 
homes, tracking down defaulters, and referring patients with side-effects to 
health personnel at the CHC. Successful C-DOTS programming is reliant on 
consistent supervision, clinical support, drug supplies from the CHC and high 
adherence of TB patients for treatment over 6 to 8 months. Timor-Leste can 
only begin to work toward the internationally recognized DOTS targets of 70% 
case detection and 85% cure rate if there is a well-functioning C-DOTS 
program. Fighting the elimination of TB will only be achieved if there are 
effective strategies and sufficient resources to improve TB patients’ adherence 
to treatment.  
 
The WHO handbook for implementing the Stop TB Strategy identified behavioral 
and environmental risk factors, such as smoking, malnutrition, indoor air 
pollution and alcohol abuse (WHO, 2008a). There are many other barriers in 
implementing the ‘Stop TB’ strategy in developing countries such as Timor 
Leste. As a result of colonization, major health infrastructure was destroyed, 
causing a shortage of equipment, supplies and public utilities with scarce 
financial and technical support (Martins, Heldal, et al., 2006; Martins, Kelly, 
Grace, & Zwi, 2006). In addition, a huge volume of marginalized and 
disadvantaged groups in the country experience high levels of malnutrition and 
a low socio-economic status. At the same time, those in remote areas live in 
poor housing with a high level of indoor air pollution (Ministry of Health Timor 
Leste, 2011), while experiencing a lack of support, with limited access to health 
services (Martins et al., 2008).   
 
Thus far, there has been little research conducted in Timor-Leste to show how 
TB patients comply with their treatments or to investigate the factors influencing 
treatment adherence. One ethnographic study  (Martins et al., 2008) has 
qualitatively addressed issues associated with TB treatment, such as local 
cultural practices, knowledge and socio-economic factors associated with 
treatment adherence. The findings of this study have been used as the 
cornerstone in modifying the DOTS expansion strategy in Timor-Leste to 
overcome treatment-associated factors. A survey was also conducted by 
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Ministry of Health Timor Leste (2011) to determine the level of knowledge, 
attitudes and practices among community members and TB patients, and an 
RCT study investigated the impact of nutritional support on TB treatment 
(Martins et al., 2009). To date, there is no quantitative, peer-reviewed journal 
article reporting the level of TB treatment adherence and factors impeding 
optimal adherence in Timor-Leste. 
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Table 4  Summary of Literature Review on TB Treatment Adherence 
 
Source Country  Study design  
Setting & 
sample size  
Threshold  
Non-
adherence 
% 
Measurement and 
recall period 
Weiguo et 
al. (2009) 
China 
Mixed 
methods, 
multi-stage 
sampling 
strategy 
13 counties 
(districts). 
670 TB patients 
90% 12.2% 
Structured 
questionnaire, 
 
Recall period: The 
whole duration of 
treatment (6-8 
months) 
Nackers et 
al. (2012) 
Kenya, 
Africa 
Cross-
sectional 
survey 
Health TB 
clinic, 279 
patients, 
Questionnaire: 
miss >25% pills, 
last 4 days. 
VAS: <80, last 
month 
INH test: 
negative 
Pill count: <80% 
VAS: 7.5% 
Urine test: 
2.4% 
Pill count: 
17.7% 
Subjective tools 
(questionnaire & 
VAS) & objective 
adherence 
monitoring tools 
(urine test & pill 
count) 
VAS: last month 
2 days for IP and 8 
days for CP. 
Kaona et al. 
(2004) 
Zambia, 
Africa 
Cross-
sectional 
study 
6 clinics, 400 
patients 
100% 30% 
Pre-structured 
survey 
questionnaire, 8 
month period 
O'Donnell et 
al. (2014) 
South 
Africa  
Prospective 
cohort study 
Kwazulu-Natal, 
South Africa  
N/A 32.3% 
Self-reported. 
Taking all pills in 
the previous 7 
days for whole 6 
months.  
Myo Su et 
al. (2015 ) 
Myanmar  
Cross 
sectional 
survey  
A specialist 
hospital  
100% 25.3% 
Morisky Medication 
Adherence Scale 
(MMAS), 4 items & 
pill count  
Eticha and 
EKassa 
(2014) 
Ethiopia  
Cross-
sectional 
study  
2 public 
hospitals, 3 
health centers 
90% 
TB/HIV co-
infected 
patients, 3 
days=53.3
% & 5 
Structured 
questionnaire, 3-5 
days period 
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Source Country  Study design  
Setting & 
sample size  
Threshold  
Non-
adherence 
% 
Measurement and 
recall period 
days=55.8
%. 
Amuha et 
al. (2009) 
Uganda 
Cross-
sectional 
study 
1 Hospital, 140 
participants 
N/A 25% 
Interviewer 
administered 
questionnaire, 5-
day period prior to 
interview. 
Corless et 
al. (2009) 
South 
Africa 
Descriptive 
Exploratory 
Design 
2 clinics, HIV 
(n=149), TB 
(n=159) 
MSMNS: 75% N/A 
MSMN Scale, 
Likert scale, 
symptoms 
assessment scale, 
QoL scale, Missed 
appointment, SOC 
Scale, MOS Scale.  
Ailinger, 
Moore, 
Nguyen, 
and Lasus 
(2006) 
USA 
Cross-
sectional 
study 
1 Urban public 
health clinic, 53 
patients 
N/A 
2nd month: 
2%, 9th 
month: 
28% 
Brief questionnaire 
and medical 
records. Number of 
month client 
complete therapy. 
Kebede and 
Wabe 
(2012) 
South 
West 
Ethiopia 
Cross 
sectional 
study 
1 district 
hospital, no 
N/A 20.8% 
Self-administered 
questionnaire  
Ailinger et 
al. (2007) 
USA 
Descriptive 
Study 
1 urban public 
health clinic, 
153 participants 
N/A 
1st month: 
16%, 8th 
month: 
66% 
Medical  records & 
number of pills 
taken 
Martins et 
al. (2009) 
Timor 
Leste 
Randomized 
Control Trial 
3 clinics, 270 
patients 
(intervention = 
137, control = 
133) 
N/A N/A 
- Clinical 
attendance 
- DOTS 
- Interview 
and 
- Pill count 
- IP: weekly, 
CP: 
fortnightly 
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Source Country  Study design  
Setting & 
sample size  
Threshold  
Non-
adherence 
% 
Measurement and 
recall period 
Ailinger et 
al. (2010) 
USA 
Pre-
Experimental 
design 
9 clinics, 131 
patients’ 
medical records 
N/A 
Improve 
adherence 
Interventio
n vs control 
groups 
(62%vs39
%) 
Self-report of 
number of pills 
taken, 9 months 
Armijos et 
al. (2008) 
Ecuador 
Cross 
sectional 
study 
1 Public health 
facility, 212 
people 
N/A N/A 
Face-to -ace 
interview using 
structured 
questionnaire 
Chiang, Lin, 
Lee, Lee, 
and Chen 
(2012)  
China 
Retrospective 
observational 
case control 
study 
1 tertiary 
medical center,  
302 patients 
N/A N/A 
Electronic records 
and medical 
charts, 6 months 
Kipp et al. 
(2011a)  
Thailand 
Cross 
sectional 
survey 
1 Hospital-
based TB clinic 
(480 patients), 
2 Hospitals 
(300 healthy 
community 
members) 
N/A 
N/A 
Questionnaire, 
treatment < 1 
month  
 
Note. IP: Intensive Phase; CP: Continuation Phase; VAS: Visual Analogue Scale; INH: isoniazid; N/A: Not Applicable, 
MSMNS: Morisky Self-reported Medication Non-adherence Scale, SOC: Sense of Coherence; MOS: Medical 
Outcome Scale.  
 
 
2.5 Framework 
Several frameworks were reviewed to find the theoretical framework that is 
most likely to capture the determinants of medication adherence. They are 
presented below. 
 
2.5.1 Behavioural Perspective  
The behavioural perspective integrates the behavioural learning theory which 
focuses on the environment and the teaching of skills to patients to manage 
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adherence (Dick et al., 2003). It is characterised by the use of the principles of 
antecedents (which are either internal thoughts or external environmental cues) 
and consequents, and patients’ influence on behaviour (Munro, Lewin, Swart, et 
al., 2007). The consequents are rewarded if they are a positive behaviour or a 
punished if they are a negative behaviour. Despite studies indicate the 
importance to compliance of patients’ organization and comprehension, there is 
a little chance in the attitude that leads to compliance with the treatment 
instructions (Leventhal & Cameron, 1987) 
 
2.5.2 Self-Regulation Perspective 
Self-regulatory theory is the most popular theory in the field of medication 
adherence. The theory is developed to conceptualize the adherence process in 
a way that focuses on the patient (Leventhal & Cameron, 1987). The theory 
assumes that people are motivated to avoid or treat illness and are active, self-
regulating problem solvers. The patients need to be interested in improving 
his/her health for treatment to be effective (Nouwen, Urquhart Law, Hussain, 
McGovern, & Napier, 2009).  
 
The behavioural perspective focuses on the environment and patients’ skill 
development to cope with treatment and self-regulation theory assumes 
patients are active, motivated and problem solvers for their own health. 
Therefore, both models focus on inviduals’ behaviours towards their health. 
However, the current study investigates 3 main aspects, namely health service 
delivery, social and demographic and individual factors. These two models were 
used as a guide for the individual disease related factors. However, the 
conceptual framework for the study was derived from the literature.  
 
2.5.3 Conceptual Framework 
The literature review revealed many factors associated with adherence to 
tuberculosis treatment. Figure 1 presents the mapping of literature related to 
health service delivery, social and economic and disease related factors. 
Arrows in Figure 1 explains the links and relationships among all variables in the 
literature. For example lack of health service accessibility would force individual 
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patients to travel to and from an available health service. As a consequence, 
patients would require financial support to meet such need.  
 
In comparison to Figure 2, the arrows of health service, social and eocnomnic 
and personal and disease related factors directly linked with adherence. This 
explains by the fact that the current study investigated the relationship of each 
aspect with treatment adherence rather than the interaction of each of the three 
main domains.The structure of the literature mapping in Figure 1 is retained in 
Figure 2 to ensure consistency of variables in the categories. However, only 
variables that were relevant to be investigated in the current study were 
included in the conseptual framework in Figure 1. 
 
Those factors are divided into three main categories, as follows: 
a. Health service and delivery factors 
There are numerous aspects identified in the literature which are related 
to health service delivery. However, this study will mainly focus on 
investigating the aspects of accessibility and availability factors due to 
limited time and resources. Accessibility aspects include cost, time and 
distance, and availability includes information, presence of health care 
workers and quality of services i.e. counseling.  
b. Social and economic factors 
Social and economic factors are two broad areas which also cover a lot 
of factors. This includes demographic characteristics, including socio-
economic status, gender, age, education, occupation and marital status. 
Social motivation, such as family support, financial support and other 
social support i.e. support from friends and relatives, will also be 
examined.  
c. Individual and disease-related factors including: 
treatment: illness characteristics and severity, treatment duration, treatment 
progress over time. Regimen: Complexity of treatment, dosage level and side-
effects, knowledge, beliefs and attitudes towards treatment and mental health 
problems such as depression, helplessness, stress and isolation (refer to Figure 
2). 
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Figure 2 Survey Conceptual Framework 
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SUMMARY 
 
Treatment adherence has been recognised as a pivotal aspect of the fight 
against TB, as poor adherence has a negative influence at both individual and 
population levels. A major public health problem that threatens the progress 
made in TB care and control worldwide is the development of multi-drug 
resistance TB (MDR-TB). It has been documented in many different settings 
around the world that drug resistance arises as a result of improper treatment 
and failure to ensure that the patients complete the whole course of their 
treatment regimen successfully. Research continues to show thresholds that 
vary between 75% and 100% as optimal adherence, while the recommended 
threshold for TB adherence is at 80%. There are a number of ways in which 
adherence to TB treatment can be measured. A common measure is the self-
report of the estimated percentage of prescribed doses taken over a given 
period of time. Yet, the self-report method sometimes leads to social desirability 
bias, which may influence the overestimation of medication adherence. 
Understanding the barriers and enabling factors to TB medication adherence is 
of paramount importance, especially in designing effective strategies to optimize 
adherence.TB is a key public health issue in Timor-Leste, and key stakeholders 
for TB programs have limited data available on the level of treatment 
adherence.Therefore, this research is designed to develop a better 
understanding of the situation for TB treatment adherence among patients in 
Timor Leste.  
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Chapter 3:  Methodology 
INTRODUCTION 
Chapter 3 describes the methodology used in this study. This chapter begins 
with the study design, the research process, description of study sites, study 
participants and the data collection procedure. Then, it presents the instrument 
development in details, which includes the variables and measurements of the 
correlates, translation of the tool and field-testing. Finally, this chapter describes 
the data analysis, data management and ethical considerations.  
3.1 Study Design 
This study employs qualitative and quantitative methods sequentially. The 
overall research design consists of four main phases. Phase one involving 
literature review, qualitative study and survey drafting. Phase 2 including 
instrument revisions, piloting and main survey. Phase 3 involving administration 
of survey, and phase 4 include survey analysis, finding synthesis and 
implication for future research (see Figure 3 for the study flow diagram). 
 
3.1.1 Phase 1: Development of the Study Survey  
Development of the questionnaire involved two sub-phases: 
 
Phase 1a: Derivation of independent variables and their relationships from 
the literature review  
In phase 1a of the study, research questions were defined and methodologies 
were determined. The study then began with a literature review to identify 
important factors related to tuberculosis medication adherence. Reviewed 
studies related to this specific health issue enabled the researcher to develop 
tools for both a qualitative semi-structured questionnaire and a tentative draft of 
cross-sectional survey. 
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This process involved identification of relevant studies on TB treatment 
worldwide. Independent variables such as patients’ demographic 
characteristics, risky lifestyle behaviours (cigarette smoking, alcohol 
consumption and illicit drug use), belief, psychological wellbeing, TB knowledge, 
social stigma, social and family supports were retrieved. Relationships among 
selected independent variables with TB treatment were also investigated.  
 
Phase 1b Derivation of additional independent variables developed from 
qualitative interview analysis 
In phase 1b, the study continued with the exploratory qualitative research to 
capture an in-depth understanding of various aspects related to tuberculosis 
medication adherence. The qualitative study involved face-to-face interviews 
with health professionals from communities to the national level and currently 
registered patients undergoing treatment at the time of the interview. The 
rationale of conducting the exploratory qualitative research was to gather ideas, 
approaches, and clues regarding any specific health issues that may not have 
been foreseen from the literature (Creswell & Plano Clark, 2011; King, 2009). 
The qualitative results were utilized to refine a draft of the quantitative survey 
prior to pilot testing. Details of the qualitative findings are presented in Chapter 
4.  
 
3.1.2 Phase 2: Construction, Revision & Pilot Study of Survey 
Phase 2 included a number of components;  
1. The questionnaire was reviewed by four experts with 10 plus years of 
experience nationally and internationally from multidisciplinary backgrounds 
and experiences in international public health, the management of TB and 
HIV/AIDS research projects and research in TB and HIV/AIDS treatments, 
health research methods, cross-cultural research, health inequality, the 
social determinants of health, clinical epidemiology, mental health, and 
culturally and logistically diverse communities.  
2. The questionnaire was further examined by two qualified translators with 
health backgrounds and the principal researcher to ensure the content was 
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valid and culturally appropriate (see Figure 4 for the translation process).  
The instrument was piloted and detailed field-testing process is outlined in 
(Section 3.4.5).  
 
3.1.3 Phase 3: Administration of Survey  
Phase three, administration of questionnaire involved recruitment and training of 
survey administrators, and data collection which included administration of 
questionnaires to 347 TB patients who currently under treatment at the time of 
data collection.  
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Figure 3 Study Flow Diagram 
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3.2 Study Sites  
Qualitative Interviews Sites 
The qualitative data was collected in Dili and Liquica Districts for the health 
professional group, and Bairopite clinic and Comoro CHC for patient group.  
 
3.2 Study Sites  
3.2.1 Qualitative Study  
The qualitative study was conducted in Dili and Liquica districts for the health 
professional group, and Bairopite Clinic and Comoro CHC for the patient group.  
 
3.1.2 Cross-Sectional Survey Sites 
The survey data was collected in nine health services (six community health 
centers, and three private clinics) in three districts. The community health 
centers included Liquica CHC (urban), Maubara CHC (rural), Bazartete CHC 
(rural), Maliana CHC (urban), Centro CHC (urban), Comoro CHC (urban), 
Motael clinic (urban), Bairopite clinic (urban), and ISMAIK Tibar (rural). 
 
Bairopite Clinic is a private clinic located in Dili, founded by Dr Dan Murphy and 
operated by himself and Timorese health professionals with the support of the 
Ministry of Health Timor Leste. The clinic plays a vital role in providing all 
consultations to meet patients’ needs on a daily bases throughout the year. The 
clinic provides diagnostic services, manages approximately one third of all TB 
cases in Timor Leste, and provides treatment to more than 1,000 people every 
year. It works collaboratively with the National TB program in providing DOTS, 
education and follow-up care. 
 
There are 16 beds in two TB wards dedicated to patients who are too sick for 
out-patient treatment in Bairopite Clinic. These beds are also used to facilitate 
patients from remote areas of the country that lack medical supervision during 
the intensive phase of treatment. Bairopite Clinic has also initiated a program to 
provide preventive treatment to young children exposed to TB. The program is 
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recommended by the WHO and the Timor-Leste National TB Program to be 
implemented, but it has been proven to be difficult to implement. Bairopite Clinic 
is the first centre in Timor-Leste to establish such a program on a large scale.  
 
Both St. Antonio Motael and ISMAIK Tibar Clinics are church operated while 
supported by the MoH Timor Leste. All patients undertaking treatment at 
ISMAIK Tibar are diagnosed at Bairopite Clinic. After diagnosis, those whose 
families live far away from a nearby clinic, or unable to walk with no support 
undertake intensive treatment in ISMAIK Clinic prior to returning home. Patients 
who are able to gain their strengths after a few months of treatment are able to 
return home and continue the continuation phase of treatment. The clinic has a 
full time nurse to provide DOTS to patients. The patients are also frequently 
visited by health professionals from Bairopite Clinic. 
 
Comoro and Centro CHCs are located in Dili, and Luqica, Bazartete, Maubara 
CHCs are located in Liquica district, Maliana CHC is located in Maliana district, 
and all CHCs are operated by the Ministry of Health. Generally, each of these 
CHCs has a pharmacist, nurse, doctor, laboratory technician, and a district TB 
assistant. Due to high demands and limited health resources, health 
professionals who work in each clinic often play multiple roles in assisting 
others to provide general consultations to the public. The district TB assistant 
and the laboratory technician are regularly supervised by the district 
tuberculosis coordinator (DTC). The DTC also assists them with the cross-
check of slides and sputum testing. CHCs provide DOTS to TB patients 
undergoing intensive phase treatment and patients under a continuation phase 
of treatment while living at home.  
3.3. Qualitative Study  
As discussed in the literature review, medication adherence is a complex issue. 
To gain a better understanding of the subject, it is crucial to take into 
consideration of contextual, individual and psychological aspects that directly or 
indirectly influence adherence. Hence, qualitative method is appropriate to 
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capture perspective of study participants (Malterud, 2001). Such method will 
also allow researcher to uncover beliefs, values and personal motivations that 
underlies health behaviours (Berkwits & Inui, 1998; Curry, Nembhard, & 
Bradley, 2009; Inui, 1996). The exploratory qualitative research was used in this 
study to validate contents of the quantitative survey, to explore issues related to 
TB adherence, and provide insights into how participants perceive adherence 
and reasons associated with non-adherence.  
 
3.3.1 Sample Size  
The qualitative study employed 10 health professionals from a national level 
(i.e. National TB Program Manager) to a sub-district level (i.e. District TB 
Assistant). Participants from I/LNGOs that contribute towards the 
implementation of TB programs were also selected. Ten patients who undertook 
treatment at the time of interview were recruited from a private clinic and a 
public service (CHC) (seeTable 5). 
 
Table 5 Matrix for Sampling in Qualitative Research 
Qualitative 
technique 
 
Participants 
Public Sector  Private Sector   
Total 
 
 
semi-
structured 
interviews  
 
 
Health providers 
director, TB Adviser 
or NGO staff 
- 1 NTP Director 
- 1 NTP Adviser  
- 1 District TB 
Coordinator 
- 1 clinic doctor  
- 2 clinic TB staff 
- 2 NGO staff  
 
10 
TB patients  2 non-adherent females 
2 non-adherent males 
1 adherent male  
2 non-adherent males 
2 adherent females 
1 adherent male  
10 
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3.3.2 Data Collection   
The qualitative data collection was conducted between September and 
November, 2012. In order to recruit patients, the researcher worked 
collaboratively with the District TB Assistants, District TB Coordinator or clinic 
staff to select patients through the TB registry list. Five male and five female 
patients were conveniently selected based on the subjective assessment of 
patients' missing appointments, as observed by the health staff. The interviews 
were undertaken in locations that were most convenient to the patients. Almost 
all participants were selected at the time they came to the clinic or CHC to 
receive their medications. Those who were willing to participate were asked for 
verbal consent prior to the interview. The semi-structured interviews were based 
on the themes of perceived benefits of medication adherence and 
consequences of non-adherence, possible facilitating factors to adherence, 
knowledge on adherence, associated cost with treatment, views and 
experiences and why they adhere or not adhere to treatment regimens (see 
Appendices C & D). 
 
The semi-structured interviews were conducted with health staff in Dili and 
Liquica Districts to discuss their views on the quality of health care, the impact 
of demographic characteristics on adherence, lifestyle, beliefs and social 
support that may directly or indirectly influence patients' adherence to treatment. 
The qualitative study provided important findings to assist in modification of the 
research questions, conceptual framework and revision of the final survey 
instrument to ensure their relevance to the context of Timor-Leste (See 
Appendix L for the interview transcripts).  
 
3.4 Survey Development  
The questionnaire was adapted from a number of studies worldwide (see 
Appendix H). There are a number of tools available for the measurement of 
medication adherence and each has its strengths and weaknesses (see Table 
6) Although self-reported questionnaire and face-to-face interview methods may 
be susceptible to social desirability bias and recall bias, they are simple, 
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inexpensive and demonstrated as the most useful method for clinical settings. 
The VAS and MARS were selected for this study due to their simplicity to be 
administered to patients, and VAS has been widely used to measure medication 
adherence in other settings that have similar social and demographic 
characteristics wit Timor Leste.  
A pilot study to test the tool was undertaken to ensure its appropriateness in 
Timor-Leste context. The survey was then revised based on the findings from 
the pilot study.  
 
Table 6 Various Methods of Measuring Medication Adherence 
 
Method Advantages Disadvantages 
 
Direct methods 
Directly observed 
therapy  
 
Most accurate Patients can hide pills in the mouth and then discard them; 
impractical for routine use 
Measurement of the 
level of medicine or 
metabolite in blood 
 
Objective  Variations in the metabolism and “white coat adherence” 
can give false impression of adherence; expensive 
Measurement of the 
biologic marker in 
blood  
Objective; in clinical 
trials, can also be 
used to measure 
placebo  
Requires expensive quantitative assays and collection of 
bodily fluids 
Indirect methods 
 
Patient questionnaire, 
patient self-reports 
Simple; inexpensive; 
the most useful 
method for the 
clinical setting 
Susceptible to error with increase in time between visits; 
results are easily distorted by the patient 
Pill counts Objective, 
quantifiable, and 
easy to perform 
Data easily altered by the patient (e.g., pill dumping) 
Rates of prescriptions 
refills  
Objective; easy to 
obtain data 
A prescription refill is not equivalent to ingestion of 
medication; requires an accessible pharmacy system 
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Method Advantages Disadvantages 
Assessment of the 
patient’s clinical 
response 
 
Simple; easy to 
obtain data 
Factors other than medication adherence can affect clinical 
response  
Electronic medication 
monitors 
Precise; results are 
easily quantified; 
tracks patterns of 
taking medication 
Expensive; requires return visits and downloading data 
from medication vials 
Measurement of 
physiological markers 
(e.g., heart rate in 
patients taking beta-
blockers) 
 
Often easy to 
perform 
Marker may be absent for other reasons (e.g., increased 
metabolism, poor absorption, lack of response) 
Patient diaries; when 
the patient is a child, 
questionnaire for 
caregiver or teacher 
Help to correct for 
poor recall; simple; 
objective 
Easily altered the patient susceptible distortion 
Note. Adapted from Osterberg, L., & Blaschke, T. (2005b). Drug Theraphy: 
Adherence to Medication the New England Journal of Medicine, 353(5), 487-
497. Retrieved from 
http://www.nclnet.org/sosrx/membersonly/sept21/adherenceNEJM08042005.pdf 
 
 
3.4.1 Dependent Variables 
The study used two measures of the dependent variable of medication 
adherence - a VAS and the Medication Adherence Rating Scale (MARS) (see 
Appendix H). The visual analogue scale (VAS) was adapted from Nackers et al.  
(2012) and estimates adherence along a continuous line between 0% and 
100%, indicating the percentage of TB doses taken by respondents in the past 
month. Patients were asked to determine about how much of their medications 
they have managed to take during the last month. For instance, zero means no 
medication has been taken; 50% means a half and 100% means they have 
taken every single dose of the prescribed regimens. The VAS had also been 
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widely used to measure TB and ART adherence (Do, Dunne, Kato, Pham, & 
Nguyen, 2013; Nackers et al., 2012; 1982). 
 
The second dependent variable was the MARS which measures adherence in 
the past month. It was adapted with minor modification to cross-validate the 
VAS adherence estimate (Thompson, Kulkarni, & Sergejew, 2000b). The MARS 
items were drawn from the combined items of the Drug Attitude Inventory (DAI) 
and Morisky Medication Adherence Scale (MMAS) to enable greater validity 
and clinical utility (Thompson et al., 2000b). The MARS asks patients to 
respond to a set of dichotomous statements in the questionnaire by circling 'yes' 
or 'no' to describe their behaviours or attitudes towards medication during the 
past month (Thompson et al., 2000b).  
 
The VAS is the most commonly used tool to estimate adherence for both TB 
and HIV/AIDS studies in various settings (Do et al., 2013; Nackers et al., 2012). 
The MARS scale has been used to measure behaviour and attitudes of patients 
towards medication adherence (Lee et al., 2013; Morisky, Green, & Levine, 
1986; Oliveira-Filho, Barreto-Filho, Neves, & Lyra Junior, 2012; Thompson, 
Kulkarni, & Sergejew, 2000a).  
 
There were five questions selected from the MARS scale. These questions ask 
whether a patient ever forgets to take medication, is careless about taking 
medication, stops taking medication when feeling better or worse, or only takes 
medication when feeling sick. If patients correctly answer the statement 4 of 5 
(80%) our 5 of 5 (100%), they are deemed as adherent. Both measurements 
used a cut-off point of <80% of drug intake classified as suboptimal adherence 
and ≥80% as adherence (Nackers et al., 2012; WHO, 1982). 
 
The questionnaire includes a set of subjective reasons for missing doses in a 
checklist of 21 items. These items have been adapted from an ART adherence 
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study by Do et al (2013). In this study, reasons for missed medications used 
'yes' or 'no' for patients’ agreement or disagreement on each statement.  
 
3.4.2 Independent Variables  
The first section of the questionnaire assessed participants’ demographic 
information such as sex, age, education, marital status and income. Second 
section consisted of questions which collected information related to patients 
lifestyle, especially cigarette smoking, alcohol consumption and illicit drug use. 
The third section included questions that measured psychological wellbeing of 
patients, their beliefs. This followed by measuring patient’s level of TB treatment 
knowledge. The fourth section contained a list of non-adherence reasons which 
patients could nominate to explain the reasons for missing their medications. 
The final section of the questionnaire contained a set of questions that 
measured the helpfulness of their communciations with health professionals as 
well as the benefits of receiving social supports.  
 
The demographic variables such as gender, participants are given two options 
such as (1) male, (2) female to be chosen from. For their ages, they were asked 
for their dates of birth, while an additional question was also asked to determine 
their current age in order to confirm their actual age (see Appendix H for the 
survey questionnaire – English version). Measurements for other indepent 
variables were as follows. 
 
Alcohol use: participants were asked about their alcohol consumption status. If 
they answered in the affirmative, they were then asked how often in the last 
month they had at least one drink of alcohol, using a response category of (1) 
daily or nearly every day (>4 time/week), (2) sometimes per week (1-4 
times/week), (3) sometimes per month (1-3 time/month), (4) drink when 
available. The quantity of the drink every time they consumed alcohol and the 
frequency of drinking more than 6 units were also asked (Do et al., 2013). A 
picture that showed a glass of wine, a pint of regular beer or a bottle of wine for 
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estimated alcohol units was presented. The picture was used to guide 
participants to roughly estimate amount of alcohol consumed as per each of the 
measurement. For instance, if a participant drink a full bottle of wine, the 
estimated measurement is roughly around 9 units.  
 
Cigarette smoking: the participants' smoking status was determined by asking 
the following whether they were:  (1) current smoker, (2) smoked in the past, (3) 
had stopped smoking at the time of treatment, or (4) never smoked. Participants 
who responded as smokers were asked a number of questions which 
highlighted how soon after they awoke they smoked their first cigarette, 
measured in minutes of (1) within 5 minutes, (2) 6-30 minutes, (3) 31-60 
minutes or (4) after 60 minutes. The number of cigarettes smoked in a day was 
also asked: (1) 10 or less; (2) 11-20; (3) 21-30; or (4) 31 or more. The last 
question about cigarette smoking asked participants to recall how many 
cigarettes they had consumed in the past 24 hours. 
 
Illicit drug use: Participants were asked if they had ever used any kind of illegal 
drugs such as illicit drug. Three options were given to assess their drug use 
status, including (1) current user, (2) used, but in the past, and (3) never. Those 
who were current users or who had ever used illicit drugs were asked their 
frequency of usage (Do et al., 2013). 
 
Psychological distress was measured by the Kessler Psychological Distress 
Scale (K10) (Slade, Grove, & Burgess, 2011). This is a 10-item, self-report 
rating scale which assesses psychological distress of participants in the last 30 
days. The scale uses a 5-point Likert scale, with a response ranging from 1 
(none of the time) to 5 (all of the time). The tool is a desirable method of 
assessment as it is a genuine attempt on the part of the clinician to collect 
information on participant’s current condition. Furth, the scale has been widely 
used and reported to have strong psychometric properties, indicating that it 
accurately measures patients’ anxiety and depressive symptoms (Slade et al., 
2011). 
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Multidimensional Health Locus of Control (MHLC): The MHLC scale (Malcarne, 
Fernandez, & Flores, 2005; Wallston, Wallston, & DeVellis, 1978) was used to 
assess the respondents’ health-related locus of control. A shortened, modified 
9-item version of the MLHC by Malcarne et al. (2005) was used. The scale has 
been widely used in many settings to measure patients’ beliefs that their health 
outcomes are determined by chance or luck. A study investigated treatment 
adherence for HIV/AIDS in Vietnam reported a strong psychometric property, 
indiciating that the tool is effective in measuring patients’ beliefs about their 
health outcomes (Do, 2011).  The four subscales of locus of control on this 9-
item scale are internal health, powerful others, and external health. The items 
are scored on a 4-point response scale ranging from 1 (strongly disagree) to 4 
(strongly agree). 
 
Tuberculosis knowledge: The Tuberculosis Knowledge Scale (TKS) was 
adapted from a survey conducted in Sudan (Mohamed, Pharm, Yousif, Ottoa, & 
Bayoumi, 2007). This 7-iten scale measures patients’ understanding about 
tuberculosis treatment, which includes knowledge on possible causes of 
tuberculosis, screening of family members and the duration for completing TB 
treatment.  
 
Stigma: The Tuberculosis Stigma Scale (TSS) (Van Rie et al., 2008) is a12-item 
scale that measures the patients' understanding of the community’s perspective 
towards tuberculosis patients and their own perspectives towards tuberculosis. 
This scale had been widely used to measure stigma for both tuberculosis and 
HIV/AIDS diseases (Kipp et al., 2011a; Sengupta et al., 2006; Van Rie et al., 
2008). The first seven questions cover the community perspective towards 
tuberculosis. This includes patients’ understanding of whether the community 
would feel that they might not want to eat or drink with a person who has 
tuberculosis, feel uncomfortable and keep their distance. The section which 
highlights the patient’s perspective towards tuberculosis assesses the feelings 
experienced by individual patients undergoing treatment, such as if the patient 
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feels hurt when others react knowing he or she has tuberculosis, feeling alone, 
afraid to tell others outside of family, causing a burden for their family or afraid 
to share their treatment status with family members(Van Rie et al., 2008). In a 
given statement, a patient answered yes or no according to their perspectives 
whether he/she agreed or disagreed with the statement.  
 
Provider-patient Communication: This was measured using the Patient 
Reaction Assessment (PRA) scale by Galassi et al. (1992). This scale has been 
shown to differentiate effective and non-effective relationships between patients 
and caregivers (Malcarne et al., 2005). It contains five items, using a response 
scale ranging from 1 (strongly disagree) to 4 (strongly agree).  
 
The final section of the questionnaire was about social and family support. 
These items have been used in the ART adherence study by Do et al. (2013), 
which aimed to measure social and family support.There are 30-items included 
in the scale which measures disclosure of treatment to family, friends, 
neighbours, peer educators and social organizations and satisfaction of patient 
on the support received during treatment.  Patients are asked to rate the 
support received from each group during their treatments. For example “to what 
extent do the following people help you to remember to take TB medication?” 
Six of the same statements are given to each group, and each with a response 
scale ranging from 0 (not at all), 1 (a little), 2 (somewhat) to 3 (a lot). The higher 
or lower the total score in each group indicates more or less support is receive 
by a patient.  
 
The K10 was used to measure anxiety and depression symptoms experienced 
by the participants in the past month. Those who scored under 20 are likely to 
be well, a score of 20-24 are likely to have a mild mental disorder, a score of 
25-29 are likely to have moderate mental disorder, and a score of 30 or above 
are likely to have a severe mental disorder (Slade et al., 2011). The internal 
consistency (Cronbach’s α for K10 was 0.806. The health locus of control was 
measured with a subscale of the multidimensional Health Locus of Control 
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Scale, with an internal consistency (Cronbach’s α = .91). The Tuberculosis 
related stigma scale measures both community and patient perspective towards 
TB (Van Rie et al., 2008), internal consistency of (Cronbach’s α = .84). A patient 
assessment tool to measure effectiveness of communication between patient 
with care provider, (Cronbach’s α = .90) (Do et al., 2013), knowledge 
(Cronbach’s α = .60), traditional healer (Cronbach’s α = .62) and social support 
(family, friend, neighbour, peer educator and social organization) (Cronbach’s α 
=.76) (Do et al., 2013; Munro, Lewin, Swart, et al., 2007). 
 
3.4.3 Translation 
The translation process was carried out by adapting methods from the WHO 
(2012a) as well as a number of guidelines for translational validity, including the 
Census Bureau Guideline for the Translation of Data Collection Instruments and 
Supporting Material (Pan & Puente, 2005), the Principles of Good Practice for 
the Translation, and the Cultural Adaptation Process for Patient-Reported 
Outcomes (Wild et al., 2005). The survey was translated from the original 
language – English to Tetum (Timor-Leste national language), and then it was 
back translated to English. The translation to Tetum from English was carried 
out by a qualified translator with health background. The translator (English to 
Tetum) worked for the Timor-Leste Ministry of Health as monitoring and 
evaluation specialist for the National TB Program. He also has years of 
experience in translating documents for various organizations. The 
questionnaire was then back-translated from Tetum to English by a different 
translator. He also has years of translation experience and worked for an 
international non-government organization as a health manager for TB. 
Although the guidelines for translation validity were closely followed, it was 
important to highlight that due to the incompleteness of the Tetum language 
(Timor-Leste National Language) (Golden, 2004), some translation required 
additional explanation to ensure that the actual meaning of the English version 
was not lost (see Appendix I). Refer to Figure 4 for the translation process.  
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Figure 4. Translation Process 
Original source of language (English) 
 
Translated to Tetum by a professional translator 
with health background 
 
Reviewed by a panel 
A health Professional 
An accredited translator with 
health background & 
The principal investigator 
The final version of the Tetum questionnaire 
 
Translated into English by a professional 
translator  
 
Reviewed by a panel 
A health Professional 
An accredited translator with 
health background & 
The principal investigator 
The final version of the back-translated English 
questionnaire  
 
Forward 
translation 
Compare original 
document with 
outcome 
Back translation 
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3.4.4 Pilot Test  
The aim of the field-test of the survey was to observe the effects the interviewer 
had on the question responses and to establish the feasibility of the question 
being administered by the interviewer. It was conducted to ascertain errors the 
respondents made on the questionnaire, the clarity of each item for the 
respondents and the respondents’ ability to answer the questions without errors 
or confusion, and whether the respondents understood the meaning of all of the 
items in the questionnaire.  
 
The patients were informed about the research activities three days before they 
came to their respective clinic. Participants were conveniently selected, as they 
appeared to receive their medication at the clinic, using the inclusion and 
exclusion criteria. Verbal consent was given at the time prior to filling out the 
pilot survey. Those who were unable to participate due to other circumstances 
or chose to not participate were excluded.  
 
Testing the questionnaire involved recruitment of 50 currently enrolled 
tuberculosis patients in several clinics across Dili and Liquica Districts in Timor 
Leste. The plan was that 50 patients were to be recruited to fill out the pilot 
questionnaire at one time. However, the pilot testing was conducted, it was 
necessary to make changes. Therefore, the questionnaire was piloted with 10 
participants per session and the same process was repeated four times. It was 
noted that many participants were not able to read and write; therefore, the 
questionnaire was read out for them. There were some participants who 
claimed to read and write; however, as they started to respond the questions, it 
was noted that they could not fill the questionnaire independently. Hence, 
participants who experienced difficulties filling the pilot questionnaire were also 
assisted and items were read out to them by the survey administrator.  
 
The responses by the participants were observed and noted according to the 
following factors: the appropriateness of each response choice in every 
question, for example if the respondent placed an "X" or tick the box available 
as directed; whether the response choice ranges were used. For instance, 
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(strongly disagree, somewhat disagree, neither agree nor disagree, somewhat 
agree, strongly agree); whether the respondents followed the directions 
correctly; checked the appropriateness of some questions within sections of the 
questionnaire and observed if more or less than half the participants responded 
to the specific items. 
 
Length of time it took to complete the questionnaire was also recorded. During 
the first stage of the testing process, it took an average of 75 to 90 minutes for 
an individual patient to complete the questionnaire. However, after several 
revisions, the final test of the questionnaire took an average of 40-50 minutes. 
This was due to the removal of a number of irrelevant questions within each 
section of the questionnaire. Participants were asked if they had used a device 
as a facilitator to remind them of the medication time. For example ‘using a 
clock or an alarm to remind medication time’. This item was removed as none of 
the participants admitted to having used any form of these devices as a 
reminder.  
 
In all sections of the questionnaire testing, the omission, inclusion and 
duplication of questions were taken into consideration. In the first part of the 
questionnaire testing, the main focus was on the structure of the questions, 
appropriateness of multiple response options and use of scientific and medical 
words. Revisions were undertaken before the second phase of questionnaire 
testing. After the first section some explanatory information was added to 
several parts and some questions were simplified. For instance, instead of 
directly asking 'how often did you miss taking your medication in the last month', 
it was necessary to ask whether at any time they had missed their medication 
prior to asking about missed medication in the previous month.  
 
In the second and third sections of the field-testing, some of the multiple options 
given in each questions were added and irrelevant options were removed. An 
example of this was that the questions asking about the frequency of using a 
type of transport, local mini bus, bus and angguna (mini truck) were combined 
into one option. Other options, such as by car as a driver were irrelevant and 
were, therefore, removed.  
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3.4.5 Integration of Findings on Composition of the Study 
Questionniare 
A number of key factors need to be considered as a result of conducting the 
pilot study. Worldwide literature reviews identified a list of factors associated 
with medication adherence, and the draft questionnaire was developed based 
upon these studies. However, after piloting the questionnaire, it was clear that 
not all factors identified in the literature were relevant for investigation in the 
present study's specific population. For instance, life style – illicit drug use was 
excluded from the questionnaire as the health professional group in the pilot 
interviews stated that there had been no illicit drug users known. The previous 
qualitative studies conducted in Timor-Leste had not assessed drug use 
(Martins et al., 2008; Ministry of Health Timor Leste, 2011) and it was assumed 
that it may be unaffordable given the poor economic background of the 
population. Although the drug scale was initially removed after the pilot study, 
through collaborative discussions with a group of panel members, it was 
advised that the scale be included in the final version of the questionnaire.  
 
The official stats suggest that approximately 65% are smokers. However, 
participants in the health professional group advised that through years of 
experience in the field, it appeared that almost all male patients were smokers. 
Therefore, the tobacco consumption variable was included in the study. Most 
commonly, smoking is also embedded as part of the culture, where presence of 
guests would be complimented with cigarette-smoking. This was evident in the 
latest WHO Global Tobacco Epidemic report which showed the latest trend of 
tobacco use for youth and adult groups. The survey reported 65.7% males and 
2.9% females as current cigarette smokers (WHO, 2015).  
 
3.5 Cross-sectional Survey  
3.5.1 Study Population  
The Democratic Republic of Timor-Leste (DRTL) consists of 13 districts, 
covering an area of 14,874 square kilometres (refer to appendix E). The data 
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collection was conducted in the three districts of Dili (capital city of Timor), 
Liquica and Maliana, including six Community Health Centers and three private 
clinics.  
 
3.5.2 Method of Sampling  
The districts were chosen based on the highest prevalence of TB cases in 
urban, semi-urban and rural areas. The classification was determined using the 
NTP data from the Ministry of Health of Timor Leste. Furthermore, in attempt to 
achieve a representative sample, the sites selected were ensured to cover a 
variety of areas with different geographic characteristics, such as mountain 
terrain, seaside, urban, rural and remote areas of the country and population 
density (see Table 7). 
Table 7 Population size, density and percentage of TB in the selected sites 
 
The annual number of tuberculosis cases recorded in the NTP database in 
2011 for Dili, Liquica and Maliana districts were 1970 (44.65), 410 (9.3%) and 
164 (3.7%) respectively (Ministery of Health Timor Leste, 2011). The study 
aimed to randomly select samples from across a number of patients registered 
in each clinic until the required sample size for each district was achieved. 
Districts Population 
(census 2010) 
Population 
Density 
Annual Report for 
TB Case Finding 
2011 Urban Rural Total 
Maliana 15,800 73,987 89,787 61/km2 410 (9.28%) 
Dili 193,563 40,768 234,331 4,000/km2 1970 (44.60%) 
Liquica 5,152 58,177 63,329 100/km2 164 (3.71%) 
Note. Adapted from  Ministery of Health Timor Leste (2011) Knowledge, 
Attitude and Practice (KAP) towards Tuberculosis and Socio-economic 
Impact of the Disease in Timor-Leste. 
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However, due to the mountain terrain and distance required to travel to sites 
and time limits, some CHCs in remote areas of Maliana district were not 
reached. Therefore, the convenient sampling method was used to interview 
patients who came to the hospital for treatment. Patients were conveniently 
selected through hospital records and those who did not meet pre-defined 
criteria were excluded. Selection was based on the pre-defined inclusion and 
exclusion criteria. Patients were included if they were undergoing TB treatment 
at the time of interview, able to speak Tetum fluently and agree to complete the 
questionnaire. Participants under 18 years of age, out of reach geographically 
with no contact provided in the TB registry and unwell or refuse to participate 
were excluded.  
 
3.5.3 Statistical Power Analyisis   
The study estimated the level of non-adherence and its associated factors 
during tuberculosis treatment among patients in Timor Leste. The estimated 
power analysis was calculated using a proportion formula of the sample size for 
estimating proportions (Daniel, 2009; Lachenbruch, 1991): 
 
 
 
The following parameters were used to calculate the sample size. Prior to the 
study there were no official estimates of adherence of TB treatment in Timor 
Leste. However, the National Tuberculosis Program Data for 2011 showed that 
the treatment outcomes of new smear positive (NSP) patients registered in 
2010 were 80% cured, 8% completed treatment, 4% failed, 4% defaulted & 4% 
transferred out. From this figure an estimation of 88% adherence (p) was given. 
The absolute precision (d) was 5% and the confidence level was 95%. This 
calculation gave a sample size of 164. In order to increase the statistical power 
and to incorporate a design effect due to the clustering within the districts 
selected, the sample was multiplied by two, which increased the sample size to 
328. The sample size was further increased by 5% to allow for any incomplete 
interviews. A minimum sample size of 345 was required. The actual data 
collected is presented in Table 8. 
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Table 8 Data Collection Sites, TB Cases and Participant Numbers for the Study 
Districts 
District Place of interview 
(Home/Clinic/CHC) 
Annual TB Case 
Finding 2011 
(n) 
Participants  
(n) 
Dili District  1970   
    CHC Centro CHC    14 
    CHC Comoro CHC    35 
    Bairopite Clinic Clinic  106 
    Motael Clinic Clinic      8 
    Home visit Home  111 
Liquica District    164   
    CHC Bazartete Home    11 
    CHC Liquica CHC    10 
    CHC Maubara CHC    13 
     ISMAIK Clinic         Clinic    19 
Maliana    410   
    CHC Maliana  Hospital    20 
Total  2544 347 
 
3.5.4 Procedure  
3.5.4.1 Recruitment of Survey Administrator 
The National Tuberculosis Program and the office of the MoH/Global Fund were 
visited. Key officials were given a brief explanation of the objective of the study, 
and data collection method was also briefly explained. These visits included the 
Global Fund Program Manager and National Tuberculosis Officer. Positive 
support for the research data collection was shown and a facility such as a 
training venue was made available to conduct the training of the survey 
administrators. The ethics committee office under the Ministry of Health was 
contacted to seek approval for research variations and after few days the 
approval was obtained. 
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The office of the Global Fund recommended the survey administrators, as those 
candidates had been involved in research activities previously conducted by the 
Ministry of Health. Recommended candidates were contacted and a brief 
introduction of the study was given. Those who were available and interested in 
the research activity were scheduled for a have a face-to-face meeting with the 
principal researcher.  
 
Positions were offered for two months, receiving a salary of USD 100 per 
month. The survey administrators were expected to work from Monday through 
to Saturday with equivalent to eight hours per day conducting the surveys 
across nine health services in three districts. Accommodation and transport 
costs were provided to individual survey administrators as part of the agreement 
package. 
 
The main roles of the research administrators were to assist the principal 
researchers with conducting a survey. This included assisting Tuberculosis 
patients who may not understand any questions or content of the survey 
questionnaire; assisting by reading out, interpreting and explaining content from 
the questionnaire and filling out the questionnaire for patients who were 
illiterate.  
 
Throughout the data collection process, the survey administrators were 
expected to frequently travel and stay overnight in districts for up to a week or 
more, depending on the task required. They were also advised to travel safely, 
as there was no health care cover for any unpredicted accidents.  
 
 3.5.4.2 Training of survey administrators 
Training of the survey administrators was conducted once they agreed to sign 
the agreement and abide by it. Out of five people that were interested, three 
were selected. Soon after the training and prior to the departure to the first 
district in the research, a survey administrator decided to leave as he had 
another job offered. As a consequence of only able to recruit two survey 
administrators, the principal investigator had to involve directly in the survey 
administration process to prevent delays of data collection in the selected sites. 
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However, the changes made to the work plan resulted in deferral of data entry, 
which was supposed to be completed prior to principal researcher’s return to 
QUT.  
 
We were fortunate to have the offer of a conference room by the Global Fund 
Division in the Ministry of Health. Such support reduced any associated cost. 
The training period took less than the two weeks originally planned. The content 
of the training began with a brief presentation of the study, including 
background, literature review and current TB status in Timor Leste. A brief 
overview on the content of the questionnaire and elaboration of the differences 
between qualitative and quantitative data was given. The team reviewed each 
question of the questionnaire. Then, the survey administrators were asked to 
explain the contents of each question in different ways to show their 
understanding. The idea was to ensure that they were able to assist patients 
who could not understand a question and provide support for patients to 
complete every survey successfully. Each participant was given a task to think 
about for each of the questions and to provide suggestions based on their 
experiences of how certain questions could be best asked. This was to avoid 
any cultural sensitivity for any question that may contain sensitive information, 
i.e. drug usage and marital status. Additionally, the principal investigator was 
aware from experience that data falsification by interviewers had occurred in 
past work in Timor Leste. Extra care was taken to ensure data quality control. 
First, the training given to all survey administrators highlighted their honesty in 
the data collection. They were advised that falsifying data was a practice of 
dishonesty and it would affect their future careers. They were also asked to 
collect accurate data from patients which would help to determine the problems 
associated with the issue investigated, and their contributions were 
acknowledge. Second, the survey administrators were assisted prior to 
collecting data from patients independently. For instance, the principal 
investigator demonstrated by administering a survey with a patient, where the 
survey administrators were able to observe how they should approach and 
greet patients.  
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 3.5.4.3 National Tuberculosis Program Support 
The Principal researcher worked closely with the NTP Timor Leste. Their 
authorization, support and collaboration allowed further contact to the selected 
sites. The NTP Director was approached to request support with access to 
contact details of NTP staff in the districts. Fortunately there was no need for a 
letter to request approval and contacts were retrieved. The districts TB 
coordinator for each selected site was contacted to inform him/her about the 
research and that there would be a visit to each CHC.  
 
3.5.4.4 Administration Protocol  
An overview of the study was given to the District TB Assistants to be 
distributed prior to the survey administration. Participants who received the 
information were asked by the clinic staff to come to the clinic. The 
administration was conducted after agreement for the most suitable time for the 
participants. 
 
Those who agreed to participate were asked if they understood the information 
delivered. Participants who were illiterate and had no family members to explain 
the information were assisted to ensure that they understood what was 
expected of them in completing the survey. During the survey administration 
process, effort was made to ensure that participants felt comfortable, and were 
not interfered by the health providers in their respective clinic. The 
administration protocol was closely followed by providing a brief session, 
confirming their willingness to participate and obtaining consent and ensuring 
confidentiality of information.  
 
For every participant, the interviewer was expected to introduce him or herself, 
explain the purpose of the study, and emphasise that the researchers did not 
represent any government body or other organization that may have been 
directly involved with the participants’ treatment. The participants were 
encouraged to provide accurate and honest responses, and the importance of 
their participation in the survey to help identify ways in which TB treatment may 
be improved was acknowledged.  
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Participants with no formal education through to high school level were 
interviewed face-to-face, while those with university qualifications were asked to 
complete the questionnaire independently. A brief guide on how to answer the 
questions was given at the beginning of the administration. The team and the 
principal researcher were also available at all times to assist participants in any 
difficulties they faced in completing the questionnaire.  
 
3.5.4.5 Procedure in each Study District 
The survey was conducted from the beginning of June until the end of 
September 2013 in the following districts. 
Liquica District 
The Liquica District TB Coordinator was contacted and an information summary 
about the research was dropped to District Health Service (DHS). However, the 
visit to the site was delayed one week later due to an annual workshop 
conducted in the district. A quick meeting with the DHS vice director was 
arranged during the first visit to the DHS office. As all sub-district CHC directors 
were present at the workshop, a brief explanation of research activities and the 
research overall plan was shared with each sub-district director. They were also 
informed that at some point the research team would visit their respective CHC 
to interview patients under treatment. Further contact details of who should be 
contacted were also provided by those CHC directors themselves. Contacts 
were made, but the activities were not carried out as planned due to other 
event, which required the district health staff’s participation.  
 
In the following week, district TB assistants (DTCs) for Bazartete, Liquica 
districts were contacted. Klibur Domin local NGO was visited to discuss the 
availability of the DTA who work directly to support the local community health 
center. A short meeting was held with the LNGO’s director to provide 
background information of the study and the data collection process.  
 
The DTA at Klibur Domin NGO agreed to have home visits for each patient 
undergoing the continuation phase of treatment to provide prior information 
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regarding the study. Those who were illiterate were given a short explanation 
about the study process and they were asked to stay at home for the following 
days. During each home visit, patients were asked again to clarify their 
understanding about our presence.  
 
Eleven patients in Bazartete sub-district were interviewed face-to-face during in-
home visits. On the same week the team was able to visit Maubara sub-district 
and collected data from 13 patients as well as 10 patients from Liquica sub-
district in the following week. It was fortunate as the Liquica District TB and 
CHC staff were supportive of the research activities. The in-home interview was 
supported by DTAs to provide translation for illiterate patients who only speak 
the local language.  
 
Maliana District 
In the following week, the team travelled to Maliana district. On the first day a 
meeting was arranged with the District Tuberculosis Coordinator (DTC) who the 
principal investigator knew personally from previous work. On the same day, 
after meeting with the DTC, the research team was also able to meet with the 
District Health Service (DHS) Director. Due to the busy schedule, the research 
team managed to convince the director to verbally approve the research 
activity. The DHS director’s requested for an evidence of approval for data 
collection for his reference and copy of the approval letter from the National 
Tuberculosis Program was provided. 
 
On the following day, the research team travelled to the hospital to wait for 
patients who came to the clinic for medication refill. Summary information 
regarding the study was not given prior to arrival due to distance required to 
travel to this site. However, the documents were prepared and presented to 
each eligible patient. Explanation was also given to all patients regarding the 
study. Those who were unsure about their participation were given the option to 
take home the information and return to the clinic in two to three days, if they 
decided to participate.  
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The majority of the patients chose to participate after explanation was given. 
This was due to the fact that most of them had travelled from the countryside. 
Only a few decided to come back within the following days for interviews as 
they lived close to the clinic. After three days, there were not many patients that 
visited the CHC. Therefore, we consulted with the DTC and DTA to accompany 
us for home visits.  
 
Phone credits were provided to CHC staff to make appointments with patients 
under the continuation phase of treatment. Those patients contacted were 
asked to stay at home on the next day for home visit interviews. A brief 
explanation of the study was given, including what was expected from the 
patients if they chose to participate. Unfortunately the team was not able to 
reach patients who lived a long distance away from the CHC due to the limited 
time and resources.  
 
Dili District 
Due to a change of plan for interview in Liquica District, which was delayed until 
one week later, the research team had to interview patients in some other sites. 
Therefore, staff of Bairopite Clinic, which is located in Dili was contacted, so that 
the team could start interviewing patients that were readily available and easily 
accessible as they visit the clinic for DOTS. Very luckily a verbal approval was 
acquired directly from the clinic director to conduct the interview. This was also 
due to the fact that the director was aware of the research study during the 
qualitative data collection. Summary information regarding the study was also 
given to the clinic TB staff to provide to patients who came to receive their 
medications.  
 
After returning from field trips to Maliana and Liquica Districts, the team 
continued to interview patients under treatment at Bairopite Clinic, Motel Clinic, 
CHC Centro and CHC Comoro. Those patients under the continuation phase of 
treatment were contacted to discuss the possibility of coming to the clinic the 
same day, the following day or any other day that suited their daily schedule.  
The interview was conducted from Monday to through to Saturday until the 
required target sample was met.  
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The research team continued to work collaboratively with TB staff at the 
selected sites throughout the recruitment and interview process, especially with 
patients in rural areas of every district. Prior to questionnaire refill or interview, 
the local clinic staff who were directly responsible for the patient’s treatment 
approached the patient at first to provide a brief overview on the purpose of the 
data collection. Then, a research interviewer was introduced to the patient for 
further interview or refill of the questionnaire.  
3.6 Data Analysis and Management  
3.6.1 Exploratory Qualitative Data Analysis   
All interviews were digitally recorded and transcribed to English.  A framework 
for the analysis was developed according to the objectives and research issues. 
The content analysis of each transcript was conducted thoroughly to identify 
themes emerged, keywords mentioned repeatedly, and identified themes that 
related to each other. 
 
3.6.2 Quantitative Content Analysis  
To prevent duplication or typographical errors in the process of data entry, 
EpiData version 3.1 was used. The program allows users to create simple data 
entry and documentation. It offers features that detect errors such as double 
entry verifications and codebook overview of data. A database was created with 
the same format and structure as the questionnaire using EpiData. To minimize 
errors during data entry, options for answering each question were created and 
specifically coded, where acceptable values for the question only can be 
entered. For instance, a question with a scale of one to four, a coding can be 
assigned where the program only accepts numbers one, two, three or four. 
However, other number such as zero, five or a combination of two numbers will 
not be accepted, and the program would prevent skipping to the next question 
until the correct answer is given to the specific question. The data was then 
converted to Statistical Package for Social Sciences (SPSS) statistical software 
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for Windows Version 20.0 (Inc., Chicago Illinois) for analysis (Allen & Bennett, 
2012).  
Steps to Data Analysis  
Data screening and preparation  
- Developing a coding manual  
- Checking to ensure there were no duplications  
- Conducting frequency distributions for all variables to check for invalid 
response and degree of missing data  
Assumptions were checked through the following methods: 
- Distributions of all continuous variables were examined. 
- A correlation test using multi-collinearity was performed to check 
variables that measured similar concepts.  
- Homegeneity of variance was considered when comparing the mean 
(SD) of two or more continuous variables to ensure similar spread.  
 
Bivariate data analysis  
A bivariate analysis was conducted to determine the association between the 
outcome variables and independent factors. Categorical independent variables 
were analysed using chi-square and univariate logistic regression and t-test for 
continuous independent variables.  
Multivariate data analysis  
The VAS scale was dichotomized to adherent and non-adherent. Prior to the 
multivariate logistic regression analysis, tests for linearity of trends with 
dependent variables and multicollinearity among independent variables was 
performed. Correlation tests were conducted to determine the inter-relationships 
of independent variables.  
In multivariate regression analysis all independent variables were entered in the 
model while simultaneously removing each insignificant variable when 
observing the impact it buffers on other variables. The same method was 
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carried out by entering all variables associated with non-adherence at p≤ 0.1 in 
univariate analysis. The logistic regression analysis was appropriate to 
determine predictors of adherence and assess the independent and multiple 
effects of those factors on adherence. The study used the probability level of 
95% for all statistical tests at the significant level of p≤0.05 and all prevalence 
estimates were calculated with 95% confidence intervals.  
 
3.7 Ethical Considerations  
All research activities involved in this project were carried out according to the 
ethical approval from both the University Human Research Ethics Committee, 
QUT (approval number 1200000458) and the Ministry of Health of Timor-Leste 
National Institute of Health (approval number CHRD-2011-0028) (see 
Appendices F & G). 
 
Given that the surveys were administered with TB patients who were chronically 
ill, all health and safety precautions were taken into consideration. This included 
the training of survey administrators before the data collection, masks were 
worn when administering the questionnaires in isolated areas, using a space 
with good ventilation and airflow system, otherwise an open area was preferred. 
 
Because the study investigated TB medication adherence and its associated 
factors, some of which were sensitive to assess, especially about illegal drug 
use and mental health, several methods were applied during the data collection 
to minimize the discomfort or emotional distress of the participants. If 
participants showed emotional distress, they were referred to their respective 
clinics for support and follow-up. Throughout the data collection, it was 
emphasised that the information provided was anonymous and confidential. It 
was ensured that respondents felt as comfortable as possible and they 
understood that each individual participant had control in completing the survey. 
There were no complaints reported by health professionals of these clinics in 
the study throughout the whole data collection period.  
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Participation in this study was voluntary, but a small package containing 
noodles, lollies, soap and washing powder (approx. AUD 2) was provided to 
patients after the interview as a symbol of appreciation of their participation in 
the qualitative data collection. For the main survey, participants were given an 
incentive worth 3 US dollars per person (approx. AUD 4) to reimburse their 
transport cost to and from their respective clinics. 
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Chapter 4:  Qualitative Study Results  
INTRODUCTION 
Chapter 4 presents the findings from the qualitative study. The chapter begins by 
describing the socio-demographic characteristics of participants, and the facilitators 
and barriers to their treatment behaviours. In addition, the qualitative study was 
conducted to gain a deep understanding of TB treatment adherence from the point of 
view of health professionals and TB patients, and to identify important factors to be 
included in the final survey.  
 
4.1 Demographic Characteristics  
4.1.1 Health Professionals 
Of the 10 health professional participants for the interviews, nine were males. 
This is common in Timor Leste, especially in the TB program employment, 
where there was only one female out of the 13 District Tuberculosis 
Coordinators (DTC) in the country at the time of the interviews. This could be 
due to the nature of the position, where part of the responsibilities include travel 
to the remote areas of the country, which sometimes can be very challenging, 
due to the long distance and poor road conditions. The age range of the 
interviewees was 25-70 years and the level of education across all participants, 
including government staff, clinic and I/LNGO was high school, college or 
university degree. 
 
4.1.2 Tuberculosis Patients  
The following is the demographic characteristics of the TB patients who 
completed the qualitative interviews. The patients’ ages ranged from 18 to 60 
years old at the time of the interviews. There were equal numbers of males and 
females, as the participants were purposely selected. All participants were 
undertaking treatment in Bairopite Clinic and Comoro CHC in Dili district. Over 
half of the participants had not completed high school (n = 6), more than half 
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were married (n = 6) and a majority (n=7) of the participants were unemployed 
(having a stable job) other than farming. Participants who were unemployed 
reported receiving financial support from their children for transport costs to 
travel to and from the clinic. Others had received social welfare support from the 
local government if they were aged 55 years or older. 
 
4.2 Framework of Qualitative Data Analysis 
Several important themes were identified in the qualitative data analysis 
process. 
Treatment-related factors  
- Long distance to the nearest health service and cost associated with 
travelling 
- Poor patient-health care relationships and limited counselling services 
- Lack of confidentiality and trust  
- Unreliable service  
- Poor management of side-effects  
- Lack of information on treatment  
- Complexity of treatment regimen.  
 
Personal factors  
- Gender (women tended to put priority on family over themselves) 
- Age  
- Depression  
- Risk behavior (alcohol and tobacco use) 
- Loss of appetite to take medication 
- Personal belief and perception of treatment regimen in comparision to 
traditional healer 
- Treatment knowledge (stopped treatment when feeling better, unaware of 
consequences for not completing treatment, considered alternative 
treatment, such as visiting traditional healers).  
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Consequents of social stigma 
- Avoided taking medication 
- Prevented patients from disclosing treatment status  
- Determined level of adherence  
 
Family and Social Support  
- Having children and being a parent  
- Husband/wife  
- Friends and relatives  
- Health professionals and community volunteers.  
-  
 4.3 How TB Patients Adhered to Treatment 
Of the 10 patients who participated in the qualitative study, four were in the 
intensive phase of treatment (admitted for treatment within 2 months) and six 
were in the continuation phase (had been under treatment for over 2 months but 
less than 8 months).  
 
When the patients were asked if at any time they had missed medications, four 
patients answered that they had not missed medications because they wanted 
to get better. They also further stated that it was important to take care of 
themselves and follow the doctor’s instruction because it was important for their 
health.A 53-year-old patient stated “I have been sick, [that is why] I come to see 
the doctor, and I have been asked to take all my medications… I want to get 
better, so I follow their instructions”. Another added “The doctors know what is 
best for us, and if they say we have to take all medications, we have to follow 
what is asked. It is for our wellbeing”.  
 
When asked how important it was for a patient to follow instructions and adhere 
to their treatment regimens, their responses clustered around the themes of 
following doctor’s instructions and wanting to get better. 
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A female patient stated: 
“It is very important for us to take all our medications. I don’t know why, 
but if I want to get better I will have to take all my medicines and follow 
what the doctors ask”. 
 
Conversely, six patients stated that they had missed their medication at various 
times and gave different reasons for this.  The most common reasons were that 
they needed to work on the farm, lived far away from the clinics, sometimes had 
a conflicting obligation such as a family-related activity, or that they simply 
forgot to take their medication. A distinctive factor which affected patients’ 
missed medication is quoted below. 
 
A 41-year-old male patient stated: 
“Yes, I have missed medication because I was busy with daily activities 
working on the farm. Sometimes I have no appetite to take them”. 
 
The health professionals also agreed that patients would adhere to the 
treatment when they felt there was an improvement in their health. However, 
they also recognized that patients who had family priorities may unintentionally 
miss their medications, even though they were aware of the consequences. 
 
4.4 Factors Influencing TB Treatment Adherence   
4.4.1 Severity of Illness 
The severity of the illness had an influence on how soon a patient sought 
treatment and how seriously he/she followed the prescribed treatment 
regimens. When asked, “how do symptoms of TB affect the level of adherence 
to treatment?”, the health professionals responded as follows: 
 
A CHC staff member stated that those who were too sick would fear death and, 
therefore, followed treatment seriously. However, those that were diagnosed 
with TB while the sickness was not very severe might not follow the treatment 
regimen if the health workers provided limited counselling and information about 
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TB and its treatment process. Furthermore, the CHC staff member stated 
“There’s a tendency to complete treatment if severity of the disease is high. This 
severity is measured through the sputum test on a scale of 1 as moderate to 3 
as severe”.  
 
A district TB coordinator also added that according to his experience, he 
observed that some patients would take medications for a few months but after 
the symptoms were gone and they felt better, they would stop. This was worse 
for those who lived some distance from available health services while busy 
with daily activities. One clinic staff member commented on the difficulties 
individual patients faced when they had to travel a long distance to access 
health services. Such a burden reduced access to medications for those who 
were chronically ill. Consequently, patients might spread the disease further to 
their family, relatives and neighbours. Several health professionals also 
mentioned that patients who started treatment and experienced drug side-
effects were likely to stop treatment, especially if their sickness was not severe 
at the time of diagnosis.   
 
4.4.2 Drug Side-effects  
In this study, the impact of medication side-effects on adherence was evident from 
the experiences of the health professionals.  
A DTC stated: 
 “patients would discontinue treatment if health workers do not describe 
clearly what would happen in terms of side-effects when taking the 
medication”. 
While, CHC staff also agreed that if health professionals did not provide sufficient 
information, patients were be less likely to adhere to treatment.  
 
Through personal experience, an NGO staff member suggested that: 
 “side-effects are a common challenge for TB patients. Therefore, it is crucial 
that health professionals spend at least 15 minutes per session explaining 
about the treatment process prior to treatment enrollment.” 
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 A clinic staff member supported the argument that if patients were given sufficient 
information regarding the side-effects of the drugs, they would understand, and 
when encountering side-effects, they would still have the willingness to adhere to 
the treatment regimens. Additionally, another health professional suggested from 
personal experience that identifying the side-effects early and treating them was 
vital. At the same time it was also important to strengthen patients' knowledge to 
help them to adhere to the treatment regimen. It was reported that, on a number of 
occasions, patients who experienced medication side-effects and were unable to 
get support tended to drop out of treatment. 
 
4.4.3 Psychological Distress 
The psychological wellbeing of individual patients was also an important aspect 
that directly determined treatment success. When participants were asked, 
"How does mental health affect patients' treatment adherence?", a number of 
insights emerged. 
 
One of the health professionals had come across numerous cases throughout 
his work. He stated: 
 "Patients that are mentally affected, even family members would refuse 
to look after them. This is due to the fact that some patients do not want 
to take their medication at all" 
 
Similar circumstances were reported by two other health professionals: 
 "Those who have mental health problems would be less likely to adhere 
to the treatment regimen. This is because patients do not follow 
treatment instructions given"  
 
At the same time, a district TB coordinator stated: 
 "People with a mental health disorder would not follow what is expected 
in the treatment. When the sickness becomes chronic, they go away to 
hide or runaway". 
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4.4.4 Traditional Healers   
Involvement of traditional healers in TB treatment was a locally derived element 
directly impacted on TB treatment. A number of health professionals shared 
their experiences of non-adherent patients who had considered the traditional 
healers as a form of treatment facility.  
 
A district TB coordinator stated:  
“when patients experience treatment side-effects, they are more likely to 
seek the support of the traditional healers, and it is worse when patients 
live far away from available health services.” 
 
Another health professional added: 
“People’s belief about the traditional healers to have healing power is a 
big thing in the country, and some patients take traditional medicine and 
falsely guided by the traditional healers that it is ok for them to consume 
alcohol and smoke cigarette.”  
 
The same health professional continued to share a case where there were 50 
patients admitted to a traditional healer for treatment and 37 of these patients 
were found to have had positive TB when diagnosed. This suggests that the 
traditional healers had a significant influence on patients with TB in the remote 
areas of the country.  
 
4.4.5 Education & Knowledge   
The health professionals seemed to have some knowledge and understanding 
of various factors associated with patients’ treatments. When asked, “Do you 
think patients’ socio-demographic characteristics, such as age, gender, job 
status, education, income etc. affect treatment completion?”, their responses 
were as follows: 
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For education and knowledge, a health professional stated:  
"Patients’ education and their knowledge of TB treatment are vital to 
treatment completion. Patients would stop treatment when they feel 
better, if they lack knowledge about TB" 
 
A DTC staff member also agreed with this statement and added that those who 
lacked knowledge, who had moderate TB symptoms felt frustrated if they were 
diagnosed with TB. 
 
At the same time, a district TB coordinator (DTC) stated: 
 "patients may have good knowledge of treatment. However, if they are 
concerned about loss of income as a result of treatment while receiving 
no family support, coupled with other factors such as residing distance 
from available health services, they will be highly likely to not adhere to 
treatment."  
 
A general comment was also given by a health professional: 
 "those who are considered to be living below the poverty line would have 
a lack of food, suffering from malnutrition and living in overcrowding and 
unhygienic conditions, and such obstacles would lead them to ignore 
treatment"  
 
The statements made by each health professional appeared to be consistent, 
indicating that patients with low treatment knowledge, along with poor financial 
support and who lived a long distance from available health services were less 
likely to fully follow their treatment regimens. Furthermore, TB treatment 
knowledge was repeatedly mentioned when discussing other factors, such as 
illness severity, drug side-effects, psychological distress and involvement of 
traditional healers in the treatment process. This was due to patients stopping 
treatment if they felt better after some months of treatment. Moreover, if patients 
experienced medication side-effects they were likely to feel stress and drop out 
or consider other treatment alternatives such as seeing a traditional healer. 
Therefore, TB treatment knowledge appeared to both directly and indirectly 
influence other factors that contributed to the overall TB treatment outcome.  
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The level of knowledge and understanding of the treatment process also 
depended on the availability and accessibility of information by individual 
patients. More importantly, sufficient information on TB treatment provided by 
the health professionals to patients at the time of diagnosis was critical to avoid 
treatment non-adherence.  
 
4.4.6 Cigarette Smoking and Alcohol Consumption 
When the health professionals were asked whether TB patients' lifestyles, such 
as alcohol consumption or tobacco smoking affected treatment adherence, a 
few statements were given as follows: 
 
A CHC staff member stated: 
 "Alcohol addicted patients may agree not to consume alcohol within the 
first two months. However, once they feel better they would be less likely 
to adhere to treatment and might start to drink again. This is common for 
those patients who live in homes where many family members are 
tobacco smokers and alcohol drinkers." 
 
 An NGO staff member agreed with this statement, and said: 
 "Patients would normally promise that they would not drink and smoke 
again at the time of diagnosis and treatment. However, in most cases 
when the family members of patients were visited, they constantly 
reported that patients had started to smoke and drink again while under 
treatment."  
 
Another health professional confirmed that patients' family members have 
reported that the patients had started smoking cigarettes and drinking alcohol 
again, therefore disobeying the agreement they had with health professionals 
prior to treatment.  
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4.4.7 Cost and Treatment Accessiblity 
When patients were asked whether age and distance from health services had 
an impact on treatment, most highlighted numerous non-adherent factors. The 
most common reasons given were, old age, distance from health services, time 
and travelling costs.  
 
A 48-year-old female patient stated: 
 “Distance is a problem for us. If we walk, the weather is too hot and the 
clinic is too far. If we travel by transport, it costs money and it becomes a 
problem because we do not have money to travel all the time”. 
 
A 51-year-old stated: 
 “Distance away from the clinic is a problem as I have to walk to the clinic 
every day. I want to catch a taxi, but it costs a lot of money. I walk every 
day, but with my old age it is very hard”. 
 
While under treatment, patients are expected to regularly visit their respective 
clinics for checks of their weight, medication side-effects, and general 
improvement of their health. A health professional also explained that distance 
to health services would involve transport costs, which many could not afford. 
Such demands discourage patients from travelling to health centers to refill their 
medication and, therefore, failed to comply with the treatment requirements.  
 
In addition, it was difficult for patients with other family priorities that may require 
them to travel, especially to the countryside. This was evident in the case of a 
male patient who agreed to be interviewed but insisted on finishing quickly as 
he had to travel to the countryside for a family-related activity. It is a common 
practice in most parts of Timor that throughout the year, people have family 
reunions and cultural celebrations where everyone is required to be present. 
Under these circumstances, health carers and patients negotiate to find the 
most suitable method, that is, provide sufficient drugs for the duration of time 
that patients are in the countryside. However, sometimes patients were 
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provided drugs that were sufficient for only a week and may not return on time 
for their medication refill, and so they ran out of pills to take.  
 
4.4.8 Patient-Carer Communication  
Communication is a fundamental aspect between health professionals and patients 
in determining a successful treatment. Poor communication may result in patients 
having limited information about the treatment process. Consequently, patients may 
seek alternative treatments or drop out if they encounter a treatment-related factor. 
When patients were asked whether having a good relationship with the health 
professionals will help their treatment progress, their responses are as follows: 
  
A 32-year-old female patient stated: 
“Yes, it is important to have a good relationship with our doctors, 
because if they don’t look after us, we may stop treatment”. 
 
A 47-year-old male patient added: 
Yes, we need to have a good relationship because it is important for us. 
The health workers attend to us and they help us with our treatment”. 
 
Although it was difficult to probe the patients to describe their relationships with 
their health carers further, it was clear that all participants agreed about the 
importance of having good relationships with their respective health carers.  
 
While discussing the patient-health professionals’ relationship, patients were 
asked about information they received from the health care providers at the time 
of diagnosis. Three of ten patients were able to recall that they were told about 
the duration of the treatment. Three participants recalled that they were asked 
by the health professionals to take medication until they were cured. One 
responded that the information given by health professionals should be kept 
secret, while several gave no answer.  
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4.4.9 Family, Social Support & Treatment Confidentiality 
In terms of who would remind patients to take their medicines, most stated 
family that family members, including children or husnbad/wife reminded them 
to take medicine, while one said he had nobody to remind him about medication 
time. In relation to how comfortable they were to share information about their 
treatments, one patient said it was important to share information about his 
treatment with his family because they were supportive of the treatments. Two 
people said that they did not tell the family members at all. One respondent said 
that he felt very uncomfortable sharing his treatment status because he was 
afraid of being stigmatized. For the support each patient received during the 
treatment only one patient said he received no support, and nine patients stated 
that they had support from family members and friends for associated travel 
costs and food. Nine of the ten patients also confirmed that they received 
support from family members with their treatment. However, they also admitted 
that information regarding their TB diagnosis was not shared.  
 
4.5 Discussion   
Analysis of the qualitative study found that participants from the higher level of 
government health services highlighted factors that were commonly found in the 
scientific literature reviews, such as the impact of poverty, overcrowded 
environments and poor access to health services. In comparison, those who 
worked for I/LNGOs were more likely to share their understanding of the 
weaknesses in the system, for example, a shortage of human resources and 
lack of training for health professionals, resulting in poor delivery of services.TB 
patients understood the importance of treatment adherence and were aware of 
the consequences of poor non-adherence, though it was difficult to probe them 
to provide further details about the treatment process due to their limited 
experience with participating in a survey. However, both patients and health 
professionals provided important insights on TB treatment in this specific 
population.  
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The current national tuberculosis program (NTP) strategy in Timor-Leste 
encourages patients to undertake treatment while living at home, as in-patient 
clinics are too costly (Ministry of Health Timor Leste, 2010). However, patients 
who are chronically ill with contagious TB, and are considered to have a low 
socioeconomic status while living in remote areas distant from accessible health 
services are eligible for short-term support to live in TB specialist clinics. 
Patients with these circumstances are also given the option to stay with their 
family. They are encouraged to stay at home as long as there is a family 
member to care for them, agree to adhere to their treatment and regularly visit 
the clinics as scheduled. 
 
The qualitative study found that both health professionals and patients had 
similar perceptions of TB medication adherence. Both agreed that poor access, 
the long distance from and to health services, and treatment-associated costs 
were major issues affecting treatment adherence. These findings are supported 
by Martins et al. (2008) in a qualitative study in Timor-Leste and a systematic 
review of qualitative research on TB by Munro, Lewin, Smith, et al. (2007). In 
their study, they found that health professionals also believed lower adherence 
to treatment was due to poor nutritional support (Munro, Lewin, Smith, et al., 
2007), and limited understanding of the treatment process (Ayisi et al., 2011). If 
they lacked knowledge at the time of admission, once they encountered 
treatment side-effects they were more likely to consider alternative treatments 
such as seeing a traditional healer (Martins et al., 2008). 
 
 In the current study, two health professionals suggested that aged people 
normally lacked knowledge about TB, yet they seemed to strictly follow 
treatment as they wanted to get better. Furthermore, few added that aged 
patients who lacked knowledge did not care about discrimination. However, 
younger patients with good education and better understanding of TB feared 
stigmatization. However, they cited instances where well-educated patients 
tended to not adhere to treatment because they were afraid of being noticed 
and feared being stigmatized. Furthermore, patients’ families sometimes found 
it hard to believe that their family members had TB. 
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Health professionals further suggested that if a patient was given thorough 
information regarding the treatment, they would be more likely to adhere and 
complete their treatments successfully. The information given by health 
professionals prior to admission of the patients to the program should highlight 
the importance of the side-effects of the drugs, length of treatment, 
consequences of not adhering to treatment, counselling, and all available 
supports.  
 
Most health professionals stated that employed patients were less likely to 
adhere to their treatment. This was due to being more concerned about losing 
their jobs than completing their treatment. Most health professionals agreed that 
patients who were educated and had substantial knowledge of TB diseases had 
higher adherence to their treatment, especially if they had been given a 
thorough explanation of the treatment process. A review of the qualitative 
literature found that both health professionals and patients may interpret the 
themes of illness and wellness differently (Munro, Lewin, Smith, et al., 2007).. 
The review also reported that patients’ knowledge, attitudes, beliefs and 
interpretation about the disease were likely to be determinants of the overall 
treatment outcome (Munro, Lewin, Smith, et al., 2007). 
 
 Patients highlighted that the most common factors associated with non-
adherence were lack of finance to support travel from and to health services 
(Munro, Lewin, Smith, et al., 2007). Patients also stated that personal 
characteristics, such as being old limited their ability to travel independently to a 
clinic. A systematic review of the qualitative research by Munro, Lewin, Smith, 
et al. (2007) discussed the organisation of treatment and care for TB patients, 
where their access to health facilities depended on the availability of transport, 
distance required to travel and their physical condition (Munro, Lewin, Smith, et 
al., 2007).The findings of the current research were  consistent with  Martins et 
al. (2008) results. Participants in the current study stated that having a good 
relationship with health professionals and stable family and social support was 
vital to the treatment process, and health professionals consistently stated that 
having good treatment knowledge was important for treatment success (Munro, 
Lewin, Smith, et al., 2007).  
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When health professionals were asked about the impact of unhealthy lifestyle 
behaviours such as tobacco smoking and alcohol abuse on TB treatment, some 
suggested that cigarette smoking and alcohol consumption directly affected 
treatment adherence. Some stated that patients were lost to follow up due to 
alcohol problems. Additionally, at the time of admission, some smokers agreed 
that they would give up smoking during treatment, yet several reports from their 
family members indicated that they continued to smoke. Some of these cases 
completed treatment over a longer duration than expected and were more likely 
to default. Peltzer (2014) recommends preventative programs because conjoint 
alcohol and tobacco use is associated with low adherence. 
 
Mental health was raised as an important aspect of TB treatment. Seven out of 
the ten health professionals stated that treatment was more complicated with 
patients who had mental health disorder. Several discussed incidents where 
family members did not want to take care of their relative with TB who 
repeatedly refused to take their medications. Often, patients experienced 
severe mental health due to experiencing no changes in their health while 
encountering treatment side-effects. It has been widely reported that some 
patients stopped treatment because of adverse side-effects, and did not know 
what to do because they were not made aware of such issues (Munro, Lewin, 
Smith, et al., 2007). 
 
The health professionals also highlighted that the patients’ knowledge of TB 
treatment was an important aspect in determining treatment success. Martins et 
al. (2008) also concluded that patients’ knowledge of the disease was one of 
the predictors of overall treatment completion. However, the qualitative finding 
of the current study found that less educated and unemployed patients are 
more likely to adhere to treatment compared to those who are educated and 
currently employed. This finding contradicts with the prevous qualitative studies 
which have reported that better education was directly influence treatment 
outcome (Armijos et al., 2008; Ayisi et al., 2011; Baral et al., 2007; Eastwood & 
Hill, 2004). This may be explained by the fact that patients who are less 
educated more likely to be unemployed. Thus, they have more time to 
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concentrate on their treatments. In comparision, those who are educated and 
employed are afraid of being stigmatised in their work place settings as result of 
having TB (Armijos et al., 2008; Finnie et al., 2011; Karim et al., 2007; Martins 
et al., 2008; Sengupta et al., 2006). A number of barriers identified in the current 
study have also been reported by Martins et al. (2008), indicating the 
consistencies of the current findings with the previous study on TB in Timor 
Leste.  
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Chapter 5:  Main Survey Results 
INTRODUCTION 
Chapter 5 presents the results from the main survey data analysis. The chapter begins 
by describing the characteristics of the study sample, including demographic variables, 
family and social features, clinical and risk behaviour characteristics (smoking, alcohol 
and drug use), health professional-patient communication, psychological distress, 
health locus of control, traditional healer, patient knowledge and stigma. The second 
section of the chapter provides the estimates of non-adherence to TB treatment among 
the sample, measured using the VAS and MARS and the degree of agreement of 
adherence and non-adherence between the two measurements. The second section 
also reports the subjective non-adherent factors listed by the patients.  
 
The last section of Chapter 5 reports the results of the statistical tests examining a 
range of factors associated with the VAS 1-month dose non-adherence. To determine 
the associations of the independent variables with VAS non-adherence, categorical 
independent variables were analysed using chi-square tests and univariate logistic 
regression, while for the continuous independent variables, chi-square and univariate 
logistic regression analysis were used. All the variables associated with non-adherence 
in the univariate analysis at p ≤ 0.1 were entered in the multivariate logistic regression 
for the final analysis. Logistic regression was used to determine the correlations of the 
outcome variables and to estimate the independent and multiple effects of the selected 
independent variables on the dependent variable. To examine the strength and 
direction of the observed association, adjusted odds ratios were examined. All 
hypotheses were tested at the 95% probability level. A draft paper for the final analysis 
of this study for publication is attached in Appendix M. 
 
5.1 Characteristics of study participants  
This section presents demographic variables, characteristics of family and 
social support, risk behaviours of participants, health professional – patient 
communication, psychological wellbeing, health locus of control, and traditional 
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healers’ involvement in treatmet, knowledge, social stigma and family and social 
support.    
 
5.1.1 Demographic Variables  
The characteristics of the participants are summarized in Table 9. There was a 
10 percent difference between males and females (55% and 45% respectively), 
and the age ranged from 18 to 73 years (M = 38.05, SD = 16.3). Just over a 
quarter (28.0%) had no formal education and 26.6% had only reached primary 
education. Over one third of the population (38.7%) were unmarried and 61.3% 
were currently married. Approximately a quarter of the sample (25.4%) had no 
job while for the majority (44.5%), the means of subsistence was from personal 
income (i.e. government subsidy for senior citizens) and 38.9% received family 
support. 
 
Table 9 Percentages and Frequencies for Demographic characteristics 
Demographic characteristic n (%) 
Gender   
    Male    191  (55) 
    Female   154  (45) 
Age (Min: 18; Max: 73; M = 38.05 ± 16.3)  
     18-29 138 (39.8) 
     30-49 89 (25.7) 
     50+ 120 (34.6) 
Marital status  
     Unmarried 134 (38.7) 
     Married 212 (61.3) 
Education (schooling attended)  
     No formal education 97 (28) 
     Primary school 92 (26.6) 
     Secondary/high school 101 (29.2) 
     College/University  56 (16.2) 
Current Job  
    No job 102 (25.4) 
    Farmer 57 (14.2) 
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Demographic characteristic n (%) 
    Labour work 70 (17.5) 
    Civil servant 24 (6.0) 
    Student 85 (21.2) 
    Housewife 43 (10.7) 
    Other 20 (5.0) 
Main source of subsistence   
    Income 176 (44.5) 
    Support from husband/wife 62 (15.7) 
    Support from family  154 (38.9) 
    Other  4 (1.1) 
Wages/family financial support 
     < 60USD/month 193 (55.6) 
     > 60USD/month  154 (44.4) 
 
5.1.2 Family and Social Characteristics  
Descriptive statistics for the family and social characteristics of the sample are 
displayed in Table 10. Almost 90% of the population lived and shared meals 
with four or more people: 46.1% with their husband/wife, 42.9% with children 
and 34.7% with extended family members. Living alone, with friends or co-
workers represented 3.2%, 1.5% and 1.2% of the sample respectively. In terms 
of care-giving received, the majority (79.5%) said they took care of themselves, 
28.5% from care providers and approximately one in five people received care-
giving support from children (19.9%) or a husband/wife (19.6%).    
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Table 10 Percentages and Frequencies for Social and Family Characteristics 
 
Family and social characteristics n (%) 
Number of people living in the same house and sharing meals 
0 4 (1.2) 
1-3 36 (10.4) 
4 or more 303 (88.4) 
Person(s) living in the same house and sharing meals 
Live alone 11 (3.2) 
Parents 77 (22.4) 
Children 147 (42.9) 
Husband/wife 158 (46.1) 
Other family members 119 (34.7) 
Friends 5 (1.5) 
Co-worker(s) 4 (1.2) 
Person most often care-giving 
Husband/wife 68 (19.6) 
Parents 50 (14.4) 
Children 69 (19.9) 
Other family members 53 (15.3) 
Friend(s) 27 (7.8) 
Co-worker(s) 12 (3.5) 
Community volunteers 11 (3.2) 
Health care providers 99 (28.5) 
Take care of myself 276 (79.5) 
 
5.1.3 Alcohol, Tobacco and Illicit drug-use 
Almost half the population (44.6%) stated that they had stopped drinking alcohol 
at the start of treatment, while 12.7% continued to drink alcohol during 
treatment (see Table 11). The percentage of people who had ever smoked was 
48.3%. For illicit drug use, 1.2% admitted to having used illicit drugs in the past. 
When stratified by gender, it was clearly evident that gender significantly 
influenced these behaviours (see Table 12). 
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Table 11 Descriptive Statistics for Risk Behaviour and Clinical Characteristics 
 
 
  Table 12 Chi-Square P-Values for Risk Behavioural Characteristics by Gender 
Variables Male (%) Female (%) 
Chi-Square 
p-value 
Status of drinking (alcohol) < 0.001 
Never 36 (19.0) 111 (75.5)  
Used to drink 121 (64.0) 33 (21.4)  
Currently drinking 32 (17.0) 12 (27.3)  
Cigarette Smoking status   < 0.001 
Never smoke 39 (20.5) 140 (89.7)  
Used to smoke 140 (73.7) 15 (9.6)  
Variables    n % 
Alcohol use (last month)   
     Never drink 147 42.6 
     Used to drink (quit drinkin start of t’ment) 154 44.6 
     Currently drinking 44 12.7 
Cigarette smoking status    
     Never smoke 179 51.7 
     Used to smoke 155 44.8 
     Currently smoking 12 3.5 
Illicit drug use   
     Never 337 98.8 
     Yes, in the past 4 1.2 
Health Services   
      Public health services with CBTC 34 9.8 
      Private clinics 134 38.6 
      Public health services  69 19.9 
      Home visit patients 110 31.7 
Travel time to nearest health service   
     Less than 30 minutes 197 58.6 
     More than 30 minutes 139 40.4 
Note. CBTC = Community Based TB Care Program.  
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Variables Male (%) Female (%) 
Chi-Square 
p-value 
Currently smoke  11 (5.8) 1(0.6)  
Status of illicit drug use      0.039 
Never use 181 (97.8) 156 (100)  
Ever use 4 (2.2) 0   
 
5.1.4 Health Professional and Patient Communications 
The descriptive statistics of patient-health care professional communication are 
presented in  
Table 13. The total mean score (M = 19.14, SD = 3.11), range 5 to 25. The 
mean score of each item assessing the information received from their health-
carers shows that almost all participants were satisfied. This is also consistent 
with level of satisfaction with the overall communication and support. It ranges 1 
- 4, where 1 was “very dissatisfied”, 4 “very satisfied”, the scale showed a mean 
score of (M = 3.27, SD = 0.54).  
 
Table 13 Means and Standard Deviations for Health Professional-Patient 
Communication Item, Total and Overall Satisfaction Scores 
Item M (SD) 
Scale of communication between patients and HCPs  
HCP told me what the possible side-effects of each of the TB drug are 3.64 (1.075) 
HCP told me what the treatment would do 4.02 (.728) 
HCP told me how the TB treatment would be 4.04 (.703) 
HCP told me the changes to expect in my health when taking TB 
medication 
4.07 (.741) 
Treatment procedure was clearly explained by the HCP 4.10 (.702) 
Mean total 19.14 (3.11) 
Overall level of satisfaction   
Satisfaction with the overall communication support from HCP 3.27 (.541) 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Strongly 
Disagree, (2) Somewhat Disagree, (3) Neither, (4) Somewhat agree (5) Strongly agree. 
Satisfaction scale, range is 1-4, assessed degree of satisfaction of support from health professional: 
(1) very dissatisfied, (2) somewhat dissatisfied, (3) Somewhat satisfied, (4) Very satisfied.  
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5.1.5 Characteristics of Participants' Psychological Distress 
Table 14 displays the scores of the degree of psychological distress of the 
sample. The total score was calculated by aggregating the items scores 
accordingly with the guideline from Kessler Psychological Distress Scale (K10). 
A score under 20 was likely to indicate being well, 20-24 was likely to indicate a 
mild mental disorder, 25-29 was likely to suggest a moderate mental disorder 
and a score of 30 or over was likely to indicate a severe mental disorder. The 
mean score for the degree of psychological distress in this sample was 26.83 
(SD = 8.0), indicating that individuals in this population likely to suffer a 
moderate mental disorder.  
Table 14 Means and Standard Deviations for Psychological Distress Item and 
Total Scores 
Items M(SD) 
In the past 30 days, about how often did you feel tired out for no good 
reasons? 
3.14(1.461) 
In the past 30 days, about how often did you feel nervous? 1.98(1.236) 
In the past 30 days, about how often did you feel so nervous that 
nothing could calm you down? 
1.76(1.110) 
In the past 30 days, about how often did you feel hopeless? 2.98(1.397) 
In the past 30 days, about how often did you feel restless or fidgety? 2.60(1.351) 
In the past 30 days, about how often did you feel so restless you could 
not sit still? 
2.44(1.310) 
In the past 30 days, about how often do you feel depressed? 2.66(1.297) 
In the past 30 days, about how often did you feel that everything is an 
effort? 
3.28(1.284) 
In the past 30 days, about how often did you feel so sad that nothing 
could cheer you up? 
3.09(1.317) 
In the past 30 days, about how often do you feel worthless? 2.85(1.427) 
Mean total psychological distress  26.83(8.00) 
Note: Scale, range is 1-5, assessed psychological distress in the past month. (1) None of the time, 
(2) A little of the time, (3) some of the time, (4) Most of the time and (5) All of the time. 
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5.1.6 Descriptive Statistics for Health Locus of Control 
The descriptive statistics for the Chance Health Locus of Control are presented 
in Table 15. As indicated in the table, the mean of this scale (with possible 
scores ranging from 9 to 36) for the sample is 29.98 (SD = 3.44). The Chance 
Health Locus of Control consists of 9 items that covers internal (I am in control 
of my health, the main thing that affects health is what I myself do and if I take 
care of myself, I can avoid illness), powerful others (regular visit with my 
doctor will avoid illness, I don’t feel well, consult with a medical professional), 
and chance (luck plays a big part in how soon I will recover from an illness, my 
good health is largely a matter of good fortune, if it is meant to be, I will stay 
healthy). The scores for this sample population in all 3 health locus of control 
domains are almost similar (ranged 3.18-3.42). However, the items describe 
that chance or luck determines one’s health were with the highest mean scores. 
This indicates that the average population in the sample having beliefs that their 
health outcomes are strongly determined by chance or luck. 
Table 15 Means and Standard Deviations for Chance Health Locus Control Item 
and Total Scores 
Chance Health Locus of Control items M (SD) 
I am in control of my health 3.28(.531) 
The only thing that affects my health is what I myself do 3.30(.570) 
If I take care of myself, I can avoid illness 3.38(.522) 
Having regular contact with my doctor is the best way to avoid illness 3.34(.509) 
When I don't feel well, I should consult a medical professional 3.18(.642) 
When I recover from illness, it's because other people have been taking care of me 3.27(.614) 
Luck plays a big part in how soon I will recover from an illness 3.36(.522) 
My good health is largely a matter of good fortune 3.42(.523) 
If it's what meant to be, I will stay healthy 3.42(.555) 
Chance HLC 29.98(3.44) 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Strongly 
Disagree, (2) Disagree, (3) Neither (4) Agree, (5) Strongly Agree. 
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5.1.7 Descriptive Statistics for Traditional Healer 
Table 16 displays the descriptive statistics for the use of traditional medicine. 
The mean of this scale (with possible scores ranging from 4 to 20) for the 
sample was 11.77 (SD = 2.45).High score indicates that patients have higher 
use of traditional healers as a form of health service.  
Table 16 Frequencies, Means and Standard Deviations for Traditional Healer 
Item and Total Scores 
Items n M SD 
Taking traditional medicine 124 3.48 0.841 
Could not be cured at the clinic 121 2.79 0.906 
There are no clinics close by 122 2.78 0.905 
Cost of transport is too expensive 122 2.75 0.923 
Total  121 11.77 2.45 
Note: Scale range is 1-5, assessed degree of agreement with each sentence. 1 
Strongly disagree, 2 Agree, 3 Neither, 4 Agree, 5 Strongly agree 
  
  
 
5.1.8 Tuberculosis knowledge 
A descriptive study of tuberculosis knowledge is displayed in Table 17 below. 
When participants were given more than one option to choose for the 
understanding of TB transmission, 64.4% cited the correct answer, as being 
through droplet infections, while 54.2% wrongly recalled it as sharing utensils, 
and 13.3% believed that it was through the punishment of bad behaviour. Thirty 
nine percent indicated that they will not eat with family members as a result of 
having TB. Almost half (47.7%) responded that it was not important to screen 
family members that directly in contact with TB patients.  
Over 90% of the participants understood that TB was curable with proper 
treatment and 87% of the population understood that TB treatment required 6-8 
months to be completely cured. However, as high as 86.4% stated that they 
could stop treatment after feeling better, even if the treatment duration had not 
been reach.  
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Table 17 Frequencies and Percentages for Knowledge of TB Patients 
Items n % 
Tuberculosis is caused by…   
Infectious droplets 224 64.4 
Sharing utensils 188 54.2 
Punishment for bad behaviors  46 13.3 
Does a person with TB eat together with members of the family? 
Yes 208 61.0 
No 133 39.0 
Do family members with direct contact need to screen for TB? 
Yes 163 52.3 
No 179 47.7 
Is tuberculosis is curable with proper treatment? 
Yes 322 93.6 
No 22 6.4 
What is the length of treatment time required to cure TB? 
0-2 months 15 4.3 
6-8 months 301 87.0 
Rest of life 4 1.2 
Varies according to individual 26 7.5 
Can you discontinue treatment after feeling better, even treatment duration 
has not been reached? 
Yes 298 86.4 
No 47 13.6 
 
5.1.9 Tuberculosis Stigma 
Table 18 displays descriptive statistics for patients’ perceptions of stigma. A set 
of questions were asked to assess the patients’ views on community members’ 
reactions towards those with TB. The majority believed the community felt 
uncomfortable about being near those with TB (84.1%), may not want to eat or 
drink with friends with TB (83. 5%), relatives (68.4%), kept their distance from 
others with TB (78.3%), were afraid of those with TB (75.3%), did not want to 
talk to others with TB (65.8%) and would not try to touch others with TB 
(50.4%).  
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The patients' perspectives towards tuberculosis, showed that 81.7% believed 
that people who have TB felt hurt with how others reacted, knowing their TB 
status, 62% believed those with TB felt lonely, 53.3% agreed that TB patients 
were afraid to tell those outside their family members, 51.5% agreed that TB 
patients felt guilty being a burden to their family, and 45.9% believed that those 
with TB were afraid to tell family members that they had TB.   
Table 18 Patients’ Perceptions of stigma  
Items 
Yes  
n (%) 
No  
n (%) 
Community perspective towards tuberculosis   
Do you think people may not want to eat or drink with friends who 
have TB? 
289 (83.5) 57 (16.5) 
Do you think people feel uncomfortable about being near those 
with TB? 
290 (84.1) 55 (15.9) 
Do you think people keep distance from others with TB? 270 (78.3) 75 (21.7) 
Do you think people do not want to talk to others with TB? 227 (65.8) 118 (34.2) 
Are people afraid of those with TB? 259 (75.3) 85 (24.7) 
Do you think people would not try to touch others with TB? 174 (50.4) 171 (49.6) 
Do you think people may not want to eat or drink with relatives 
who have TB? 
236 (68.4) 109 (31.6) 
Patient Perspectives towards tuberculosis   
Do you think people who have TB feel hurt with how others react 
knowing they have TB? 
282 (81.7) 63 (18.3) 
Do people have TB feel alone? 214 (62.0) 131 (38.0) 
Do you think people who have TB are afraid to tell those outside 
their family members? 
183 (53.5) 159 (46.5) 
Do you think people who have TB feel guilty because their family 177 (51.5) 167 (48.5) 
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Items 
Yes  
n (%) 
No  
n (%) 
has the burden of caring for them? 
Do you think people who have TB are afraid to tell their family that 
they have TB? 
158 (45.9) 186 (54.1) 
 
5.1.10 Social and Family Supports 
Descriptive statistics for family social and supports are presented in Table 19. 
The mean for disclosure of treatment status was 12.68 (SD = 2.82), with scores 
ranging from 5 to 20. For each group, the mean of disclosure level to family was 
the highest (M = 3.51, SD = 0.75) and the disclosure level to social organization 
was the lowest (M = 1.29, SD = 0.68). High score in disclosing treatment to a 
group indicates that patients are more open to share their treatment status. 
Similarly, the sources of support include family, friends, neighbour, peer 
educator and social organization. Among these sources of support, the mean 
total for family support was the highest (M = 12.65, SD =3) and the lowest was 
organization support (M = 5.3, SD = 2.02). This means that family provided 
more support to patients compare to the other groups, especially the 
organization support as it is being the lowest.The level of satisfaction for the 
support received also reflected a similar pattern, where family support had the 
highest satisfaction (M = 3.3, SD = 0.66) and social organization was the lowest 
(M = 1.6, SD = 0.86). 
Table 19 Family and Social Support, Mean and Standard Deviation  
Family and social characteristics M(SD) 
Disclosure of TB treatment  
Family 3.51(.750) 
Friends 2.58(.992) 
Neighbors 2.51(.976) 
Peer educators 2.79(.945) 
Social organization 1.29(.677) 
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Family and social characteristics M(SD) 
Total 12.68(2.82) 
Family support  
Help to take TB medication 3.29(.898) 
Emotional support 3.17(.880) 
Tangible support 3.04(1.026) 
Information support 3.16(.854) 
Total 12.65(3.00) 
Friends Support  
Help to take TB medication 2.33(1.037) 
Emotional support 2.34(.926) 
Tangible support 1.98(.988) 
Information support 2.39(.940) 
Total 9.03(3.14) 
Neighbors Support   
Help to take TB medication 2.20(1.012) 
Emotional support 2.21(.866) 
Tangible support 1.87(.936) 
Information support 2.28(.917) 
Total 8.53(2.92) 
Peer educators support  
Help to take TB medication 2.70(.999) 
Emotional support 2.51(.981) 
Tangible support 1.96(1.062) 
Information support 2.47(.936) 
Total 9.60(3.212) 
Social organization support  
Help to take TB medication 1.27(.659) 
Emotional support 1.24(.580) 
Tangible support 1.14(.453) 
Information support 1.26(.623) 
Total 5.30(2.02) 
Satisfaction level  
Family 3.33(.665) 
Friends 2.83(.841) 
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Family and social characteristics M(SD) 
Neighbors 2.75(.875) 
Peer educators 2.97(.851) 
Social organization 1.65(.858) 
Total 13.56(2.758) 
Note: Scale, range is 1-4, assessed level of discloser, support and satisfaction with 
family, friends, peer educators and social organizations: (1) not at all, (2), a little, (3) 
somewhat, (4) a lot.  
 
5.2 Subjective Non-adherent Factors Listed by Patients  
To further explain factors associated with the level of medication adherence, a 
number of possible reasons as to why patients do not take their medications 
were analysed. Table 20 shows an extensive number of reasons patients 
missed their medications. The three most common reasons indicated by this 
specific group were that they simply forgot (72.4%), were busy with other things 
(64.7%) or were away from home (50.3%). The least common reason for not 
taking their medication was that they illicit used drugs (1%). The top 3 reasons 
for missed medication were simply forgot or relapse in memory or out of their 
normal routines.  
Table 20 Percentage and Frequency of Non-adherent Factors Listed by 
Patients 
Items 
Responses 
N (%) 
Simply forgot 207 (72.4) 
Felt good 83 (29.0) 
were away from home 144 (50.3) 
Had too many pills to take 27 (9.4) 
Wanted to avoid side effect 33 (11.5) 
Clinic is too far 96 (33.6) 
Had a change in daily routine 93 (32.5) 
Felt like the drug was toxic/harmful 49 (17.1) 
Felt asleep/slept through dose time 64 (22.4) 
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Items 
Responses 
N (%) 
Felt sick 31 (10.8) 
Felt depressed/overwhelmed 24 (8.4) 
Had problems taking pills at specific times 58 (20.3) 
Health clinic did not give pills to me 18 (6.3) 
Were busy with other things 185 (64.7) 
Use drugs 3 (1.0) 
Drink alcohol 14 (4.9) 
Took them, then get nausea, but did not take the 
replacement 
54 (18.9) 
Don't have money for eating and health care seeking 81 (28.3) 
Ran out of pills but could not go to the clinic to get 
them 
86 (30.1) 
Did not want others to notice you taking medication 36 (12.6) 
Don't believe in the usefulness of the drug 14 (4.9) 
 
5.3 Level of Adherence (two measures)   
The VAS and the MARS scales were dichotomized with 80% cut-off point. 
Patients whose scores were 80% or under are deemed to be suboptimal 
adherent and 80% or higher are optimally adherent to their regimens. The 
results show that the VAS suboptimal adherence was almost 40% and 
suboptimal adherence was just over a quarter for the MARS. 
 
5.3.1 Visual Analogue Scale  
When considering adherence as a continuous variable on the VAS, the mean 
adherence score was 76.24 (SD = 19.29), indicates that the average sample of 
adherence was just below the recommended 80% cut-off point. The median 
score was 80 and the scores ranged from 10 to 100. Figure 5 displays the 
distribution of the VAS adherence scores for the study sample. Figures 5 & 6 
shows that the data for VAS and MARS are left skewed. A dichotomous 
adherence variable representing optimal and suboptimal adherence was used 
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to examine its association with other factors in the logistic regression analysis. 
In total, 39.6% of patients whose scores fell below 80% were categorized in the 
suboptimal adherence group and 60.4% who had scored equal or greater than 
80% were categorized as optimally adherent. 
 
5.3.2 Medication Adherence Rating Scale  
The MARS consist of five questions, in which participants are asked to respond 
to a statement of each question by circling yes or no to best describe their 
behaviour towards medication during the past month. The answer was coded 
zero for no and one for yes. When considering the MARS adherence as a 
continuous scale, the mean of the adherence score was 3.94 (SD = 1.004), with 
scores ranging from 0 to 5.The total values were added and participant who 
scored ≥ 4 were deemed as optimally adherent and a score of < 4 was 
considered to be suboptimally adherent (see Figure 6) 
 
 
 
 
 
 
 
 
 
Figure 5. VAS Distribution 
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Figure 6. MARS Distribution 
5.3.3 Comparison between the Two Measurements   
The prevalence of 1-month suboptimal adherence measured by the VAS was 
39.6% (134/338), while the past month suboptimal adherence for the MARS 
was 25.3% (85/336). The observed agreement between both measurements 
was 69.4%, with a Kappa coefficient of 0.323 (SE = 0.052, p < 0.0001). This 
suggested that the majority of individuals were classified as either adherent or 
as non-adherent by the two measures, while 30.6% had discordant 
classifications (see Table 21). 
 
Table 21 Agreement between the VAS and MARS on TB medication adherence 
  MARS Score  
  
Suboptimal 
adherence 
n (%) 
Optimal 
adherence 
n (%) 
Total 
n (%) 
VAS Score  
Sub-optimal 
adherence 
58(17.6%) 
75(22.7%) 
133(40.3%) 
Optimal adherence 26(7.9%) 171(51.8%) 197(59.7%) 
Total  84(25.5%) 246(74.5%) 330(100%) 
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5.4 Univariate Logisctic Regression Analysis 
A summary of the univariate logistic regression analysis associated with 
treatment adherence is presented in At the same time, those who never 
smoked or used to smoke were four times more likely to adhere to treatment 
regimens compared to those who smoked while under treatment (OR=0.235, p 
< 0.05). 
Table 22 and Table 23.The socio-demographic factors of gender, age, marital 
status, and education were not significantly associated with treatment 
adherence. However, for those who received family financial support or whose 
wage was more than USD 60 per month, the likely chance of adhering to 
treatment was multiplied 2.96 times compared to those who had a lack of 
support or with a salary less than USD60 (OR = 2.96, p < 0.001).  
In relation to service providers, the quality of services provided by clinics, 
hospitals or community health centers contributed to the likely chance of a 
patient adhering to a treatment regimen. Those who believe they received poor 
overall services were less likely to adhere to treatment compared to those who 
were sufficiently satisfied with the services (OR = 0.79, p = 0.037).  
Behavioural risk factors such as alcohol consumption, that is, those who 
currently drank alcohol while under treatment were found to be four times less 
adherent compared to those who never drank alcohol (OR = 0.24, p < 0.001). At 
the same time, those who never smoked or used to smoke were four times 
more likely to adhere to treatment regimens compared to those who smoked 
while under treatment (OR=0.235, p < 0.05). 
 
Suboptimal 
adherence 
58(17.6%) 
75(22.7%) 
133(40.3%) 
Optimal 
adherenc 
26(7.9%) 171(51.8%) 
197(59.7%) 
 
Total 84(25.5%) 246(74.5%) 330(100%)  
Note. MARS = Medication Adherence Rating Scale; VAS = Visual 
Analogue Scale. 
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Table 22 Univariate Analysis of Factors Associated with VAS Adherence 
Factors 
Optimal 
adherence n 
(%) 
Suboptimal 
adherence n (%) 
Crude OR 
(95%CI) 
p-value 
Socio-demographic factors     
 Gender     
      Male 110(59.8) 74(40.2) 1  
      Female 94(61.0) 60(39.0) 1.05(0.68-1.03) 0.814 
 Age      
      18-29 82(60.3) 54(39.7) 1  
      30-49 53(60.2) 35(39.8) 0.99(0.58-1.73) 0.992 
      50+ 69(60.5) 45(39.5) 1.01(0.61-1.68) 0.970 
 Marital status     
      Single 63(53.8) 54(46.2) 1  
      Married 139(63.5) 80(36.5) 1.45(0.94-2.35) 0.087 
 Education     
      No formal education 63(66.3) 32(33.7) 1  
      Primary school 49(55.7) 39(44.3) 0.64(0.35-1.16) 0.141 
      Secondary/high school 57(58.2) 41(41.8) 0.71(0.39-1.28) 0.244 
      College/University  34(60.7) 22(39.3) 0.78(0.40-1.56) 0.488 
 Income/family support     
      ≤60USD/month 94(49.5) 96(50.5) 1  
       >60USD/month 110(74.3) 38(25.7) 2.96(1.86-4.71) <0.001 
Behavioural factors     
 Alcohol use (last month)     
      Never drink 92(64.3) 51(35.7) 1  
      Used to drink 97(64.7) 53(35.3) 1.02(0.63-1.64) 0.953 
      Currently drinking 13(30.2) 30(69.8) 0.24(0.12-0.50) <0.001 
 Tobacco use (last month)     
      Non-smoker 107(61.5) 67(38.5) 1  
      Used to smoke§ 93(61.2) 59(38.8) 0.99(0.63-1.54) 0.954 
      Currently smoking§ 3(27.3) 8(72.7) 0.24(0.06-0.92) 0.037 
 Illicit drug use past month     
      Never 197(60.1) 131(39.9) 1  
      Yes, in the past 2(50.0) 2(50.0s) 0.67(0.09-4.78) 0.685 
 Note: § current smoke and ever smoke were combined due to small cell sizes.  
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Table 23  Univariate Analysis of Factors Associated with VAS Adherence cont. 
 
A lack of caregivers and people to remind the TB patients of medication time 
were significantly associated with non-adherence (OR = 0.60, p < 0.001). The 
higher the score on the stigma scale, the more likely an individual patient having 
stronger perception of being stigmatized. Those who perceived TB patients to 
experience some form of stigma from the community were sub-optimally 
adhered to their treatment regimen (OR = 0.88, p = 0.001). Similarly, patients 
who visited a traditional healer to seek treatment options were less adherent to 
treatment compared to those who did not visit a traditional healer (OR = 0.93, p 
< 0.001).   
 
For every unit decrease in the psychological distress scale, the odds of 
suboptimal adherent were multiplied (OR = 0.96, p = 0.003). In other words, the 
higher the psychological distress score the higher the likely chance of being 
non-adherent. Also, for every unit increase in the patients’ scores on change 
health locus of control, the odds of non-adherent were multiplied by (OR = 0.83, 
p < 0.001).   
  
Factors 
Optimal 
adherence 
(n = 204) 
M 
Suboptimal 
adherence 
(n = 134) 
M 
Univariate analysis 
Crude OR 
(95%CI) 
p-value 
Quality of service received  2.66 2.89 0.79(0.63-0.99) 0.037 
HP-patient communication 22.91 23.41 0.96(0.91-1.02) 0.223 
Disclosure of treatment 12.61 12.72 0.98(0.91-1.07) 0.726 
People remind medication time 0.88 1.48 0.60(0.49-0.74) <0.001 
Social support  44.71 45.38 0.99(0.97-1.02) 0.603 
Patient’s TB knowledge 5.94 5.50 1.34(0.10-1.64) 0.004 
Psychological distress 25.70 28.52 0.96(0.93-0.98) 0.003 
Patients perception of stigma 7.49 8.74 0.88(0.82-0.95) 0.001 
Traditional healer 3.36 6.08 0.93(0.90-0.98) <0.001 
External Health Locus Control 28.13 30.26 0.83(0.78-0.89) <0.001 
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For every unit increase on the knowledge scale score, the odds of being 
adherent was multiplied by (OR =1.34, p = 0.004). In other words, patients with 
a better TB treatment knowledge optimally adhered to treatment compared to 
those that lacked treatment knowledge. 
 
5.5 Univariate Analysis of Participants’ Perception of Stigma  
When conducting Chi-square analysis of individual questions on the stigma scale, the 
results showed significant associations of these individual questions with suboptimal 
adherence. From the community perspective of tuberculosis those who believed or 
may have experienced other people feeling uncomfortable while being near a person 
with TB were significantly associated with non-adherence. Participants who believed or 
may have experienced people who refused to eat or drink with a person with TB were 
also significantly associated with non-adherence.  
With the participants beliefs about TB patient perspectives the analysis found that 
patients who were afraid to tell other people outside their family that they had TB were 
significantly less likely to be adherent. Also, patients who felt guilty that their family 
needs to care for them were significantly associated with medication non-adherence, 
and those who were afraid to tell family members that they had TB were also 
significantly associated with treatment non-adherence (see to Table 24).   
 
Table 24 Univariate Analysis of VAS with Perceive Stigma 
Items 
Optimal 
adherence 
n (%) 
Suboptimal 
adherence  
n (%) 
Chi-square 
Community perspective towards tuberculosis 
Do you think people may not want to eat or drink with friends who have TB? 
Yes 166 (58.9) 116 (41.1) 0.244 
No 37 (67.3) 18 (32.7)  
Do you think people feel uncomfortable about being near those with TB? 
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Items 
Optimal 
adherence 
n (%) 
Suboptimal 
adherence  
n (%) 
Chi-square 
Yes 161 (56.9) 122 (43.1) 0.05 
No 41 (77.4) 12 (22.6)  
Do you think people keep distance from others with TB? 
Yes 155 (58.9) 108 (41.1) 0.400 
No 47 (64.4) 26 (35.6)  
Do you think people do not want to talk to others with TB? 
Yes 132 (59.7) 89 (40.3) 0.839 
No 70 (60.9) 45 (39.1)  
Are people afraid of those with TB? 
Yes 151 (59.7) 102 (40.3) 0.836 
No 50 (61.0) 32 (39.0)  
Do you think people would not try to touch others with TB? 
Yes 107 (63.7) 61 (36.3) 0.181 
No 95 (56.5) 73 (43.5)  
Do you think people may not want to eat or drink with relatives who have TB? 
Yes 130 (56.5) 100 (43.5) 0.047 
No 72 (67.9) 34 (32.1)  
Patient Perspectives towards tuberculosis 
Do you think people who have TB feel hurt because other people’s reaction knowing they have 
TB? 
Yes 164 (59.9) 110 (40.1) 0.835 
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Items 
Optimal 
adherence 
n (%) 
Suboptimal 
adherence  
n (%) 
Chi-square 
No 38 (61.3) 24(38.7)  
Do people who have TB feel alone? 
Yes 120 (57.7) 88 (42.3) 0.247 
No 82 (64.1) 46 (35.9)  
Do you think people who have TB are afraid to tell those outside their family members? 
Yes 84 (47.5%) 93 (52.5) <0.001 
No 116 (74.4) 40 (25.6)  
Do you think people who have TB feel guilty because their family has the burden of caring for 
them? 
Yes 80 (46.5) 92 (53.5) <0.001 
No 121(74.2) 42 (25.8)  
Do you think people who have TB are afraid to tell their family that they have TB? 
Yes 64 (41.8) 89 (58.2) <0.001 
No 138 (75.8) 44 (24.2)  
 
5.6 Multivariate Analysis of Factors Associated with Medication 
Adherence 
Table 25 presents a number of factors that were found in a multivariate logistic 
regression model to influence non-adherence, after taking into account other 
risk factors for non-adherence.  
 
After adjustment, factors that remained significantly associated with non-
adherence were quality of health service providers, low income or lack of family 
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financial support, lack of a care giver or people to remind the participants to 
take their medication, low treatment knowledge, use of a traditional healer, 
perceive stigmatization and chance health locus of control.  
 
Controlling for other variables in the model, for every unit increase in the income 
scale, the odds of adherence was increased by 1.87. Poor health service 
provision was significantly associated with non-adherence (OR = 0.72; p < 
0.05). Similarly, patients who lacked caregivers or people to remind them of 
their medication time were associated with non-adherence (OR = 0.70; p = 
0.009).  
 
For every unit increase on the knowledge scale, the odds of adherence were 
multiplied by 1.35. In contrast, for stigma, traditional healer and health locus of 
control, for every unit increase in each of these scales, the odds of being non-
adherent to treatment were multiplied by 0.91, 0.94 & 0.86 respectively.  
 
The model, as a whole, accounted for 32.3% of the variance in TB medication 
non-adherence prevalence (R2 = 0.323), to which the service provider variable 
contributed 1.8%, the income variable contributed 8.5%, the lack of caregivers 
or people to remind medication time variable contributed 9.3%, the treatment 
knowledge variable contributed 4.2%, the stigma variable contributed 4.8%, the 
traditional healer contributed 5.9% and the health locus of control contributed 
11.9% of the variance. 
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Table 25 Multivariate Analysis of Factors Associated with VAS Adherence Cont. 
 
Factors 
Optimal 
adherence  
n (%) 
Suboptimal 
adherence  
n (%) 
Adjusted OR 
(95%CI) 
p-
value 
Socio-demographic factors 
 Gender     
      Male 110(59.8) 74(40.2) 1  
      Female 94(61.0) 60(39.0) 1.10(0.60-1.98) 0.778 
 Age      
      18-29 82(60.3) 54(39.7) 1  
      30-49 53(60.2) 35(39.8) 1.10(0.48-2.21) 0.805 
      50+ 69(60.5) 45(39.5) 1.09(0.39-3.04) 0.871 
 Marital status     
      Single 63(53.8) 54(46.2) 1  
      Married 139(63.5) 80(36.5) 1.84(0.81-4.15) 0.143 
 Education     
      No formal education 63(66.3) 32(33.7) 1  
      Primary school 49(55.7) 39(44.3) 1.32(0.55-3.15) 0.538 
      Secondary/high school 57(58.2) 41(41.8) 0.91(0.31-2.64) 0.854 
      College/University  34(60.7) 22(39.3) 1.63(0.48-5.47) 0.431 
 Income/family support 
      <60USD/month 94(49.5) 96(50.5) 1  
       >60USD/month* 110(74.3) 38(25.7) 1.87(1.01-3.47) 0.048 
Behavioural factor 
 Alcohol use (last month)     
      Never drink 92(64.3) 51(35.7) 1  
      Used to drink 97(64.7) 53(35.3) 1.01(0.51-2.33) 0.975 
      Currently drinking 13(30.2) 30(69.8) 0.41(0.15-1.12) 0.083 
 Tobacco use (last month)     
      Non-smoker 107(61.8) 66(38.2) 1  
      Ever smoke 81(59.1) 56(39.4) 1.67(0.63-4.40) 0.302 
 Illicit drug use     
      Never 197(60.1) 131(39.9)   
      Yes, in the past 2(50.0) 2(50.0s)   
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Table 26 Multivariate Analysis of Factors Associated with VAS Adherence Cont. 
 
CONCLUSION 
 
Chapter 5 reports the characteristics of the study sample and an estimate of the 
agreement between the VAS and MARS measurements of adherence. The VAS 
measurement showed the proportion of patients missing a dose in the previous month 
was 39.6%, and MARS estimated 25.3%. The chapter also analysed the VAS 
adherence and subjective reasons listed by the participants with various potential 
factors directly or indirectly associated with non-adherence. These independent factors 
included the participants’ characteristics, treatment-related factors, and social, family 
and individual-related factors. The multivariate logistic regression analysis shows better 
quality of services by service providers are more likely to support patients to adhere to 
treatment, and having a caregiver to remind of medication time is also found to be a 
determinant factor to treatment adherence. However, those with minimum income, no 
additional financial support, a lack treatment of knowledge, those who consider using 
traditional healers as a form of health service, having strong perception of being 
stigmatized or believe that health outcome is determined by chance or luck are less 
likely to be adherent to treatment regimens.  
Quality 
Optimal 
adherence 
(n=204) 
M 
Suboptimal 
adherence 
(n=134) 
M 
Multivariate analysis 
Adjusted OR 
(95%CI) 
p-value 
Quality of services received* 2.66 2.89 0.72(0.54-0.95) 0.021 
HP-patient communication 22.91 23.41 1.10(0.96-1.17) 0.233 
Disclosure of treatment 12.61 12.72 0.92(0.77-1.10) 0.923 
People remind medication time* 0.88 1.48 0.70(0.54-0.92) 0.009 
Social support 44.71 45.38 0.99(0.97-1.03) 0.929 
Patient’s TB knowledge* 5.94 5.50 1.35(1.05-1.72) 0.018 
Psychological distress 25.70 28.52 0.99(0.95-1.04) 0.815 
Perceive stigmatisation* 7.49 8.74 0.91(0.83-1.00) 0.049 
Traditional healer* 3.36 6.08 0.94(0.90-0.98) 0.006 
Chance Health Locus Control** 28.13 30.26 0.86(0.79-0.93) <0.001 
Note. OR = odds ratio mutually adjusted for all other variables in the table; CI = confidence 
interval for true estimate of adjusted odds ratio; p-value = statistical significance of the 
adjusted OR. Model used enter method (-2 Log likelihood: 287.334; R2 :0.323) 
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Chapter 6:  Discussion  
The qualitative study found that the health professionals and patients had 
similar perceptions of medication adherence. The health professionals often 
thought that adhering to treatment regimens was a challenge due to a lack of 
access to health services, patients residing too far from available health 
services, poor nutritional intake and a lack of treatment knowledge. The patients 
reported that a lack of financial support, limited access to transport, and old age 
were the major constraints affecting their goal to achieve optimal treatment 
adherence. The list of reasons nominated by patients most often was consistent 
with the qualitative results. These barriers included forgetting to take medication 
on time, being busy with daily activities or away from home, running out of pills, 
and unexpected changes in daily routines. 
 
Using the VAS measurement with 80% cut-off point, the analysis found an 
overall 39.6% suboptimal adherence. When broadly comparing this result to 
research in some developing countries, the level of non-adherence varies. 
Adherence in Timor-Leste was much lower compared to most studies. For 
example, a study conducted in Ndola, Zambia that measured adherence in 
patients taking TB drugs daily for 8 months found  that 29.8% of patients 
stopped taking TB drug at some point during the treatment (Kaona et al., 2004). 
A cross-sectional survey assessed TB adherence with numerous tools, in which 
the VAS for patients who missed medication in the previous 4 days was 
reported to be as low as 7.5% (Nackers et al., 2012). Also, in Jiangsu Province, 
China, a study measuring adherence using a structured questionnaire with a 
90% cut-off point found a TB medication non-adherence rate of 12.2% (Weiguo 
et al., 2009). 
 
 Other studies reported lower percentages of non-adherence compared to the 
current study (Kaona et al., 2004; Myo Su et al., 2015 ; Nackers et al., 2012; 
Weiguo et al., 2009). The differences may be explained by time frames, in 
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which this study used one month rather than the four days used in other 
studies. Moreover, the previous studies used cut-off points for adherence which 
varied between 75% and 100%. However, according to the International Union 
Agent Tuberculosis Committee on Prophylaxis (1982), the recommended cut-off 
point for TB adherence is 80%. The differing cut-off points used to measure 
adherence in other studies may lead to inconsistent findings, where the actual 
levels of adherence may be under- or overestimated.  
 
6.1 Factors Associated with TB Medication Adherence   
A number of important themes were identified from the analysis of the insights 
from both the health professionals and patients in the qualitative study. These 
themes included service factors (service delivery, human resources, 
information), discrimination, low social and family support, disease-related 
factors, medication side-effects, personal beliefs, age, risk behaviours, 
knowledge, and illness severity.  
 
Most of the findings in the qualitative study were consistent with the quantitative 
findings, where the critical barriers to adherence were identified as those with 
low family income of less than USD 60 per month, alcohol use, high levels of 
psychological distress, perception of stigmatization, a preference for a 
traditional healer over modern medicine, lack of treatment knowledge and an 
external health locus of control. The facilitating adherent factors included the 
support of care providers, and patients who had caregivers or somebody to 
remind them of medication time.  
 
Various supports of the patients involving peer educators, health professionals, 
friends and family were not association with adherence in this study. However, 
the analysis showed a significant interaction among these variables with 
psychological distress. This may be explained by patients who received 
substantially adequate support improved their overall psychological well-being 
which, therefore, contributed towards their better treatment adherence.  
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There are other factors that can be considered either as barriers to or facilitators 
of adherence. For instance, those who lacked treatment knowledge were more 
likely to be non-adherent with their treatment regimens. This finding is 
consistent with many studies that found that the better the knowledge, the 
higher the likelihood of treatment adherence (Armijos et al., 2008; Ayisi et al., 
2011; Demissie & Kebede, 1994; Gebremariam, Bjune, & Frich, 2010; Getahun 
& Aragaw, 2001; Hoa, Chuc, & Thorson, 2009; Martins et al., 2008; Sagbakken, 
Frich, & Bjune, 2008b; Shargie & Lindtjorn, 2007; Tekle, Mariam, & Ali, 2002). 
Additionally, the present study found that disclosure of treatment status could 
be either a facilitating factor to gain support or a barrier to treatment. This 
depended on the people to whom the patients disclosed their treatment status. 
If those people had a better knowledge and understanding of the treatment, 
they were more likely to be supportive and vice versa. Consequently, positive 
responses could encourage patients to complete treatment and negative 
responses could cause patients to feel being discriminated, which was directly 
linked with non-adherence. Research has reported that those who disclose their 
treatment status were afraid of losing their jobs or feeling hurt, insulted, shamed 
and isolated as a result of being stigmatized. Therefore, disclosure of treatment 
status can be a barrier to patients under treatment (Do et al., 2013; Karim et al., 
2007; Somma et al., 2008). Despite this, research has suggested that 
adherence can be improved through the sharing of treatment status, so that 
individual patients receive social support throughout the treatment. Family and 
social support benefits patients both directly (positive encouragement and 
reinforcement) and indirectly (reduced depression, anxiety and stress relief) (Do 
et al., 2013). Moreover, improving the patients’ and family members’ knowledge 
and understanding of the treatment is likely to be a key factor in adherence 
(Armijos et al., 2008; Ayisi et al., 2011; Gebremariam et al., 2010; Getahun & 
Aragaw, 2001; Hoa et al., 2009; Martins et al., 2008; Tekle et al., 2002). 
 
The qualitative findings showed the factors of distance from available health 
services and a good relationship between the patient and health carers were 
potentially associated with medication adherence. However, the survey analysis 
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did not detect an association of these variables with medication adherence, 
which is consistent with the literature on antiretroviral therapy (Mills et al., 
2006).  
 
6.1.1 Health Service Delivery Factors    
The qualitative interviews revealed a number of health service factors 
associated with TB treatment. Almost all health professionals suggested that 
one of the main reasons for the poor treatment services was the staff being 
responsible for multiple roles. This was also associated with the acknowledged 
lack of human resources in the health workforce in Timor Leste. (see Appendix 
L).  Consequently, TB patients were likely to receive a short duration of 
individualized service with insufficient information, and no proper counselling 
services, which means they were less likely to adhere to treatment after 
enrolment (Awofeso, 2008; Chaulk, Kazandjian, & Panel, 1998; Garner et al., 
2007; Munro, Lewin, Swart, et al., 2007; Munro, Lewin, Smith, et al., 2007; 
Nguyen et al., 2003; Orr, 2011; Sumartojo, 1993).  
 
Such poor services to meet patients’ needs also result in patients extending 
their treatment duration, delaying seeking treatment, and/or being more likely to 
consider alternative treatments such as seeing a traditional healer (Finnie et al., 
2011). Suboptimal adherent factors listed by patients in the quantitative findings 
also suggested that 30% of the sample ran out of drugs and could not get them 
and more than a quarter of the sample (33.6%) believed that the clinic was too 
far. These findings are consistent with the results of the univariate and 
multivariate analyses, where those who received poor services from certain 
community health centers (CHC) or clinics were associated with suboptimal 
adherence.  
 
Additionally, the health professionals in the qualitative study stated that the 
CHCs and clinics across the country may not have complete testing tools, 
involving an X-ray, sputum culture, skin test and other necessary equipment to 
assist in the early detection of TB and enrolment in treatment. As a 
consequence, in some cases patients were likely to wait a long time for the final 
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results before starting treatment. Hence, for those who required immediate 
treatment, many were encouraged to travel to other clinics or CHCs to receive 
TB testing. Such processes required time and effort from individual patients. 
Consequently, they discouraged patients from using health facilities, especially 
if they had to travel a long distance to an available health service. The interview 
results from the patients also confirmed the health professionals’ views, in which 
they found that distance from a health services was a major constraint in 
treatment adherence. This is especially a challenge when patients have to travel 
to available health services for drug refills, as patients are responsible for 
associated travel costs that many cannot afford. The current findings are 
consistent with a study in Ethiopia, which reported that a lack of access to 
treatment facilities was a major factor in treatment non-compliance (Shargie & 
Lindtjørn, 2007). 
 
 A study by Needham et al. (2004), which investigated barriers to TB medication 
adherence in Zambia, found that the cost of transport to travel to and from 
health services accumulated to a considerable16% of patients' monthly income. 
This percentage doubled if patients required a caregiver to accompany them 
(Needham et al., 2004). Furthermore, quantitative studies in developing 
countries have also found that distance to health services is a barrier to TB 
treatment adherence (Awofeso, 2008; Garner et al., 2007; Gebremariam et al., 
2010; Ministry of Health Timor Leste, 2011; Munro, Lewin, Swart, et al., 2007; 
Munro, Lewin, Smith, et al., 2007; Nackers et al., 2012; Needham et al., 2004; 
Nezenega, Gacho, & Tafere, 2013; Sagbakken et al., 2008a; Tachfouti et al., 
2012; Thiam et al., 2007; Zvavamwe & Ehlers, 2008). However, the findings of 
the present study on distance travelled to and from available health services 
were inconsistent with findings from the previous studies. This may be 
explained by the majority of the participants admitting to treatment in Dili, the 
capital city of Timor Leste, and temporarily residing with family and relatives, 
which allowed them easy access to health services. Therefore, further studies 
on TB treatment for people travelling from different places to detect associations 
between distance and overall treatment outcomes are warranted.  
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6.1.2 Social and Economic Factors   
Social and economic factors contributed to overall TB treatment adherence. If 
individual patients were socially connected and economically stable, it was 
more likely that these factors influenced their treatment adherence in a positive 
way. However, those who experienced social isolation and economic instability 
would likely to find it difficult to meet the expectations of medication adherence 
throughout the treatment process. This was likely to be due to patients who 
underwent treatment being absent from their jobs or lacking the ability to earn, 
and, therefore, being less likely to sustain an income. Such concerns may be 
likely to affect their psychological well-being, knowing that it would be six to 
eight months before the treatment could be completed. Furthermore, patients 
may feel guilty that they may become a burden to their family members who 
have to look after them throughout the duration of the treatment. This was 
supported with evidence which showed that 51.5% of the patients indicated that 
they experienced guilt because their family had the burden of caring for them 
(Table 18). 
 
Financial security for a patient undergoing treatment has been identified as one 
of the most important factors in adherence. A number of studies have found that 
low income can be a barrier to TB treatment adherence (Armijos et al., 2008; 
Cambanis et al., 2005; Farmer et al., 1991; Jackson et al., 2006; Needham et 
al., 1998). Although TB drugs are free for patients in some countries, 
inaccessibility of services, which requires commitments to travel and transport 
can cost more than purchasing the drugs (Zvavamwe & Ehlers, 2008). 
Additionally, evidence has suggested that many patients estimate the 
opportunity cost of treatment, such as time to travel and the implications for 
their employment status (Munro, Lewin, Smith, et al., 2007). The results of a 
KAP survey in Timor-Leste also supported the finding that financial constraints 
are a major issue when it comes to TB treatment (Ministry of Health Timor 
Leste, 2011).  
 
The qualitative findings of the present study were consistent with the results of 
other studies, while the quantitative analysis also yielded consistency, in which 
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those who earned or received financial support of less than USD 60 per month 
had higher levels of non-adherence. Adequate income is a vital supporting 
element of treatment, as those who have sufficient support are likely to have 
enough to spare for transport and other treatment costs, therefore making it 
more likely that they successfully complete treatment.  
 
A report from the WHO on the evidence for action to sustain long-term therapies 
also identified finance as a contributing factor to adherence (Dick et al., 2003). 
Furthermore, a synthesis of cross-sectional survey and qualitative research in 
China found that cost was the most cited reason for treatment default. It has 
been found to be worse in cases where providers utilize patients as a way of 
generating revenues (Qian et al., 2011). A mixed-methods study by Weiguo et 
al. (2009) also found that a heavy financial burden was directly associated with 
medication non-adherence. Cost associated with treatment forced patients to 
give up due to conflicts between work and treatment, treatment-related costs, 
expenses exceeding available resources (Dick et al., 2003; Lönnroth et al., 
2001; Martins et al., 2008; Ministry of Health Timor Leste, 2011; Munro, Lewin, 
Smith, et al., 2007; Needham et al., 2004; Noyes & Popay, 2007; Qian et al., 
2011; Sengupta et al., 2006; Weiguo et al., 2009), and unexpected expenditure, 
that is, the cost of a taxi to a clinic varies depending on the negotiation with the 
driver, which is common in developing and third world countries.  
 
Along with financial problems, stigma related to TB has been identified as an 
important element that influences those affected by TB (Baral et al., 2007; 
Brassard et al., 2008; Dodor et al., 2008; Gibson et al., 2005; Kipp et al., 2011a; 
Sengupta et al., 2006; Somma et al., 2008; Yang et al., 2010). Stigma is a 
socially constructed phenomenon which reflects prevailing attitudes and 
behaviours of others towards individuals affected by a disease or disability 
(Harper, 1987; Karim et al., 2007; Somma et al., 2008). The experience of 
stigma can cause people to socially isolate themselves from family, health 
professionals and other people to avoid becoming a subject of gossip (Baral et 
al., 2007). Consequently, patients who encountered stigmatization have severe 
suffering, which, in turn, results in non-compliance (Dodor et al., 2008). Several 
studies have described the impact of stigma on tuberculosis medication 
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adherence (Baral et al., 2007; Dodor et al., 2008; Karim et al., 2007). The 
univariate logistic regression analysis in the present study also found a negative 
association between patients who did not want others to know that they were 
taking medication and their level of treatment adherence. Research has shown 
that patients may not want others to know of their regimen intake, as they often 
encounter stigmatization, and negative reactions and/or responses related to 
their treatment status (Baral et al., 2007; Brassard et al., 2008; Dodor et al., 
2008; Gibson et al., 2005; Harper, 1987; Johansson et al., 1999; Kipp et al., 
2011a; Sengupta et al., 2006; Somma et al., 2008; Yang et al., 2010). Further 
analysis in both the univariate and multivariate logistic regression analyses 
confirmed that experience of stigma was strongly associated with suboptimal 
adherence. Studies of TB stigma and factors associated with adherence, such 
as level of education, gender and religion (Dodor & Kelly, 2010; Johansson et 
al., 2000; Kipp et al., 2011a; Rubel & Garro, 1992; Sengupta et al., 2006; 
Somma et al., 2008; Woith & Larson, 2008; Zhang et al., 2007), incorrect 
knowledge of its cause, mode of transmission and treatment (Baral et al., 2007; 
Dodor & Kelly, 2010; Eastwood & Hill, 2004; Johansson et al., 2000; Karim et 
al., 2007; Long et al., 1999; Rubel & Garro, 1992; Sengupta et al., 2006; 
Somma et al., 2008), and contagiousness of TB transmission (Baral et al., 
2007; Dodor et al., 2008; Eastwood & Hill, 2004; Mavhu et al., 2010) have also 
been conducted in other countries. 
 
6.1.3 Individual and Disease-Related Factors   
The qualitative interviews yielded evidence that health professionals believed 
patients were more likely to complete the treatment if their sickness was severe 
prior to admission. The most cited reasons were that when the level of sickness 
was severe, people were afraid of death and, therefore, were willing to follow 
the treatment instructions. Regardless of their ability to comply with the 
expectations for the treatment, in these cases, family members were more likely 
to share responsibility for the patient's care.  
 
However, health professionals also believed that the patients were less likely to 
seriously undertake treatment after two months of enrolling in the program when 
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they felt better. In addition, those who had less serious symptoms at the time of 
diagnosis did not take treatment seriously as when they started the treatment. 
This was due to their belief that they did not have TB, despite the confirmation 
of test results indicating they had positive TB. The qualitative findings also 
showed that those who had mild TB symptoms tended to feel frustrated when 
informed that they had TB. This finding also highlighted that most often those 
with mild TB symptoms did stop taking their medication after two months of 
treatment due to a lack of knowledge about the treatment process. It was also 
likely that the health professionals had provided limited information relating to 
the treatment process at the time of the treatment enrolment. Hence, the 
patients may have had a limited understanding about the whole treatment 
process and the consequences of not fully following treatment as expected. In 
comparison, patients who had severe symptoms at the time of diagnosis 
adhered to treatment and closely followed the instructions even if they felt 
symptomatic improvement over time after taking medication. This also 
depended on the level of knowledge and understanding patients had about the 
treatment as well as the support they received during treatment. Patients who 
experienced symptomatic improvement after enrolling in a treatment were more 
likely to follow the treatment regimens as they believed that they were 
recovering. Moreover, there were also a number of important factors that 
directly influenced the treatment outcomes, such as knowledge and 
understanding of the treatment process, in terms of side-effects, and 
consequences of not completing the treatment successfully (i.e. death, 
development of MDR-TB, further spread of the disease).  
 
Studies have also reported that social connectedness is crucial in encouraging 
patients to successfully follow the treatment regimens (Do et al., 2013; Weiguo 
et al., 2009). Additionally, those who lacked support are expected to have a 
poor treatment outcome. This is evident in the findings of the current study in 
which patients who lacked caregivers and people to remind them of medication 
times were associated with non-adherence. These findings are consistent with 
the results of a study which investigated TB/HIV co-infected patients in Ethiopia 
(Eticha & EKassa, 2014) 
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Individual risk behaviours, such as alcohol use and cigarette smoking were 
found to influence the overall outcome TB treatment. The health professionals 
were aware of the negative impact of tobacco smoking and alcohol intake on TB 
treatment adherence. Indeed, health professionals collaborated with family 
members to work towards ensuring that the patients did not consume alcohol or 
smoke tobacco while undergoing treatment. Therefore, this result suggests that 
interventions to effectively manage such behaviour for patients in treatment are 
vital.  
 
Alcohol consumption has been reported from other settings to be directly 
associated with non-adherence. According to an HIV/AIDS study in Vietnam 
that investigated factors associated with optimal antiretroviral medication 
adherence, alcohol use was found to be significantly associated with medication 
non-adherence (Do et al., 2013). Furthermore, alcohol was also frequently 
mentioned in the context of TB treatment non-adherence by a study conducted 
in Russia (Jakubowiak, Bogorodskaya, Borisov, Danilova, & Kourbatova, 2007). 
The findings of the present study were consistent with both these studies, 
suggesting that alcohol consumption was significantly associated with 
suboptimal medication adherence.  
 
Although some research has shown an influence of illicit drug use on treatment 
adherence, the current study found no association. This was likely to be due to 
there being only four of the 347 patients in the sample who stated that they had 
used drugs in the past. Culturally, in Timor-Leste, illicit drugs are known as 
harmful substances, also perhaps many could not afford them if they were 
illegally distributed. Previous studies in Timor-Leste have not assessed illicit 
drug usage, could be due its perceived irrelevancy and low incidence (Martins 
et al., 2008; Ministry of Health Timor Leste, 2011). The current study also found 
that less than 1% of the sample have ever taken illicit drug in their past.  
 
Given the direct impact of risk behaviours on patients’ health and overall 
treatment outcome, people with TB who are depressed may also experience 
impaired ability to follow treatment (Do, 2011). This may be because within the 
treatment context, patients have negative thoughts, anxiety and feelings of 
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hopelessness associated with their treatment. Therefore, such feelings may 
impact on their ability to cope with the illness, thereby increasing the likelihood 
of ceasing treatment because they feel they are unable to control events in their 
lives (Abadia et al., 2010; DiMatteo & Martin, 2002; Do et al., 2013). The 
present qualitative study indicates that people who had mental health disorders 
were not likely to follow treatment. It was also reported that a few incidents had 
been encountered where patients who were mentally ill had family and relatives 
who were unwilling to take care of them. Some of these findings are consistent 
with the qualitative component of a HIV/AIDS adherence study in Vietnam (Do, 
2011) and a study in Ethiopia that investigated the pattern of depression in 
patients with TB (Adem, Tesfaye, & Mohammed, 2014). In addition, the 
univariate analysis of the current study also complimented the notion that 
depression was strongly associated with suboptimal medication adherence.  
 
Individual disease-related factors such as duration of treatment and severity of 
sickness are more likely to affect the treatment recovery. In a case with TB, the 
sickness severity experienced by individual patients varied throughout the 
duration of treatment. This particularly depended on how chronic the sickness 
was at the time of admission and the length of time a patient was on treatment. 
The findings in the qualitative study showed that those who experienced illness 
severely were afraid of death, which produced a higher tendency and 
willingness to adhere to treatment. Due to the severity of the sickness at the 
start of treatment, a patient may be unable to take care of him or herself. Under 
these circumstances, it was most commonly observed that a patient would 
receive extensive support from immediate family members, explained perhaps 
by their fear of losing a loved one. 
 
As explained in Chapter 2, “locus of control” is a psychological term related to 
individuals' beliefs about who is responsible for their own actions, regardless of 
it being desirable or undesirable (Do, 2011). Locus of control includes the belief 
that chance or luck significantly influences one’s destiny, including the 
individual’s health outcome. Health locus of control is the degree to which an 
individual’s health is believed to be controlled by internal or external factors. 
The causal attributions that individuals assign to their illness are likely to affect 
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their way of coping with it. If a treatment regimen recommended by a health 
practitioner is consistent with an individual’s understanding of what caused his 
or her illness, then the individual is more likely to adhere. An individual who 
ascribes external factors that are out of his or her control to the cause of the 
illness is less likely to be self-motivated to improve his or her health status, 
compared to an individual who believes they are in control of what happens to 
them. 
 
Do et al. (2013) suggested that adherence to the treatment regimen of 
individuals depends upon their attitude. Energetic people are believed to adhere 
to treatment better compared to those who have a 'do not care' attitude. 
Therefore, those who have a positive attitude, which perhaps is influenced by 
the support received, or who personally accept their sickness status are more 
likely to adhere to treatment. In comparison, those who believe that their health 
is controlled by others or is determined by a deity are likely to let things be, and 
accept what will happen. Our study used the multidimensional health locus of 
control scale, shortened version, which has been used by Do and her team (Do 
et al., 2013). The analysis showed that chance health locus of control was 
significantly associated with poor adherence. This result has significant 
implications for future care and treatment of TB patients as it can suggest that 
health carers can provide health education and effective counselling by 
emphasizing the harm of the belief that chance or luck determines an 
individual’s health outcomes, as such beliefs are likely to negatively influence a 
patient's adherence.  
 
The use of traditional healers for treatment is common across many societies. 
This may be explained by the strong traditional beliefs that many people still 
have about traditional healers’ influence on their health. In Sub-Saharan African 
countries, approximately 40% of people use traditional healers, according to 
some studies (Salaniponi et al., 2000; Wilkinson, Gcabashe, & Lurie, 1999). 
One study also found that women use traditional healers more often than men 
(Eastwood & Hill, 2004). Traditional healers are thought to provide an 
understandable explanation of one’s health symptoms (Eastwood & Hill, 2004). 
The study also found that the use of traditional healers may be related to a lack 
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of knowledge, as traditional healers are used more by less educated people. It 
is reported that patients who prefer a traditional healer as an alternative source 
of treatment delay seeking early treatment and do not follow treatment 
recommendations after diagnosis (Finnie et al., 2011). A survey conducted 
across five districts (urban & rural) in Timor-Leste indicated that 14.5% of the 
total population used traditional healers as some form of health facility and 
34.6% considered traditional healers as an option for health care (Ministry of 
Health Timor Leste, 2011). Due to the mountainous, high terrain and poor road 
conditions in the remote areas of Timor Leste, visiting traditional healers have 
been common. In addition, traditional healers may have been approachable and 
accessible both socially and geographically. The univariate and multivariate 
analysis confirmed patients were less likely to adhere to treatment if they used a 
traiditional healer as a form of treatment facility. This may be due to patients 
being distracted from the effort to seek and maintain treatment. Given that TB 
treatment requires six to eight months for a patient to be fully cured, those who 
have a second option for treatment may believe that if a traditional healer can 
use magic to treat the sickness, they no longer have to undergo treatment for 
such a long period of time. Given the presence of traditional healers, and that 
their efforts to cure people with their magical abilities have been falsely believed 
to be true for generations, an effort should be made to educate and work 
collaboratively with them in providing health care services. This proposed 
strategy could be achieved by identifying the existing traditional healers in the 
communities where patients reside and provide basic helath education related 
to TB which will enable them to conduct case detection and referral to health 
services.   
6.2 Limitations of the Study   
The current study had some limitations that may have affected the validity and 
generalizability of the results. The following biases are identified and the 
methods used to attempt to minimize these problems are addressed. 
 
Acquiescence bias, also known as the ”friendliness effect”, is created when 
respondents tend to agree with what an interviewer presents to them. This 
142 Discussion 
could have happened if respondents felt the tendency to agree and to give the 
“right answer” as they wished not to offend the interviewer. Because a 
considerable percentage of people in Timor-Leste are illiterate and it is most 
likely that those who participated had limited experience of being interviewed or 
completing a questionnaire, it was possible that acquiescence bias was present. 
To reduce such bias, interviewers were expected to provide thorough 
information about the research activity. They would stress the importance that it 
would be much more helpful if they provided information that was accurate and 
true; that is, if they had forgotten to take medication, they were asked to 
accurately respond to the questionnaire with statements which best described 
their behaviour. To the best of the interviewers’ ability, brief but thorough 
information about the data collection was provided to ensure that the patients 
provided accurate information about what they had encountered throughout the 
duration of treatment.   
 
Selection bias may have occurred, as it could have been that those who turned 
up to replenish their medications at the clinic and agreed to participate in the 
study were also those who were more likely to adhere to treatment. Additionally, 
there were patients who met the inclusion criteria, but were excluded as they 
could not be reached or lived a long distance from the health service. These 
patients may have had important information that may have not have been 
captured in the study. In an attempt to minimise these problems, data were 
collected from patients across nine health services in three districts. For most of 
the clinics, the principal investigator worked collaboratively with clinic staff to 
randomly select patients through the TB registers.  
 
According to the National Tuberculosis Program, Timor-Leste database, from 
January 2013 to September 2013, 1160 TB patients at the age of 18 years or 
older were registered. Of these registered patients, 29.9% (n = 347) participated 
in the study. Due to limited time and funding, convenience sampling was used 
in most of the clinics. The results may be generalizable to these health services, 
but not necessarily reflect treatment practices in Timor Leste.  
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6.3 Significance of the Study 
A review of the literature suggested that the present study was the first mixed-
methods study to investigate TB medication adherence in Timor-Leste. The 
research provided evidence for the factors associated with medication non-
adherence among TB patients.The study provided findings related to service 
delivery, socioeconomic and cultural issues, individual and disease related 
factors that could be addressed to improve the level of adherence to better 
treatment and care in a resource-limited setting in the Southeast Asian region.  
 
A strength of the study is the fairly large sample that enabled the identification 
of TB medication non-adherence in different contexts. The team ensured that 
the design and implementation of both the qualitative method and quantitative 
survey were carefully considered to be appropriate to social and cultural values. 
Thorough procedures for survey development and validation were followed 
systematically. The instrument was first drafted based on worldwide literature 
and revised to integrate findings from the qualitative study. The qualitative study 
finding also helped to improve the validity of the quantitative measures. Input 
from experts in the field and other relevant fields was incorporated in the 
survey. Then, it was translated and back translated by professional language 
translators with health backgrounds. The WHO guide for questionnaire 
translation was used to ensure that the accuracy and meaning of the questions 
was not reduced or lost. Finally, repetitive pilot study testing of the 
questionnaire was conducted. Further comments, suggestions and observations 
from the pilot study were incorporated to ensure the reliability and validity of the 
questionnaire.  
 
There were a number of issues that arose from this study that warrant further 
research. The worldwide literature found a significant association between non-
adherence and some factors not observed in the present study. It is 
recommended that factors should be further researched, such as education 
level, patient-health professional communication with family, friends, neighbours 
and social supports, treatment disclosure, level of satisfaction with support 
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received and distance to nearby service provider. In addition, illicit drug use has 
been reported to be significantly correlated with non-adherence, yet, due to a 
small number of people admitting to having used drugs in our sample, there 
was no significant association found. However, due to unclear policy and free 
trading in the country and the likelihood that the number of drug users could 
increase, future research on the subject is encouraged. The present study 
contributes to the literature on TB medication adherence by presenting new 
patterns of factors that were not investigated in previous studies especially 
psychological distress, support of caregivers or people to remind medication 
time and health locus of control. It is also vital for future research to examine 
levels of adherence throughout the whole period of treatment. This is likely to 
reveal further knowledge and understanding on levels of adherence in each 
month, while allowing the identification of any other behavioural and 
psychological factors that may hinder adherence. Medication adherence does 
not solely depend on a single factor. It is a complex, yet pivotal subject, and 
therefore requires further studies into a range of factors that are associated with 
individual patients.  
 
6.4 Public Health Implications    
Given a rate of almost 40% of patients having poor adherence, practical, yet 
simple guidelines on strategies to manage adherence are important. These may 
include guidelines on ongoing counselling for adherence to prescribed doses, 
monitoring and follow-up, and methods to identify the influential factors 
associated with adherence (Martins et al., 2009). Furthermore, incentives of 
reimbursement of travel cost and the expenses of attending treatment centers, 
and ongoing financial support for patients who struggle with financial security 
are likely encourage and attract patients, thereby reducing the chance of 
missing appointments and scheduled drug replenishment. Despite the results of 
the randomized control trial study in Timor-Leste indicating that food incentives 
had no significant benefits for TB treatment (Martins et al., 2009), studies from 
other settings have demonstrated the importance of food incentives on the 
overall outcome (Baldwin et al., 2004; Gupta et al., 2009; Ramakrishnan et al., 
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1961). Martins et al. (2009) may not have found a correlation due to 
geographical location, because patients who participated in the study had been 
undertaking treatment in Dili, where food is plentiful compared to remote areas 
of the country. Evidence suggested that nutritional support showed more rapid 
clearance of bacteria and radiographic changes in addition to greater weight 
gain. Hence, nutritional supplementation assists patients in a fast recovery, 
particularly in underdeveloped areas of the world where food is scarce, and it 
may be an effective measure of TB control (Ramakrishnan et al., 1961).  
 
The present study found that alcohol consumption impacted on adherence, and 
of the 12.7% that drank while under treatment, it was more common with men 
(72.7%) than women (27.3%) in Timor-Leste. Therefore, it is recommended that 
the national TB care and treatment program should assist patients with alcohol 
issues. Counselling and special treatment can be offered in an attempt to 
reduce alcohol intake during treatment.  
 
It is crucial to provide effective counselling and treatment of patients with 
depressive symptoms, given the likely severity of its effect on adherence. 
Depression is common among patients with chronic medical illness, such as 
diabetes, HIV/AIDS and TB (Adem et al., 2014; Ciechanowski, Katon, & Russo, 
2000; Patel, Simon, Chowdhary, Kaaya, & Araya, 2009). The findings of the 
current study indicate that most often, patients experience constant pressure as 
a result of having TB. Such feeling may cause them to feel guilty and blame 
themselves for having the disease (Nyblade et al., 2003). Adem et al. (2014) 
suggested that TB treatment and care should incorporate psychiatric co-
morbidities to achieve the treatments’ primary outcomes. Another study also 
suggested that treatment, such as antidepressants and psychotherapy are 
effective and should be integrated into primary care in managing depression in 
low and middle income countries (Adem et al., 2014). Furthermore, Peltzer et 
al. (2012) suggested training of providers to improve necessary skills in 
screening adult patients with sign of depression, anxiety, and able to assist with 
referral and treatment intervention is important. To provide a conceptual model 
for health behaviour, a number of psychosocial constructs have also been 
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proposed (Ajzen & Fishbein, 1980; Centers of Disease Control and Prevention, 
1993; Dick & Lombard, 1997; Dick, Van der Walt, Hoogendoorn, & Tobias, 
1996; Glanz, Rimer, & Viswanath, 2008).  
 
Currently, in Timor-Leste, the number of available professional counsellors is 
unknown. To date there appears to be very few health workers in TB services 
who are qualified in counselling. The MoH in Timor-Leste should encourage 
medical students to undertake counselling studies. Meanwhile, capacity building 
through adequate training on basic counselling services should be provided to 
the current health workers. Adequate treatment of depression will potentially 
enhance patients’ overall health quality, and hence improve treatment 
outcomes.  
A public health approach to reducing stigma is to work with self-help, advocacy 
and support groups. According to a number of studies, access to support 
groups is likely to reduce the effects of stigma on patients undergoing treatment 
(Demissie, Getahun, & Lindtjorn, 2003; Lyon & Woodward, 2003). Support 
groups can enable patients to exchange information and receive mutual 
support, which can help improve their self-esteem (Heijnders & van der Meij, 
2006).  
 
Social support from family members, friends, and health professionals can be 
important for optimal treatment adherence. Social connectedness has been 
reported in the field of HIV/AIDS to be an influencing factor on adherence, as 
can help with reinforcement, reassurance or encouragement (Do, 2011). Given 
that TB patients are likely to interact and receive support from different groups 
during treatment, establishing a strong relationship is likely to be vital. Often, 
sick patients are cared for by their family members, community health 
volunteers and health care professionals, and it has been reported in a case 
with HIV/AIDS in other settings that such care can cause the experience of 
stigma (Nyblade et al., 2003). An important key aspect to be addressed is to 
educate those caring for patients, especially with their knowledge about the 
disease, and the appropriate language used to communicate to patients during 
Discussion 147 
their daily interactions (Kidd & Clay, 2003). Because many TB patients reside in 
remote areas of the country, Kidd and Clay (2003) suggested that improved 
education can help empowering community members, especially patients’ 
family members who could benefit patients with their treatment. Thus, educating 
different groups of people who are involved directly in patients’ TB treatment 
could also directly influence the success of treatment completion.  
 
Strong beliefs associated with traditional healers in Timor-Leste are part of the 
culture and their existence has been historically embedded in the community for 
generations. Due to the strong beliefs of the elders about traditional healers, 
many people can easily be influenced by such beliefs. In Timor-Leste many TB 
patients visit traditional healers before seeking proper treatment, and such 
behaviour is found to be consistent with patients in other settings (Colvin et al., 
2014). Given the history and background of traditional healers, to address 
issues related to TB treatment and to improve overall health outcome of the 
population, effective interventions are required. Other societies which have 
encountered the same issues have proposed solutions to address such pivotal 
concerns. A potential solution to the problem is to blend conventional services 
and traditional healers in terms of supervision of TB treatment, provide possible 
community TB education, and engage in collaborative case findings and 
diagnosis (Wilkinson et al., 1999). Additionally, a study conducted in Zulu-Natal, 
South Africa, suggested that traditional healers are potentially an important 
resource to be integrated into TB control programs (Colvin, Gumede, 
Grimwade, Maher, & Wilkinson, 2003).  
 
In order to achieve a better community-based TB intervention with the 
involvement of traditional healers, first, the MoH Timor-Leste could work more 
collaboratively with the local health professionals and community members to 
identify potential traditional healers. Second, improved training, such as general 
knowledge and understanding in identifying and screening individuals with TB 
symptoms is important. In addition, it is vital to train and monitor traditional 
healers to independently refer patients, conduct DOTS and assist patients with 
ongoing treatment (Colvin et al., 2014).  
148 Discussion 
 
The current study found no association between adherence and social support. 
Also, disclosure of treatment status was not significantly associated with 
adherence. However, the present study found a significant interaction of these 
variables with psychological distress, which suggested that individuals who 
received adequate support were likely to have a better psychological well-being, 
and thus be more likely to adhere successfully to treatment. This result 
suggests that social support can be an important element which may not 
directly impact adherence, but it can reinforce, reassures and buffers the effects 
of variables that directly influence adherence. Hence, efforts to strengthen 
treatment and care, and the participation of family members and social support 
to maintain social connectedness may help improve treatment adherence. 
 
CONCLUSION 
Medication adherence for TB is of utmost importance in helping to cure patients, 
prevent further spread of the disease and avoid the development of drug 
resistance. Hence, identifying patients prone to non-adherence, and 
determining the level of adherence and its influencing factors is crucial. In doing 
so, it allows health carers to recognize individuals with special characteristics 
that should be carefully supported to maximise treatment adherence. The result 
of this study suggested that it is vital to ensure that assistance is given to those 
who struggle financially, and attention is needed to screen for sign of 
depression and alcohol use. Evidence also suggests that TB care and treatment 
services should integrate effective treatment for depression, counselling for 
risky behaviours, traditional healers, and the belief that chance or luck 
determines health outcomes. Furthermore, to empower patients, support should 
be given to maintain social connectedness with family and the community.  
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Table 27  Summary of Worldwide Qualitative Studies on TB treatment  
Factors Country/Author 
Categories Theme  
Health Service Delivery 
Factors 
Accessibility: cost, time & 
distance 
Availably: Information, presence 
of health care worker and quality 
of services. 
 
Service provider & health care 
professional 
Kenya (Ayisi et al., 2011) 
Systematic review of qualitative research (Munro, Lewin, 
Smith, et al., 2007) 
Timor-Leste (Martins et al., 2008) 
Nepal (Baral et al., 2007) 
22 TB high-burden countries (Figueroa-Munoz et al., 
2005) 
Sub-Saharan African Countries (Finnie et al., 2011), 
(Needham et al., 2004) 
Gambia (Eastwood & Hill, 2004), (Harper et al., 2003) 
Vietnam  (Hoa et al., 2009), (Lönnroth et al., 2001) 
Thailand (Sengupta et al., 2006) 
Treatment related cost, transport cost 
and economic burden 
Kenya (Ayisi et al., 2011) 
Ho Chi Minh City, Vietnam (Lönnroth et al., 2001) 
Ethiopia (Gebremariam et al., 2010) 
Russia (Belilovsky et al., 2010) 
Hlabisa, South Africa (Connolly et al., 1999) 
Gambia (Eastwood & Hill, 2004), (Harper et al., 2003) 
Nepal (Baral et al., 2007) 
Systematic review of qualitative research (Munro, Lewin, 
Smith, et al., 2007) 
Thailand (Kipp et al., 2011a), (Sengupta et al., 2006) 
Timor-Leste (Martins et al., 2008) 
Ho Chi Minh City, Vietnam (Lönnroth et al., 2001) 
Treatment accessibility Gambia (Eastwood & Hill, 2004) 
Systematic review of qualitative research (Munro, Lewin, 
Smith, et al., 2007) 
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Timor-Leste (Martins et al., 2008) 
Sub-Saharan African Countries (Finnie et al., 2011) 
Directly Observed Treatment Short-
Course, Directly Observed Therapy 
Ethiopia (Gebremariam et al., 2010) 
WHO Geneva (Garner et al., 2007) 
Gambia (Harper et al., 2003) 
Qualitative meta-analysis (Noyes & Popay, 2007) 
Gambia, West Africa (Eastwood & Hill, 2004), (Harper et 
al., 2003) 
Systematic review of qualitative research (Munro, Lewin, 
Smith, et al., 2007) 
WHO Geneva (Garner et al., 2007) 
 
 
 
 
 
 
 
Social and Economic Factors 
 
SES, gender, age, education, 
occupation and marital status 
Social motivation: family/friend 
support & health workers and 
social support 
Education and knowledge  Kenya (Ayisi et al., 2011),  
Ecuador (Armijos et al., 2008) 
Gambia (Eastwood & Hill, 2004), (Harper et al., 2003) 
Systematic review of qualitative research (Munro, Lewin, 
Smith, et al., 2007) 
Nepal(Baral et al., 2007) 
Timor-Leste (Martins et al., 2008) 
Vietnam (Hoa et al., 2009) 
Gender  Gambia (Eastwood & Hill, 2004), (Harper et al., 2003) 
Canada (Brassard et al., 2008),  (Gibson et al., 2005) 
Ghana (Dodor et al., 2008) 
Vietnam (Johansson et al., 1999), (Johansson et al., 
2000), (Long et al., 1999) 
Bangladesh (Karim et al., 2007) 
Thailand (Kipp et al., 2011a), (Sengupta et al., 2006) 
Bangladesh, India, Malawi and Colombia  (Somma et al., 
2008), (Karim et al., 2007) 
Family, friends and relative support  Gambia (Eastwood & Hill, 2004) 
Timor-Leste (Martins et al., 2008) 
Systematic review of qualitative research (Munro, Lewin, 
Smith, et al., 2007) 
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Sub-Saharan, South Africa (Naidoo & Mwaba, 2010) 
Thailand (Sengupta et al., 2006), (Van Rie et al., 2008) 
Stigma (individual and community)  Bangladesh (Karim et al., 2007) 
Ecuador (Armijos et al., 2008) 
Kenya (Ayisi et al., 2011) 
Nepal (Baral et al., 2007) 
Gambia (Eastwood & Hill, 2004) 
Sub-Saharan African Countries (Finnie et al., 2011) 
Timor-Leste (Martins et al., 2008) 
Thailand (Sengupta et al., 2006) 
Personal and disease related 
factors 
 
Treatment, risk behaviour, 
knowledge, belief and attitude 
towards treatment, mental 
health and locus of control 
Traditional healer, belief, perception, 
attitude, behaviour and  cultural 
factors  
Ecuador (Armijos et al., 2008) 
Gambia (Eastwood & Hill, 2004) 
Malawi (Brouwer, Boeree, Kager, Varkevisser, & Harries, 
1998) 
Hlabisa, South Africa (Connolly et al., 1999) 
Vietnam (Johansson et al., 1999), (Hoa et al., 2009)  
Systematic review of qualitative research (Munro, Lewin, 
Smith, et al., 2007) 
Canada (Gibson et al., 2005),   
Ethiopia (Gebremariam et al., 2010) 
Colombia (Jaramillo, 1998) 
Timor-Leste (Martins et al., 2008) 
 
Side-effect, diagnosis, depression  Ethiopia (Gebremariam et al., 2010) 
Colombia (Jaramillo, 1998) 
Timor-Leste (Martins et al., 2008) 
Systematic review of qualitative research (Munro, Lewin, 
Smith, et al., 2007) 
Sub-Saharan, South Africa (Naidoo & Mwaba, 2010) 
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Table 28 Summary of Quantitative Studies on TB 
 
Source Country  Study Design Research 
aim(s)/research 
question(s) 
Measurement Setting and sample size Results  
(Weiguo et 
al., 2009)  
China Mixed method, 
multi-stage 
sampling 
strategy 
To gain insights into 
the factors that could 
contribute to 
adherence.  
Quantitative: structured 
questionnaire, highlighting basic 
characteristics, SES, treatment 
history, adherence to anti-
tuberculosis treatment. Non-
adherent participants were 
presented 16 reasons of non-
adherent. Observed treatment was 
divided into groups accordingly with 
types of group support.  
 
Qualitative methods: in-depth 
interview. A semi-schematized guide 
covering general as well as specific 
questions was used. Interviews 
focused on healthcare seeking 
history, knowledge and attitude 
towards TB, and their adherence on 
treatment. 
Jiangsu Province, eastern 
cost of China. Thirteen 
municipalities and 106 
counties (districts), with a 
total population of 74 
million.  
 
A total of 670 patients 
were successfully enrolled 
for quantitative study. 
Nineteen patients were 
conveniently selected for 
in-depth interview. 
 
Overall proportion of non-adherent was 12.2% 
(82/670). Almost half of non-adherent patients 
interrupted their treatment intermittently (missed a 
total of more than 10% of all doses).  
Illiterate, divorced/widowed, lacked health 
insurance or were migrants, were more likely to be 
non-adherent. The crude ORs (95%CIs) were 
2.38(1.37-4.13), 2.42(1.30-4.52), 1.89(1.07-3.32), 
1.98(1.03-3.83), respectively.  
 
Risk of non-adherent was lower among patients 
under direct observations by village doctors or 
home visit by health workers with ORs (95%CIs) of 
0.19 (0.10-0.36) and 0.23 (0.10-0.51), 
respectively. 
 
Main reasons for non-adherent listed by patients 
were adverse reaction to drugs (37.8%), relieved 
symptoms (26.8%), long course of regimen and 
large dose of drugs (15.9%) and worry about 
danger of drugs (15.9%) 
(Ailinger et 
al., 2007) 
USA Descriptive 
Study 
Examine the 
predictors of Latent 
Tuberculosis Infection 
(LTBI) therapy in 
Latino immigrants at a 
public health clinic.  
- 160 records were randomly 
chosen, 2 clients had been 
treated with Rifampin and five 
records were incomplete. 
Therefore, total of 153 for data 
analysis.  
- Adherence was defined as the 
number of doses of INH taken 
as reported by the client. Full 
adherence is defined by the 
CDC as completion of 270 
doses in 12 months. 
- Participants were considered 
Population of Latino 
immigrant, majority came 
from El Salvador, Bolivia, 
or Guatemala. Total 
sample of 153 records 
were included for analysis 
A total 52 patients (34%) completed the 8 months 
of LTBI therapy and were given final month supply. 
Seventy two participants (47%) completed 6 
months of LTBI therapy. Fifty eight clients (38%) 
reported side effect and of those only four cases 
(3%) were discontinued with medical advice. Side-
effects occurred most often in the first month of 
therapy in 24 patients (16%).  
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Source Country  Study Design Research 
aim(s)/research 
question(s) 
Measurement Setting and sample size Results  
non-adherent if they did not 
show up for their clinic 
appointment and did not 
respond to the public health 
nurse's phone calls or letter 
(Ailinger et 
al., 2010) 
USA Pre-
Experimental 
design  
Examine the effect of 
a cultural intervention 
(CI) on increasing 
adherence to latent 
tuberculosis infection 
(LTBI) therapy among 
Latino immigrants. 
- Adherence was measured by 
the number of pills reported by 
the clients, which was 
documented in the medical 
record.  
- The total number of pills for 8 
months was recorded for this 
comparison between the 
experimental and the historical 
groups. 
 
Public health chest clinic 
in an urban country of 
Virginia with over 20% of 
Latino population. A 
random sample of 131 
records was drawn from 
over 600 records 
The intervention group took greater number of pills 
than the comparison group and the difference is 
statistically significant t (85) = 1.94, p=0.028. The 
mean of doses taken by the intervention group 
was 157 (5.2 months) and 129 (4.3 months) for the 
comparison group. This comes to a difference of 
28 doses, which is approximately a month's 
treatment. 
(Armijos et 
al., 2008)  
Ecuador Cross sectional 
study  
To explore knowledge, 
beliefs, perceptions, 
and attitudes about 
Tuberculosis in a high-
risk group in Ecuador.  
Convenient sampling. Face to face 
interview using structured 
questionnaire containing close and 
open-ended questions.  
A national institute of 
hygiene - Public health 
facility. There were 212 
adults, 18 years or over 
who did not have any 
known conditions that that 
may impede their ability to 
respond to questions.  
Almost 70% of the participants were male. Many 
participants held misconceptions or lacked of 
knowledge, which lead to delaying diagnoses and 
treatment non-adherent, as a consequence lead 
the disease to spread further. Patients with a prior 
personal or family TB history were more likely to 
report familiarity with TB (89.3% vs 66%; 2=11; 
p=0.001). Furthermore, those with more than nine 
years of formal schooling have better recognition 
and understanding compare to less educated 
counterparts (78.2% vs. 61%; 2=7; p=0.008). 
Education was the single most important of 
knowledge, beliefs, perceptions and attitudes. 
(Chiang et 
al., 2012)  
China Retrospective 
observational 
case control 
study 
To evaluate the 
reversible factors 
that could possibly 
affect outcomes of 
anti-tuberculosis 
anti-TB treatment. 
 
Data collected from both electronic 
record and medical charts. 
Laboratory data including albumin, 
aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), 
total bilirubin, conjugated bilirubin, 
and serum alkaline phosphate (ALP) 
were obtained from the 
computerized laboratory reporting 
system. 
 
The study involved 302 
newly diagnosed TB 
patients in Taipei. 
Participants who ever smoke had more negative 
treatment outcome compare to those who never 
smoke (60% vs. 43.2%, p=0.005). High tobacco 
consumption (>20 cigarettes per day) was 
significantly associated with decreased odds of 
achieving a positive treatment outcome (odds ratio 
(OR) 0.23, 95% confidence interval (CI) 0.05–0.98, 
p = 0.047), and even moderate smokers (1–20 
cigarettes per day) registered borderline 
insignificance (OR 0.61, 95% CI 0.35–1.05, p = 
0.073) compared to those who did not consume 
tobacco. 
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Source Country  Study Design Research 
aim(s)/research 
question(s) 
Measurement Setting and sample size Results  
 
(Corless et 
al., 2009) 
South 
Africa 
Descriptive 
Exploratory 
Design  
Examined sense of 
coherence, social 
support, symptom 
status, quality of life, 
and adherence to 
medications in two 
samples of individuals 
being treated either for 
TB or human 
immunodeficiency 
virus/acquired 
immunodeficiency 
syndrome (HIV/AIDS).  
Self-report questionnaire was used 
to collect data highlighting 
demographic items, measures of 
sense of coherence (SOC), social 
support, symptom status, QoL, 
adherence to ARV therapy or TB 
medication and clinic visit 
 
Two independent groups diagnosed 
with HIV (n=149) and TB (n=159).  
Clinics across different 
settings included semi-
private hospital-based HIV 
clinic, freestanding clinic 
conducting HIV research 
located in a shopping 
center in an area with low-
income housing in Durban, 
South Africa.  
Sense of Coherence (SOC) measuring an 
individual’s sense of social belonging was 
significantly lower for individuals with TB compare 
to the HIV sample (mean TB=67.9, SD=24.4, 
mean HIV=77.4, SD=23.6, p 
0.001). In addition, social support was lower in TB 
sample compare to the HIV sample (mean 
TB=55.5, SD=11.1, mean HIV=64.4, SD=14.7, 
p0.001). 
  
For both diseases, there were no significant 
differences in the average of missed appointments 
(mean HIV=1.8, SD=1.6, mean TB=1.85, SD=1.7, 
p=0.76). While, the Morisky medication adherence 
scale scores were equivalently high in both groups 
(mean HIV=3.7, SD=0.69, mean TB=3.8, 
SD=0.55, p=0.49).  
 
(Nackers et 
al., 2012) 
Kenya, 
Africa 
Cross sectional 
survey  
To measure 
adherence to TB 
treatment among 
patients receiving 6 
months of standard 
TB chemotherapy with 
FDC under SAT in a 
limited resource, high 
TB-HIV burden 
setting. 
Recent adherence (last 4 days) and 
adherence in the last month 
measure using two subjective 
(questionnaire and VAS) and two 
objective adherence monitoring tools 
(urine test for INH and a pill count) 
The study was conducted 
in Homa Bay district, 
Nyanza Province in 
Western Kenya. 212 of 
279 eligible patients were 
assessed for adherence. 
The estimated level of adherence was high using 
all the adherence measurement tools. Overall, 
95.2% [95%CI: 91.3 to 97.7] of the patients 
reported not having missed a pill in the last 4 days. 
On the VAS, complete adherence was estimated 
at 92.5% [95%CI: 88.0 to 95.6]. Urine INH test was 
positive for 97.6% [95%CI: 94.6 to 99.2] of the 
patients. Pill count could only be assessed among 
70% of the interviewed patients. The proportion of 
pills taken by the patient was classified 
as complete for 82.3% [95%CI: 75.1 to 88.1]. 
Except for the VAS, main adherence results 
tended to be better during the intensive  phase 
than during the continuation phase.  
(Kipp et al., 
2011a) 
Southern 
Thailand 
Cross sectional 
survey  
Use formally validated 
tools to measure the 
level of TB stigma 
among patients with 
Data were collected from two 
different groups of participants: TB 
patients and healthy community 
members. Questionnaire on socio-
The study was conducted 
in Southern Thailand. 
Participants included 480 
TB patients and 300 
The mean community TB stigma score was higher 
than the mean perceived TB stigma score reported 
by patients (20.13 vs.18.43) or 18.25 after 
standardization) and exclusion of patients with 
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Source Country  Study Design Research 
aim(s)/research 
question(s) 
Measurement Setting and sample size Results  
TB and healthy 
community members. 
demographic characteristics, and 
available tools to measure stigma 
was used.  
healthy community 
members 
known HIV infection). Believing that TB increases 
the chance of getting AIDS was associated with 
experienced/felt TB stigma among patients (MD 
2.16; 95% CI: 1.38, 2.94) and knowing someone 
who died of TB was associated with community TB 
stigma among community members (2.59; 95% CI: 
0.96, 4.22). Older age (0.66; 0.22, 1.11 per 10 
year increase) and Muslim religion (-1.37; 95% CI: 
-2.32, -0.42) were both associated with perceived 
TB stigma, while being female (-0.80; 95% CI: -
1.67, 0.07) was only associated with 
experienced/felt TB stigma. Patients with some or 
no primary education reported higher scores on 
both TB stigma scales, especially the 
experienced/felt stigma scale (1.22; 95% CI: 0.17, 
2.28), compared to patients who completed 
secondary education.  
(Kaona et 
al., 2004) 
Ndola, 
Zambia 
Cross sectional 
study 
Factors contributing to 
treatment adherence 
and knowledge of TB 
transmission among 
patients on TB 
treatment  
Compliance refers to patients who 
took their TB drugs daily for 8 
months. Patients are considered 
non-adherent if they stopped taking 
TB drug during the treatment period. 
Using the medical records 
from six clinics, a total of 
736 samples were 
selected and 400 were 
recruited.  
Compliance of patients 
over time to prescribed TB 
drug regimens identified 
from medical records. 
While TB patients were 
also asked directly if they 
had ever stopped taking 
the drugs since the 
starting of treatment.  
A total of 114 (29.8%) out of 382 patients stopped 
taking TB drugs at some point during the 
treatment. 
There were 39.1% females and 29.8% males 
reported to have stopped taking medication within 
the first 2 months of commencing treatment. 
 Demographic factors such as sex, education, 
marital status were not significantly associated 
with non-adherence. Other factors such as sharing 
room, friend suffered from TB, number of times 
suffered from TB and use of traditional healer was 
also not significant.  
(Martins et 
al., 2009) 
Timor 
Leste 
Randomized 
Control Trial 
Determine the 
effectiveness of the 
provision of whole 
food to enhance 
completion of 
treatment for 
tuberculosis  
Primary measure: Confirmation of 
clearance of acid fast bacilli from the 
sputum after completion or 8 months 
of treatment. 
Secondary measure: clinic 
attendance and pill counts.  
3 Primary clinics in Dili, 
Timor Leste.  
 
270 previously untreated 
newly diagnosis 
pulmonary TB, 18 years or 
older.  
Food as incentive improved outcome with TB 
treatment with higher weight gain, but no 
significant correlation to treatment adherence or 
successful completion of treatment.  
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Appendix C 
Qualitative Interview Questions for Health Professionals 
Date: 
Interviewer: 
Health Professional: 001  
Data Source: Health Professionals 
Method: Qualitative Semi-Structured Interview  
Introductions: First the interviewer should introduce himself and then read the following 
script below, describing the purpose of the session. 
Why we are here:  We are here to ask you about your perceptions about on 
Tuberculosis treatment. The interview will highlight demographic characteristics, lifestyle, 
education, beliefs and social and family support given to an individual patient receiving 
treatment.  
Your consent is important: We will share the information you provide us today only with 
your consent. You are required to provide consent by signing a consent form. Any input 
you provide will not be associated with you personally, but rather as group input. If you 
are in any way uncomfortable with this arrangement, we will delete your names 
altogether from this discussion’s transcripts and not include them at all in the document. 
Length of interview: We will take no longer than an hour 
1. How do you think patients’ demographic characteristic is associated with completion of TB 
treatment? (Examples of demographic characteristics: age, education, marital status, employment, income, and 
living condition). 
2. How does TB patients’ lifestyle affect TB treatment adherence? (Examples of lifestyle: smoking, 
alcohol and drug use) 
3. How does quality of life affect (mental disorder, health symptoms and illness characteristics) 
patient’s treatment adherence?  
4. Do knowledge, beliefs and attitude of a patient impact treatment adherence? Probing how and 
why 
5. What is the common adherent factors affecting medication treatment?  
6. What system and structures are in place in our current health system to support TB patients for 
their treatment? (I.e. diagnosis, medical availability, staff etc.) 
7. What is the formal and non-formal support provided towards a TB patient during his/her 
treatment? 
8. What adherence aids do patients usually use to remind them to take medication? (I.e. family 
members, using clock, alarm, mobile alarm or calendar). 
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Appendix D 
 Qualitative Interview Questions for TB Patients 
Name of Interviewer:  
Date: 
Data Source: Tuberculosis Patients 
Patient number:  
Method: Qualitative Semi-Structured Interview  
Introductions: First the interviewer should introduce himself and then read the 
following script below, describing the purpose of the session. 
Why we are here:  We are here to ask you about your perceptions about on 
Tuberculosis treatment. The interview will highlight demographic characteristics, 
lifestyle, education, beliefs and social and family support given to an individual patient 
receiving treatment.  
Your consent is important: We will share the information you provide us today only 
with your consent. Any input you provide will not be associated with you but rather as 
group input. If you are in any way uncomfortable with this arrangement, we will delete 
your names altogether from this discussion’s transcripts and not include them at all in 
the document. 
1. Has there been any time that you miss taking your medication? Why? Why not? Probing  
 If the patient says no continue to ask (has there been any time at all that you nearly forget to take 
your medication?) 
2. What makes you so organized that you do not forget to take your medication? 
3. What do you normally use to remind yourself of the time to take your medication? 
We heard that some people stop their treatment due to some specific reasons? Would you 
like to explain it to us? 
4. Based on your knowledge, how important do you think it is for a patient to follow instruction 
and adhere to their medication regimen? Why? Why not? Probing  
5. Do you think people’s age, level of education, their job and distance from the health 
services will have impact on their treatment adherence? Explain 
6. Do you think having a good relationship with them will help with your treatment progress? If 
so, why and why not? Probing  
7. Do you family, friends and colleagues from work know about your TB treatment? 
8. How comfortable do feel to share about your treatment? Why? Why not? Probing  
9. What kind of support do you usually get from: 
 Family members 
 Friends  
 Peer educators 
 Social Organizations  
10. Can you tell us what kind of information you were given by the health care providers when 
you start diagnosis and treatment? 
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Figure 7 Map of Timor Leste 
 
 
Data was collected in Dili, Liquica and Bobonaro (Maliana) Distircts. 
186 Appendices 
 
 
 
 
 
 
 
 
 
 
Appendix F 
Human Ethics Approval Certificate 
 
Queensland University of Technology 
Appendices 187 
 
188 Appendices 
Appendix F 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices 189 
 
 
 
 
 
 
Appendix G 
Human Ethics Approval Certificate 
 
Approval Letter 
 
Research Cabinet and Health Development 
 
Ministry of Health, Timor Leste 
 
190 Appendices 
 
 Appendix G 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices 191 
 
192 Appendices 
 
 
 
 
 
 
 
Appendix H 
 
Quantitative Survey Questionnaire 
English Version 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Appendices 193 
Appendix H 
Survey Questionnaire 
Instruction: The answers you give on this form will be treated confidentially and will only be used by the 
researcher to develop a plan to help people who have Tuberculosis to better follow their regimens. Please 
do the best you can to answer all the questions. If you do not wish to answer a question, please leave it 
blank or circle refused option where available. If a question is not clear, please ask the researcher to clarify 
for you. Thank you for participating in this important study! 
Your answers will be kept confidential since they will be used for the purpose of the study only. 
Section I. Questions about You and Your Health 
 
A. Question about yourself:  Demographic Information  
Please place (×) or tick  a number which best represents your answer.   
Question Response 
A1 Sex 
Male 1 
Female 2 
A2 What is your date of birth?    
 
                               └─┴─┴─┴─┘  
                                    y  y   y    y 
A3 How old are you?  Years 
 
└─┴─┘ 
A4 
In total, how many years have you spent 
at school or in full-time study (excluding 
pre-school)? 
Years 
└─┴─┘ 
A5 
Which district & sub-district are you 
from? 
District___________  Sub-district___________ 
 
EXPANDED: Demographic Information  
Please place (×) or tick  a number which best represents your answer.   
A6 
What is the highest level of 
education you have completed? 
 
No formal schooling 1 
 
High school 3 
Primary school 2 College/University 4 
Secondary School 3   
A7 What is your marital status? 
Never married 1 Separated/ Divorced 3 
Currently married 2 Widowed 4 
  
  
A8 
Which of the following best 
describes your main work status 
over the past 12 months? 
Select responses that are 
appropriate 
 
 
 
No job/jobless 1 Housewife 6 
Farmer 2 Unemployed (able to work) 7 
Labor work 3 Unemployed (unable to 
work) 
8 
 Government staff 4 Other (please 
specify)_______ 
9 
Student or pupil 5   
A9 
What is the main subsistence 
(financial support) in current time? 
Select responses that are 
appropriate 
From your income(s) 1 Others (please 
specify)______ 
5 
Support from husband/wife 2 None 6 
Support from family 3   
 
Support from friend 4   
 
   
A10 
What is the monthly total average 
income of your family (including all 
people who share house and meal 
with you? 
Select one response 
< 30USD/month 1 121USD-150USD/month 5 
31USD-60USD/month 2 151USD-180USD/month 6 
61USD-90USD/month 3 181USD-210USD/month 7 
91USD-120USD/month 4 >210USD/month 8 
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A11 
Does your family have these items? 
Select responses that are 
appropriate 
 
Solid roof 1 TV 7 
Solid floor 
Solid bathS 
2 Mobile phone 8 
Solid bath room 3 Bicycle 9 
Standard toilet 4 Fridge 10 
Water pumping machine 5 Motorbike 11 
Wardrobe 6 Car 12 
A12 
Who do you live and share main 
meals with? 
Select responses that are 
appropriate 
Stay alone 1 Other family members 5 
Husband/wife 2 Friends 6 
Parent(s) 3 Co-worker(s) 7 
Children 4   
      
A13 
How many people whom are you 
living with and sharing the main 
meal with? 
Select one response 
 
Only myself 1 More than four people 5 
Two of us 2
R
e
f
u
s
e
d 
  
Three people including 
myself 
3   
Four people including
myself 
4   
A14 
Who is the person taking care of 
you and reminding you to take your 
medication frequently? 
Select responses that are 
appropriate 
Husband/wife 1 Co-worker(s) 6 
7 Parent 2
2 
PSF (Family Health 
Promoter) Children 3 Community Health Cen -
staff 
8 
Other family members 4 None/take care mysel 9 
Friend(s) 5   
A15 
About how long would it take you to 
walk from your home to your 
nearest clinic/Health 
Post/CHC/Referral Hospital? 
15 minutes or less 1 >1 hour  but < 2 hours 5 
16-30 minutes 2 2 hours or longer 6 
31-45 minutes 3 Don’t know 7 
46-60 minutes 4   
A16 
For all journeys combined, in the 
past 12 months, which types of 
transport were used more 
frequently?  Select responses that 
are appropriate 
Local mini bus 1 Walking to/from a destination 5 
Local bus/truck 2   
Bicycle 3   
Scooter/motorbike 4   
 
B. Lifestyle - Alcohol Use  
Please place (×) or tick  a number which best represents your answer.   
Question Response 
B1 Do you drink alcohol? Yes 1 No, continue to B5 2 
B2 
How often have you had a drink 
containing alcohol – a glass of beer, 
wine, local wine, a mixed drink or any 
kind of alcohol beverage? 
Daily or nearly daily 
 (> 4 times a week) 
1 Some/month (1 – 3 times/month) 3 
Some week  
(1-4 times/week) 
2 Drink when available 4 
B3 
How many UNITS of alcohol do you 
drink on a typical day when you are 
drinking? 
1 to 2 1 7 to 8 4 
3 to 4 2 9+ 5 
5 to 6 3   
B4 
How often do you have 6 or more 
UNITS of alcohol on one occasion?  
Never 1 Weekly 4 
Less than monthly 2 Daily or almost daily 5 
Monthly 3   
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Lifestyle: Smoking  
Please place (x) or tick (√) a number which best represents your answer.   
Question Response 
B5 Do you smoke tobacco? 
Currently smoking 1 Never 4 
Used to smoke 2 If Never, continue to section B9  
Stopped smoking started of 
treatment 
3   
B6 
How soon after wake up do 
you smoke your first 
cigarette?  
Within 5 minutes 
 
 
1 
After 60 minutes 4 6-30 minutes 2 
31 – 60 minutes 3 
B7 
Normally, how many 
cigarettes do you smoke 
each day? 
10 or less 1 21-30 3 
 11-20 2 31 or more 4 
B8 
How many cigarettes did you 
smoke in the last 24 hours? 
_________________ 
 
  
______________    
 
 
 
Lifestyle – Illicit Drug Use  
The following are questions asking about your drug use. Once again, your answer will be kept confidential since 
they will be used for study purpose only. 
Please place (×) or tick  a number which best represents your answer.   
Question Response 
B9 
Have you ever used illicit 
drug? 
Yes and I currently use it 1 
Never 
Continue to the next section 
3 
Yes, but I used it in the past 2   
B10 
In the last month, how 
often have you used 
drug? 
Daily or nearly daily 
 (> 4 times a week) 
1 Some/month (1 – 3 times/month) 3 
Some week  
(1-4 times/week) 
2 Use only when available 4 
 
Section II  
C. Psychological Distress  
Please place (×) or tick  a number which best represents your answer.   
 
Question 
 
Response N
o
n
e
 
o
f 
th
e
 
ti
m
e
 
A
 l
it
tl
e
 
o
f 
th
e
 
ti
m
e
 
S
o
m
e
 
o
f 
th
e
 
ti
m
e
 
M
o
s
t 
o
f 
th
e
 
ti
m
e
 
A
ll
 o
f 
th
e
 t
im
e
 
C1
. 
During the past 30 days, about how often did you feel tired out for no good 
reasons? 
1 2 3 4 5 
C2
. 
During the past 30 days, about how often did you feel nervous? 1 2 3 4 5 
C3
. 
During the past 30, how often did you feel so nervous that nothing could calm 
you down? 
1 2 3 4 5 
C4
. 
During the past 30 days, about how often did you feel hopeless? 1 2 3 4 5 
C5
. 
During the past 30 days, about how often did you feel restless or fidgety? 1 2 3 4 5 
C6
. 
During the past 30 days, about how often did you feel so restless you could not 
sit still? 
1 2 3 4 5 
C7
. 
During the past 30 days, about how often did you feel depressed? 1 2 3 4 5 
C8
. 
During the past 30 days, about how often did you feel that everything is an effort?  1 2 3 4 5 
C9
. 
During the past 30 days, how often did you feel so sad that nothing would cheer 
you up? 
1 2 3 4 5 
C1
0. 
During the past 30 days, about how often do you feel worthless? 1 2 3 4 5 
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Session III: We would like to know how much you understand about Tuberculosis. 
E. Your TB Knowledge about Tuberculosis  
Please place (×) or tick  a number which best represents your answer.   
E1.  How is Tuberculosis transmitted from one person to 
another? 
Infectious droplet 
spread 
1   
Sharing eating utensils 2   
Punishment of bad 
behavior 
3   
E2. 
Would a person with TB eat together with other family 
members? 
No 1   
Yes 2   
      
E3. Do family contacts need to be screened for TB? 
No 1   
Yes 2   
E4. Is Tuberculosis curable with proper treatment? 
No 1   
Yes 2   
E5. 
Can Tuberculosis be cured with a week course of 
treatment? 
No 1   
Yes 2   
  
  
E6. What is the length of treatment required to cure TB? 
1-2 months  1 Rest of life your life 3 
6-8 months  2 
Varies according to 
individual 
4 
E7. 
Can treatment be discontinued once you feel better, 
even the prescribed treatment duration has not been 
reached? 
No 1   
Yes 2   
  
  
 
Section  IV: Treatment Adherence  
We would like you to answer these questions to understand how people with TB are really doing with their pills, but not 
evaluating your medication taking.  Don’t worry about telling us that you don’t take some of your pills or forget to take 
them. We need to know what is really happening, to improve your and others’ TB adherence. No one involved in your 
medical care will hear about what you have told us. 
F. Taking Your Medication  
Please place (×) or tick  a number which best represents your answer.   
F1 Do you ever forget to take your medication? Yes 1 No 2  Skip to 
G 
D.  Multidimensional Health Locus of Control Scales - Shortened Version  
Please place (×) or tick  a number which best represents your answer.   
 
Question 
 
Response 
S
tr
o
n
g
ly
  
D
is
a
g
re
e
 
D
is
a
g
re
e
 
A
g
re
e
 
S
tr
o
n
g
l
y
 A
g
re
e
 
D1 I am in control of my health 0 1 2 3 
D2. The main thing that affects health is what I myself do. 0 1 2 3 
D3. If I take care of myself, I can avoid illness. 0 1 2 3 
D4. Having regular contact with my doctor is the best way to avoid illness.   0 1 2 3 
D5. When I don't feel well, I should consult a medical professional.  0 1 2 3 
D6. When I recover from an illness, it's because other people have been taking care of me 0 1 2 3 
D7. Luck plays a big part in how soon I will recover from an illness. 0 1 2 3 
D8. My good health is largely a matter of good fortune. 0 1 2 3 
D9. If it's meant to be, I will stay healthy.  0 1 2 3 
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F2 Are you careless at times at taking medication? Yes 1 No 2  
F3 When you feel better do you sometimes stop taking your medication? Yes 1 No 2  
F4. 
Sometimes if you feel worse when you take the medication do you stop 
taking it? 
Yes 1 No 2  
F5. Do you take medication only when you feel sick? Yes 1 No 2  
F6. By staying on medication, can you prevent getting sick? Yes 2 No 1  
F7 Does medication make you feel sick? Yes 1 No 2  
F8 Do you feel weird on medication? Yes 1 No 2  
Compliant = code 2 in all questions  
For the following question please circle (O) or tick (√) a percentage which best represents your answer.   
F9 
We would like to get your best guess about how much of your TB medications you have managed to take during 
the last month. We would be surprised if this was 100% for many people. Please make a mark on the 
line to show how many of your TB pills you think you managed to take in the last month (e.g. 0 means you have 
taken no medication; 50% means you have taken half of our medication, 100% means you have taken every 
single dose of medication  
 
How often did you follow the medication instruction in the last month? 
 
 
 
   
 
  
 
   
 
     
 
  
 
 0 10% 20% 30% 40% 
50
% 
60% 70% 80% 90% 100% 
 
   
 
     
 
  
 
 
 
   
 
  
 
Reason for missing dose 
People may miss taking their medications for various reasons. Here is a list of possible 
reasons why you may miss taking your medications during the last month.  
G. Adherent Factors  
 Reasons for missing a dose: Each item below is a statement about your health state 
Please place (×) or tick  a number which best represents your answer.   
 
Did you miss taking your medications during the last month because you:  Y
e
s
 
N
o
 
G1. Simply forgot 1 2 
G2. Felt good 1 2 
G3. Were away from home 1 2 
G4. Had too many pills to take 1 2 
G5. Wanted to avoid side effect 1 2 
G6. Clinic is too far 1 2 
G7. Had a change in daily routine 1 2 
    
G8. Felt like the drug was toxic/ harmful 1 2 
G9. Felt asleep /slept through dose time 1 2 
G1
0. 
Felt sick 1 2 
G1
1. 
Felt depressed/ overwhelmed 1 2 
G1
2. 
Had problems taking pills at specified times (with meals, on empty stomach, before bed time etc.) 1 2 
G1
3. 
Health clinic did not give pills to me 1 2 
G1
4. 
Were busy with other things 1 2 
G1
5. 
Use drugs 1 2 
G1
6. 
Drink alcohol 1 2 
G1
7. 
Took them, then get nausea, but did not take the replacement 1 2 
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Traditional Healers  
These people are including elderly or those claims to have healing power to treat sick 
people in the community. Each item below is a statement about your health state. 
Please circle the number that response for indicating your level of 
agreement/disagreement to the following reasons of why you might visit a traditional 
healer. 
 
G1
8. 
Don’t have money for eating and to cover transport cost 1 2 
G1
9. 
Ran out of pills but could not go to the clinic to get them 1 2 
G2
0. 
Did not want others to notice you taking medication 1 2 
G2
1. 
Don’t believe in the usefulness of the drug 
 
1 2 
Section V Stigma 
H. Tuberculosis related stigma scales 
Please place (×) or tick  a number which best represents your answer.   
 
Community perspectives toward tuberculosis Ye
s
 
N
o
 
H1. Do you think people may not want to eat or drink with friends who have TB? 1 2 
H2. 
 
Do you think people feel uncomfortable about being near those with TB? 1 2 
H3. Do people keep their distance from others with TB? 1 2 
H4. 
 
Do you think people do not want to talk to others with TB? 1 2 
H5. Are people afraid of those with TB? 1 2 
H6. Do you think people would not try to touch others with TB? 1 2 
H7. Do you think people may not want to eat or drink with relatives who have TB? 1 2 
 
Patient perspectives toward tuberculosis Ye
s
 
N
o
 
H8. Do you think people who have TB feel hurt of how others react to knowing they have TB 1 2 
H9. Do people who have TB feel alone? 1 2 
H10. Do you think people who have TB are afraid to tell those outside their family members?  1 2 
H11. Do you think people who have TB feel guilty because their family has the burden of caring for 
them? 
1 2 
H12. Do you think people who have TB are afraid to tell their family that they have TB? 1 2 
I. Traditional Healers 
Please place (×) or tick  a number which best represents your answer.   
 
I13. 
 
Do you ever visit a traditional healer? (No, continue to next section) 
Y
e
s
 
N
o
 
 
1 2 
Why do you visit a traditional healer? 
S
tr
o
n
g
ly
 
D
is
a
g
re
e
 
S
o
m
e
w
h
a
t 
D
is
a
g
re
e
 
N
e
it
h
e
r 
A
g
re
e
 n
o
r 
D
is
a
g
re
e
  
S
o
m
e
w
h
a
t 
A
g
re
e
 
S
tr
o
n
g
ly
 
A
g
re
e
 
I14. I want a traditional medicine 1 2 3 4 5 
I15. I could not be cured at the clinic 1 2 3 4 5 
I16. There are no clinics close to where I live 1 2 3 4 5 
I17. Cost of transport is too expensive 1 2 3 4 5 
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Section VII: Social and Family Support: 
 
The following questions ask you about the support you receive from your family and community. 
In order to help you have better idea of who they are, we divided them in to four groups: 
a. Family: Just count your extended family members whom you are living with and sharing 
meals with. Those people also can include people who do not live with you but regularly 
communicate with you, and you feel they are closed to you.  
b. Friends: People whom you make friends by yourself, but not through any organizations 
and social groups. For example, whom you know from classes, workplaces, relatives… 
but not, home-based care, SISCa/TB Volunteers. 
c. Peer educators:, people who come to check you up regularly and report to CHC your 
treatment progress(e.g. SISCa Volunteers, SISCa TB volunteers), home-based care, 
peer educator, groups/clubs.  
d. Health Care Support and Social Organization: staff who are working for mass 
organizations (MSS or staff who work for mass organizations (committee,) or health 
clinics.  
 
 
 
 
 
 
Section VI: HCP- Patient Communication  
J. These people including doctors, nurses, DTC/DTA, lab technician & SISCa/TB volunteers.  
Please place (×) or tick  a number which best represents your answer.   
 
Question 
 
Response 
S
tr
o
n
g
ly
 
D
is
a
g
re
e
 
S
o
m
e
w
h
a
t 
D
is
a
g
re
e
 
N
e
it
h
e
r 
A
g
re
e
 n
o
r 
D
is
a
g
re
e
  
S
o
m
e
w
h
a
t 
A
g
re
e
 
S
tr
o
n
g
ly
 
A
g
re
e
 
J1. HCP told me what the possible side-effects of each of the TB drug are? 1 2 3 4 5 
J2. HCP told me what treatment would do 1 2 3 4 5 
J3. HCP told me how the TB treatment would be 1 2 3 4 5 
J4. HCP told me the changes to expect in my health when taking TB medication 1 2 3 4 5 
J5. Treatment procedure was clearly explained by the HCP 1 2 3 4 5 
 
Question 
 
Circle a number which represent the appropriate 
response  
V
e
ry
 
D
is
s
a
ti
s
fi
e
d
 
S
o
m
e
w
h
a
t 
d
is
s
a
ti
s
fi
e
d
 
S
o
m
e
w
h
a
t 
s
a
ti
s
fi
e
d
  
V
e
ry
 
S
a
ti
s
fi
e
d
 
0 1 2 3 
J6. In general, how satisfied are you with the overall support you get from the HCP? 0 1 2 3 
K. Social and Family Support  
Please place (×) or tick  a number which best represents your answer.   
 
Question: Do you tell some of the following people that you are having TB treatment? 
 N
o
t 
A
t 
A
ll
 
A
 L
it
tl
e
 
S
o
m
e
w
h
a
t 
A
 L
o
t 
K1. Family  0 1 2 3 
K2. Friends 0 1 2 3 
K3 Neighbor(s)  0 1 2 3 
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K4. Peer educators (SISCa volunteers) 0 1 2 3 
K5. MSS (Ministry Solidarity Social) 0 1 2 3 
 
Question: To what extent do the following people help you to remember to take TB medication? 
 N
o
t 
A
t 
A
ll
 
A
 L
it
tl
e
 
S
o
m
e
w
h
a
t 
A
 L
o
t 
K6. Family  0 1 2 3 
K7. Friends 0 1 2 3 
K8 Neighbor(s)  0 1 2 3 
K9. Peer educators (SISCa volunteers) 0 1 2 3 
K10. MSS (Ministry Solidarity Social) 0 1 2 3 
 
Question: To what extent do the following people provide you emotional support (e.g. 
acceptance, freedom to talk openly about your health, care, ability to confide in, ability to share 
grief, and the like)? 
 
N
o
t 
A
t 
A
ll
 
A
 L
it
tl
e
 
S
o
m
e
w
h
a
t 
A
 L
o
t 
K11. Family  0 1 2 3 
K12. Friends 0 1 2 3 
K13 Neighbor(s)  0 1 2 3 
K14. Peer educators (SISCa volunteers) 0 1 2 3 
K15. MSS (Ministry Solidarity Social) 0 1 2 3 
   
Question: To what extent do the following people provide you tangible support (e.g. finances, 
transportation, house chore, housing, clothing, food supplies, medical supplies, children 
education and the like)? N
o
t 
A
t 
A
ll
 
A
 L
it
tl
e
 
S
o
m
e
w
h
a
t 
A
 L
o
t 
K16. Family  0 1 2 3 
K17. Friends 0 1 2 3 
K18 Neighbor(s)  0 1 2 3 
K19. Peer educators (SISCa volunteers) 0 1 2 3 
K20. MSS (Ministry Solidarity Social) 0 1 2 3 
 
Question: To what extent do the following people provide you information support (e.g. advise, 
guidance, feedback or information on a variety of issues and the like)? No
t 
A
t 
A
ll
 
A
 L
it
tl
e
 
S
o
m
e
w
h
a
t 
A
 L
o
t 
K21. Family  0 1 2 3 
K22. Friends 0 1 2 3 
K23 Neighbor(s)  0 1 2 3 
K24. Peer educators (SISCa volunteers) 0 1 2 3 
K25. MSS (Ministry Solidarity Social) 0 1 2 3 
 
Question: In general, how satisfied are you with the overall support you get from the following? 
 N
o
t 
A
t 
A
ll
 
A
 L
it
tl
e
 
S
o
m
e
w
h
a
t 
A
 L
o
t 
K26. Family  0 1 2 3 
K27. Friends 0 1 2 3 
K28 Neighbor(s)  0 1 2 3 
K29. Peer educators (SISCa volunteers) 0 1 2 3 
K30. MSS (Ministry Solidarity Social) 0 1 2 3 
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Thank you very much for you participation! 
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Tetum Version 
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Appendix I 
Survey Questionnaire 
Instrusaun: Ita nia resposta iha formulariu Ida ne sei konsidera hanesan segredu, no sei uja deit 
atu dezenvolve planu ruma hodi tulun maluk sira ne’ebe infetaduTuberculoze hodi kumpri 
tratamentu ho diak. Favor responde pergunta hirak ne’e tuir ita nia kapasidade. Se pergunta 
ruma mak la klaru favor husu klarifikasaun husi peskisador nebe asisti ita bo’ot. Brigado wain 
ba ita nia participasaun iha estudu importante ida ne! 
Ita nia resposta ne segredu e sei uja deit para completu estudu ne. 
Section I. Perguntas Kona ba Ita Nia An 
 
A.  Informasaun demografiku  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
Pergunta  Resposta 
A1 Seksu 
Mane 1 
Feto 2 
A2 Ita moris sa tinan?    
 
                               └─┴─┴─┴─┘ exemplu: 1983 
                                    t   t   t    t 
A3 Ita tinan hira?  Tinan 
 
└─┴─┘ 
A4 
Iha total, tinan hira ita gasta iha eskola (la inklui 
TK) 
Tinan 
└─┴─┘ Note 0 = Nunka eskola 
A5 Ita husi distritu no sub-distritu nebe? Distritu: Sub-distritu: 
 
EXPANDED: Informasaun demografiku  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
A6 Ita nia nivel edukasaun ikus liu mak 
saida? 
La iha edukasaun formal 1 
 
Sekundaria - SMA 3 
Eskola primaria (SD) 2 Colegio/Universidade 4 
Eskola primaria (SMP) 3   
A7 Estadu sivil? 
  
  
klosan 1 Fahe malu 3 
Kaben nain 2 Laen/fen mate 4 
A8 
Opsaun sira ne, ida nebe mak esplika diak 
liu kona ba ita nia servisu iha fulan 12 
liuba? 
Hili liu husi opsaun ida, ba sira ne’ebe 
apropria 
 
 
 
Laiha servisu 1 Dona de casa 6 
To’os nain 2 Desempregado (bele 
servs) 
7 
Swasta/buru kasar 3 Desemprego (la bele 
servs)  
8 
 
Funsionariu publiku 4 Seluk (spesifika)______ 9 
Estudante 5   
  
  
A9 
Apoiu finanseiru saida mak bain-bain ita 
hetan? 
Hili liu husi opsaun ida, ba sira ne’ebe 
apropria 
Salario rasik 1 Suporta husi kolega 4 
Suporta husi kaben 2 Seluk (spesifika)_______ 5 
 
Suporta husi familia 3   
  
  
A10 Total salario kada fulan iha ita nia familia 
(inklui ema ne’ebe hela ho ita iha uma) 
maiz ou menuz hira? 
Hili opsaun ida nebe apropria 
< 30USD/fulan 1 121USD-150USD/fulan 5 
31USD-60USD/fulan 2 151USD-180USD/fulan 6 
61USD-90USD/fulan 3 181USD-210USD/fulan 7 
91USD-120USD/fulan 4 >210USD/fulan 8 
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A11 
Iha ita nia familia laran, sasan hirak tuir mai ne’e 
iha glae? 
Hili liu husi opsaun ida, ba sira ne’ebe 
apropria 
Uma kalen 1 Televizaun 7 
Uma laran sementi 2 Telemovel 8 
Haris fatin nebe ho 
estandar 
3 Bisikaleta 9 
 Saneamentu estandar 4 Jaleira 10 
Motabomba 5 Motor 11 
Armari ropa 6 Kareta 12 
A12 
Ita hela hamutuk ho se? 
Hili liu husi opsaun ida, ba sira ne’ebe 
apropria 
Hela mesak 
Stay alone  
1 Membru familia seluk 5 
In n man 2 Kolegas 6 
Ho oan 3 Kolega servisu 7 
Hela ho fen/laen 4   
      
A13 
Ema nain hira mak hela hamutuk ho ita? 
Hili opsaun ida ne’ebe apropria 
Hau mesak  1 Ema nain hat 4 
Ami nain rua 2
R
ef
us
ed 
Liu husi ema nain hat 5 
          Ema nain tolu 
hela ho ita 
3   
  
  
A14 
Semak bain-bain fo hanoin ita atu bele hemu 
aimoruk tuir orariu nebe pesoal saude sira fo 
ona? 
Hili liu husi opsaun ida, ba sira ne’ebe 
apropria 
Ita nia laen/fen 1 Kolega servisu(s) 6 
7 Inan aman 2 PSF 
Oan Sira 3 Peasoal Saude 8 
Membru familia seluk 4 Hau hemu rasik 9 
Kolegas 5   
A15 
Husi uma, maiz ou menuz oras/minitu hira ita lao 
ba klinik/Posto Saude/CHC/Hispital Referral 
nebe besik liu? 
Minute 15 ou menuz 1 Minute 46-60  
 
4 
Minute 16-30  
 
2 Oras 1 - 2 5 
Minute 31-45  3 Oras 2 ou liu   
 
6 
  
  
A16 
Iha kombinasaun fulan 12 nia laran dala hira ita 
uja trasporte nebe hanesan?  Hili liu husi 
opsaun ida, ba sira ne’ebe apropria 
Mikrolet/Anguna 1 Scooter/Motor 4 
Bis/Trek                     2             Lao deit 
tratamentu 
/from a destination 
5 
Taxi                           
Biskaleta 
 
 
 
 
 
3  
  
  
 
B. Vida moris – Hemu tua manas  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
Pergunta Resposta 
B1 Ita hemu tua manas? Sim 1 Lae, continua ba B5 3 
Para hemu wainhira hahu tratamentu 2   
B2 
Dala hira ita hemu tua manas 
hanesan beer, tinto, tua mutin/tua 
sabu ou tua manas ruma kahur ho 
alkohol? 
Loro-loron ou de vez 
enkuandu 
(> dala 4 kada 
semana) 
1 
Dala balun kada fulan 
(dala 1-3 kada fulan) 
3 
Semana-semana 
(dala 1 - 3 kada 
semana) 
2 Hemu wainhira iha 4 
B3 
Alkohol ho quantidade hira mak ita 
bo’ot bain-bain konsume? 
(refere ba figura iha leten) 
1 to 2 1 7 to 8 4 
3 to 4 2 9+ 5 
5 to 6 3   
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B4 
Ita hemu tua manas dala hira ho 
quantidade 6 ou liu iha tempu ita 
hemu? 
Nunka 1 Kada semana 4 
Kadavez  2 Loron-loron 5 
Kada fulan 3   
 
 
Vida moris: Fuma Sigaru/Tobacco  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
Pergunta  Resposta 
B5 Ita fuma sigaru? 
Agora sei fuma hela 1 Nunka 4 
Uluk mak fuma 2 Se nunka, continua ba B9  
Para fuma wainhira hahu  
tratamentu 
3  
 
B6 
Wainhira hader iha dader, minitu hira 
tia mak ita hahu fuma sigaru lolon 
primeiru? 
Minitu 5 nia laran 
 
1 
Depois de oras ida nia laran 4 Minitu 6 - 30 2 
Minitu 31-60 3 
  
  
B7 
Bain-bain sigaru lolon hira mak ita 
fuma kada loron ida? 
10 ou menus 1 21-30 3 
 11-20 2 31 ou liu 4 
B8 
Iha oras 24 nia laran liu ba, ita fuma 
sigaru lolon hira? 
Lolon_________________ 
 
  
______________    
 
 
Vida moris – Droga  
Perguntas hirak tuir mai husu ita kona ba uja droga. Dala ida tan, ita nia resposta sei tau hanesan segredu 
no sei uja deit para atinji objetivu ba estudu ne’e.  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
Question Response 
B9 Ita uja droga? 
Sim, agora sei uja hela 1 
Nunka 
Se nunka, continua ba sesaun C. 
3 
Simi, maibe iha pasado 2   
B10 
Iha fulan liu ba nia laran, 
dala hira ita uja droga? 
Loro-loron ou dala ruma 
 (>  dala 4 semana ida) 
1 
Kadavez iha fulan ida (1 – 3 
kada/fulan) 
3 
Kadavez iha samena ida 
(1-3 kada/semana) 
2 Usa wainhira iha 4 
 
Sesaun II 
C. Psychological Distress  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
Iha loron 30 nia laran liu ba: 
N
u
n
k
a
 
D
a
la
 
ru
m
a
 
T
e
m
p
u
 
b
a
lu
n
 
D
a
la
 
b
a
ra
k
 
S
e
m
p
re
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C1 Mais ou menus dala hira ona ita sente kolen ho laiha razaun? 1 2 3 4 5 
C2 Mais ou menus dala hira mak ita sente nakdedar? 1 2 3 4 5 
C3 Dala hira ona mak ita sente nakdedar los no laiha buat ida atu hakalma? 1 2 3 4 5 
C4 Mais ou menus dala hira ona mak ita sente laiha esperansa ba moris? 1 2 3 4 5 
C5 Mais ou menus dala hira ita la bele deskansa ho diak? 1 2 3 4 5 
C6 Dala hira ita sente la bele los atu deskansa ho diak no tur la metin? 1 2 3 4 5 
C7 Mais ou menus dala hira ona mak ita sente depresaun (tekanan)? 1 2 3 4 5 
C8 Dala hira mak ita sente katak halo buat hotu ne esforsu ida ba ita? 1 2 3 4 5 
C9 Dala hira mak ita sente triste liu e laiha buat ida mak bele halo kontente? 1 2 3 4 5 
C10
. 
Mais ou menus dala hira ona mak ita sente moris ne’e la vale? 1 2 3 4 5 
 
 
 
 
Session III: Ami hakarak hatene ita nia komprensaun kona ba moras tuberculoze 
E. Your TB Knowledge about Tuberculosis  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
E1  Oin sa Tuberkuloze bele hada’et husi ema ida ba ema 
seluk? 
Mear la taka ibun 1 
Causa husi 
espiritu a’at 
3 
Han hamutuk 2   
E2 Ita bele han hamutuk ho membru familia sira? Sim 1 Lae 2 
E3 Familia direita presisa halo screening/teste ba tuberculoze? Sim 1 Lae 2 
E4 Tuberculoze bele kura ho tratamentu nebe propria? Sim 1 Lae 2 
E5 
Tuberculoze bele kura durante tratamentu iha semana ida 
nia laran?  
Sim 1 Lae 2 
D.  Multidimensional Health Locus of Control Scales - Shortened Version  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
 
Pergutans 
 
Resposta 
L
a
 a
s
e
it
a
 l
iu
 
L
a
 a
s
e
it
a
 
A
s
e
it
a
 
A
s
e
it
a
 l
iu
 
D1 Hau rasik mak kontrola hau nia saude 1 2 3 4 
D2. Hau rasik responsavel ba buat nebe afeita ba hau nia saude 1 2 3 4 
D3. Se hau kuidadu hau nia an, hau bele hadok an husi moras. 1 2 3 4 
D4. Iha kontaktu regularmente ho doutor maka dalan diak atu hado’ok an husi moras.   1 2 3 4 
D5. Wainhira hau laran baruk, hau sei halo konsultasaun ho pesoal saude sira. 1 2 3 4 
D6. Wainhira hau diak husi moras, ne’e tanba iha ema seluk nebe tau matan ba hau 1 2 3 4 
D7. Sorti sai hanesan parte ida oinsa hau bele hetan diak lalais husi moras.  1 2 3 4 
D8. Hau nia saude diak sai nudar sorti diak ida mos ba hau.  1 2 3 4 
D9. Se ida ne mak nune duni ona, hau hakarak moris saudavel.  1 2 3 4 
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E6 
Atu kura moras Tuberculoze, presiza tuir tratamentu to’o 
wainhira? 
Fulan 1 – 2 1 Iha moris tomak 3 
Fulan 6-8 nia laran 2 
La hanesan entre 
pasiente 
4 
E7 
Tratamentu bele hakotu klae, wainhira laiha ona simtomas, 
maske durasaun ba tratamentu nebe determina seidauk 
remata? 
Sim 1 Lae 2 
 
 
Section  IV: Kumpri Tratamentu  
Ami husu ita atu responde perguntas hirak tuir mai atu komprende lolos realidade nebe akontese ba 
ita hemu ita nia aimoruk, maibe sei la evalua ita hemu ita nia aimoruk ou lae. La bele tauk atu 
informa ami katak ita hemu ita nia aimoruk ou haluha atu hemu. Ami presisa atu hatene lolos saida 
mak akontese atu bele ajuda sira seluk nebe la kumpri ba sira nia tratamentu. Laiha doutor ou 
profesaun saude sira nebe tau matan ba ita mak sei hatene ou rona kona ba saida mak ita hatete 
mai ami.  
F. Hemu Ita Nia Aimoruk 
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
F1 Kadavez ita haluha hemu ita nia aimoruk glae?  
Si
m 
1 
La
e 
2 
F2 Karik dala balun mak ita la iha interese wainhira atu hemu aimoruk? 
Si
m 
1 
La
e 
2 
F3 Wainhira ita sente diak ona, ita la kontinua (para) atu hemu ita nia aimoruk? 
Si
m 
1 
La
e 
2 
F4 Kadavez se ita sente moras liu tan wainhira hemu aimoruk, ita para hemu? 
Si
m 
1 
La
e 
2 
F5 Ita hemu ita nia aimoruk deit wainhira ita sente moras? 
Si
m 
1 
La
e 
2 
F6 Liu husi hemu aimoruk, ita bele hadook an husi moras? 
Si
m 
2 
La
e 
1 
F7 Hemu aimoruk ne’e halo ita bele moras? 
Si
m 
1 
La
e 
2 
F8 Ita sente aneh wainhira hemu aimoruk? 
Si
m 
1 
La
e 
2 
Compliant = code 2 in all questions  
Ba pergunta tuir mai favor sirkulu (O) or marka (√) pursentu nebe representa ita nia responde diak liu   
F9 
Ami hakarak ita bo’ot atu sik kona ba aimoruk hira ona mak ita konsege hemu iha fulan liu ba. Ami sei supresa se 
ema barak hemu 100%. Favor marka linha iha kraik atu representa aimoruk hira maka ita konsege hemu iha fulan 
liu ba (exemplu 0 indika katak ita la hemu aimoruk ruma, 50% indika katak ita hemu sorin balun no 100% indika ita 
hemu aimoruk ho completu).  
Dala hira ona ita halo tuir instrusaun hemu aimoruk iha fulan kotuk liu ba? 
 
 
 
   
 
  
 
   
 
     
 
   
 
 0 10% 20% 30% 40% 
50
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90
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Rasaun tanba sa la hemu aimoruk 
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Ema barak bele la konsege hemu sira nia aimoruk ho rasaun oin-oin. Refere ba lista 
tuir mai, karik ita bele identifika rasaun ruma nebe karik impede ita hemu ita nia 
aimoruk iha fulan liu ba.  
G. Fator kompromisiu 
Razaun la hemu aimoruk: Deklarasaun hirak tuir mai sei aprezenta ita nia estatutu saude. 
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
 
Ita haluha hemu ita nia aimoruk iha fulan ida liu ba nia laran tanba:  S
im
 
L
a
e
 
G1 Haluha deit? 1 2 
G2 Sente diak ona? 1 2 
G3 Do’ok husi uma? 1 2 
G4 Tanba iha aimoruk barak liu? 1 2 
G5 Hakarak evita efeitu koleteral? 1 2 
G6 Postu Saude/Klinika/CHC/Ospital Referal do’ok liu? 1 2 
G7 Troka rutina loro-loron? 1 2 
G8 Sente aimoruk ne’e hanesan veneno/perigozu? 1 2 
G9 Sente matan dukur bebeik tanba doze aimoruk? 1 2 
G10 Sente moras? 1 2 
G11 Sente depresaun (tertekan)? 1 2 
G12 Hetan problema atu hemu tuir tempu espesifikadu (han ho hahan, kabun mamuk, antes toba sst)? 1 2 
  G13 Postu Saude/Klinika/CHC/Ospital Referal la fo aimoruk mai hau? 1 2 
G14 Okupadu ho atividade barak seluk? 1 2 
G15 Uja droga? 1 2 
G16 Hemu tua? 1 2 
G17 Hemu sente laran sa’e no la hemu tan? 1 2 
G18 Laiha osan ba hahan no selu transporte? 1 2 
G19 Aimoruk remata no la konsege ba foti iha Postu Saude/Klinika/CHC/Ospital Referal? 1 2 
G20 Lakohi ema seluk hatene katak hau hemu aimoruk? 1 2 
G21 La fiar ba funsaun aimoruk ne? 1 2 
 
Section V Stigma 
H. Tuberculosis related stigma scales 
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
 
Pespetivo komunidade hasoru moras tuberculoze S
im
 
L
a
e
 
H1. Tuir ita nia hanoin ema lakohi atu han ou hemu hamutuk ho kolega sira nebe sofre moras TB? 1 2 
H2. 
 
Tuir ita nia hanoin ema sente la seguru wainhira besik ema sira nebe ho moras tuberculoze? 1 2 
H3. Tuir ita nia hanoin ema hadook an husi sira nebe sofre moras tuberculoze? 1 2 
H4. 
 
Tuir ita nia hanoin ema lakohi atu koalia ho sira nebe sofre moras tuberculoze? 1 2 
H5. Tuir ita nia hanoin ema tauk ho sira nebe sofre moras tuberculoze? 1 2 
H6. Ita sente ema tauk atu kaer liman ho sira nebe sofre moras tuberculoze? 1 2 
H7. Ita sente ema lakohi atu han e hemu hamutuk ho membru familia nebe sofre moras tuberculoze? 1 2 
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Perspectivo pasiente hasoru moras tuberculoze S
im
 
L
a
e
 
H8. Ita hanoin ema nebe sofre moras tuberculoze sente laran moras tanba ema nia reasaun hatene katak 
sira moras TB? 
1 2 
H9. Ita hanoin ema nebe sofre moras tuberculoze sente mesak-mesak (maluk laiha)? 1 2 
H10
. 
Ita hanoin ema nebe sofre moras tuberculoze tauk atu hatete ba ema seluk nebe laos nia familia? 1 2 
H11
. 
Ita hanoin ema nebe sofre moras TB sente sala tanba hatene katak sira nia familia lakon tempu tau 
matan ba sira?  
1 2 
H12
. 
Ita hanoin ema nebe sofre moras TB tauk atu hatete ba nia familia kona ba sira nia status moras? 1 2 
 
Matan dook sira 
Ema hirak ne’e inklui katuas ou ferik sira nebe rekonhese sira nia an katak sira iha 
abilidade atu kura ema moras iha komunidade. Pontus hirak tuir mai nudar 
deklarasaun kona ba ita nia saude. Favor tau sinal ruma ba numeru nebe indika se ita 
aseita ou la aseita ho rasaun sira tuir mai tanba sa ita hakarak visita matan dook sira. 
 
 
 
I. Traditional Healers 
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
 
I13 
 
Ita visita matan dook sira? (Se lae, kontunua ba seasaun tuir mai) 
S
i
m
 
L
a e
  
1 2 
Tanba sa ita visita matan dook sira? 
L
a
 
a
s
e
it
a
 
li
u
 
L
a
 
a
s
e
it
a
 
N
e
tr
a
l 
 
A
s
e
it
a
 
A
s
e
it
a
 
li
u
 
I14 Hau hakarak atu hemu aimoruk tradisional 1 2 3 4 5 
I15 Hau la bele hetan kura iha klinik/CHC/Postu saude? 1 2 3 4 5 
I16 Laiha klinika/CHC/Postu saude ruma mak besik hau nia hela fatin? 1 2 3 4 5 
I17 Kostu ba transporte karun liu 1 2 3 4 5 
Section VI: Komunikasaun entre pesoal saude ho pasiente  
J. Ema hirak ne inklui doutor, Infermeira, DTC/DTA, lab technician & PSF  
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
 
Pergunta 
 
Resposta 
L
a
 a
s
e
it
a
 
li
u
 
L
a
 a
s
e
it
a
 
N
e
tr
a
l 
 
A
s
e
it
a
 
A
s
e
it
a
 l
iu
 
J1 Pesoal saude fo hatene mai hau saida mak efeitu kolateral husi aimoruk TB nian 1 2 3 4 5 
J2 Pesoal saude dehan saida mak tratamentu TB sei fo mai hau 1 2 3 4 5 
J3 Pesoal saude dehan mai hau oinsa klala’ok tratamentu nian 1 2 3 4 5 
J4 Pesoal saude dehan kona ba mudanca ba hau nia saude wainhira hemu aimoruk 
TB 
1 2 3 4 5 
J5 Pesoal saude esplika klaru los kona ba lalao’k tratamentu 1 2 3 4 5 
 
Pergunta 
 
Respsta  
L
a
 s
a
ti
s
fa
z
 
li
u
 
L
a
 s
a
ti
s
fa
z
 
S
ti
s
fa
z
 
S
a
ti
s
fa
z
 
li
u
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Section VII: Suporta familia no suporta sosial 
 
Pergunta sira tuir mai sei husu kona ba suporta sira mak ita simu husi ita nia familia no husi 
komunidade. Atu fo idea mak diak kona ba se make ma sira ne’e, sei fahe ba grupu 4 hanesan 
tuir mai ne’e: 
a. Familia: sura deit membru familia rasik mak ita hela ho no han hamutuk. Ema sira ne’e 
mos bele inklui sira ne’ebe la’os hela hamutuk maibe komunka regular ho ita, no ita 
sente besik ba sira. 
b. Kolega: ema sira ne’ebe ita halo kolega ho maibe la’os liu husi organizasaun ou grupu 
sosial ruma. Ezemplu: kolega eskola, kolega servisu, parenti… maibe la’os husi pesoal 
no voluntariu saude sira. 
c. Peer edukador sira: ema sira ne’e be mak regulamente mai trata/fo konsulta ita no 
relata ba CHC kona ba ita nia tratamentu nia progresu. Ezemplu mak voluntariu SISCa 
no pesoal saude husi CHC.  
d. Organizasaun sosial komum (Ministeriu Solidaridade Social ou funsinariu komite nebe 
servisu ba organizasaun o klinika saude.  
J6 Iha jeral, ita satisfaz ho suporta ne’ebe ita hetan husi pesoal saude ka lae? 1 2 3 4 
K. Suporta Sosial ho Suporta Familia 
Favor tau sinal (Χ) ou marka  numeru nebe representa diak liu ita nia resposta.   
 
Pergunta: Ita bele hatete ba ema hirak tuir mai katak ita tuir hela tratamentu 
Tuberculoze? 
L
a
e
  
O
it
o
a
n
 
B
a
ra
k
 
o
it
o
a
n
 
B
a
ra
k
 
K1 Familia 1 2 3 4 
K2 Kolegas 1 2 3 4 
K3 Vizinho  1 2 3 4 
K4 Voluntariu SISCa & pesoal saude  1 2 3 4 
K5 Membru Ministeriu Solidaridade Sosial no organizasaun social seluk 1 2 3 4 
Pergunta: Husi ema sira tuir mai ne’e, se mak fo hanoin ita bebeik ita atu 
hemu ita nia aimoruk? La
e
  
O
it
o
a
n
 
B
a
ra
k
 
o
it
o
a
n
 
B
a
ra
k
 
K6 Familia 1 2 3 4 
K7 Kolegas 1 2 3 4 
K8 Vizinho  1 2 3 4 
K9 Voluntariu SISCa & pesoal saude 1 2 3 4 
K10 Membru Ministeriu Solidaridade Sosial  no organizasaun social seluk 1 2 3 4 
   
   
Pergunta: Husi lista ema sira tuir mai ne’e, se mak fo suporta emosional? (eg. 
Simu realidade kona ba moras ne’e, libre atu ko’alia kona ba ita nua estutu 
moras nian, kuidadu no abilidade atu rai konfidensia, abilidade atu bele fahe 
tristeza) 
L
a
e
  
O
it
o
a
n
 
B
a
ra
k
 o
it
o
a
n
 
B
a
ra
k
 
K11 Familia 1 2 3 4 
K12 Kolegas 1 2 3 4 
K13 Vizinho  1 2 3 4 
K14 Voluntariu SISCa & pesoal saude 1 2 3 4 
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Brigado wa’in tebes ba ita nia partisipasaun! 
K15 Membru Ministeriu Solidaridade Sosial no organizasaun social seluk 1 2 3 4 
Pergunta:  ema hirak tuir mai, se mak bele fo suporta bebeik (Ezemplu: 
finanseiru, transporte, hela fatin, roupa, hahan, mediku, labarik sira nia eskola, 
no suporta sira seluk). 
L
a
e
  
O
it
o
a
n
 
B
a
ra
k
 
o
it
o
a
n
 
B
a
ra
k
 
K16 Familia 1 2 3 4 
K17 Kolegas 1 2 3 4 
K18 Vizinho  1 2 3 4 
K19 Voluntariu SISCa & pesoal saude  1 2 3 4 
K20 Membru Ministeriu Solidaridade Sosial no organizasaun social seluk 1 2 3 4 
Pergunta:  ema hirak tuir mai, se mak fornese suporta informasaun (Ezemplu : 
sujestaun, mata dalan, lian menon ou informasaun)? L
a
e
  
O
it
o
a
n
 
B
a
ra
k
 
o
it
o
a
n
 
B
a
ra
k
 
K21 Familia 1 2 3 4 
K22 Kolegas 1 2 3 4 
K23 Vizinho  1 2 3 4 
K24 Voluntariu SISCa & pesoal saude 1 2 3 4 
K25 Membru Ministeriu Solidaridade Sosial no organizasaun social seluk 1 2 3 4 
Pergunta:  Iha jeral, ita sinte satisfaz husi suporta ne’ebe ita hetan husi grupu 
ema sira tuir mai ka lae? 
L
a
 s
a
ti
s
fa
z
 
li
u
 
L
a
 s
a
ti
s
fa
z
 
S
ti
s
fa
z
 
S
a
ti
s
fa
z
 
li
u
 
K26 Familia 1 2 3 4 
K27 Kolegas 1 2 3 4 
K28 Vizinho  1 2 3 4 
K29 Voluntariu SISCa & pesoal saude 1 2 3 4 
K30 Membru Ministeriu Solidaridade Sosial no organizasaun social seluk 1 2 3 4 
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Management of TB Treatment Interruption 
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Source: (2008; Peloquin, 2003) 
 
Figure 8 Management of TB Treatment Interruption 
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Appendix K 
 
In-depth Univariate Analysis 
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Appendix K 
 
Table 29 In-depth Univariate Analysis 
Socio-
demographic 
factors 
N
u
m
b
e
r 
p
a
ti
e
n
t 
(%
) Adherence Scale Lifestyle 
MARS (16 of 16 = 
adherent) 
VAS 
(≥90% = adherent) 
Alcohol consumption (%) Tobacco Smoking Illicit drug use 
Adherent 
(N, %) 
Non-
adherent 
(N, %) 
Adherent 
(N, %)) 
Non-
adherent 
(N, %) 
Current 
drinker 
Stop at 
start of 
treatment 
Never 
Currently 
smoking 
Used to 
smoke 
Stop 
start of 
t'ment 
Never 
Yes, in 
the 
past 
Never 
Min:0, max:8, 
Mean: 5.92±1.45 
Min: 10, max: 100 
Mean: 76.24±19.3 
Age               
18-29 119 
(34.3) 
20  
(14.9) 
114 
(85.1) 
24 
(25.5) 
70 
(74.5) 
18 
(13.1) 
47 
(34.3) 
72 
(52.6) 
5  
(3.6) 
11  
(8.0) 
41 
(29.7) 
81  
(58.7) 
2 
(1.5) 
133 
(98.5) 
30-39 63 
(18.2) 
5 
(9.4) 
48 
(90.6) 
13 
(14.8) 
75 
(85.2) 
8 
(14.8) 
27 
(50.0) 
19 
(35.2) 
2 
(3.7) 
2 
(3.7) 
32 
(59.3) 
18 
(33.3) 
1 
(1.9) 
51 
(98.1) 
40-49 38 
(11.0) 
2 
(6.1) 
31 
(93.9) 
4 
(14.8) 
23 
(85.2) 
4 
(11.8) 
17 
(50.0) 
13 
(38.2) 
0  
(0.0) 
6 
(17.6) 
13 
(38.2) 
15 
(44.1) 
1 
(2.9) 
33 
(97.1) 
50-59 35 
(10.0) 
3 
(9.1) 
30 
(90.9) 
12 
(16.7) 
60 
(63.3) 
6 
(16.2) 
16 
(43.2) 
15 
(40.5) 
2  
(5.4) 
1  
(2.7) 
11 
(29.7) 
23 
(62.2) 
0 
(0.0) 
37 
(100) 
60+ 92 
(26.5) 
8  
(10.0) 
72 
(90.0) 
11 
(19.6) 
45 
(80.4) 
8 
(9.6) 
47 
(56.6) 
28 
(33.7) 
3 
(3.6) 
12 
(14.5) 
26 
(31.3) 
42 
(50.6) 
0 
(0.0) 
83 
(100) 
Gender               
Male  191 
(55.0) 
18 
 (9.8) 
166 
(90.2) 
28 
(15.2) 
156 
(84.8) 
32 
(16.9) 
121 
(64.0) 
36 
(19.0) 
11  
(5.8) 
27 
(14.2) 
113 
(59.5) 
39 
(20.5) 
4 
(2.2) 
181 
(97.8) 
Female 156 
(45.0) 
20 
(13.4) 
129 
(86.6) 
36 
(23.4) 
118 
(76.6) 
12 
(7.7) 
33 
(21.2) 
111 
(71.2) 
1 
(0.6) 
5 
(3.2) 
10 
(6.4) 
140 
(89.7) 
0 
(0.0) 
156 
(100) 
Marital 
Status 
              
Never married 118 
(34.2) 
13 
 (11.2) 
103 
(88.8) 
17 
(14.4) 
101 
(85.6) 
19 
(16.0) 
50 
(42.0) 
50 
(42.0) 
4 
(3.4) 
11 
(9.2) 
46 
(38.7) 
58 
(48.7) 
2 
(1.7) 
115 
(98.3) 
Married 212 
(61.4) 
25 
(12.4) 
177 
(87.6) 
43 
(21.1) 
161 
(78.9) 
23 
(11) 
100 
(47.6) 
87 
(41.4) 
8 
(3.8) 
16 
(7.6) 
73 
(34.6) 
114 
(54.0) 
2 
(1.0) 
206 
(99.0) 
Div/sep/wid 15 
(4.4) 
0 
 (0.0) 
14 
(100) 
4 
(26.7) 
11 
(73.3) 
1 
(6.7) 
4 
(26.7) 
10 
(66.7) 
0 
(0.0) 
5 
(33.3) 
4 
(26.7) 
6 
(40.0) 
0 
(0.0) 
15 
(100) 
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N
u
m
b
e
r 
p
a
ti
e
n
t 
(%
) 
Adherence Scale Lifestyle 
MARS (16 of 16 = 
adherent) 
VAS 
(≥90% = adherent) 
Alcohol consumption (%) Tobacco Smoking Illicit drug use 
Adherent 
(N, %) 
Non-
adherent 
(N, %) 
Adherent 
(N, %)) 
Non-
adherent 
(N, %) 
Current 
drinker 
Stop at 
start of 
treatment 
Never 
Currently 
smoking 
Used to 
smoke 
Stop 
start of 
t'ment 
Never 
Yes, in 
the 
past 
Never 
Education               
No education 98 
(28.3) 
8 
(8.8) 
83 
(91.2) 
24 
(25.5) 
70 
(74.5) 
8 
(8.2) 
48 
(49.5) 
41 
(42.3) 
4 
(4.1) 
8 
(8.2) 
31 
(32.0) 
54 
(55.7) 
0 
(0.0) 
97 
(100) 
Primary  92 
(26.6) 
10 
(11.2) 
79 
(88.8) 
13 
(14.8) 
75 
(85.2) 
10 
(11.0) 
48 
(52.7) 
33 
(36.3) 
3 
(3.3) 
9 
(9.8) 
35 
(35.0) 
48 
(48.9) 
1 
(1.1) 
91 
(98.9) 
Secondary 28 
(8.1) 
3 
(11.1) 
24 
(88.9) 
4 
(14.8) 
23 
(85.2) 
6 
(22.2) 
8 
(29.6) 
13 
(48.1) 
1 
(3.7) 
1 
(3.7) 
9 
(33.3) 
16 
(59.3) 
0 
(0.0) 
27 
(100) 
High school 72 
(20.7) 
8 
(11.4) 
62 
(88.6) 
12 
(16.7) 
60 
(83.3) 
9 
(12.3) 
30 
(41.1) 
34 
(36.6) 
3 
(4.1) 
8 
(11.0) 
31 
(42.5) 
31 
(42.5) 
1 
(1.5) 
67 
(98.5) 
College/Uni 56 
(16.1) 
9 
(16.4) 
46 
(83.6) 
11 
(19.6) 
45 
(80.4) 
11 
(19.6) 
20 
(35.7) 
25 
(44.6) 
1 
(1.8) 
6 
(10.7) 
17 
(30.4) 
32 
(57.1) 
2 
(3.6) 
54 
(96.4) 
Income 
USD/month 
              
<30  146 
(42.1) 
12  
(8.5) 
129 
(91.5) 
24 
(16.8) 
119 
(83.2) 
21 
(14.4) 
65 
(45.5) 
60 
(41.1) 
6 
(4.1) 
15 
(10.3) 
49 
(33.6) 
76 
(52.1) 
2 
(1.4) 
142 
(98.6) 
31-60 47 
(13.5) 
6  
(13.3) 
39 
(86.7) 
4 
(8.5) 
43 
(91.5) 
12 
(26.1) 
23 
(50.0) 
11 
(23.9) 
3 
(6.4) 
6 
(12.8) 
19 
(40.4) 
19 
(40.4) 
1 
(2.2) 
45 
(97.8) 
61-90 18 
(5.2) 
2  
(11.8) 
15 
(88.2) 
4 
(23.5) 
13 
(76.5) 
1 
 (5.9) 
10 
(58.8) 
6 
(35.3) 
0 
(0.0) 
2 
(11.8) 
8 
(47.1) 
7 
(41.2) 
0 
(0.0) 
17 
(100) 
91-120 37 
(10.7) 
4  
(11.4) 
31 
(88.6) 
8 
(22.9) 
27 
(77.1) 
3  
(8.1) 
14 
(37.8) 
20 
(54.1) 
1 
(2.7) 
3 
(8.1) 
14 
(37.8) 
19 
(51.4) 
1 
(2.8) 
35 
(97.2) 
121-150 22 
(6.3) 
3 
 (14.3) 
18 
(85.7) 
7 
(35.0) 
13 
(65.0) 
3  
(13.6) 
5 
(22.7) 
14 
(63.6) 
0 
(0.0) 
3 
(13.6) 
5 
(22.7) 
14 
(63.6) 
0 
(0.0) 
22 
(100) 
151-210 7 
(2.0) 
2 
 (28.6) 
5 
(71.4) 
2 
(28.6) 
5 
(71.4) 
0  
(0.0) 
2 
(28.6) 
5 
(71.4) 
0 
(0.0) 
0 
(0.0) 
2 
(28.6) 
5 
(71.4) 
0 
(0.0) 
6 
(100) 
>210 29 
(8.4) 
4  
(14.3) 
24 
(85.7) 
5 
(17.9) 
23 
(82.1) 
4  
(13.8) 
15 
(51.7) 
10 
(34.5) 
2 
(6.9) 
2 
(6.9) 
12 
(41.4) 
13 
(44.8) 
0 
(0.0) 
29 
(100) 
Do not know 41 
(11.8) 
5 
 (12.8) 
34 
(87.2) 
10 
 (24.4) 
31 
(75.6) 
0  
(0.0) 
20 
(48.8) 
21 
(51.2) 
0 
(0.0) 
1 
(2.4) 
14 
(34.1) 
26 
(63.4) 
0 
(0.0) 
41 
(100) 
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Psychological distress K10 
 
Min: 10, max: 48, Mean: 26.83±8.0 
Patients' TB Knowledge 
Eat with family 
members 
Screen family   
with direct 
contact 
TB curable 
TB cured in one 
week treatment 
Discontinue 
treatment after 
feeling better 
Length of time required to cure 
TB 
L
ik
e
ly
 t
o
 
b
e
 w
e
ll 
 
M
ild
 m
e
n
ta
l 
d
is
o
rd
e
r 
M
o
d
e
ra
te
 
m
e
n
ta
l 
d
is
o
rd
e
r 
S
e
v
e
re
 
m
e
n
ta
l 
d
is
o
rd
e
r 
1
-2
 
m
o
n
th
s
 
6
-8
 
m
o
n
th
s
 
R
e
s
t 
o
f 
lif
e
 
V
a
ri
e
s
 
b
e
tw
e
e
n
 
p
a
ti
e
n
ts
 
Yes No Yes No Yes No Yes No Yes No 
 N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % 
Age                   
18-29 41 
(33.1) 
15  
(12.1) 
33 
(26.6) 
35 
(28.2) 
80  
(58.8) 
56 
(41.2) 
76 
(56.3) 
59 
(43.7) 
124 
(90.5) 
13 
(9.5) 
22 
(16.8) 
109 
(83.2) 
25 
(18.4) 
111 
(81.6) 
3 
(2.2) 
122 
(89.7) 
2 
(1.5) 
9 
(6.6) 
30-39 7 
(13.5) 
8 
(15.4) 
16 
(30.8) 
21 
(40.4) 
31 
(57.4) 
23 
(42.6) 
27 
(50.9) 
26 
(49.1) 
52 
(98.1) 
1 
(1.9) 
5 
(9.3) 
49 
(90.7) 
3 
(5.6) 
51 
(94.4) 
2 
(3.7) 
48 
(88.9) 
0 
(0.0) 
4 
(7.4) 
40-49 5 
(14.7) 
8 
(23.5) 
10 
(29.4) 
11 
(32.4) 
21 
(63.6) 
12 
(36.4) 
15 
(42.9) 
20 
(57.1) 
32 
(91.4) 
3 
(8.6) 
4 
(11.8) 
30 
(88.2) 
8 
(22.9) 
27 
(77.1) 
1 
(2.9) 
32 
(91.4) 
1 
(2.9) 
1 
(2.9) 
50-59 8 
(22.9) 
7 
(20.0) 
5 
(14.3) 
15 
(42.9) 
24 
(64.9) 
13 
(35.1) 
14 
(37.8) 
23 
(62.2) 
36 
(97.3) 
1 
(2.7) 
5 
(13.9) 
31 
(86.1) 
5 
(13.5) 
32 
(86.5) 
2 
(5.4) 
31 
(83.8) 
0 
(0.0) 
4 
(10.8) 
60+ 12 
(15.2) 
14 
(17.7) 
20 
(25.3) 
33 
(41.8) 
52 
(64.2) 
29 
(35.8) 
31 
(37.8) 
51 
(62.2) 
78 
(95.1) 
4 
(4.9) 
7 
(8.9) 
72 
(91.1) 
6 
(7.2) 
77 
(92.8) 
5 
(6.1) 
68 
(82.9) 
1 
(1.2) 
8 
(9.8) 
Gender                   
Male  38 
(21.3) 
30 
(16.9) 
51 
(28.7) 
59 
(33.1) 
116 
(61.7) 
72 
(38.3) 
87 
(46.3) 
101 
(53.7) 
176 
(92.6) 
14 
(7.4) 
20 
(10.9) 
164 
(89.1) 
26 
(13.8) 
163 
(86.2) 
6 
(3.2) 
167 
(88.8) 
3 
(1.6) 
12 
(6.4) 
Female 35 
(24.0) 
22 
(15.1) 
33 
(22.6) 
56 
(38.4) 
92 
(60.1) 
61 
(39.9) 
76 
(49.4) 
78 
(50.6) 
146 
(94.8) 
8 
(5.2) 
23 
(15.3) 
127 
(84.7) 
21 
(13.5) 
135 
(86.5) 
7 
(4.5) 
134 
(85.9) 
1 
(0.6) 
14 
(9.0) 
Marital 
Status 
                  
Never married 32 
(29.6) 
14 
(13.0) 
36 
(33.3) 
26 
(24.1) 
65 
(55.1) 
53 
(44.9) 
65 
55.1) 
53 
(44.9) 
108 
(91.5) 
10 
(8.5) 
14 
(12.2) 
101  
(87.8) 
21 
(17.6) 
98 
(82.4) 
3 
(2.5) 
107 
(89.9) 
1 
(0.8) 
8 
(6.7) 
Married 37 
(18.4) 
36 
(17.9) 
45 
(22.4) 
83 
(41.3) 
133 
(64.3) 
74 
(35.7) 
133 
(64.3) 
74 
(35.7) 
199 
(94.8) 
11 
(5.2) 
27 
(13.3) 
176 
(86.7) 
25 
(11.9) 
185 
(88.1) 
9 
(4.3) 
180 
(86.1) 
3 
(1.4) 
17 
(8.1) 
Div/sep/wid 3 
(21.4) 
2 
(14.3) 
3 
(21.4) 
6 
(42.9) 
9 
(60.0) 
6 
(40.0) 
9 
(60.0) 
6 
(40.0) 
14 
(93.3) 
1 
(6.7) 
2 
(13.3) 
13 
(86.7) 
1 
(6.7) 
14 
(93.3) 
1 
(6.7) 
13 
(86.7) 
0 
(0.0) 
1 
(6.7) 
Education                   
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Min: 10, max: 48, Mean: 26.83±8.0 
Patients' TB Knowledge 
Eat with family 
members 
Screen family   
with direct 
contact 
TB curable 
TB cured in one 
week treatment 
Discontinue 
treatment after 
feeling better 
Length of time required to cure 
TB 
L
ik
e
ly
 t
o
 
b
e
 w
e
ll 
 
M
ild
 m
e
n
ta
l 
d
is
o
rd
e
r 
M
o
d
e
ra
te
 
m
e
n
ta
l 
d
is
o
rd
e
r 
S
e
v
e
re
 
m
e
n
ta
l 
d
is
o
rd
e
r 
1
-2
 
m
o
n
th
s
 
6
-8
 
m
o
n
th
s
 
R
e
s
t 
o
f 
lif
e
 
V
a
ri
e
s
 
b
e
tw
e
e
n
 
p
a
ti
e
n
ts
 
Yes No Yes No Yes No Yes No Yes No 
No education 13 
(14.3) 
18 
(19.8) 
24 
(26.4) 
36 
(39.6) 
69 
(73.4) 
25 
(26.6) 
69 
(73.4) 
25 
(26.6) 
91 
(95.8) 
4 
(4.2) 
10 
(11.0) 
81 
(89.0) 
8 
(8.3) 
88 
(91.7) 
4 
(4.2) 
87 
(91.6) 
0 
(0.0) 
4 
(4.2) 
Primary  15 
(17.4) 
13 
(15.1) 
14 
(16.3) 
44 
(51.2) 
52 
(56.5) 
40 
(43.5) 
52 
(56.5) 
40 
(43.5) 
87 
(94.6) 
5 
(5.4) 
14 
(15.6) 
76 
(84.4) 
12 
(13.2) 
79 
(86.8) 
5 
(5.5) 
73 
(80.2) 
2 
(2.2) 
11 
(12.1) 
Secondary 1 
(3.7) 
6 
(22.2) 
9 
(33.3) 
11 
(40.7) 
15 
(62.5) 
9 
(37.5) 
15 
(62.5) 
9 
(37.5) 
25 
(92.6) 
2 
(7.4) 
2 
(8.0) 
23 
(92.0) 
3 
(11.1) 
24 
(88.9) 
0 
(0.0) 
25 
(92.6) 
1 
(3.7) 
1 
(3.7) 
High school 22 
(33.3) 
9 
(13.6) 
20 
(30.3) 
15 
(22.7) 
43 
(58.1) 
31 
(41.9) 
31 
(58.1) 
41 
(41.9) 
66 
(90.4) 
7 
(9.6) 
11 
(15.5) 
60 
(84.5) 
16 
(21.6) 
58 
(78.4) 
4 
(5.4) 
64 
(86.5) 
1 
(1.4) 
5 
(6.8) 
College/Uni 21 
(39.6) 
6 
(11.3) 
17 
(32.1) 
9 
(17.0) 
29 
(51.8) 
27 
(48.2) 
29 
(51.8) 
27 
(48.2) 
52 
(92.9) 
4 
(7.1) 
6 
(10.7) 
50 
(89.3) 
8 
(14.3) 
48 
(85.7) 
0 
(0.0) 
51 
(91.1) 
0 
(0.0) 
5 
(8.9) 
Income 
USD/month 
                  
<30  22 
(16.5) 
20 
(15.0) 
35 
(26.3) 
56 
(42.1) 
78 
(53.8) 
67 
(46.2) 
78 
(53.8) 
67 
(46.2) 
137  
(94.5) 
8 
(5.5) 
16 
(11.3) 
126 
(88.7) 
18 
(12.4) 
127 
(87.6) 
8 
(5.5) 
120 
(82.8) 
2 
(1.4) 
15 
(10.3) 
31-60 7 
(15.9) 
9 
(20.5) 
9 
(20.5) 
19 
(43.2) 
23 
(48.9) 
24 
(51.1) 
23 
(48.9) 
24 
(51.1) 
44 
(93.6) 
3 
(6.4) 
8 
(17.0) 
396 
(83.0) 
7 
(14.9) 
40 
(85.1) 
1 
(2.1) 
39 
(83.0) 
1 
(2.1) 
6 
(12.8) 
61-90 6 
(33.3) 
3 
(16.7) 
4 
(22.2) 
5 
(27.8) 
13 
(76.5) 
4 
(23.5) 
13 
(76.5) 
4 
(23.5) 
18 
(100.) 
0 
(0.0) 
2 
(11.8) 
15 
(88.4) 
1 
(5.6) 
17 
(94.4) 
0 
(0.0) 
16 
(88.9) 
0 
(0.0) 
2 
(11.2) 
91-120 8 
(23.5) 
7 
(20.6) 
7 
(20.6 
12 
(35.3) 
24 
(68.6) 
11 
(31.4) 
24 
(68.6) 
11 
(31.4) 
34 
(94.4) 
2 
(5.6) 
4 
(12.1) 
29 
(87.9) 
6 
(16.7) 
30 
(83.3) 
1 
(2.8) 
34 
(94.4) 
0 
(0.0) 
1 
(2.8) 
121-150 7 
(31.8) 
3 
(13.6) 
6 
(27.3) 
6 
(27.3) 
12 
(54.5) 
10 
(45.5) 
12 
(54.5) 
10 
(45.5) 
21 
(95.6) 
1 
(4.5) 
1 
(4.5) 
21 
(95.5) 
3 
(13.6) 
19 
(86.4) 
0 
(0.0) 
22 
(100) 
0 
(0.0) 
0 
(0.0) 
151-210 4 
(57.1) 
0 
(0.0) 
3 
(42.9) 
0 
(0.0) 
5 
(71.4) 
2 
(28.6) 
5 
(71.4) 
2 
(28.6) 
6 
(85.7) 
1 
(14.3) 
2 
(28.6) 
5 
(71.4) 
0 
(0.0) 
7 
(100) 
0 
(0.0) 
5 
(71.4) 
0 
(0.0) 
2 
(28.6) 
>210 8 
(29.6) 
2 
(7.4) 
9 
(33.3) 
8 
(29.6 
18 
(66.7) 
9 
(33.3) 
18 
(66.7) 
9 
(33.3) 
26 
(89.7) 
3 
(10.3) 
5 
(17.2) 
24 
(82.8) 
6 
(20.7) 
23 
(79.3) 
3 
(10.7) 
25 
(89.3) 
0 
(0.0) 
0 
(0.0) 
Do not know 11 
(28.2) 
8 
(20.5) 
11 
(28.2 
9 
(23.1) 
35 
(85.4) 
6 
(14.6) 
35 
(85.4) 
6 
(14.6) 
36 
(90.0) 
4 
(10.0) 
5 
(13.5) 
32 
(86.5) 
6 
(14.6) 
35 
(85.4) 
0 
(0.0) 
40 
(97.6) 
1 
(2.4) 
0 
(0.0) 
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Multidimensional Health Locus of control Scale (MHLCS) 
Internal (6,12,13) 
Min: 7, max: 12, Mean: 9.96±1.1 
Powerful Others (3,5,14) 
Min: 3, max: 12, Mean:9.8±1.52 
 
I am in control of my health 
 
Main thing affect health 
is what I do myself 
 
 
If I take care myself I 
will avoid illness 
 
 
Regular contact with 
doctor will avoid illness 
Do not feel well consult 
with medical 
professionals 
Get better because other 
people's care 
S
tr
o
n
g
ly
 
D
is
a
g
re
e
/d
is
a
g
re
e
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 N, % N, % N, % N, % N, % N, % N,% N, % N, % N, % N, % N, % N, % N, % N, % N, %   
Age                   
18-29 4 
(2.9) 
88 
(64.7) 
44 
(32.4) 
7 
(5.1) 
81 
(59.6) 
48 
(35.3) 
2 
(1.5) 
82 
(59.9) 
53 
(38.7) 
1 
(0.7) 
92 
(66.7) 
45 
(32.6) 
13 
(9.5) 
83 
(60.6) 
41 
(29.9) 
13 
(9.4) 
79 
(57.2) 
46 
(33.3) 
30-39 1 
(1.9) 
34 
(63.0) 
19 
(35.2) 
3 
(5.6) 
31 
(57.4) 
20 
(37.0) 
1 
(1.9) 
27 
(50.0) 
26 
(48.1) 
0 
(0.0) 
30 
(55.6) 
25 
(44.4) 
6 
(11.1) 
26 
(48.1) 
22 
(40.7) 
2 
(3.7) 
29 
(53.7) 
23 
(42.6) 
40-49 1 
(2.9) 
26 
(70.3) 
8 
(22.9) 
1 
(2.9) 
23 
(65.7) 
11 
(31.4) 
0 
(0.0) 
22 
(62.9) 
13 
(37.1) 
0 
(0.0) 
23 
(65.7) 
12 
(34.3) 
4 
(11.4) 
24 
(68.6) 
7 
(20.0) 
4 
(11.4) 
20 
(57.1) 
11 
(31.4) 
50-59 2 
(5.4) 
26 
(70.3) 
9 
(24.3) 
0 
(0.0) 
23 
(62.2) 
14 
(37.8) 
2 
(5.4) 
21 
(56.8) 
14 
(37.8) 
0 
(0.0) 
27 
(73.0) 
10 
(27.0) 
5 
(13.5) 
24 
(16.9) 
8 
(21.6) 
5 
(13.5) 
19 
(51.4) 
13 
(35.1) 
60+ 1 
(1.2) 
53 
(64.6) 
28 
(34.1) 
3 
(3.7) 
53 
(64.4) 
26 
(31.7) 
1 
(1.2) 
49 
(59.0) 
33 
(39.8) 
1 
(1.2) 
52 
(62.7) 
30 
(36.1) 
5 
(6.0) 
53 
(63.9) 
25 
(30.1) 
5 
(6.0) 
47 
(56.6) 
31 
(37.3) 
Gender                   
Male  5 
(2.7) 
121 
(64.4) 
62 
(33.0) 
7 
(3.7) 
120 
(63.8) 
61 
(32.4) 
4 
(2.1) 
106 
(55.8) 
80 
(42.1) 
2 
(1.0) 
119 
(62.3 
70 
(36.6 
19 
(9.9) 
113 
(59.2) 
59 
(30.9) 
16 
(8.4) 
107 
(56.0) 
68 
(35.6) 
Female 4 
(2.6) 
121 
(64.4) 
46 
(29.5) 
7 
(4.5) 
91 
(58.3) 
58 
(37.3) 
2 
(1.3) 
95 
(60.9) 
59 
(37.8) 
0 
(0.0) 
105 
(67.3) 
51 
(32.7) 
14 
(9.0) 
113 
(59.2) 
59 
(30.9) 
13 
(8.3) 
87 
(55.8) 
56 
(35.9) 
Marital Status                   
Never married 2 
(1.7) 
80 
(67.2) 
37 
(31.1) 
6 
(5.0) 
68 
(57.1) 
45 
(37.8) 
1 
(0.8) 
65 
(55.1) 
52 
(44.1) 
1 
(0.8) 
74 
(62.2) 
44 
(37.0) 
12 
(10.2) 
69 
(58.5) 
37 
(31.4) 
9 
(7.6) 
68 
(57.1) 
42 
(35.3) 
Married 7 
(3.3) 
138 
(66.0) 
6 
(40.0) 
6 
(2.9) 
131 
(62.7) 
72 
(34.4) 
5 
(2.4) 
131 
(61.8) 
76 
(35.8) 
1 
(0.5) 
143 
(67.5) 
68 
(32.1) 
20 
(9.4) 
131 
(61.8) 
61 
(28.8) 
18 
(8.5) 
120 
(56.6) 
74 
(34.9) 
Div/sep/wid 0 
(0.0) 
9 
(60.0) 
6 
(40.0) 
2 
(13.3) 
11 
(73.3) 
2 
(13.3) 
0 
(0.0) 
5 
(33.3) 
10 
(66.7) 
0 
(0.0) 
6 
(40.0) 
9 
(60.0) 
1 
(6.7) 
9 
(60.0) 
5 
(33.3) 
2 
(13.3) 
6 
(40.0) 
7 
(46.7) 
Education                   
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Internal (6,12,13) 
Min: 7, max: 12, Mean: 9.96±1.1 
Powerful Others (3,5,14) 
Min: 3, max: 12, Mean:9.8±1.52 
 
I am in control of my health 
 
Main thing affect health 
is what I do myself 
 
 
If I take care myself I 
will avoid illness 
 
 
Regular contact with 
doctor will avoid illness 
Do not feel well consult 
with medical 
professionals 
Get better because other 
people's care 
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No education 4 
(4.2) 
67 
(70.5) 
24 
(25.3) 
1 
(1.1) 
64 
(67.4) 
30 
(31.6) 
3 
(3.1) 
63 
(64.9) 
31 
(32.0) 
1 
(1.0) 
71 
(73.2) 
25 
(25.8) 
7 
(7.2) 
70 
(72.2) 
20 
(20.6) 
9 
(9.3) 
60 
(61.9) 
28 
(28.9) 
Primary  1 
(1.1) 
60 
(65.9) 
30 
(33.0) 
4 
(4.4) 
50 
(54.9) 
37 
(40.7) 
1 
(1.1) 
53 
(57.6) 
38 
(41.3) 
0 
(0.0) 
58 
(63.0) 
34 
(37.0) 
14 
(15.2) 
49 
(53.3) 
29 
(31.5) 
12 
(13.0) 
44 
(47.8) 
36 
(39.1) 
Secondary 1 
(3.7) 
19 
(70.4) 
7 
(25.9) 
0 
(0.0) 
22 
(81.5) 
5 
(18.5) 
1 
(3.7) 
13 
(48.1) 
13 
(48.1) 
1 
(3.7) 
13 
(48.1) 
13 
(48.1) 
4 
(14.8) 
12 
(44.4) 
11 
(40.7) 
2 
(7.4) 
14 
(51.9) 
11 
(40.7) 
High school 2 
(2.7) 
45 
(60.8) 
27 
(36.5) 
5 
(6.8) 
41 
(55.5) 
28 
(37.8) 
1 
(1.4) 
44 
(59.5) 
29 
(39.2) 
0 
(0.0) 
45 
(60.8) 
29 
(39.2) 
7 
(9.5) 
43 
(58.1) 
24 
(32.4) 
6 
(8.1) 
39 
(52.7) 
29 
(39.2) 
College/Uni 1 
(1.8) 
35 
(62.5) 
30 
(35.7) 
4 
(7.1) 
34 
(60.7) 
18 
(32.1) 
0 
(0.0) 
27 
(49.1) 
28 
(50.9) 
0 
(0.0) 
36 
(64.3) 
20 
(35.7) 
1 
(1.8) 
35 
(63.6) 
19 
(34.5) 
0 
(0.0) 
36 
(64.3) 
20 
(35.7) 
Income 
USD/month 
                  
<30  6 
(4.1) 
83 
(57.2) 
56 
(38.6) 
8 
(5.5) 
88 
(60.7) 
49 
(33.8) 
4 
(2.7) 
63 
(43.2) 
79 
(54.1) 
1 
(0.7) 
72 
(49.3) 
73 
(50.0) 
19 
(13.0) 
67 
(45.9) 
60 
(41.1) 
17 
(11.6) 
61 
(41.8) 
68 
(46.6) 
31-60 0 
(0.0) 
28 
(59.6) 
19 
(40.4) 
2 
(4.3) 
30 
(63.8) 
15 
(31.9) 
1 
(2.1) 
22 
(46.8) 
24 
(51.1) 
0 
(0.0) 
25 
(53.2) 
22 
(46.8) 
3 
(6.4) 
23 
(48.9) 
21 
(44.7) 
1 
(2.1) 
22 
(46.8) 
24 
(51.1) 
61-90 0 
(0.0) 
10 
(55.6) 
8 
(44.4) 
0 
(0.0) 
13 
(72.2) 
5 
(27.8) 
0 
(0.0) 
9 
(50.0) 
9 
(50.0) 
0 
(0.0) 
10 
(55.6) 
8 
(44.4) 
0 
(0.0) 
12 
(66.7) 
6 
(33.3) 
0 
(0.0) 
9 
(50.0) 
9 
(50.0) 
91-120 0 
(0.0) 
28 
(77.8) 
8 
(22.2) 
2 
(5.6) 
25 
(69.4) 
9 
(25.0) 
0 
(0.0) 
27 
(73.0) 
10 
(27.0) 
1 
(2.7) 
29 
(78.4) 
7 
(18.9) 
3 
(8.1) 
27 
(73.0) 
7 
(18.9) 
4 
(10.8) 
26 
(70.3) 
7 
(18.9) 
121-150 1 
(4.5) 
14 
(63.6) 
7 
(31.8) 
1 
(4.5) 
12 
(54.5) 
9 
(40.9) 
0 
(0.0) 
15 
(68.2) 
7 
(31.8) 
0 
(0.0) 
16 
(72.7) 
6 
(27.3) 
2 
(9.1) 
17 
(77.3) 
3 
(13.6) 
3 
(13.6) 
13 
(59.1) 
6 
(27.3) 
151-210 0 
(0.0) 
5 
(71.4) 
2 
(28.6) 
0 
(0.0) 
5 
(71.4) 
2 
(28.6) 
0 
(0.0) 
5 
(83.3) 
1 
(16.7) 
0 
(0.0) 
6 
(85.7) 
1 
(14.3) 
0 
(0.0) 
5 
(71.4) 
2 
(28.6) 
0 
(0.0) 
6 
(85.7) 
1 
(14.3) 
>210 0 
(0.0) 
23 
(82.1) 
5 
(17.9) 
1 
(3.6) 
15 
(53.6) 
12 
(42.9) 
0 
(0.0) 
25 
(86.2) 
4 
(13.8) 
0 
(0.0) 
22 
(89.7) 
3 
(10.3) 
4 
(13.8) 
23 
(79.3) 
2 
(6.9) 
3 
(10.3) 
21 
(72.4) 
5 
(17.2) 
Do not know 2 
(4.9) 
36 
(87.8) 
3 
(7.3) 
0 
(0.0) 
23 
(56.1) 
18 
(43.9) 
1 
(2.4) 
35 
(85.4) 
5 
(12.2) 
0 
(0.0) 
40 
(97.6) 
1 
(2.4) 
2 
(5.0) 
36 
(90.0) 
2 
(5.0) 
1 
(2.4) 
36 
(87.8) 
4 
(9.8) 
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ocio-demographic 
factors 
Multidimensional Health Locus of control Scale (MHLCS) 
Chance  
Min: 7, max: 12, Mean: 10.2±1.45 
Sum MHLC 
 
 
Luck plays big part in how soon I will 
recover from an illness 
 
My good health is largely a matter 
of good fortune 
 
 
If it meant to be I will stay 
healthy 
Min: 23, max:36, Mean: 29.983±3.443 
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 N, % N, % N, % N, % N, % N, % N,% N, % N, % N, % N, % N, % N, % 
Age              
18-29 4 
(2.9) 
89 
(64.5) 
45 
(32.6) 
1 
(0.7) 
79 
(57.7) 
57 
(41.6) 
3 
(2.2) 
76 
(55.1) 
59 
(42.8) 
0 
(0.0) 
6 
(4.4) 
121 
(89.6) 
8 
(5.9) 
30-39 1 
(1.9) 
27 
(50.0) 
26 
(48.1) 
1 
(1.9) 
27 
(50.0) 
26 
(48.1) 
0 
(0.0) 
26 
(48.1) 
28 
(51.9) 
0 
(0.0) 
2 
(3.7) 
49 
(90.7) 
3 
(5.6) 
40-49 2 
(5.7) 
22 
(62.9) 
11 
(31.4) 
2 
(5.7) 
18 
(51.4) 
15 
(42.9) 
1 
(2.9) 
19 
(54.3) 
15 
(42.9) 
0 
(0.0) 
2 
(5.7) 
31 
(88.6) 
2 
(5.7) 
50-59 0 
(0.0) 
24 
(64.9) 
13 
(35.1) 
1 
(2.7) 
22 
(59.5) 
14 
(37.8) 
1 
(2.7) 
22 
(59.5) 
14 
(37.8) 
0 
(0.0) 
3 
(8.1) 
33 
(89.2) 
1 
(2.7) 
60+ 0 
(0.0) 
45 
(54.9) 
37 
(45.1) 
0 
(0.0) 
43 
(51.8) 
40 
(48.2) 
0 
(0.0) 
45 
(54.2) 
38 
(45.8) 
0 
(0.0) 
2 
(2.4) 
74 
(90.2) 
6 
(7.3) 
Gender              
Male  4 
(2.1) 
114 
(60.0) 
72 
(37.9) 
2 
(1.1) 
100 
(52.6) 
88 
(46.3) 
0 
(0.0) 
105 
(55.0) 
86 
(45.0) 
0 
(0.0) 
9 
(4.8) 
168 
(89.4) 
11 
(5.9) 
Female 3 
(1.9) 
93 
(59.6) 
60 
(38.5) 
3 
(1.9) 
89 
(57.1) 
64 
(41.0) 
5 
(3.2) 
83 
(53.2) 
68 
(43.6) 
0 
(0.0) 
6 
(3.9) 
140 
(90.3) 
9 
(5.8) 
Marital Status              
Never married 4 
(3.4) 
70 
(58.8) 
45 
(37.8) 
1 
(0.8) 
66 
(55.9) 
51 
(43.2) 
1 
(0.8) 
63 
(52.9) 
55 
(46.2) 
0 
(0.0) 
4 
(3.4) 
104 
(89.7) 
8 
(6.9) 
Married 3 
(1.4) 
131 
(62.1) 
77 
(36.5) 
3 
(1.4) 
119 
(56.1) 
90 
(42.5) 
3 
(1.4) 
122 
(57.5) 
87 
(41.0) 
0 
(0.0) 
10 
(4.7) 
190 
(90.0) 
11 
(5.2) 
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Multidimensional Health Locus of control Scale (MHLCS) 
Chance  
Min: 7, max: 12, Mean: 10.2±1.45 
Sum MHLC 
 
 
Luck plays big part in how soon I will 
recover from an illness 
 
My good health is largely a matter 
of good fortune 
 
 
If it meant to be I will stay 
healthy 
Min: 23, max:36, Mean: 29.983±3.443 
S
tr
o
n
g
ly
 
D
is
a
g
re
e
/d
is
a
g
re
e
 
A
g
re
e
 
S
tr
o
n
g
ly
 
a
g
re
e
 
S
tr
o
n
g
ly
 
D
is
a
g
re
e
/d
is
a
g
re
e
 
A
g
re
e
 
S
tr
o
n
g
ly
 
a
g
re
e
 
S
tr
o
n
g
ly
 
D
is
a
g
re
e
/d
is
a
g
re
e
 
A
g
re
e
 
S
tr
o
n
g
ly
 
a
g
re
e
 
S
tr
o
n
g
ly
 
d
is
a
g
re
e
 
D
is
a
g
re
e
 
A
g
re
e
 
S
tr
o
n
g
ly
 
a
g
re
e
 
Div/sep/wid 0 
(0.0) 
6 
(40.0) 
9 
(60.0) 
1 
(6.7) 
4 
(26.7) 
10 
(66.7) 
1 
(6.7) 
3 
(20.0) 
11 
(73.3) 
0 
(0.0) 
1 
(6.7) 
13 
(86.7) 
1 
(6.7) 
Education              
No education 0 
(0.0) 
63 
(65.6) 
33 
(34.4) 
1 
(1.0) 
61 
(62.9) 
35 
(36.1) 
1 
(1.0) 
62 
(63.9) 
34 
(35.1) 
0 
(0.0) 
5 
(5.2) 
88 
(91.7) 
3 
(3.1) 
Primary  2 
(2.2) 
51 
(55.4) 
39 
(42.4) 
2 
(2.2) 
45 
(48.9) 
45 
(48.9) 
3 
(3.3) 
47 
(51.1) 
42 
(45.7) 
0 
(0.0) 
5 
(5.4) 
78 
(84.8) 
9 
(9.8) 
Secondary 0 
(0.0) 
14 
(51.9) 
13 
(48.1) 
0 
(0.0) 
14 
(51.9) 
13 
(48.1) 
0 
(0.0) 
14 
(51.9) 
13 
(48.1) 
0 
(0.0) 
1 
(3.7) 
25 
(92.6) 
1 
(3.7) 
High school 2 
(2.7) 
45 
(60.8) 
27 
(36.5) 
1 
(1.4) 
39 
(53.4) 
33 
(45.2) 
1 
(1.4) 
38 
(51.4) 
35 
(47.3) 
0 
(0.0) 
3 
(4.1) 
65 
(89.0) 
5 
(6.8) 
College/Uni 3 
(5.4) 
33 
(58.9) 
20 
(35.7) 
1 
(1.8) 
30 
(53.6) 
25 
(44.6) 
0 
(0.0) 
27 
(48.2) 
29 
(51.8) 
0 
(0.0) 
1 
(1.9) 
51 
(94.4) 
2 
(3.7) 
Income USD/month              
<30  3 
(2.1) 
67 
(46.2) 
75 
(51.7) 
3 
(2.1) 
62 
(42.5) 
81 
(55.5) 
2 
(1.4) 
64 
(43.8) 
80 
(54.8) 
0 
(0.0) 
11 
(7.6) 
119 
(82.1) 
15 
(10.3) 
31-60 0 
(0.0) 
25 
(53.2) 
22 
(46.8) 
2 
(4.3) 
20 
(43.5) 
24 
(52.4) 
1 
(2.1) 
20 
(42.6) 
26 
(55.3) 
0 
(0.0) 
1 
(2.2) 
41 
(89.1) 
4 
(8.7) 
61-90 1 
(5.6) 
9 
(50.0) 
8 
(44.4) 
0 
(0.0) 
8 
(44.4) 
10 
(55.6) 
0 
(0.0) 
7 
(38.9) 
11 
(61.1) 
0 
(0.0) 
0 
(0.0) 
17 
(94.4) 
1 
(5.6) 
91-120 0 
(0.0) 
27 
(73.0) 
10 
(27.0) 
0 
(0.0) 
24 
(64.9) 
13 
(35.1) 
1 
(2.7) 
23 
(62.2) 
13 
(35.1) 
0 
(0.0) 
1 
(2.7) 
36 
(97.3) 
0 
(0.0) 
121-150 0 
(0.0) 
17 
(77.3) 
5 
(22.7) 
0 
(0.0) 
12 
(54.5) 
10 
(45.5) 
0 
(0.0) 
11 
(50.0) 
11 
(50.0) 
0 
(0.0) 
0 
(0.0) 
22 
(100) 
0 
(0.0) 
151-210 0 
(0.0) 
6 
(85.7) 
1 
(14.3) 
0 
(0.0) 
5 
(71.4) 
2 
(28.6) 
0 
(0.0) 
6 
(85.7) 
1 
(14.3) 
0 
(0.0) 
0 
(0.0) 
6 
(100) 
0 
(0.0) 
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ocio-demographic 
factors 
Multidimensional Health Locus of control Scale (MHLCS) 
Chance  
Min: 7, max: 12, Mean: 10.2±1.45 
Sum MHLC 
 
 
Luck plays big part in how soon I will 
recover from an illness 
 
My good health is largely a matter 
of good fortune 
 
 
If it meant to be I will stay 
healthy 
Min: 23, max:36, Mean: 29.983±3.443 
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>210 0 
(0.0) 
24 
(82.8) 
5 
(17.2) 
0 
(0.0) 
23 
(79.3) 
6 
(20.7) 
1 
(3.4) 
22 
(75.9) 
6 
(20.7) 
0 
(0.0) 
1 
(3.4) 
28 
(96.6) 
0 
(0.0) 
Do not know 3 
(7.3) 
32 
(78.0) 
6 
(14.6) 
0 
(0.0) 
35 
(85.4) 
6 
(14.6) 
0 
(0.0) 
35 
(85.4) 
6 
(14.6) 
0 
(0.0) 
1 
(2.5) 
39 
(97.5) 
0 
(0.0) 
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 N, % N, % N, % N, % N, % N, % N,% N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, 
% 
Age                      
18-29 82 
(59.4) 
36 
(26.1) 
50 
(36.2) 
10 
(7.2) 
22 
(16.3) 
40 
(29.2) 
40 
(29.4) 
16 
(11.6) 
33 
(23.9) 
14 
(10.1) 
9 
(6.7) 
28 
(20.7) 
9 
(6.6) 
70 
(51.1) 
2 
(1.5) 
10 
(7.3) 
18 
(13.1) 
35 
(25.5) 
34 
(24.8) 
23 
(16.9) 
8 
(5.8) 
30-39 38 
(70.4) 
10 
(18.5) 
21 
(38.9) 
6 
(11) 
2 
(3.7) 
14 
(25.9) 
15 
(27.8) 
9 
(16.7) 
6 
(11.1) 
4 
(7.5) 
3 
(5.7) 
6 
(11.1) 
4 
(7.4) 
31 
(57.4) 
0 
(0.0) 
1 
(1.9) 
6 
(11.1) 
9 
(17.0) 
16 
(29.6) 
5 
(9.3) 
2 
(3.7) 
40-49 20 
(57.1) 
8 
(22.9) 
16 
(45.7) 
2 
(5.7) 
4 
(11.4) 
9 
(25.7) 
8 
(22.9) 
5 
(14.7) 
10 
(29.4) 
6 
(17.1) 
0 
(0.0) 
4 
(11.4) 
1 
(2.9) 
16 
(48.5) 
0 
(0.0) 
2 
(5.7) 
6 
(17.1) 
8 
(22.9) 
7 
(20.0) 
2 
(5.7) 
0 
(0.0) 
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50-59 20 
(54.1) 
8 
(21.6) 
22 
(59.5) 
1 
(2.7) 
0 
(0.0) 
12 
(32.4) 
12 
(32.4) 
5 
(13.5) 
2 
(5.4) 
1 
(2.7) 
2 
(5.4) 
9 
(24.3) 
0 
(0.0) 
27 
(73.0) 
0 
(0.0) 
0 
(0.0) 
9 
(24.3) 
11 
(29.7) 
7 
(18.9) 
1 
(2.7) 
1 
(2.7) 
60+ 47 
(57.3) 
21 
(25.3) 
35 
(42.7) 
8 
(9.6) 
5 
(6.1) 
21 
(25.3) 
18 
(21.7) 
14 
(16.9) 
13 
(15.9) 
6 
(7.3) 
10 
(12.0) 
11 
(13.3) 
4 
(4.8) 
41 
(50.0) 
1 
(1.2) 
1 
(1.2) 
15 
(18.1) 
18 
(21.7) 
22 
(26.5) 
5 
(6.0) 
3 
(3.6) 
Gender                      
Male  118 
(62.1) 
46 
(24.1) 
77 
(40.3) 
15 
(7.9) 
18 
(9.5) 
49 
(25.7) 
47 
(24.7) 
27 
(14.2) 
36 
(18.6) 
18 
(19.4) 
11 
(5.9) 
28 
(14.8) 
12 
(6.3) 
103 
(54.5) 
3 
(1.6) 
12 
(6.3) 
30 
(15.7) 
43 
(22.5) 
47 
(24.6) 
17 
(8.9) 
11 
(5.8) 
Female 89 
(57.1) 
37 
(23.7) 
67 
(43.2) 
12 
(7.7) 
15 
(9.7) 
47 
(30.3) 
46 
(29.7) 
46 
(29.7) 
28 
(18.2) 
13 
(8.4) 
13 
(8.4) 
30 
(19.4) 
6 
(3.9) 
82 
(53.2) 
0 
(0.0) 
2 
(1.3) 
24 
(15.5) 
38 
(24.7) 
39 
(25.2) 
19 
(12.3) 
3 
(1.9) 
Marital 
Status 
                     
Never married 73 
(61.3) 
33 
(27.7) 
52 
(43.7) 
10 
(8.4) 
21 
(17.9) 
42 
(35.6) 
39 
(33.1) 
16 
(13.4) 
33 
(27.7) 
15 
(12.7) 
9 
(7.8) 
23 
(19.5) 
11 
(9.4) 
66 
(56.4) 
2 
(1.7) 
8 
(6.8) 
19 
(16.1) 
32 
(27.1) 
34 
(28.8) 
20 
(17.1) 
11 
(9.3) 
Married 126 
(59.7) 
46 
(21.7) 
83 
(39.3) 
16 
(7.5) 
12 
(5.7) 
51 
(24.1) 
50 
(23.7) 
27 
(12.8) 
26 
(12.4) 
15 
(7.1) 
13 
(6.2) 
33 
(15.7) 
5 
(2.4) 
111 
(52.9) 
1 
(0.5) 
5 
(2.4) 
27 
(12.7) 
43 
(20.4) 
45 
(21.2) 
14 
(6.6) 
2 
(0.9) 
Div/sep/wid 7 
(46.7) 
4 
(26.7) 
9 
(60.0) 
1 
(6.7) 
0 
(0.0) 
3 
(20.0) 
4 
(26.7) 
5 
(33.3) 
4 
(26.7) 
1 
(6.7) 
2 
(13.3) 
2 
(13.3) 
2 
(13.3) 
7 
(46.7) 
0 
(0.0) 
1 
(6.7) 
7 
(46.7) 
6 
(40.0) 
7 
(46.7) 
2 
(13.3) 
1 
(6.7) 
Education                      
No education 57  
(58.8) 
14 
(14.4) 
37 
(38.5) 
4 
(4.1) 
3 
(3.1) 
27 
(27.8) 
22 
(22.7) 
12 
(12.4) 
11 
(11.3) 
5 
(5.2) 
6 
(6.2) 
12 
(12.4) 
4 
(4.1) 
51 
(53.1) 
1 
(1.0) 
1 
(1.0) 
18 
(18.6) 
20 
(20.6) 
16 
(16.5) 
3 
(3.1) 
2 
(2.1) 
Primary  58 
(63.7) 
31 
(33.7) 
48 
(52.2) 
8 
(8.7) 
5 
(5.4) 
22 
(23.9) 
28 
(30.4) 
16 
(17.4) 
12 
(13.2) 
4 
(4.3) 
7 
(7.8) 
16 
(17.4) 
1 
(1.1) 
56 
(60.9) 
0 
(0.0) 
2 
(2.2) 
15 
(16.3) 
25 
(27.2) 
28 
(30.4) 
8 
(8.7) 
1 
(1.1) 
Secondary 21 
(77.8) 
7 
(25.9) 
14 
(51.9) 
1 
(3.7) 
0 
(0.0) 
9 
(33.3) 
7 
(25.9) 
4 
(15.4) 
4 
(15.4) 
3 
(11.5) 
0 
(0.0) 
6 
(23.1) 
1 
(3.7) 
18 
(69.2) 
0 
(0.0) 
2 
(7.4) 
6 
(22.2) 
5 
(19.2) 
8 
(29.6) 
1 
(3.7) 
1 
(3.7) 
High school 42 
(56.8) 
16 
(21.6) 
27 
(36.5) 
9 
(12.2) 
14 
(19.4) 
22 
(30.1) 
16 
(21.9) 
9 
(12.2) 
20 
(27.0) 
13 
(17.6) 
6 
(8.5) 
16 
(22.2) 
8 
(11.0) 
32 
(43.8) 
1 
(1.4) 
5 
(6.8) 
10 
(13.5) 
19 
(25.7) 
19 
(25.7) 
13 
(17.6) 
7 
(9.5) 
College/Uni 29 
(51.8) 
15 
(26.8) 
18 
(32.1) 
5 
(8.9) 
11 
(20.0) 
16 
(28.6) 
20 
(36.4) 
8 
(14.3) 
16 
(28.6) 
6 
(10.7) 
5 
(8.9) 
8 
(14.3) 
4 
(7.3) 
28 
(50.9) 
1 
(1.8) 
4 
(7.3) 
5 
(9.1) 
12 
(21.8) 
15 
(27.3) 
10 
(18.5) 
3 
(5.5) 
Income 
USD/month 
                     
<30  91 
(62.8) 
43 
(29.5) 
71 
(49.0) 
11 
(7.5) 
14 
(9.8) 
56 
(38.6) 
37 
(25.5) 
29 
(19.9) 
32 
(22.1) 
9 
(6.2) 
14 
(9.7) 
27 
(18.5) 
6 
(4.1) 
75 
(51.7) 
1 
(0.7) 
4 
(2.7) 
30 
(20.5) 
43 
(29.5) 
41 
(28.1) 
13 
(8.9) 
5 
(3.4) 
31-60 29 
(61.7) 
15 
(31.9) 
28 
(59.6) 
5 
(10.6) 
7 
(15.2) 
16 
(34.0) 
14 
(30.4) 
9 
(19.1) 
8 
(17.0) 
7 
(15.2) 
3 
(6.4) 
5 
(10.9) 
7 
(15.6) 
28 
(60.9) 
1 
(2.2) 
6 
(13.0) 
10 
(21.7) 
17 
(37.8) 
18 
(39.1) 
12 
(26.1) 
6 
(13.) 
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61-90 12 
(66.7) 
5 
(27.8) 
6 
(33.3) 
2 
(11.1) 
1 
(5.6) 
6 
(33.3) 
4 
(22.2) 
3 
(16.7) 
6 
(33.3) 
2 
(11.1) 
0 
(0.0) 
1 
(5.6) 
1 
(5.6) 
8 
(44.4) 
0 
(0.0) 
0 
(0.0) 
1 
(5.6) 
2 
(11.1) 
4 
(22.2) 
2 
(11.1) 
0 
(0.0) 
91-120 22 
(59.5) 
6 
(16.2) 
9 
(24.3) 
3 
(8.1) 
1 
(2.7) 
8 
(21.6) 
11 
(29.7) 
2 
(5.6) 
2 
(5.4) 
3 
(8.3) 
2 
(5.4) 
7 
(19.4) 
0 
(0.0) 
22 
(61.1) 
0 
(0.0) 
2 
(5.4) 
6 
(16.2) 
6 
(16.2) 
8 
(21.6) 
2 
(5.4) 
0 
(0.0) 
121-150 9 
(40.9) 
3 
(13.6) 
4 
(18.2) 
2 
(9.1) 
2 
(9.1) 
1 
(4.5) 
4 
(18.2) 
1 
(4.5) 
6 
(27.3) 
3 
(13.6) 
3 
(13.6) 
5 
(22.7) 
0 
(0.0) 
7 
(31.8) 
0 
(0.0) 
0 
(0.0) 
2 
(9.1) 
3 
(13.6) 
3 
(13.6) 
4 
(18.2) 
1 
(4.5) 
151-210 2 
(28.6) 
2 
(28.6) 
1 
(14.3) 
0 
(0.0) 
2 
(28.6) 
1 
(14.3) 
2 
(28.6) 
0 
(0.0) 
2 
(28.6) 
0 
(0.0) 
1 
(14.3) 
1 
(14.3) 
0 
(0.0) 
3 
(42.9) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
2 
(28.6) 
1 
(14.3) 
0 
(0.0) 
0 
(0.0) 
>210 14 
(48.3) 
4 
(13.8) 
11 
(37.9) 
1 
(3.4) 
2 
(6.9) 
2 
(6.9) 
7 
(24.1) 
2 
(6.9) 
4 
(14.3) 
2 
(6.9) 
1 
(3.7) 
7 
(24.1) 
3 
(10.3) 
14 
(50.0) 
0 
(0.0) 
0 
(0.0) 
3 
(10.3) 
2 
(6.9) 
7 
(24.1) 
2 
(6.9) 
1 
(3.4) 
Do not know 28 
(68.3) 
5 
(12.2) 
14 
(34.1) 
3 
(7.3) 
4 
(9.8) 
6 
(14.6) 
14 
(34.1) 
3 
(7.3) 
4 
(9.8) 
5 
(12.2) 
0 
(0.0) 
5 
(12.5) 
1 
(2.4) 
28 
(68.3) 
1 
(2.4) 
2 
(4.9) 
2 
(4.9) 
6 
(14.6) 
4 
(9.8) 
1 
(2.4) 
1 
(2.4) 
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 N, % N, % N, % N, % N, % N, % N,% N, % N, % N, % N, % N, % 
Age             
18-29 110  
(80.3) 
113 
(82.5) 
102 
(74.5) 
81 
(59.1) 
100 
(73.5) 
54 
(39.4) 
85 
(62.0) 
109 
(79.6) 
79 
(57.7) 
67 
(48.9) 
70 
(51.1) 
57 
(41.9) 
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30-39 44 
(81.5) 
43 
(79.6) 
38 
(70.4) 
31 
(57.4) 
37 
(68.5) 
27 
(50.0) 
38 
(70.4) 
42 
(77.8) 
36 
(66.7) 
31 
(59.6) 
25 
(46.3) 
22 
(40.7) 
40-49 30 
(85.7) 
31 
(88.6) 
30 
(85.7) 
27 
(77.1) 
28 
(80.0) 
24 
(68.6) 
26 
(74.3) 
31 
(88.6) 
20 
(57.1) 
19 
(55.9) 
19 
(55.9) 
19 
(54.3) 
50-59 32  
(86.5) 
33 
(89.2) 
32 
(86.5) 
29 
(78.4) 
30 
(81.1) 
23 
(62.2) 
26 
(70.3) 
29 
(78.4) 
25 
(67.6) 
20 
(54.1) 
19 
(51.4) 
16 
(43.2) 
60+ 73 
(88.0) 
70 
(85.4) 
68 
(82.9) 
59 
(72.0) 
64 
(78.0) 
46 
(56.1) 
61 
(74.4) 
71 
(86.6) 
54 
(65.9) 
46 
(56.1) 
44 
(53.7) 
44 
(57.3) 
Gender             
Male  160 
(84.2) 
164 
(86.3) 
149 
(78.4) 
123 
(64.7) 
140 
(74.1) 
91 
(47.9) 
128 
(67.4) 
152 
(80.0) 
110 
(57.9) 
96 
(51.1) 
91 
(48.1) 
83 
(43.7) 
Female 129 
(82.7) 
126 
(81.3) 
121 
(78.1) 
104 
(67.1) 
119 
(78.8) 
83 
(53.5) 
108 
(69.7) 
130 
(83.9) 
104 
(67.1) 
87 
(56.5) 
86 
(55.5) 
75 
(48.7) 
Marital Status             
Never married 98 
(83.1) 
100 
(84.7) 
85 
(72.0) 
66 
(55.9) 
81 
(74.8) 
45 
(38.1) 
74 
(62.7) 
92 
(78.0) 
62 
(52.5) 
57 
(48.7) 
59 
(50.0) 
44 
(37.6) 
Married 181 
(85.4) 
178 
(84.0) 
175 
(82.5) 
150 
(70.8) 
166 
(78.3) 
128 
(58.5) 
154 
(72.6) 
176 
(83.0) 
143 
(67.5) 
116 
(55.2) 
109 
(51.7) 
106 
(50.0) 
Div/sep/wid 9 
(60.0) 
11 
(78.6) 
9 
(64.3) 
10 
(71.4)  
8 
(57.1) 
5 
(35.7) 
8 
(57.1) 
13 
(92.9) 
8 
(57.1.) 
9 
(64.3) 
8 
(57.1) 
7 
(50.0) 
Education             
No education 81 
(83.5) 
82 
(85.4) 
83 
(86.5.) 
68 
(70.8) 
75 
(78.1) 
56 
(58.3) 
73 
(76.0) 
82 
(85.4) 
67 
(69.8) 
53 
(55.8) 
49 
(51.0) 
48 
(50.0) 
Primary  82 
(89.1) 
81 
(88.0) 
74 
(80.4) 
73 
(79.3) 
72 
(78.3) 
52 
(56.5) 
64 
(69.6) 
80 
(87.0) 
64 
(69.6) 
54 
(59.3) 
51 
(56.0) 
42 
(46.2) 
Secondary 22 
(84.6) 
22 
(84.6) 
20 
(76.9) 
16 
(61.5) 
20 
(76.9) 
13 
(50.0) 
16 
(61.5) 
23 
(88.5) 
17 
(65.4) 
18 
(69.2) 
16 
(61.5) 
15 
(57.7) 
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High school 59 
(79.7) 
61 
(82.4) 
53 
(71.6) 
39 
(52.7) 
55 
(74.3) 
32 
(43.2) 
52 
(70.3) 
57 
(77.0) 
39 
(52.7) 
33 
(45.2) 
33 
(44.6) 
30 
(40.5) 
College/Uni 44 
(78.6) 
43 
(76.8) 
39 
(69.6) 
30 
(53.6) 
36 
(65.5) 
21 
(37.5) 
30 
(53.6) 
39 
(69.6) 
26 
(46.4 
24 
(42.9) 
27 
(48.2) 
22 
(39.3) 
Income USD/month             
<30  130 
(89.0) 
129 
(89.0) 
114 
(78.6) 
93 
(64.1) 
112 
(77.2) 
69 
(47.6) 
105 
(72.4) 
122 
(84.1) 
104 
(71.7) 
95 
(65.5) 
93 
(64.1) 
79 
(54.5) 
31-60 38 
(80.9) 
42 
(89.4) 
38 
(80.9) 
27 
(57.4) 
35 
(74.5) 
21 
(44.7) 
32 
(68.1) 
36 
(76.6) 
25 
(53.2) 
21 
(46.7) 
26 
(56.5) 
26 
(55.3) 
61-90 16 
(88.9) 
15 
(83.3) 
14 
(77.8) 
15 
(83.3) 
11 
(61.1) 
9 
(50.0) 
13 
(72.2) 
14 
(77.8) 
11 
(61.1) 
11 
(61.1) 
10 
(55.6) 
9 
(50.0) 
91-120 24 
(66.7) 
23 
(63.9) 
28 
(72.2) 
22 
(61.1) 
26 
(72.2) 
16 
(44.4) 
21 
(58.3) 
29 
(80.6) 
23 
(63.9) 
16 
(45.7) 
15 
(41.7) 
13 
(36.1) 
121-150 17 
(77.3) 
17 
(77.3) 
18 
(81.8) 
15 
(68.2) 
16 
(72.7) 
12 
(54.5) 
14 
(63.6) 
18 
(81.8) 
12 
(54.5) 
10 
(45.5) 
11 
(50.0) 
9 
(40.9) 
151-210 7 
(100) 
6 
(85.7) 
7 
(100) 
5 
(71.4) 
5 
(83.3) 
5 
(71.4) 
6 
(85.7) 
7 
(100) 
3 
(42.9) 
3 
(42.9) 
4 
(57.1) 
2 
(28.6) 
>210 24 
(82.8) 
24 
(82.8) 
23 
(79.3) 
20 
(69.0) 
21 
(72.4) 
18 
(62.1) 
20 
(69.0) 
21 
(72.4) 
12 
(41.4) 
10 
(34.5) 
10 
(34.5) 
10 
(34.5) 
Do not know 33 
(80.5) 
34 
(82.9) 
30 
(73.2) 
30 
(73.2) 
33 
(80.5) 
24 
(58.5) 
25 
(61.0) 
35 
(85.4) 
24 
(58.5) 
17 
(41.5) 
8 
(19.5) 
10 
(25.0) 
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HCP explained possible side 
effect of TB drug 
HCP explained what 
treatment would be 
HCP explained how 
treatment would be 
HCP explained changes 
expect in health when 
taking TB medication 
HCP explained treatment 
procedures clearly 
Overall support satisfaction 
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 N, % N, % N, % N, % N, % N, % N,% N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % 
Age                    
18-29 30 
(21.7) 
12 
(8.7) 
96 
(69.6) 
7 
(5.1) 
11 
(8.0) 
119 
(86.9) 
6 
(4.4) 
9 
(6.6) 
122 
(89.1) 
7 
(5.1) 
5 
(3.6) 
126 
(91.3) 
7 
(5.1) 
6 
(4.3) 
125 
(90.6) 
0 
(0.0) 
8 
(5.9) 
82 
(60.3) 
46 
(33.8) 
30-39 13 
(24.1) 
3 
(5.6) 
38 
(70.4) 
3 
(5.6) 
2 
(3.7) 
49 
(90.7) 
2 
(3.7) 
4 
(7.4) 
48 
(88.9) 
2 
(3.7) 
0 
(0.0) 
52 
(96.3) 
2 
(3.7) 
3 
(5.6) 
49 
(90.7) 
0 
(0.0) 
2 
(3.7) 
24 
(44.4) 
28 
(51.9) 
40-49 7 
(20.0) 
2 
(5.7) 
26 
(74.3) 
2 
(5.7) 
3 
(8.6) 
30 
(85.7) 
0 
(0.0) 
5 
(14.3) 
30 
(85.7) 
1 
(2.9) 
2 
(5.7) 
32 
(91.4) 
1 
(2.9) 
2 
(5.7) 
32 
(91.4) 
0 
(0.0) 
0 
(0.0) 
27 
(81.8) 
6 
(18.2) 
50-59 9 
(24.3) 
2 
(5.4) 
26 
(70.3) 
2 
(5.4) 
4 
(10.8) 
31 
(83.8) 
1 
(2.7) 
4 
(10.8) 
32 
(86.5) 
2 
(5.4) 
4 
(10.8) 
31 
(83.8) 
1 
(2.7) 
2 
(5.4) 
32 
(91.9) 
0 
(0.0) 
1 
(2.7) 
27 
(73.0) 
9 
(24.3) 
60+ 19 
(22.9) 
14 
(16.9) 
50 
(60.2) 
7 
(8.4) 
5 
(6.0) 
71 
(85.5) 
7 
(8.4) 
5 
(6.0) 
71 
(85.5) 
6 
(7.2) 
9 
(10.8) 
68 
(81.9) 
4 
(4.9) 
9 
(11.0) 
69 
(84.1) 
0 
(0.0) 
5 
(6.0) 
57 
(68.7) 
21 
(25.3) 
Gender                    
Male  36 
(18.8) 
16 
(8.4) 
139 
(72.8) 
11 
(5.8) 
9 
(4.7) 
170 
(89.5) 
7 
(3.7) 
13 
(6.8) 
171 
(89.5) 
7 
(3.7) 
10 
(5.2) 
174 
(91.1) 
7 
(3.7) 
12 
(6.3) 
172 
(90.1) 
0 
(0.0) 
8 
(4.3) 
118 
(62.8) 
62 
(33.0) 
Female 42 
(26.9) 
17 
(10.9) 
97 
(62.2) 
10 
(6.4) 
16 
(10.3) 
130 
(83.3) 
9 
(5.8) 
14 
(9.0) 
132 
(85.2) 
11 
(7.1) 
10 
(6.4) 
135 
(86.5) 
8 
(5.2) 
10 
(6.5) 
137 
(88.4) 
0 
(0.0) 
8 
(5.2) 
99 
(63.9) 
48 
(31.0) 
Marital Status                    
Never married 24 
(20.2) 
13 
(10.9) 
82 
(68.9) 
4 
(3.4) 
11 
(9.3) 
103 
(87.3) 
3 
(2.5) 
11 
(9.3) 
104 
(88.1) 
3 
(2.5) 
11 
(9.3) 
104 
(88.1) 
4 
(3.4) 
4 
(3.4) 
111 
(93.3) 
0 
(0.0) 
5 
(4.2) 
72 
(61.0) 
41 
(34.7) 
Married 51 
(24.1) 
18 
(8.5) 
143 
(67.5) 
16 
(7.5) 
12 
(5.7) 
184 
(86.8) 
12 
(5.7) 
14 
(6.6) 
186 
(87.7) 
12 
(5.7) 
14 
(6.6) 
186 
(87.7) 
10 
(4.7) 
16 
(7.6) 
185 
(87.7) 
 10 
(4.8) 
132 
(63.2) 
67 
(32.1) 
Div/sep/wid 3 
(20.0) 
1 
(6.7) 
11 
(73.3) 
1 
(6.7) 
1 
(6.7) 
13 
(86.7) 
1 
(6.7) 
1 
(6.7) 
13 
(86.7) 
1 
(6.7) 
1 
(6.7) 
13 
(86.7) 
1 
(6.7) 
1 
(6.7) 
13 
(86.7) 
0 
(0.0) 
1 
(6.7) 
12 
(80.0) 
2 
(13.3) 
Education                    
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Socio-
demographic 
factors 
Health Care Professional-Patients Communication 
 
HCP explained possible side 
effect of TB drug 
HCP explained what 
treatment would be 
HCP explained how 
treatment would be 
HCP explained changes 
expect in health when 
taking TB medication 
HCP explained treatment 
procedures clearly 
Overall support satisfaction 
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No education 28 
(28.9) 
13 
(13.4) 
56 
(57.7) 
7 
(7.2) 
4 
(4.1) 
86 
(88.7) 
6 
(6.2) 
8 
(8.2) 
83 
(85.6) 
8 
(8.2) 
8 
(8.2) 
81 
(83.5) 
5 
(5.2) 
7 
(7.3) 
84 
(87.5) 
0 
(0.0) 
4 
(4.1) 
72 
(74.2) 
21 
(21.6) 
Primary  20 
(21.7) 
5 
(5.4) 
67 
(72.8) 
9 
(9.8) 
5 
(5.4) 
78 
(84.8) 
6 
(6.6) 
3 
(3.3) 
82 
(90.1) 
6 
(6.5) 
6 
(6.5) 
80 
(87.0) 
5 
(5.4) 
6 
(6.5) 
21 
(88.0) 
0 
(0.0) 
7 
(7.6) 
52 
(56.5) 
33 
(35.9) 
Secondary 10 
(37.0) 
4 
(14.8) 
13 
(48.1) 
1 
(3.7) 
5 
(18.5) 
21 
(77.8) 
1 
(3.7) 
3 
(11.1) 
23 
(85.2) 
1 
(3.7) 
2 
(7.4) 
24 
(88.9) 
3 
(11.1) 
2 
(7.4) 
22 
(81.5) 
0 
(0.0) 
2 
(8.0) 
14 
(56.0) 
9 
(36.0) 
High school 10 
(13.5) 
5 
(6.8) 
59 
(79.7) 
4 
(5.5) 
4 
(5.5) 
65 
(89.0) 
2 
(2.7) 
7 
(9.5) 
65 
(87.8) 
2 
(2.7) 
2 
(2.7) 
70 
(94.6) 
1 
(1.4) 
1 
(1.4) 
72 
(97.3) 
0 
(0.0) 
2 
(2.8) 
48 
(66.7) 
22 
(30.6) 
College/Uni 10 
(17.9) 
6 
(10.7) 
40 
(71.4) 
0 
(0.0) 
7 
(12.5) 
49 
(87.5) 
1 
(1.8) 
6 
(10.7) 
49 
(87.5) 
1 
(1.8) 
2 
(3.6) 
53 
(94.6) 
1 
(1.8) 
5 
(8.9) 
50 
(89.3) 
0 
(0.0) 
1 
(1.8) 
30 
(53.6) 
25 
(44.6) 
Income 
USD/month 
                   
<30  30 
(20.5) 
10 
(6.8) 
106 
(72.6) 
12 
(8.3) 
10 
(6.9) 
123 
(84.8) 
12 
(8.3) 
13 
(9.0) 
120 
(82.8) 
12 
(8.2) 
14 
(9.6) 
120 
(82.2) 
13 
(8.9) 
12 
(8.2) 
121 
(82.9) 
0 
(0.0) 
11 
(7.6) 
80 
(55.2) 
54 
(37.2) 
31-60 8 
(17.0) 
7 
(14.9) 
32 
(68.1) 
1 
(2.1) 
9 
(19.1) 
37 
(78.7) 
0 
(0.0) 
8 
(17.0) 
39 
(83.0) 
0 
(0.0) 
5 
(10.6) 
42 
(89.4) 
0 
(0.0) 
5 
(10.6) 
42 
(89.4) 
0 
(0.0) 
1 
(2.2) 
23 
(51.1) 
21 
(46.7) 
61-90 4 
(22.2) 
0 
(0.0) 
14 
(77.8) 
1 
(5.6) 
2 
(11.1) 
15 
(83.3) 
1 
(5.6) 
0 
(0.0) 
17 
(94.4) 
0 
(0.0) 
1 
(5.6) 
17 
(94.4) 
0 
(0.0) 
1 
(5.6) 
17 
(94.4) 
0 
(0.0) 
0 
(0.0) 
10 
(55.6) 
8 
(44.4) 
91-120 10 
(27.0) 
4 
(10.8) 
23 
(62.2) 
1 
(2.7) 
2 
(5.4) 
34 
(91.9) 
0 
(0.0) 
3 
(8.1) 
34 
(91.9) 
2 
(5.4) 
0 
(0.0) 
35 
(94.6) 
1 
(2.8) 
1 
(2.8) 
34 
(94.4) 
0 
(0.0) 
0 
(0.0) 
28 
(77.8) 
8 
(22.2) 
121-150 4 
(18.2) 
1 
(4.5) 
17 
(77.3) 
0 
(0.0) 
0 
(0.0) 
22 
(100) 
0 
(0.0) 
1 
(4.5) 
21 
(95.5) 
0 
(0.0) 
0 
(0.0) 
22 
(100) 
0 
(0.0) 
1 
(4.5) 
21 
(95.5) 
0 
(0.0) 
0 
(0.0) 
17 
(77.3) 
5 
(22.7) 
151-210 1 
(14.3) 
0 
(0.0) 
6 
(85.7) 
0 
(0.0) 
0 
(0.0) 
7 
(100) 
0 
(0.0) 
0 
(0.0) 
7 
(100) 
0 
(0.0) 
0 
(0.0) 
7 
(100) 
0 
(0.0) 
0 
(0.0) 
7 
(100) 
0 
(0.0) 
0 
(0.0) 
3 
(42.9) 
4 
(57.1) 
>210 7 
(24.1) 
1 
(3.4) 
21 
(72.4) 
4 
(13.8) 
1 
(3.4) 
24 
(82.8) 
2 
(6.9) 
2 
(6.9) 
25 
(86.2) 
2 
(6.9) 
0 
(0.0) 
27 
(93.1) 
1 
(3.4) 
1 
(3.4) 
27 
(93.1) 
0 
(0.0) 
3 
(10.3) 
19 
(65.5) 
7 
(24.1) 
Do not know 14 
(34.1) 
10 
(24.4) 
17 
(41.5) 
2 
(4.9) 
1 
(2.4) 
38 
(92.7) 
1 
(2.4) 
0 
(0.0) 
40 
(97.6) 
2 
(4.9) 
0 
(0.0) 
39 
(95.1) 
0 
(0.0) 
1 
(2.4) 
40 
(97.6) 
0 
(0.0) 
1 
(2.4) 
37 
(90.2) 
3 
(7.3) 
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Socio-demographic 
factors 
Traditional Healer 
Visit traditional 
healer 
Traditional medicine  Could not be cured at the clinic 
Clinics too far 
 
Unaffordable cost of transport 
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Yes No 
 
 N, % N, % N, % N, % N, % N,% N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % N, % 
Age                       
18-29 53 
(38.7) 
84 
(61.3) 
3 
(5.7) 
6 
(11.3) 
17 
(32.1) 
25 
(47.2) 
2 
(3.8) 
3 
(5.9) 
22 
(43.1) 
13 
(25.5) 
12 
(23.5) 
1 
(2.0) 
1 
(1.9) 
21 
(40.4) 
15 
(28.8) 
13 
(25.0) 
2 
(3.8) 
1 
(1.9) 
21 
(40.4) 
14 
(26.9) 
12 
(23.1) 
4 
(7.7) 
30-39 22 
(40.7) 
32 
(59.3) 
0 
(0.0) 
1 
(4.5) 
6 
(27.3) 
15 
(68.2) 
0 
(0.0) 
2 
(9.5) 
8 
(38.1) 
7 
(33.3) 
4 
(19.0) 
0 
(0.0) 
3 
(14.3) 
10 
(47.6) 
5 
(23.8) 
3 
(14.3) 
0 
(0.0) 
4 
(19.0) 
10 
(47.6) 
5 
(23.8) 
2 
(9.5) 
0 
(0.0) 
40-49 10 
(28.6) 
25 
(71.4) 
0 
(0.0) 
0 
(0.0) 
2 
(20.0) 
7 
(70.0) 
1 
(10.0) 
1 
(10.0) 
2 
(20.0) 
4 
(40.0) 
3 
(30.0) 
0 
(0.0) 
0 
(0.0) 
3 
(30.0) 
4 
(40.0) 
3 
(30.0) 
0 
(0.0) 
0 
(0.0) 
4 
(40.0) 
5 
(50.0) 
1 
(10.0) 
0 
(0.0) 
50-59 16 
(43.2) 
21 
(56.8) 
0 
(0.0) 
0 
(0.0) 
5 
(31.2) 
11 
(68.8) 
0 
(0.0) 
0 
(0.0) 
5 
(31.3) 
7 
(43.8) 
4 
(25.0) 
0 
(0.0) 
0 
(0.0) 
8 
(50.0) 
4 
(25.0) 
4 
(25.0) 
0 
(0.0) 
0 
(0.0) 
9 
(56.3) 
5 
(31.3) 
2 
(12.5) 
0 
(0.0) 
60+ 23 
(27.7) 
60 
(72.3) 
2 
(8.7) 
2 
(8.7) 
5 
(21.7) 
13 
(56.5) 
1 
(4.3) 
1 
(4.3) 
6 
(26.1) 
10 
(43.5) 
6 
(26.1) 
0 
(0.0) 
1 
(4.3) 
7 
(30.4) 
10 
(43.5) 
5 
(21.7) 
0 
(0.0) 
1 
(4.3) 
5 
(21.7) 
12 
(52.2) 
5 
(21.7) 
0 
(0.0) 
Gender                       
Male  68 
(35.8) 
122 
(64.2) 
4 
(5.9) 
5 
(7.4) 
19 
(27.9) 
39 
(57.4) 
1 
(1.5) 
6 
(9.1) 
25 
(37.9) 
18 
(27.3) 
16 
(24.2) 
1 
(1.5) 
4 
(6.1) 
29 
(43.9) 
19 
(28.8) 
14 
(21.2) 
0 
(0.0) 
4 
(6.1) 
29 
(43.9) 
20 
(30.3) 
11 
(16.7) 
2 
(3.0) 
Female 56 
(35.9) 
100 
(64.1) 
1 
(1.8) 
4 
(7.1) 
16 
(28.6) 
32 
(57.1) 
3 
(5.4) 
1 
(1.8) 
18 
(32.7) 
23 
(41.8) 
13 
(23.6) 
0 
(0.0) 
1 
(1.8) 
20 
(35.7) 
19 
(33.9) 
14 
(25.0) 
2 
(3.6) 
2 
(3.6) 
20 
(35.7) 
21 
(37.5) 
11 
(19.6) 
2 
(3.6) 
Marital Status                       
Never married 44 
(37.3) 
74 
(62.7) 
4 
(9.1) 
4 
(9.1) 
17 
(38.6) 
18 
(40.9) 
1 
(2.3) 
3 
(7.0) 
15 
(34.9) 
12 
(27.9) 
12 
(27.9) 
1 
(2.3) 
1 
(2.3) 
17 
(38.6) 
14 
(31.8) 
12 
(27.3) 
0 
(0.0) 
1 
(2.3) 
15 
(34.1) 
13 
(29.5) 
11 
(25.0) 
4 
(9.1) 
Married 74 
(34.9) 
138 
(65.1) 
1 
(1.4) 
4 
(5.4) 
15 
(20.3) 
51 
(68.9) 
3 
(4.1) 
4 
(5.6) 
25 
(34.7) 
27 
(37.5) 
16 
(22.2) 
0 
(0.0) 
4 
(5.6) 
28 
(38.9) 
22 
(30.6) 
16 
(22.2) 
2 
(2.8) 
5 
(6.9) 
30 
(41.7) 
26 
(36.1) 
11 
(15.3) 
0 
(0.0) 
Div/sep/wid 5 
(33.3) 
10 
(66.7) 
0 
(0.0) 
1 
(20.0) 
2 
(40.0) 
2 
(40.0) 
0 
(0.0) 
0 
(0.0) 
2 
(40.0) 
2 
(40.0) 
1 
(20.0) 
0 
(0.0) 
0 
(0.0) 
3 
(60.0) 
2 
(40.0) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
3 
(60.0) 
2 
(40.0) 
0 
(0.0) 
0 
(0.0) 
Education                       
No education 26 
(26.8) 
71 
(73.2) 
2 
(7.7) 
2 
(7.7) 
7 
(26.9) 
15 
(57.7) 
0 
(0.0) 
1 
(3.8) 
9 
(34.6) 
8 
(30.8) 
8 
(30.8) 
0 
(0.0) 
1 
(3.8) 
10 
(38.5) 
8 
(30.8) 
7 
(26.9) 
0 
(0.0) 
1 
(3.8) 
11 
(42.3) 
10 
(38.5) 
4 
(15.4) 
0 
(0.0) 
Primary  44 
(47.8) 
48 
(52.2) 
0 
(0.0) 
3 
(6.8) 
7 
(15.9) 
31 
(70.5) 
3 
(6.8) 
2 
(4.5) 
14 
(31.8) 
20 
(45.5) 
8 
(18.2) 
0 
(0.0) 
2 
(4.5) 
16 
(36.4) 
15 
(34.1) 
10 
(22.7) 
1 
(2.3) 
3 
(6.8) 
18 
(40.9) 
17 
(38.6) 
6 
(13.6) 
0 
(0.0) 
Secondary 7 
(26.9) 
19 
(73.1) 
1 
(14.3) 
0 
(0.0) 
1 
(14.3) 
5 
(71.4) 
0 
(0.0) 
1 
(14.3) 
2 
(28.6) 
2 
(28.6) 
1 
(14.3) 
1 
(14.3) 
1 
(14.3) 
4 
(57.1) 
1 
(14.3) 
1 
(14.7) 
0 
(0.0) 
1 
(14.3) 
4 
(57.1) 
0 
(0.0) 
1 
(14.3) 
1 
(14.3) 
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factors 
Traditional Healer 
Visit traditional 
healer 
Traditional medicine  Could not be cured at the clinic 
Clinics too far 
 
Unaffordable cost of transport 
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Yes No 
 
High school 23 
(31.1) 
51 
(68.1) 
1 
(4.3) 
2 
(8.7) 
10 
(43.5) 
9 
(39.1) 
1 
(4.3) 
2 
(10.0) 
6 
(30.0) 
4 
(20.0) 
8 
(40.0) 
0 
(0.0) 
1 
(4.8) 
8 
(38.1) 
6 
(28.6) 
5 
(23.8) 
1 
(4.8) 
1 
(4.8) 
5 
(23.8) 
7 
(33.3) 
7 
(33.3) 
1 
(4.8) 
College/Uni 24 
(42.9) 
32 
(57.1) 
1 
(4.2) 
2 
(8.3) 
10 
(41.7) 
11 
(45.8) 
0 
(0.0) 
1 
(4.2) 
12 
(50.0) 
7 
(29.2) 
4 
(16.7) 
0 
(0.0) 
0 
(0.0) 
11 
(45.8) 
8 
(33.3) 
5 
(20.8) 
0 
(0.0) 
0 
(0.0) 
11 
(45.8) 
7 
(29.2) 
4 
(16.7) 
2 
(8.3) 
Income USD/month                       
<30  51  
(34.9) 
95 
(65.1) 
1 
(2.0) 
3 
(5.9) 
15 
(29.4) 
30 
(58.8) 
2 
(3.9) 
4 
(8.2) 
13 
(26.5) 
23 
(46.9) 
9 
(18.4) 
0 
(0.0) 
3 
(6.0) 
17 
(34.0) 
19 
(38.0) 
11 
(22.0) 
0 
(0.0) 
3 
(6.0) 
17 
(34.0) 
22 
(44.0) 
7 
(14.0) 
1 
(2.0) 
31-60 25 
(53.2) 
22 
(46.8) 
1 
(4.0) 
1 
(4.0) 
7 
(28.0) 
15 
(60.0) 
1 
(4.0) 
2 
(8.0) 
4 
(16.0) 
12 
(48.0) 
7 
(28.0) 
0 
(0.0) 
1 
(4.0) 
4 
(16.0) 
12 
(48.0) 
7 
(28.0) 
1 
(4.0) 
1 
(4.0) 
3 
(12.0) 
10 
(40.0) 
9 
(36.0) 
2 
(8.0) 
61-90 9 
(50.0) 
9 
(50.0) 
0 
(0.0) 
1 
(11.1) 
3 
(33.3) 
5 
(55.6) 
0 
(0.0) 
0 
(0.0) 
4 
(44.4) 
2 
(22.2) 
3 
(33.3) 
0 
(0.0) 
0 
(0.0) 
6 
(66.7) 
0 
(0.0) 
3 
(33.3) 
0 
(0.0) 
1 
(11.1) 
6 
(66.7) 
0 
(0.0) 
2 
(22.2) 
0 
(0.0) 
91-120 13 
(36.1) 
23 
(63.9) 
1 
(7.7) 
3 
(23.1) 
1 
(7.7) 
7 
(53.8) 
1 
(7.7) 
0 
(0.0) 
7 
(58.7) 
1 
(8.3) 
4 
(33.3) 
0 
(0.0) 
0 
(0.0) 
7 
(58.3) 
2 
(16.7) 
2 
(16.7) 
1 
(8.3) 
0 
(0.0) 
9 
(75.0) 
2 
(16.7) 
1 
(8.3) 
0 
(0.0) 
121-150 8 
(36.4) 
14 
(63.6) 
0 
(0.0) 
0 
(0.0) 
4 
(50.0) 
4 
(50.0) 
0 
(0.0) 
0 
(0.0) 
4 
(50.0) 
2 
(25.0) 
2 
(25.0) 
0 
(0.0) 
0 
(0.0) 
3 
(37.5) 
3 
(37.5) 
2 
(25.0) 
0 
(0.0) 
0 
(0.0) 
3 
(37.5) 
4 
(50.0) 
1 
(12.5) 
0 
(0.0) 
151-210 2 
(28.6) 
5 
(71.4) 
0 
(0.0) 
0 
(0.0) 
1 
(50.0) 
1 
(50.0) 
0 
(0.0) 
0 
(0.0) 
2 
(100) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
2 
(100) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
1 
(50.0) 
1 
(50.0) 
0 
(0.0) 
0 
(0.0) 
>210 6 
(20.7) 
23 
(79.3) 
0 
(0.0) 
0 
(0.0) 
2 
(33.3) 
4 
(66.7) 
0 
(0.0) 
0 
(0.0) 
5 
(83.3) 
0 
(0.0) 
1 
(16.7) 
0 
(0.0) 
0 
(0.0) 
6 
(100) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
6 
(100) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
Do not know 10 
(24.4) 
31 
(75.6) 
2 
(20.0) 
1 
(10.0) 
2 
(20.0) 
5 
(50.0) 
0 
(0.0) 
1 
(10.0) 
4 
(40.0) 
1 
(10.0) 
3 
(30.0) 
1 
(10.0) 
1 
(10.0) 
4 
(40.0) 
2 
(20.0) 
3 
(30.0) 
0 
(0.0) 
1 
(10.0) 
4 
(40.0) 
2 
(20.0) 
2 
(20.0) 
1 
(10.0) 
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Appendix L 
Table 30 Health Professional Interview Transcripts 
Questions/Health 
Professional 
HP 1 HP 2 HP 3 HP 4 HP 5 
How do you think 
patients' 
demographic 
characteristic is 
associated with 
completion of TB 
treatment? 
Women tend to put priority for 
their family over themselves. 
People that are employed tend 
to have frequent access 
regardless the distance to 
accessible health service. 
Those that are employed most 
commonly have better living 
conditions. 
Illiterate rate is high, chances of 
completing treatment is low. Better 
understand by patients about the 
expectation if they are educated. 
Illiteracy rate contributes towards 
people completing treatment. 
Distance and transport cost is an 
issue especially if they have to 
travel to treatment centers. 
Employment status is not relevant. 
Those who live below poverty line 
have more chances of suffering 
from TB. Because of poverty, there 
is lack of food, malnutrition, 
overcrowding. Poverty leads to 
ignorance of symptoms, duration 
of treatment, types of treatment, 
unhygienic conditions, and no 
sanitation. 
Those who have good education 
may be likely to adhere to 
treatment. However, if they are 
concerned with income loss, lack 
of support, reside far from health 
services while facing other direct 
factors, they are most likely to not 
adhere to treatment regardless of 
their knowledge of the treatment. 
 
 
Employment does not 
really matter as it does 
not make people 
understand about TB, 
especially those that do 
not work in health areas. 
Income may not be an 
issue also due to the fact 
that everything is free of 
access. Well transport 
cost may be an issue 
though. Health education 
is the main factors for 
everything. Patients 
would stop treatment 
after feeling better if they 
have lack of knowledge 
on TB. 
Living conditions: city or 
remote areas, there is an 
association, yet there is 
no study to be certain 
about it. Marital status 
may not really have 
connection. Yet level of 
education may have some 
connection 
How does TB 
patients' life style 
affect TB treatment 
adherence? (i.e. 
lifestyle, smoking, 
alcohol and drug) 
All TB cases who are male are 
smokers. Those who drink 
tend to not follow instruction 
given by HW nor taking advice 
from family members. 
It is proved that smoking is 
common cause of death in TB 
patient.  
TB patients who smoke have 
higher death rates. Chronic alcohol 
raise liver problems (liver cirocis 
known factors to develop TB). 
Those defaulters are chronic 
alcoholics. Consume more alcohol 
and not bother to continue 
medication. 
Living condition that is below 
standard.  
Poor hygiene etc. Drink and 
smoke are not affecting TB, 
however it helps facilitating a 
person to get TB and worse. 
 Alcohol addictive person 
that is under treatment, 
within 2 months there may 
be no complains of not 
drinking. Yet, once they 
feel better they are less 
likely to adhere and 
getting back to the drink 
routine. This is due to the 
fact that he or she is in the 
community living with 
people that smoke or 
drink. 
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How does mental 
health affect 
(mental disorder, 
health symptoms 
and illness 
characteristic) 
patient's treatment 
adherence? 
People that have mental 
health disorder would not want 
to follow treatment. When the 
sickness becomes chronic 
they go away to hide or to run 
away. 
Very few incidents in that problem. 
It is not too relevant. 
 If we were to measure anxiety 
depression maybe relevant. 
 
People that already have 
mental health problems 
would not be able to get 
treatment as they do not 
follow suggestions for 
treatment well. 
If a person is too 
depressed is really hard to 
be control therefore will 
likely not being able to 
complete treatment. 
How do the 
symptoms of TB 
affect level of 
adherence to 
treatment? 
All patients take medication for 
2 months and once feel better 
and the symptoms are gone 
they would decide to not take 
medicine. Even worst if the 
patient live in distance or busy 
with daily life. 
Severity of disease, there here is a 
tendency to complete.  
How severity is measured is 
important. Severity is measured 
through (1+, 2+ and 3+). It is 
evident that those who complete 
successfully are those who are 
chronically ill. Delay of getting 
treatment. Those smokers more 
likely to think that coughing due to 
smoking. Therefore presenting 
themselves later. 
Those that have lack of knowledge 
and have light symptoms of TB 
tend to feel frustrated when 
informed of having TB.  
Those that are having heavy level 
of symptoms tend to adhere as 
they have experienced the 
sickness and wanting to get better, 
therefore wanting to be treated 
and adhere. This can also be due 
to the fact that patients do not 
receive sufficient information when 
diagnosed. 
When the symptoms are 
not too serious (light) 
he/she would rather take 
anti-biotic. 
There is a huge difference 
between those who have 
suffered from TB and not 
able to get treated earlier 
to those who are early 
detected. Those that are 
too sick are afraid of 
death, therefore they are 
happy to follow treatment. 
Yet, those that early 
diagnosed, without good 
counselling and lack of 
information and 
knowledge will be hard. 
How does side 
effect of the drug 
affect treatment 
adherence of an 
individual patient? 
Side effect that is not too much 
to be handled is kind of ok. 
Yet, if it is getting worst and 
involve injection, many 
patients would not be able to 
handle the pain. 
Identifying side effect timely and 
treating them is important. 
Boosting moral and strengthening 
knowledge helps adhere to 
treatment. 
People discontinue their 
medication due to the fact that 
health workers do not explain 
clearly what would happen in 
terms of side effect when 
consuming the medicine. 
Patients are supposed to 
be informed side effect of 
drugs at the time of 
diagnosis. 
If health professionals do 
not provide sufficient 
information, patient will 
less likely to adhere to 
treatment. 
Do 
knowledge, beliefs 
and attitude of a 
patient impact 
treatment 
adherence Probing 
how and why? 
Many TB cases would 
prioritize traditional healers 
before going to the clinics.  
 Patients think that traditional 
healer and treatment are 
related. Therefore they need to 
do some cultural ceremony 
before going to clinic for 
diagnosis. People that have 
Knowledge: pt have no knowledge 
will have lack of access to 
services, diagnosis, don't have the 
sickness and therefore stopping 
treatment. Beliefs: besides 
following treatment pt also have 
their own things which they believe 
in. Therefore they will stil spend 
money to do cultural beliefs. 
Lack of knowledge also because 
lack of information given by the 
health worker at the time of 
diagnosis.  
If information in relation to 
treatment and basic health 
education is clearly given in the 
first place, it would be much easier 
for the patient to follow treatment 
Low level of knowledge 
would affect patient to 
follow up treatment. 
Good level of knowledge: 
Positive idea about 
treatment and otherwise. 
Traditional beliefs, people 
that believe in traditional 
stuff is due to lack of 
knowledge. Those that 
have bad attitude towards 
other life style (drinking, 
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lack of education tend to be 
more honest about their status 
of sickness compare to those 
who have good level of 
education. Those that are 
educated are afraid of being 
discriminated. 
Family abandoned the sick ones 
due to lack of knowledge of the 
family members. Some cases, 
ladies are not allowed to cook 
once identified as TB. Stop 
breastfeeding as they are afraid it 
will transmit through the milk. 
Unfavourable outcome on 
treatment at the end. Attitude, after 
two months of treatment they will 
stop treatment because they feel 
better and not wanting to listen to 
directions. Attitude also related to 
other responsibilities which they 
may think is more prioritizing than 
their treatment. 
without any doubt. Attitude: if we 
make patient realize for all 
information we need to give, they 
should not have any problem and 
eventually would change their 
attitude. 
smoking) may also have 
problems. 
Overall, what 
factors do you think 
may affect 
medication 
treatment? 
Nutrition, knowledge on good 
nutrition, distance and 
relationship between 
volunteers and patients. 
Co-morbidity: along with TB 
patients have other diseases also. 
 So if their disease is not 
managed, there will be 
unfavourable outcome. I.e. HIV or 
Diabetes while having TB. 
Whatever a person eats and the 
medicine is sufficient. Yet patient 
tends to have some special diets 
which cost them more. Distance 
between DOT providers and 
patients' resident is also important 
towards completion of treatment. 
Time and place: agriculture person 
would live early and come home 
late. But DOT providers may not 
be able to provide medicine. 3As = 
Accessible, Acceptable and 
Accountable to the health system. 
Lack of social support and there is 
discrimination against people 
affected with TB. This is also due 
to lack of health education in the 
community. 
Lack of knowledge would 
make people not 
knowing what sickness 
they are experiencing. 
Therefore, not following 
their treatment. Lack of 
human resources. 
Those that have family, 
especially a male patient 
that have many 
dependents while having 
low socio-economic status 
is a challenge. This is due 
to the fact that he is 
responsible for many 
while having no money to 
travel. Poor living 
conditions, lack of food 
and water is also a 
challenge for a patient to 
follow treatment. Lack of 
family support is 
important. Poor family 
support can also affect so 
much on their treatment. 
Health professionals have 
to have good 
responsibility to provide 
enough information and 
provide good support 
towards patients' 
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treatment. 
What system and 
structures are in 
place in our current 
healthy system to 
support TB patients 
for their treatment? 
(diagnosis, medical 
availability, staff 
etc) 
All staff have multiple roles 
and responsibilities. 
 Quality of work is poor. 
People that work for TB 
program also have to 
contribute their time to support 
other programs (lack of human 
resources) 
Heath workers in village or CHC 
level need further training to be 
able to do their job. Increase 
volunteers' capacity, provide more 
supervision and monitoring. 
Lack of health staff, lack of training 
Diagnosis is great, 
medical availability, 
distribution of drugs, 
examination. Lack of 
human resources due to 
multi-function of jobs. 
From level National TB 
Program, District TB 
Coordinator and TB 
assistance and volunteer. 
Medical availability and 
structure is also in place. 
DTA is not only 
responsible for TB 
program. He or she is 
multi-function therefore 
affect the quality of work 
which he/she does. Lack 
of follow up, not able to 
get medicine on time, 
stock out etc. 
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What is the informal 
support for a TB 
patient during 
his/her treatment? 
Support in terms of 
information: suggestion, 
motivation, information on side 
effect and information on the 
consequences of not 
completing treatment. Work 
with local leaders and 
volunteers if the patient live 
distance from available health 
services. 
We do not have informal support, 
generally. 
There is no informal support 
We have local food 
which we grow yet, we 
do not have the 
knowledge to prepare it 
well. 
Family support, 
supposedly people that 
have low SES should be 
supported by Ministry 
Social Solidarity should 
support. In the past there 
was, but not anymore. 
There is no law in place, it 
was a temporary decision. 
Counselling support to 
encourage is important is 
already happening, yet it 
is not systematic. DTA 
and DTC need to work 
hard to help patients. 
What adherence 
aid do patients 
usually use to 
remind them to take 
their medication? 
(i.e. family 
members, using 
clock, alarm, mobile 
alarm or calendar) 
Family members' support is 
vital. 
Patients need to come to the clinic 
daily for two months.  
Continuation phase for two days. 
Not necessary to investigate. 
PSF in the community normally 
will have 
 agreement whether pt will go to 
PSFs house or otherwise. 
Family member and 
health professionals 
Family and health 
professional. Yet number 
of health professional is 
limited. Geographically it 
is impossible to travel to 
receive DOTS. 
 
 
 
Questions/Health 
Professional 
HP 6 HP 7 HP 8 HP 9 HP 10 
How do you think patients' 
demographic characteristic is 
associated with completion of 
TB treatment? 
Distance, access to 
transport, malnutrition as a 
risk factor, majority of TB 
patients are farmers or 
having labour work, more 
males of approximately 80% 
are having TB out of all 
registered TB patients 
because they are mobilizing 
everywhere. Majority within 
Completing treatment does 
not depend on education.  
In some cases, those that 
are older, even have lack of 
education, they are likely to 
seek for treatment and follow 
their treatment successfully. 
The young ones are likely to 
not follow treatment and 
prioritize work or other 
Those who are educated 
normally would less likely 
to follow treatment. 
Whereas, those who are 
old more likely to follow 
treatment completely. 
This is due to the fact 
that those who are 
educated more likely to 
feel shame of themselves 
Those who have lack of 
education are less likely 
to feel 
 to be discriminated. 
Whereas those who are 
educated, they are more 
likely to feel that they 
may be discriminated if 
others know that he/she 
has TB. Those that do 
TB is everywhere and East 
Timor is the worst.  
If you eliminated all the easy 
bacteria, you end up with the 
hard one and it spreads all 
over. The prevalence data 
currently used is not from 
Timor. TB is overwhelming in 
the country. Using wrong 
database to make everything 
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the age range of 15-24 years 
of age. Houses lack of 
ventilation systems, poor 
living conditions. 
activities than their 
treatment. Also those who 
work are likely to prioritize 
their work rather than 
treatment. Those that have 
no job have lack of money to 
travel, yet there is family and 
social support to provide 
their needs. 
for getting the disease. 
Therefore, it is very 
important if health 
workers provide sufficient 
and clear information 
regarding TB treatment. 
For instance, side effect, 
duration of treatment and 
consequences of not 
following the treatment 
until the end of treatment 
duration. Cost of 
transport can be a 
problem. Therefore, 
those who do not have 
transport will have 
support from the health 
workers by giving them 
medicine up to 3 days 
instead of getting it from 
the clinic every single 
day. 
not work or do not have a 
job are likely to adhere to 
their treatment. However, 
those who are employed 
most of the time they 
would worry about losing 
their job. Therefore they 
prioritize their work rather 
than their treatment. 
looks good. Giving the 
estimated TB is taken from 
other country that has similar 
economic standard. 
145/100.000 is very low and it 
is not the real thing. TB is 
everywhere and it is number 
one problem in East Timor. 
From Bairopite Clinic in 2011, 
296 cases positive sputum. 
85% success rate is the 
biggest mistake miscalculation 
ever. If suggestion is given to 
MoH, they would refuse and 
may say "our number looks 
good to be spread around the 
world" so we don't want to 
hear anything more.  
 
Popular participation, 
decentralization.  
 
 
 
How does TB patients' life 
style affect TB treatment 
adherence? (i.e. lifestyle, 
smoking, alcohol and drug) 
Smoking and drinking are 
not directly causing TB but, 
somewhat it becomes 
facilitating factors for a 
patient to get TB. 
Those that have smoked 
normally have high impact 
on their 
 treatment. There are some 
that are committed to not 
smoke or drink. However, 
after getting sick again, 
normally their family will 
reveal that he/she had 
started smoking or drinking 
again. Much worst for the 
youth group, where normally 
they would drink for 2 weeks 
or so and started drinking 
and/smoking again. This 
could be due to the fact that 
There are some patients 
that promise that they will 
not 
 smoke or drink. 
However, most cases 
when the families of the 
patients are visited, they 
often say that patients 
still do drink and/smoke. 
Therefore it is sometimes 
important to give 
counselling to provide 
support during the 
treatment. 
Normally, they would be 
encouraged to not drink 
and smoke. They are 
given thorough 
explanation regarding the 
impact of smoking and 
drinking on treatment. 
However, it seems that 
some family members 
report that those who are 
under treatment 
sometimes still drink or 
smoke. But not all of 
them though. 
Housing in East Timor 
contributes to TB treatment.  
GASPORTO 
use of PCR, nucleic acid of 
sputum. 
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they have lack of 
understanding about the 
treatment. 
How does mental health affect 
(mental disorder, health 
symptoms and illness 
characteristic) patient's 
treatment adherence? 
  Some patients that are 
mentally affected. Even 
the family 
 and relatives do not want 
to look after them, 
because the patients do 
not want to take their 
medicine. Some cases 
we suggest that the 
patients to stay in half 
way home (alberque) to 
follow the treatment until 
he/she finishes 
treatment. 
Some patients feel really 
stressful when they take 
the medicine and get side 
effect. They would feel 
really stress and 
complain about the side 
effect. There are some 
that would report their 
problem and get support. 
There is no link and people in 
the community not even part 
of what is going on. Our 
training is not very good. Our 
attitude is no good. We are 
the most under-utilized system 
everywhere. People prefer to 
go to see traditional healer 
rather than to see a doctor. It 
is because people are not part 
of the people. 
How do the symptoms of TB 
affect level of adherence to 
treatment? 
Severe TB patients more 
likely to adhere. Different 
perceptions depend on the 
patient's knowledge. Some 
get better after taking 
medication would continue 
treatment, but some would 
stop. 
There are some that all they 
care is to get better 
regardless 
 of their symptoms. In the 
past experience, where there 
are some patients who got 
really sick and cannot get 
themselves to the clinic. 
However, now we have the 
half -way house (alberque) 
where people can stay 
temporarily up to 2 months. 
There are some patients 
that stop in the middle of  
treatment. This is due to 
the length of treatment 
and that they have to 
come back and forth to 
clinic to receive medicine. 
This can also be because 
the health workers in the 
clinic did not provide 
sufficient information 
regarding the treatment. 
So far those patients 
under our care follow 
instruction given. 
 They are to receive their 
medicine in the clinic. 
However, sometimes 
they are given medicine 
for up to 2 or 3 days 
because they complain of 
travelling long distance 
and no money for 
transport cost. Those that 
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By the end of 2 months they 
normally will be able to move 
around freely and so will be 
able to go back home and 
receive their medicine from 
nearby clinics or health 
centers. 
Therefore, to follow up on 
patients having this type 
of behaviour, it is best to 
check their monthly 
medication record and 
visit them to ensure that 
they can get back to their 
normal routine of taking 
medication to get better. 
normally take medicine 
home, we will not be able 
to comment whether they 
drink or not. When they 
are in the clinic and we 
ask to drink they will 
drink. But once they are 
at home and they have to 
drink by themselves we 
would not know if they 
do. 
How does side effect of the 
drug affect treatment 
adherence of an individual 
patient? 
Side effect is a common 
challenge for patients to 
adhere to their treatments. 
However, due to lack of 
information provided at the 
time of diagnosis by the 
health workers. There should 
at least be a 15 minutes 
session explaining about the 
treatment process prior to 
patients enrols to treatment. 
Some patients that even get 
side effect from the drug, 
they are still willing to follow 
their treatment. 
 This is due to the fact that 
they were provided sufficient 
information regarding the 
side effect of the drug. 
Therefore, they know that 
such reaction of side effect 
may take place. But there 
are many that complain a lot 
about the side effect, and if 
they are not convinced well 
they are more likely to go to 
other clinic for treatment or 
stop treatment after all. For 
instance, there were some 
that have headache, 
stomach-ache etc will 
complain previously they do 
not feel that, yet after taking 
the medicine they start to 
feel sick. 
 
There are some that 
have itchy skin, fever or 
headache.  
Once they report to us, 
we will be able to tell 
them that it is normal as 
a consequence of 
drinking the medicine. 
So, once they know the 
reason why than they are 
likely to adhere and 
continue their treatment. 
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Do knowledge, beliefs and 
attitude of a patient impact 
treatment adherence Probing 
how and why? 
Lack of knowledge still links 
to side effect. If people have 
lack of knowledge about TB 
and its treatment process, 
this will become a 
determinant factor to adhere 
to treatment or not.  
 
When a patient experiences 
side effect, they more likely 
to seek for traditional 
healers. Attitude links with 
ignorance of not seeking for 
treatment, even worst when 
the health service is distance 
from where the patient lives. 
Some people take traditional 
medicine.  
So, in many cases they say 
that because they have 
taken traditional medicine, it 
is ok to drink or smoke. 
Many that so adhere to their 
treatment, yet they complain 
about cost of transport to 
travel every day. Beliefs of 
traditional healers still a big 
thing in the country. In a 
case in one of the sub-
districts where there were no 
patient admitted to the health 
center, but there were nearly 
50 patients that were looked 
after by a traditional healer. 
Out of the 50 patients were 
diagnosed and found that 37 
patients had positive TB. 
 In regards to belief and 
attitude, in some cases, 
even though patients 
have been diagnosed 
with TB many family 
members would not 
believe it. They 
sometimes will not accept 
it easily as they think that 
their family will have no 
way to have got TB. 
 
Overall, what factors do you 
think may affect medication 
treatment? 
Cultural beliefs and beliefs of 
ancestors connection 
Geographic location is a big 
issue in the country. Due to  
distance people have to 
travel from their homes to a 
clinic or health centers, they 
are more likely to seek for a 
nearby traditional healer 
instead. People are also 
likely to drop out from 
treatment if they are not 
committed to travel distance 
over a period of time. 
   
242 Appendices 
What system and structures 
are in place in our current 
healthy system to support TB 
patients for their treatment? 
(diagnosis, medical availability, 
staff etc) 
We do have system that is 
established from National to 
village levels. However, 
there is still lack of human 
resources and lack of 
knowledge of some health 
workers. There is sufficient 
diagnosis equipment, though 
we still need more. 
Informal support from SISCa 
(Community Integrated  
Health System) in the 
community. 
 
There is system and 
structure in place for our 
clinic,  
yet I do not know if any 
other clinics or health 
centers throughout the 
country would have 
things that we have in 
this clinic. 
 
What is the informal support 
for a TB patient during his/her 
treatment? 
   
There are some informal 
supports provided by 
Ministry of Social 
Solidarity. Yet, it is only 
for those who are really 
in need. This support can 
be monetary to support 
transport cost or food. 
 
What adherence aid do 
patients usually use to remind 
them to take their medication? 
(i.e. family members, using 
clock, alarm, mobile alarm or 
calendar) 
   
No other adherence aid 
that any patient would 
normally use. But, most 
common aid patients get 
is their family members. 
Normally their family 
members would remind 
them to drink their 
medicine. 
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Factors Associated with Medication Adherence Among Tuberculosis Patients in Timor-Leste: A 
Cross-Sectional Study 
Juliao dos Reis1, Xiang-Yu Hou1, Michael P Dunne1 
 
Abstract 
Background: Adhering to tuberculosis (TB) treatment is one of the most important components for 
treatment success. This study assessed potential barriers and enabling factors associated with optimal TB 
medication adherence among patients in Timor-Leste (also known as East Timor). 
Methods: The study used a cross-sectional design. In-person survey was conducted to collect data from 347 
pulmonary TB patients at six community health centres and three specialist clinics in three districts of 
Timor-Leste  
Results: The visual analogue scale (VAS) was used to measure suboptimal adherence over a one-month 
period and adherence prevalence was 39.6%. After taking into account socio-demographic factors, the 
optimal adherence impediments were poor health services received (p=0.021), use of a traditional healer as a 
form of health service (p=0.006), an external health locus of control (p=<0.001), and perceived stigma 
(p=0.049). Enabling factors for TB medication adherence were the patients’ TB knowledge (p=0.018), 
reasonable income or sufficient family financial support (p=0.048) and the availability of a caregiver to 
remind the patient of his/her medication time (p=0.009). 
Conclusions: This study provides important evidence on specific factors that may influence treatment 
adherence direct or indirectly. Furthermore, the study contributes towards a limited number of quantitative 
studies on TB medication adherence in the Southeast Asia region The evidence strongly suggests that TB 
programs in Timor-Leste should focus on strengthening health education to address stigma prevention, 
ongoing individual deleterious health behaviours such as smoking and drinking, counselling to support 
patients' psychological well-being, beliefs that chance or luck are determinants of health outcomes, and 
appropriate interventions to work cooperatively with local traditional healers.   
Keywords: medication adherence, stigma, Timor-Leste, tuberculosis, health services, patients’ knowledge, 
financial support. 
 
Background 
Tuberculosis (TB) is a major contributor to the global burden of disease, predominantly in low- and mid-
income countries [1]. it is ranked the second most fatal, worldwide communicable disease after HIV/AIDS 
[2]. 
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There are approximately 9 million new cases of TB per year [3], and TB itself contributes to 2.8% of the 
global disability burden [4]. Over 95% of TB deaths occur in low and middle-income countries and 
approximately 10 million children worldwide have been orphaned due to the death of a parent from TB [3, 
5]. In 2013 alone, 1.5 million people died from the disease, an estimated 550,000 children became ill, and of 
these, 80,000 HIV-negative children died of TB [2]. Southeast Asia and the Western Pacific regions 
collectively accounted for 56% of the cases worldwide in 2013 [2]. 
 
 In developing nations, especially East Timor, where poverty is widespread, people are facing high 
incidences of infectious diseases, such as TB, malaria, and measles. Timor-Leste is a small nation located in 
Southeast Asia, with an estimated population of 1.17 million in 2014 and a population density of 76.2 people 
per square kilometre.  The World Bank estimated that in 2015, almost 53% of people lived on less than 
US$1.25 per day. Poor TB treatment is likely to be affected by many challenges including high population 
density (especially in some districts), in combination with high rates of illiteracy, low community awareness, 
poor health-seeking with relatively poor use of health facilities, mountainous terrain, long distances between 
villages and health centres, bad roads, and nascent health systems [6]. 
 
The Ministry of Health (MoH) of Timor-Leste has identified TB as one of the major public health problems 
facing the country [6]. While a large-scale survey of TB prevalence and incidence have not yet been 
undertaken, the estimated incidence rate of TB is 115 - 175 new smear positive cases (NSP/100,000/year) 
[6]. Furthermore, as a consequence of civil war, many senior health officers left the country or lost their 
lives, and much of the country’s physical infrastructures were destroyed, resulting in an inadequate supply of 
public utilities [7]. 
 
Several studies examined factors associated with TB medication adherence and have found that lack 
treatment knowledge, beliefs, poor attitudes and negative perceptions, unemployment, poor health services 
and long distance to the nearest health service are associated with poor medication adherence [4, 8-14]. A 
study in Ecuador involving a sample of 212 adults undergoing diagnostic TB testing found that 
misconceptions or a lack of key knowledge could adversely affect early diagnosis, treatment adherence and 
the further spread of the disease. It was also highlighted that education was the most important predictor of 
knowledge, beliefs, perceptions and attitudes [4]. Furthermore, a mixed-methods survey conducted in Jingsu 
Province in China found that patients being illiterate, divorced/widowed and having no health insurance were 
more likely to be non-adherent. 
 
Weiguo et al’s findings showed that patients who experienced social stigma, an adverse drug reaction and a 
heavy financial burden were more likely to unsuccessfully complete treatment. The study also found that 
patients who received direct and regular home visits by health workers appeared to reduce the risk of non-
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adherence [11]. Additionally, in Kenya, a cross-sectional survey was conducted among new TB patients 
receiving six months of standard TB treatment. The study reported the reasons provided by the non-adherent 
patients were that they ran out of pills, which was likely to be explained by missed appointments, a loss of 
pills, and being away from home, mostly due to economic activities [9].  
 
Similarly, a case control study of 384 TB patients conducted in Ndola, Zambia found an overall of 29.8% of 
the sample had stopped taking TB drugs at some point during the treatment. The most common reasons 
given for stopping treatment by both the adherent and non-adherent patients were that they felt better (45.1% 
and 38.6%, respectively). Additionally, the most frequently described reasons were including a lack of 
knowledge of the benefit of completing treatment (25.7%), the TB drugs being too strong (20.1%) and a lack 
of food at home (11. 4%). While, non-complaint patients described  the most frequent reasons for stopping 
treatment as that they ran out of drugs at home (25.4%) and that the TB drugs were too strong (20.2%) [8] 
 
Another case control study was conducted in Morocco, North Africa that involved 290 TB patients. The 
study found non-adherence was significantly associated with education, distance to the nearest health 
services, treatment knowledge, health-professional and patient communication, health service provider, and 
attitudes towards treatment [10]. Some of the findings were consistent with a cross-sectional study in China 
which showed that a lack of knowledge and longer travel to the nearest health services were significantly 
associated with poor treatment adherence [15].  
 
Thus far, there has been little research conducted in Timor-Leste to examine the ways that TB patients 
comply with treatment or to investigate the factors influencing treatment adherence. One ethnographic study 
in Timor-Leste qualitatively addressed issues associated with TB treatment, such as local cultural practices, 
knowledge and socio-economic factors associated with treatment adherence [16]. A survey was also 
conducted by the Ministry of Health Timor Leste [17] to determine the level of knowledge, attitudes and 
practices among community members and TB patients, and an RCT study investigated the impact of 
nutritional support on TB treatment [18]. To date, there is no quantitative, peer-reviewed study reporting the 
level of TB treatment adherence and factors impeding optimal adherence in Timor-Leste [15]. 
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Methods 
 
Study sites 
Participants were recruited from the patient lists of six community health centres (CHCs) and three specialist 
clinics in three districts of Timor Leste. Of the six CHCs, three were located in areas of Dili, the capital city 
of Timor-Leste and six in rural areas. All six CHCs are operated by Ministry of Health staff, while local 
clinics are run by church organization or local NGOs,  
 
Study participants 
Participants were selected from the TB registry and those above 18 years of age were approached. Prior to 
the data collection, three survey administrators who had previously conducted surveys for the ministry of 
health of Timor Leste were recruited and trained. Patients who spoke Tetum (Timor Leste’s national 
language) fluently or their local language could be translated by the survey administrators and agreed to 
complete the survey were selected. Participants who were too ill, refused to participate or were 
geographically out of reach were excluded. Patients from the health services in rural and remote areas were 
recruited when they came to receive their medication at the health centres, and those that were not able to 
come to the clinic were contacted by CHC staff to organize an interview time in their homes. Due to 
participants’ poor understanding and limited experience in completing a survey, the questionnaire was 
administered by survey administrators to patients who were with high school education or lower. Participants 
with a university education were asked to complete the questionnaire independently under supervision.  
 
Measurement of tuberculosis medication adherence 
The study used two measures for medication adherence. A visual analogue scale (VAS) was adopted from 
Nackers et al. [9] as it is the most commonly used tool to measure adherence for both TB and HIV/AIDS 
studies [9, 19]. Second, the Medication Adherence Rating Scale (MARS) was used to measure adherence in 
the past month, and was adopted with modification to cross-validate the VAS adherence estimate [20]. The 
MARS scale has been used to measure the behaviours and attitudes of patents towards medication adherence 
[20]. Both measurements used a cut-off point of < 80% classified as suboptimal adherent and ≥ 80% as 
optimal adherence [9, 21]. Studies using the VAS and other measurement methods to determine adherence to 
HIV treatment have reported good agreement [19, 22] 
 
Measurement of factors related to medication adherence 
The variables were selected based on a global literature review [16, 23, 24] and findings from a pilot study 
conducted by the research team prior to the main survey. The variables on medication adherence were 
classified into three categories of health service delivery, social and economic, and personal and disease-
related factors. Health service delivery factors were comprised of health services (urban or rural), patient-
health professional communication, distance from home to clinic, and patient’s satisfaction [25]. Social and 
economic factors involved gender, age, marital status, education, income, lifestyle choice (alcohol, smoking 
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and drug intake), social support (by family, friends, and neighbours, community volunteer and social 
organization) and involvement of traditional healer [25]. The final category was personal and disease-related 
factors, comprising psychological distress, stigma (of the patients or from the community), TB knowledge 
and chance health locus of control (i.e. the degree to which individuals believed that their health status was 
controlled by chance or luck) [25].  
 
The Kessler Psychological Distress Scale (K10) was used to measure anxiety and depressive symptoms 
experienced by the participants in the past month [26]. The internal consistency (Cronbach’s α) for the K10 
was 0.806. Chance health locus of control was measured with a subscale of the multidimensional Health 
Locus of Control Scale  (Cronbach’s α=0.911) [27]. The Tuberculosis-Related Stigma Scale measures both 
community and patient perspectives toward TB with a Cronbach’s α of 0.841) [28]. A patient assessment 
tool with Cronbach’s α=0.895 was used to measure the effectiveness of communication between patient and 
care provider [19]. A traditional healer scale (Cronbach’s α=0.623) to measure the influence of the 
Traditional healers on TB patients and social support (family, friend, neighbour, peer educator and social 
organization) (Cronbach’s α=0.761) was also used to determine the level of support received by TB patients 
throughout their treatments [19, 29]. 
 
Questionnaire translation 
The translation process was carried out by adapting the World Health Organization Translation Guideline 
[30] as well as a number of translational validity methods, including Principles of Good Practice for the 
Translation and Cultural Adaptation process for Patient-Reported Outcomes by Wild, Grove [31]. The tool 
was translated from the original language of English to Tetum (Timor Leste’s national language) by a 
translator with background in health. The translation was further reviewed by two translators with 
backgrounds in health and by the principal researcher. The final version in Tetum was back-translated by a 
professional language translator and the same process was repeated. Although the guidelines for the 
translation validity process were closely followed, due to the incompleteness of the Tetum vocabulary [32], 
some translations were refined by adding further justification and explanation to ensure that the accuracy of 
the content and meaning of the English version was preserved. As part of the data collection quality control, 
the three survey administrators were provided an intensive three days of training on the content of the 
questionnaire and its administration process.  
 
Interview process 
For every participant, the survey administrator introduced him/herself and highlighted the purpose of their 
presence and that we did not represent any government body, health professional or any other organization 
directly involved with the participant's treatment. The participants were encouraged to provide accurate and 
honest responses and acknowledged the importance of their participation in the survey to help identify ways 
in which TB treatment may be improved. The questionnaire took an average of 45 minutes to an hour to 
complete and the majority of the questionnaire was completed at clinics, community health centers and 
Appendices 249 
patients’ homes. The research administrators’ tasks were to supervise, answered questions, checked 
understanding and completion of the survey, and read the items to the illiterate participants.  
 
Data Analysis 
The survey data were entered in EpiData version 3.1 and converted to SPSS version 21 to be analysed. 
Univariate logistic regression analysis was used to estimate the associations between each independent 
variable and medication adherence. Multivariate logistic regression analysis was conducted by including all 
independent variables associated with adherence at p ≤ 0.1, while controlling for the demographic variables. 
Independent variables that were not considered as confounders were simultaneously removed from 
multivariate logistic regression analysis to determine the relative contributions of each variable to treatment 
adherence at a significance level of p < 0.05. 
 
Results 
 
Characteristics of study participants 
According to the database of the National TB Program in Timor Leste, between 1st January, 2013 and 1st 
September, 2013 there were 1160 patients, 18 years and older registered in six community health centres and 
three private clinics selected across three districts in Timor Leste. The majority of these patients were 
scattered across remote and difficult-to-reach areas that had no contact.  Of those registered in the National 
TB Program database, 29.9% (359) were eligible, but 1% (4) were too unwell to participate, 5% (1.4%) 
could not be contacted, 0.56% (2) were willing to participate but no translator could assist, 0.28% (1) was 
taking a trip to the countryside.  96.7% (347) patients were able to complete the questionnaire.  
 
From the 347 participants, 16.2% (56) who had a university/college education completed the questionnaire 
independently while closely supervised, and 83.8% (291) who had trouble reading the items for themselves 
received support from a research administrator. The participants’ demographic, behavioural and clinical 
characteristics are summarized in Table , indicating that 55% were male and the ages ranged from 18 to 84 
years (Mean: 38.76, ±17.14). Over 60% were married, almost one third of the sample had no formal 
education, and over 50% reported income or family financial support of less than USD$60 per month. More 
than half of the sample reported that they currently or previously drank alcohol and almost 50% reported 
current or previous cigarette smoking.  
 
Tuberculosis medication adherence  
The prevalence of a one-month, suboptimal adherence measured by the VAS was 39.6%, while the past 
month suboptimal adherence for MARS is 25.3%. The observed agreement of both measurements was 
69.4%, with a kappa coefficient of 0.323 (standard error=0.052, p<0.0001). This suggests that the majority of 
individuals were classified as either adherent or as non-adherent by the two measures, while 30.6% had a 
discordant classification (Table 2) 
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Factors associated with tuberculosis medication adherence 
Table 3 presents the results of the univariate and multivariate logistic regression analysis of the factors 
associated with tuberculosis medication adherence, measured by the VAS. 
 
The univariate analysis showed a significant association of adherence with low income or limited family 
financial support, alcohol consumption, quality of health service received, and caregivers to remind 
medication time, patients’ poor TB knowledge, psychological distress, the patients’ perception of stigma, use 
of traditional healers and external health locus of control.  
 
After controlling the socio-demographic variables, the risk factors that remained significantly associated with 
non-adherence in the multivariate logistic regression were quality of health service provided, low income or 
lack of family financial support, lack of a caregiver or people to remind the participants to take their 
medication, low treatment knowledge, use of a traditional healer, perceived stigmatization and external 
health locus of control.  
 
When the other variables were controlled for in the model, for every unit increase on the income scale, the 
odds of adherence was increased by 1.87 suggesting that financial support is directly associated with 
treatment adherence. Poor health service provision was significantly associated with non-adherence (OR = 
0.72; p < 0.05). Similarly, patients who lacked caregivers or people to remind them of their medication time 
were associated with non-adherence (OR = 0.70; p = 0.009).  
 
For every unit increase on the knowledge scale, the odds of adherence were multiplied by 1.35 indicating 
that better TB treatment knowledge is associated with optimal adherence. In contrast, for stigma, traditional 
healer and health locus of control, for every unit increase in each of these scales, the odds of being non-
adherent to treatment were multiplied by 0.91, 0.94 & 0.86, respectively.  
 
Factors associated with non-adherence listed by the participants 
There were 21 common factors listed by the participants as affecting adherence (see Table 4). Among the 
most common factors cited by over 70% of the participants simply forgot to take medication (72.4%), busy 
with other things (64.7%), away from home (50.3%), health service too far (33.6%) and had a change in 
daily routine (32.5%).  Furthermore, almost one in every three people cited to have no money for eating and 
health care seeking (28.3%). Illicit drug use was the least reported reason for suboptimal adherence (1.0%). 
 
Discussion 
The study using the VAS to measure adherence in the previous month found a suboptimal adherence of 
39.6%. In comparison with other studies, the percentage of non-adherence varies. A study conducted in 
Ndola, Zambia measured adherence of patients taking TB drugs daily for eight months and reported that 
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29.8% patients stopped taking TB drug at some point during the treatment [8]. In Kenya, a cross-sectional 
survey assessed adherence with numerous tools, in which VAS for patients missed medication in the past 
four days and found 7.5% of non-adherence [9]. In Jiangsu Province, China, a study measured adherence 
using a structured questionnaire, with a 90% cut-off point and found a 12.2% non-adherence rate [11]. 
According to the International Union Agent Tuberculosis Committee on Prophylaxis, the recommended cut-
off point for TB adherence is 80% [21]. These studies indicate lower percentages of non-adherence 
compared to the results of the current study may be due to the time reference such as adherence in the “past 
four days” rather than “the past month”, or perfect adherence to treatment regimens.  
 
The study conducted by Weiguo et al. [11] in Jingsu Province, China, recruited 780 sputum-smear positive 
patients in 13 counties (districts), and patients who missed 10% of their medication were deemed to be non-
adherent. The study found that financial burden was associated with medication non-adherence, despite the 
Chinese government's free TB service policy. Similarly, treatment provided by public health services in 
Timor-Leste is free of charge. In addition, the Timor-Leste National Stop TB Strategy Plan 2011-2015 also 
highlighted that poor patients and those living in remote areas are compensated for the indirect cost of TB 
treatment and food supplements where applicable [6]. However, the present study revealed that those who 
received support or had an income of less than  USD60 per month were associated with suboptimal 
adherence, which is consistent with Weiguo et al.’s finding in  China [11]. Therefore, the results of the 
current study and the study in China suggest that free treatment alone is not likely to improve treatment 
adherence, and implementation of the free-treatment policy warrants further research.  
 
Research on the association between quality of health service delivery and TB medication adherence is 
limited [25]. In Timor Leste, community-based TB services are responsible for the provision and training of 
peer educators to provide directly observed treatment short courses (DOTS) to patients. But some urban 
health services and private clinics have no community-based integrated TB program. This may be a reason 
that the quality of service provided contributes to the overall level of treatment adherence.   
 
A systematic review of qualitative research by Munro et al. [1] suggested that family and community support 
strongly influence treatment adherence. Several studies have confirmed types of support, such as financial, 
emotional, counselling, sharing of knowledge and reminder of medication time can be enabling factors 
associated with medication adherence [24, 33, 34]. However, an HIV/AIDS antiretroviral medication 
adherence study by Do et al. [19] did not find a significant relationship between medication adherence and 
support received among these individual groups. The present study’s results were consistent with Do et al.’s 
finding and suggested that family, friends and peer educators’ support were not strongly associated with 
treatment adherence.  
 
Several studies have described the impact of stigma on tuberculosis medication adherence [35-37]. A 
qualitative study in Nepal investigated the causes of stigma and discrimination associated with TB. The 
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study found that, if disclosure of treatment status caused supportive behaviour from others, it may be useful 
for increasing treatment adherence. However, disclosing the treatment status to family and friends may also 
facilitate further disclosure, which may result in patients feeling discriminated. In the Nepal study, although 
TB patients were reminded routinely by health workers that TB stops being infectious after two weeks of 
commencing treatment, self-discrimination remained high throughout the eight months of treatment [35].  
 
Additionally, some of the participants perceived that disclosure of information might cause the risks such as 
loss of business, loss of job, emotional injury and stigmatization from others [38]. This was confirmed in our 
study, where the perception of stigma by the participants was significantly associated with medication non-
adherence. Patients who encountered stigmatization had severe suffering, which in turn was likely to result in 
non-compliance [36]. Stigma could cause people to become socially isolated from family, health 
professionals and people outside their family to avoid becoming a subject of gossip [35]. Disclosure of 
treatment status to may gain social support or causing discrimination depends on the level of knowledge and 
understanding of those who receive the information.  
 
In addition to support received, the current study showed that participants who have people to remind them 
about the medication time are more likely to be adherent compared to those who did not have such support. 
This finding agrees with Weiguo et al.’s study in China, where the risk of non-adherence was lower among 
patients under direct observation by village doctors or receiving home visits by health workers [11].  
 
In relation to risky behaviours, a multi-level analysis of a nationally representative sample of the South 
African population conducted in Cape Town showed that cigarette smoking and alcohol consumption were 
significant predictors of TB risk factors [39], while a systematic review and meta-analysis conducted by 
Hsien-Ho Lin et al. [40] also found consistent evidence that tobacco smoking was associated with an 
increased risk of TB. Cigarette smoking may delay treatment completion, due to a deficiency in the function 
of the respiratory system [41]. However, cigarette smoking itself may not directly contribute to sub-optimal 
adherence, as confirmed by the current study which found no significant relationship between smoking and 
medication non-adherence.  
 
 An antiretroviral HIV/AIDS study investigating factors associated with optimal adherence of HIV patients 
in Vietnam found that alcohol use was significantly associated with medication non-adherence [19]. Alcohol 
was also frequently mentioned as an influencing factor in the context of TB treatment non-adherence by a 
study conducted in Russia [40]. The finding of the current study is consistent with both studies, suggesting 
that alcohol consumption is significantly associated with suboptimal adherence. Therefore, future 
interventions to identify and address patients with alcohol issue while under treatment is necessary for 
improving level of treatment adherence in Timor Leste.  
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Traditional healers in certain countries have much influence on tuberculosis treatment completion. It is 
reported that patients who prefer a traditional healer as an alternative source of treatment are likely to delay 
seeking early treatment [42]. A survey conducted across five districts (urban & rural) in Timor-Leste 
indicated that 14.5% of the total population cited traditional healers as some form of health facility and 
34.6% considered traditional healers as an option for health care [17]. The current study found that those 
who considered traditional healers as a form of treatment were less likely to adhere to medication regimens. 
In order to improve patients’ treatment adherence, it is crucial for the Ministry of Health in Timor-Leste to 
work collaboratively with the traditional healers. In addition, provision of general training and understanding 
in identifying and screening people with TB symptoms is important. Moreover, monitor traditional healers to 
independently refer patients and assist them with ongoing treatment would improve level of adherence and 
treatment completion [43].  
 
Many studies have showed general agreement that knowledge is likely to be an important factor to determine 
the successfulness of TB treatment [4, 15, 18, 33, 34, 44]. Our study found that patients' knowledge was 
positively significantly associated with adherence. Both quantitative and qualitative studies worldwide have 
shown that improved levels of knowledge are likely to reduce stigma and negative attitudes towards 
treatment. Additionally, those who have accurate knowledge and understanding of the treatment process are 
less likely to have treatment interruptions and not considering untested treatment such as a traditional healer 
[4, 16, 33, 34, 44]. Often, sick patients are cared for by their family members, community health volunteers 
and health care professionals, and it has been reported in a case with HIV/AIDS in other settings that such 
care can cause the experience of stigma [45]. An important key aspect to be addressed is to educate those 
caring for patients, especially with their knowledge about the disease, and the appropriate language used to 
communicate to patients during their daily interactions [46]. Because many TB patients reside in remote 
areas of the country in Timor Leste, Kidd and Clay [46] suggested that improved education can help 
empowering community members, especially patients’ family members who could benefit patients with their 
treatment. Thus, educating different groups of people who are involved directly in patients’ TB treatment 
could also directly influence the success of treatment completion.  
 
Adherence research generally finds that psychological distress affects compliance with the TB medication 
regimen [24]. This study confirmed that psychological distress was significantly associated with TB 
medication non-adherence. One of the psychological factors investigated in our study was the dimensional 
health locus of control that assessed the belief that chance or luck significantly influenced one's destiny, 
including the outcome of an individual's health. After adjusting for demographic variables, the multivariate 
analysis indicated that chance health locus of control remained a significant predictor of TB medication 
adherence, where participants who believed in chance, luck or powerful control by others were less likely to 
be adherent. This finding is useful to guide health professionals in Timor-Leste to discuss fatalistic beliefs as 
barriers to self-care and healthy behaviours.  
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Conclusion 
This study provides much needed evidence on TB treatment adherence in a developing country and of the 
specific enabling and impeding factors direct or inderectly influencing the TB overall treatment. Participants 
were from diverse health services include private, public, rural and urban health settings in Timor Leste.. 
Factors impeding treatment adherence in Timor-Leste include poor health services received, preference for 
traditional healers as alternative theraphists, an external health locus of control, and percieved stigma of the 
patients or from the community. Enabling factors include patients accurate knowledge on TB treatment, the 
availability of caregivers to remind patients of their medication time and satisfactory income or adequate 
family financial support. The findings of this study could be used as scientific evidence for the Ministry of 
Health of Timor-Leste to implement more effective TB intervention program to optimize the level of 
treatment adherence. The findings may also provide a helpful guide for decision makers in other countries 
with similar settings. 
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Table 1 Participant’s socio-demographics, behaviours and clinical characteristics (N=347) 
 
 
 
Socio-demographic 
characteristics 
n %  Behaviour and clinical characteristics n % 
Gender (male) 191 55  Alcohol use (last month)   
Age (Mean: 38.76±17.14)         Never drink 147 42.6 
     18-29 138 39.8       Used to drink 154 44.6 
     30-49 89 25.7       Currently drinking 44 12.7 
     50+ 120 34.6  Cigarette smoking status (last month)   
Marital status         Never smoke 179 51.7 
     Unmarried 134 38.7       Used to smoke 155 44.8 
     Married 212 61.3       Currently smoking 12 3.5 
Education     Illicit drug use   
     No formal education 97 28       Never 337 98.8 
     Primary school 92 26.6       Yes, in the past 4 1.2 
     Secondary/high school 101 29.2  Health Services   
     College/University  56 16.2        Public health services with CBTC 34 9.8 
Wages/family support           Private clinics 134 38.6 
     <60USD/month 193 55.6        Public health services  69 19.9 
     >60USD/month  154 44.4        Home visit patients 110 31.7 
    Time to nearest health service   
         Less than 30 minutes 197 58.6 
         More than 30 minutes 139 40.4 
CBTC, Community Based TB Care Program   
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Table 2 Agreement between two measures of TB medication adherence 
 
 
 
 
 
 
 
 
 
 
 
  MARS Score1  
  Non-adherence Adherence Total 
VAS Score 2 
Non-adherence 58(17.6%) 75(22.7%) 133(40.3%) 
Adherence 26(7.9%) 171(51.8%) 197(59.7%) 
Total  84(25.5%) 246(74.5%) 330(100%) 
 Non-adherence 58(17.6%) 75(22.7%) 133(40.3%) 
Adherence 26(7.9%) 171(51.8%) 197(59.7%)  
Total 84(25.5%) 246(74.5%) 330(100%)  
1MARS, Medication Adherence Rating Scale, 2VAS, Visual Analogue Scale.  
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Table 3 Factors associated with TB medication adherence measured by Visual Analogue Scale 
(n=347) 
   Univariate Multivariate 
Factors 
Optimal 
adherence 
frequency 
(%) 
Suboptimal 
adherence 
frequency 
(%) 
Unadjusted OR 
(95%CI) 
p 
value 
Adjusted OR 
(95%CI 
p 
value 
Socio-demographic factors       
 Gender       
      Male 110(59.8) 74(40.2) 1  1  
      Female 94(61.0) 60(39.0) 1.05(0.68-1.03) 0.814 1.10(0.60-1.98) 0.778 
 Age        
      18-29 82(60.3) 54(39.7) 1  1  
      30-49 53(60.2) 35(39.8) 0.99(0.58-1.73) 0.992 1.10(0.48-2.21) 0.805 
      50+ 69(60.5) 45(39.5) 1.01(0.61-1.68) 0.970 1.09(0.39-3.04) 0.871 
 Marital status       
      Single 63(53.8) 54(46.2) 1  1  
      Married 139(63.5) 80(36.5) 1.45(0.94-2.35) 0.087 1.84(0.81-4.15) 0.143 
 Education       
      No formal education 63(66.3) 32(33.7) 1  1  
      Primary school 49(55.7) 39(44.3) 0.64(0.35-1.16) 0.141 1.32(0.55-3.15) 0.538 
      Secondary/high school 57(58.2) 41(41.8) 0.71(0.39-1.28) 0.244 0.91(0.31-2.64) 0.854 
      College/University  34(60.7) 22(39.3) 0.78(0.40-1.56) 0.488 1.63(0.48-5.47) 0.431 
 Income/family support       
      <60USD/month 94(49.5) 96(50.5) 1  1  
       >60USD/month 110(74.3) 38(25.7) 2.96(1.86-4.71) <0.001 1.87(1.01-3.47) 0.048 
Behavioural factor       
 Alcohol use (last month)       
      Never drink 92(64.3) 51(35.7) 1  1  
      Used to drink 97(64.7) 53(35.3) 1.02(0.63-1.64) 0.953 1.01(0.51-2.33) 0.975 
      Currently drinking 13(13.2) 30(69.8) 0.24(0.12-0.50) <0.001 0.41(0.15-1.12) 0.083 
 
    Tobacco use (last 
month)ϴ 
      
      Non-smoker 107(61.8) 66(38.2)     
      Ever smoke 81(59.1) 56(39.4) 0.89(0.56-1.41) 0.626 -  
 Illicit drug use       
      Never 197(60.1) 131(39.9) 1    
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      Yes, in the past 2(50.0) 2(50.0s) 0.67(0.09-4.78) 0.685 -  
        
 
Mean of 
optimal 
adherent 
(n=204) 
Mean of 
subopti
mal 
adherent 
(n=134) 
Univariate analysis Multivariate analysis 
Unadjusted OR 
(95%CI) 
p value 
Adjusted OR 
(95%CI) 
p 
value 
Psychological distress 25.70 28.52 0.96(0.93-0.98) 0.003 0.99(0.95-1.04) 0.815 
Health Locus Control 28.13 30.26 0.83(0.78-0.89) <0.001 0.86(0.79-0.93) <0.001 
Perceived stigma 7.49 8.74 0.88(0.82-0.95) 0.001 0.91(0.83-1.00) 0.049 
Traditional healer 3.36 6.08 0.93(0.90-0.98) <0.001 0.94(0.90-0.98) 0.006 
Patient’s TB knowledge 5.94 5.50 1.34(0.10-1.64) 0.004 1.35(1.05-1.72) 0.018 
HP-patient communication 22.91 23.41 0.96(0.91-1.02) 0.223 - - 
Service provider 2.66 2.89 0.79(0.63-0.99) 0.037 0.72(0.54-0.95) 0.021 
Disclosure of treatment 12.61 12.72 0.98(0.91-1.07) 0.726 - - 
People remind medication 
time 
0.88 1.48 0.60(0.49-0.74) <0.001 0.70(0.54-0.92) 0.009 
Family support 12.73 12.45 1.03(0.96-1.11) 0.415 - - 
Friend support 8.79 9.30 0.95(0.88-1.02) 0.144 - - 
Neighbour support 8.37 8.70 0.96(0.89-1.04) 0.963 - - 
Peer educator support 9.60 9.52 1.01(0.94-1.08) 0.809 - - 
Social organization support 5.22 5.41 0.95(0.86-1.06) 0.402 - - 
ϴ currently smoking and used to smoke were combined due to small cell sizes 
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Table 4 Suboptimal adherent factors listed by patients 
 
Items 
Responses 
n % 
Simply forgot 207 72.4 
Felt good 83 29.0 
were away from home 144 50.3 
Had too many pills to take 27 9.4 
Wanted to avoid side effect 33 11.5 
Clinic is too far 96 33.6 
Had a change in daily routine 93 32.5 
Felt like the drug was toxic/harmful 49 17.1 
Felt asleep/slept through dose time 64 22.4 
Felt sick 31 10.8 
Felt depressed/overwhelmed 24 8.4 
Had problems taking pills at specific times 58 20.3 
Health clinic did not give pills to me 18 6.3 
Were busy with other things 185 64.7 
Use drugs 3 1.0 
Drink alcohol 14 4.9 
Took them, then get nausea, but did not take the replacement 54 18.9 
Don't have money for eating and health care seeking 81 28.3 
Ran out of pills but could not go to the clinic to get them 86 30.1% 
Did not want others to notice you taking medication 36 12.6% 
Don't believe in the usefulness of the drug 14 4.9% 
 
 
